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Abstract 
Duplication  of  the  proteolipid  protein  (PLP1)  gene,  which  encodes  the  most 
abundant protein of central nervous system (CNS) myelin, is the most common 
cause of Pelizaeus Merzbacher disease (PMD). Various animal models have been 
generated to study the effect of Plp1 gene overexpression on oligodendrocyte 
and myelin sheath integrity. The #72 line harbours 3 additional copies of the 
murine Plp1 gene per haploidic chromosomal set. Homozygous #72 mice appear 
phenotypically  normal  until  three  months  of  age,  after  which  they  develop 
seizures leading to premature death at around 4 months of age. An earlier study 
examining the optic nerve showed a progressive demyelination accompanied by 
marked  microglial  and  astrocytic  responses.  Using  electron  microscopy  and 
immunohistochemistry, I demonstrated that initial myelination of the #72 corpus 
callosum was followed by a progressive demyelination, probably mediated by a 
distal “dying back” phenomenon of the myelin sheath. No evidence of effective 
remyelination  was  observed  despite  the  presence  and  proliferation  of 
oligodendrocyte  progenitor  cells  (OPCs).  A  marked  increase  in  density  and 
reactivity  of  microglia/macrophages  and  astrocytes,  and  the  occurrence  of 
axonal swellings, accompanied the demyelination. In situ and in vitro evaluation 
of  adult  #72  OPCs  provided  evidence  of  impaired  OPC  differentiation. 
Transplantation  of  neurospheres  (NS)  into  adult  #72  mouse  corpus  callosum 
confirmed that axons were capable of undergoing remyelination. Furthermore, 
NS transplanted into neonatal CNS integrated into the parenchyma and survived 
up to 120 days, demonstrating the potential of early cell replacement therapy. 
Taking advantage of the spatially distinct pathologies between the retinal and 
chiasmal region of the #72 optic nerve, I evaluated the capability of diffusion 
weighted MRI to identify lesion type. I found significant differences between #72 
and wild type optic nerves, as well as between the two distinct pathological 
regions within the #72 optic nerve. These results confirm the potential of the 
#72 mouse to serve as a model to study chronic demyelination. The study also 
demonstrates the utility of the #72 mouse to evaluate cell transplant strategies 
for the treatment of chronic CNS white matter lesions and PMD. Additionally, DW 
MRI  has  potential  as  a  modality  capable  of  diagnosing  myelin-related  white 
matter changes, and may be applicable to the clinical setting. iii 
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1  Introduction 
 
1.1  Background 
 
Central  nervous  system  (CNS)  myelin  is  a  lipid  rich  structure  synthesised  by 
oligodendrocytes  and  wrapped  around  axons  in  order  to  reduce  transfibre 
capacitance  and  enable  saltatory  conduction  of  the  electrical  potential.  This 
results in a much higher speed of electrical impulse transmission in myelinated 
compared to non myelinated axons (Frankenhaeuser, 1952). The importance of 
myelin is illustrated by the devastating consequences of diseases that affect it. 
The genetic developmental disorders of myelin, such as the leukodystrophies, 
are progressive and invariably untreatable debilitating diseases (reviewed in Biffi 
et  al.,  2011;Schiffmann  and  Boespflug-Tanguy,  2001;Schiffmann  and  van  der 
Knaap, 2004). Pelizaeus-Merzbacher disease (PMD), as a specific example of a 
leukodystrophy,  is  caused  by  a  mutation  in  the  PLP1  gene  and  spans  a  wide 
spectrum  of  clinical  severity,  ranging  from  severe,  connatal  forms  which  are 
incompatible with life, to relatively mild forms with a late onset and a normal 
life expectancy (reviewed in (Seitelberger, 1995;Yool et al., 2000;Hudson et al., 
2004). In the severe connatal form of PMD there is a failure to form normal 
myelin (dysmyelination), whereas in classical PMD there is a failure to maintain 
myelin (demyelination). 
 
Multiple  sclerosis  (MS),  the  archetypical  demyelinating  disease,  is  relatively 
common, especially among Caucasians (reviewed in  Noseworthy et al., 2000). 
Progressive  demyelination  leads  to  chronic  disability  and,  in  some  cases,  to 
premature  death.  In  general,  changes  in  myelin  affect  the  myelin  sheath 
integrity  and  lead  to  neurological  dysfunction  including  motor  dysfunction, 
cognitive dysfunction, seizures, mental health impairment and death, depending 
on the extent of, and the CNS region affected by, the demyelination. 
 
In MS the histopathological changes are not only restricted to the myelin sheath 
but  also  involve  the  axon.  Axonal  changes  may  occur  concomitant  with 
inflammatory  demyelination  or  later,  possibly  as  a  consequence  of  chronic 2 
demyelination (Bjartmar et al., 2003;Bjartmar and Trapp, 2003;Dutta and Trapp, 
2011).  Axonal  changes  may  even  occur  in  some  primarily  dysmyelinating 
disorders  without  demyelination  (Edgar  et  al.,  2004b;Griffiths  et  al.,  1998; 
reviewed  in  Edgar  and  Garbern,  2004;Nave,  2010a;Nave,  2010b).  The 
involvement  of  the  axon  in  disorders  primarily  affecting  the  myelin  sheath 
highlights  the  importance  of  a  normal  functioning  axonal-glial  interaction  in 
order  to  maintain  axonal  integrity  (reviewed  in  Nave,  2010a;Nave, 
2010b;Gruenenfelder et al., 2011). 
 
Remarkable progress has been made in the diagnosis and monitoring of myelin 
disorders following the development of magnetic resonance imaging (MRI). The 
non-invasive  nature,  superior  soft  tissue  resolution  and  high  sensitivity  for 
detecting  pathological  changes  in  soft  tissues,  compared  to  other  imaging 
modalities,  makes MRI a useful tool to investigate white matter changes and 
progression in vivo (reviewed in Ciumas et al., 2008). However the specificity for 
determining the lesion type is not high with standard MRI sequences and it is 
currently not possible to distinguish between acute and chronic demyelination 
(Bitsch  et  al.,  2001).  Diffusion  tensor  imaging  (DTI),  which  measures  the 
directionality of water diffusion in tissue, is influenced by tissue ultrastructure 
and allows detection of microstructural changes in white matter tracts. If acute 
inflammatory  demyelination  could  be  distinguished  from  chronic  silent 
demyelination,  it  would  provide  the  research  and  clinical  community  with 
invaluable information about disease development and therapy response. Only 
recently a study by (Xie et al., 2010) has attempted to investigate if DTI detects 
differences between active demyelination with inflammation and chronic silent 
demyelination, the two hallmarks of MS lesions. 
 
1.2  The central nervous system (CNS) 
 
The white and grey matter of the CNS differs substantially in cell architecture 
and function. Astroglia, oligodendroglia, oligodendroglial precursor cells (OPCs) 
and  microglia  are  distributed  throughout  the  grey  and  white  matter,  while 
neuronal cell bodies with dendrites are predominantly located in the grey matter 
and axons are largely arranged in parallel bundles in the white matter. In the 3 
brain, the grey matter is macroscopically identified as the cortex or, in deeper 
structures,  as nuclei. The white matter is macroscopically present below the 
cortex or in between the nuclei. 
 
A magnitude of precisely timed neuronal-neuronal interactions are necessary for 
normal  function  of  the  CNS.  To  maintain  the  demand  for  fast  and  precise 
communication  between  neurons,  highly  organised  and  rapid  propagation  of 
electrical signals along axons is crucial. The rate of propagation of the electrical 
potential  is  dependent  on  both  axonal  diameter  and  myelination  status.  The 
larger the axonal diameter, the lower its resistance, and the faster electrical 
impulses  are  propagated.  The  evolution  of  myelin  serves  to  maximise  fast 
conduction of electrical impulses while minimising the amount of space, which is 
required to contain the millions of nerve fibres that constitute the vertebrate 
CNS (Rushton, 1951). With myelination of axons, the necessity for large axonal 
diameters to enable fast electrical potential transmission is overcome. Saltatory 
conduction is also highly energy efficient, since action potentials need only be 
generated at the node of Ranvier, and not constitutively as in non myelinated 
nerves (reviewed in Rosenbluth et al., 1994). 
 
1.2.1 The neuron 
 
The neuron consists of the cell body, dendrites and one or more axons.  The 
neuronal cell body processes signal inputs and generates the electrical potential 
at the level of the axonal hillock for signal output. The dendrites conduct inputs 
to the neuronal cell body and the axons conduct outputs from the cell body to 
other neurons or (in the peripheral nervous system [PNS]) effecter organs. Most 
of  the  neurons  in  the  CNS  are  multipolar;  in  which  multiple  dendrites  and 
multiple axons are present in one neuron. Communication between neurons is 
mediated  at  synapses,  a  specialised  region  where  the  electrical  signal  is 
converted into a chemical signal, affecting the post synaptic/effector neuron. 
The chemical signal binds to receptors on the postsynaptic membrane, which 
then produce either an excitatory or inhibitory signal in the target neuron. In 
some cases direct transmission of the electrical signal between the neurons can 
occur (Blumenfeld, 2002). 4 
1.2.2 The axon 
 
The axon is the long extension of the neuronal cell body that allows information 
to be transferred over long distances. Axons of projection neurons can extend 
for up to several feet. Axonal diameter varies between axons, with the average 
diameter in the CNS being around 1µm. In general,  the diameter is constant 
along the entire axon (Friede and Samorajski, 1970), except at nodal regions. 
The electrical compound potential generated at the axonal hillock is conducted 
along the axon to the presynaptic membrane (reviewed in  Hildebrand et al., 
1993; Blumenfeld, 2002). Most CNS axons have a diameter larger than 0.2µm and 
are myelinated (reviewed in Hildebrand et al., 1993). 
 
The axolemma, or axonal membrane is a lipid bilayer and maintains the resting 
potential of the axon (reviewed in Hildebrand et al., 1993). The molecules in the 
axolemma are also responsible for action potential generation and propagation. 
In the myelinated axon there is an accumulation of electron microscopy (EM) 
dense structures in the axolemma of the axonal hillock and at the level of the 
node of Ranvier, which are related to ion channels  (Rosenbluth, 2009). Actin 
filaments  located  beneath  provide  support  to  the  axolemma.  In  the  cytosol, 
there is a dense network of neurofilaments and microtubules (Amos and Amos, 
1987). The neurofilaments, which are 10 nm thick unbranched fibres, give the 
axon  structure  and  stability  (Brady  et  al.,  1999).  Neurofilaments  become 
phosphorylated  during  the  myelination  process  and  this  increases  filament 
spacing, concomitantly increasing axonal diameter. Microtubules are 25nm thick 
unbranched tubes, consisting of heterodimers of α – and β tubulin (Brady et al., 
1999). Microtubules are utilised by molecular motor proteins for the anterograde 
and retrograde transport of organelles. This is an important transport mechanism 
since most of the transcriptional entities of the neuron are located in the cell 
body or synapses. The axons itself is dependent on the synthesis and transport of 
cellular  products  from  the  cell  body.  In  the  cytosol,  mitochondria  are  found 
along  the  entire  axon  and  are  also  transported  in  both  directions  on  the 
microtubular system to supply the axon with adenosine triphosphate (ATP). 
 5 
1.2.3 The oligodendrocyte 
 
The oligodendrocyte is a multiprocess–bearing cell that forms the CNS myelin 
sheath. Oligodendrocytes  are located in the grey and white matter, with the 
highest density in the white matter ranging between 350 – 1000/mm
2, depending 
on  the  white  matter  tract  and  the  thickness  of  the  tissue  section  in  which 
density  is  measured  (see  Chapter  5  and  Al-Saktawi  et  al.,  2003).  The 
oligodendrocyte is metabolically highly active during myelination, and a single 
oligodendrocyte can synthesise up to 50,000µm
2 of membrane per day (reviewed 
in Pfeiffer et al., 1993). One single oligodendrocyte can produce and maintain 
up to 60 individual myelin sheaths (reviewed in Hildebrand et al., 1993). The 
advantage  of  myelination  is  clear  (see  above).  The  disadvantage  is  the 
vulnerability of the complex myelin sheath to injury (reviewed in Hildebrand et 
al., 1993).  
 
1.2.4 The myelin sheath and its adjacent structures 
 
The  myelin  sheath is  not a continuous  structure and  multiple myelin  sheaths 
align along one axon. Individual oligodendrocyte processes wrap multiple times 
around an axonal segment; in some cases up to 160 times (Hildebrand et al., 
1993),  to  form  the  compact  myelin  sheath.  The  lateral  and  longitudinal 
dimensions  of  the  myelin  sheath  segment  are  directly  coupled  to  the  axon 
diameter. In general this results in a ratio between axon diameter and fibre 
diameter  (G-ratio)  of  approximately  0.6;  the  optimal  ratio  for  maximal 
conduction velocity (Hildebrand and Hahn, 1978). Between each myelin sheath 
segment  there  is  a  gap  of  0.8  –  0.9µm,  which  is  referred  to  as  the  node  of 
Ranvier (Hildebrand and Waxman, 1984). There are four distinct regions which 
can  be  distinguished  along  a  myelinated  axonal  segment:  the  internodal 
segment, the node or Ranvier, the paranode and the juxtaparanode. 
 
The internodal segment is the unit between the lateral edges of each myelin 
sheath. The length of an internodal segment varies in the CNS but increases in 
general with larger diameters and ranges between 100 to 1700µm (Hildebrand et 
al., 1993).  6 
The node of Ranvier, which is not covered by the myelin sheath, contains various 
voltage  gated  sodium  channels.  The  node  is  mainly  responsible  for  the 
generation of the action potential for the saltatory conduction but also interact 
with oligodendrocytes and OPCs (reviewed in Salzer, 2003). 
 
The paranode, which is adjacent to the node, constitutes of non-compact myelin 
loops, which interact with the axolemma. The axolemmal cis complex, which is 
composed of caspr and contactin, interacts with the glial expressed NF155 and is 
believed to regulate junction development and stabilisation (reviewed in Salzer, 
2003;Nave, 2010a). The interaction between caspr/contactin and NF155 is also 
believed to influence axon-glial communication (reviewed in Salzer, 2003;Nave, 
2010a).  
 
The juxtaparanode mainly harbours voltage gated Kv 1.1/1.2 potassium channels 
and Caspr2 expressed on the axolemma. The glial expressed Tag-1 protein forms 
a cis complex with Caspr2.  The function of the juxtaparanode is believed to 
prevent hyperexcitation and backfiring of action potentials (reviewed in Salzer, 
2003;Nave, 2010a). 
 
1.2.4.1 Myelin ultrastructure 
 
The concentric layers of the oligodendrocyte process as it wraps around the axon 
gives myelin an ordered structure. Between the cytoplasmic surfaces of each 
wrap, the major dense line forms when cytoplasm is extruded and the myelin 
sheath compacts.  Between the extracellular surfaces of consecutive wraps of 
compact myelin lies a 2 nm thick space, called the intraperiod line or space. The 
distance  between  two  adjacent  major  dense  lines  is  defined  as  one  myelin 
period and, in CNS tissue processed for EM, measures 15.65nm (Agrawal et al., 
2009;Hildebrand et al., 1993;Edgar and Griffiths, 2009). The outermost rim of 
the oligodendrocyte process is a cytoplasm-filled channel that forms the inner 
and  outer  tongues  and  the  paranodal  loops  of  each  myelin  sheath  segment. 
Together, these constitute non-compact myelin.  At the paranode,  the myelin 
sheath is attached by transverse bands to the axolemma (reviewed in Edgar and 
Griffiths,  2009).  Finally,  the  radial  component  which  appears  as  a  dense 7 
thickening in consecutive intraperiod lines in electron micrographs, spans the 
whole  or  part  of  the  compact  myelin,  and  represents  the  tight  junctions 
(Hildebrand and Mohseni, 2005;Kosaras and Kirschner, 1990). 
 
1.2.4.2 Biochemical composition of myelin 
 
Biochemical  and  histochemical  analysis  of  the  myelin  sheath  have  identified 
multiple proteins and lipids. Proteins account for about 30% of the myelin dry 
mass.  The most abundant protein is proteolipid protein (PLP)  and its isoform 
DM20, followed by myelin basic protein (MBP). Less abundant proteins include 
myelin associated oligodendrocytic basic protein (MOBP), 2’-3’-cyclic nucleotide-
3’-phosphodiesterase (CNP), myelin associated glycoprotein (MAG) and Claudin 
11. Small amounts of myelin/oligodendrocyte protein (MOG) and oligodendrocyte 
myelin glycoprotein (OMpg) are also present. Recently a large number of myelin 
proteins were identified using mass spectrometry (Jahn et al., 2009). 
 
Lipids account for approximately 70% of the dry mass of myelin (Norton, 1984). 
Four main classes are histochemically identifiable including galactosphingolipids 
(cerebrosides  and  their  sulphated  derivates,  sulfatides);  sterols,  mainly 
cholesterol;  phospholipids;  and  plasmalogens  (Bosio et al.,  1998;Saher et al., 
2011). 
 
1.2.4.2.1  Myelin Proteins 
 
1.2.4.2.1.1  Proteolipid Protein/DM20 (PLP/DM20) 
 
PLP  and  its  isoform  DM20  is  the  major  myelin  protein  in  the  CNS.  Recent 
proteomics studies suggest that together, PLP/DM20 account for around 17% of 
all  myelin  protein  (Jahn  et  al.,  2009).  PLP  and  DM20  are  predicted  to  be 
tetraspan proteins. DM20 differs from PLP in that it lacks 35 amino acids in the 
second intracellular loop. Prior to myelination, DM20 is the predominant isoform 
in the CNS. Once myelination is initiated, PLP becomes the predominant form. 
The role of PLP/DM20 in CNS myelin is still not fully understood, but it has been 8 
shown to be important for formation and maintenance of the intraperiod line of 
compact  CNS  myelin  (Klugmann  et  al.,  1997)  and  for  the  transport  of  other 
proteins  into  compact  myelin  (Werner  et  al.,  2007).  More  detail  about  the 
proteolipid  protein  gene  structure  and  function  are  found  in  1.5.2.1  The 
proteolipid protein gene in the CNS: normal structure, function and the role in 
the aetiology of Pelizaeus-Merzbacher disease. 
 
1.2.4.2.1.2  Myelin basic protein (MBP) 
 
MBP is the second most abundant myelin protein. Its relative contribution to the 
total  myelin  protein  content  is  about  8%  (Jahn  et  al.,  2009).  MBP  is  a 
cytoplasmic protein mainly located in the major dense line. There are at least 
five  isoforms  which  become  upregulated  during  myelination  (reviewed  in 
Campagnoni and Skoff, 2001). It has been demonstrated that the Mbp gene is 
part of a larger gene complex, the gene of oligodendrocyte lineage (Golli-Mbp 
gene). GOLLI-MBP proteins are only expressed at a low level in the CNS. However 
GOLLI-MBP products have been found in T-cells and macrophages in the thymus 
and are believed to play a role in the induction of experimental autoimmune 
encephalitis (EAE) (reviewed in (Campagnoni and Skoff, 2001). In the CNS, MBP is 
responsible  for  the  fusion  of  the  two  cytoplasmic  myelin  sheath  membrane 
surfaces,  forming  the  major  dense  line.  MBP  has  also  been  demonstrated  to 
stabilise microtubules in differentiating oligodendrocytes (Galiano et al., 2006). 
Lack of MBP function in the naturally occurring shiverer mutant mouse and the 
Long Evans shaker rat (O'connor et al., 1999;Readhead and Hood, 1990) causes 
severe hypomyelination of the CNS. 
 
1.2.4.2.1.3  Claudin 11/OSP 
 
Claudin 11 also referred to oligodendrocyte specific protein (OSP) is the third 
most abundant myelin protein and accounts for about 7% of the total myelin 
proteins (Bronstein et al., 1997). It is a tetraspan protein and its structure is 
similar to PLP/DM20.  Claudin11 is located between the extracellular surfaces 
and is detectable as the radial component of the CNS myelin. It is believed that 9 
Claudin11 forms tight junctions and is thought to play a structural role in myelin 
formation and maintenance  (Gow et al., 1999). However, Claudin11 deficient 
mice,  like  PLP/DM20  null  mice,  morphologically  develop  a  relatively  normal 
myelin  sheath.  However,  Claudin11*PLP/DM20  double  knockout  mice  have  a 
severe  deficiency  in  myelin  compaction  leading  to  neurological  deficits, 
suggesting  an  interaction  between  PLP/DM20  and  Claudin11  for  myelin 
compaction (Chow et al., 2005). 
 
1.2.4.2.1.4  2’-3’-cyclic nucleotide-3’-phosphodiesterase (CNP) 
 
CNP constitutes about 4% of total myelin protein (Jahn et al., 2009). CNP is an 
enzyme  which  is  expressed  in  oligodendrocytes  from  very  early  in  the 
myelination  process.  CNP  is  located  in  the  non-compact  myelin,  such  as  the 
inner and outer tongue, the paranodal loops and, in the PNS, in the Schmitt-
Lantermann incisures. However the substrate of CNP has not been found in the 
CNS and the function of CNP in oligodendrocytes is not clear. Overexpression of 
CNP impairs distal oligodendrocyte process extension (Gravel et al., 1996). CNP 
can bind to RNA and suppress translation, indicating that it may be involved in 
trafficking RNA to the distal oligodendrocyte process (Gravel et al., 2009). Cnp1 
null mice form almost completely normal myelin except for swelling of the inner 
tongue  process  of  some  oligodendrocytes,  but  develop  an  early-onset 
axonopathy (Edgar et al., 2009 and Lappe-Siefke et al., 2003). 
1.2.4.2.1.5  Myelin associated glycoprotein (MAG) 
 
MAG accounts for approximately 1% of total myelin protein (reviewed in Schnaar 
and Lopez, 2009). MAG is a transmembranous glycosylated protein located in the 
periaxonal membrane of the oligodendrocyte. MAG is believed to interact with 
the axon through gangliosides and through the Nogo and p75 receptor on the 
axolemma. The main function of MAG seems to be in the support of the axono-
glial  stabilisation  and  mediates  neurofilament  phosphorylation  (reviewed  in 
(Schnaar and Lopez, 2009). Although MAG is not essential for myelination, a late 
onset axonopathy has been observed in MAG deficient mice  (Fruttiger et al., 
1995). Recently MAG was shown to play a role in the molecular organisation of 10 
the node of Ranvier (Marcus et al., 2002). It also inhibits axonal growth after 
injury  (McKerracher  et  al.,  1994).  However  the  role  of  MAG  in  axonal 
regeneration is not fully understood (reviewed in Schnaar and Lopez, 2009). 
 
1.2.4.2.2  Myelin lipids 
 
Of the four main classes of myelin lipids, galactocerebrosides and cholesterol, 
have been the focus of in depth investigation and will be briefly presented. 
 
1.2.4.2.2.1  Cerebrosides and sulfatides 
 
Twenty seven percent of myelin lipids  originate from the galactocerebrosides 
and  their  sulphated  derivatives,  the  sulfatides  (Norton  and  Cammer,  1984). 
Galactocerebrosides  (GalC)  are  expressed  from  the  early  stages  of 
oligodendrocyte  development  (reviewed in  Pfeiffer  et  al.,  1993).  It  has  been 
shown  that  application  of  antibodies  against  (GalC)  results  in  a  Ca
++  influx 
mediated  re-arrangement  of  microtubules  in  oligodendrocytes  (Dyer  and 
Benjamins, 1988;Dyer and Benjamins, 1990) and inhibit the myelination process 
in vitro and in vivo (Fry et al., 1974;Rosenbluth et al., 1994). Mouse models 
lacking GalC showed that myelin formation takes place without GalC, but the 
myelin has impaired insulation properties and lacks long term stability (Coetzee 
et al., 1996). 
 
1.2.4.2.2.2  Cholesterol 
 
Cholesterol is an important structural lipid in the cell membrane of vertebrates. 
It contributes to the semi-permeability of cell membranes and influences cell 
membrane fluidity (Ikonen, 2008). In myelin, cholesterol constitutes about 28% 
of the lipid content and it is locally synthesised in oligodendrocytes (Morell and 
Jurevics,  1996;Saher  et  al.,  2005).  Mice  deficient  in  cholesterol  synthesis  in 
oligodendrocytes  manifest  hypomyelination  of  the  CNS  during  post-natal 
development,  leading  to  tremor,  ataxia  and  in  some  cases  premature  death. 
However,  in  surviving  animals,  the  phenotype  stabilises  with  age  and 11 
myelination returns to more normal levels. The recovery is related to the supply 
of cholesterol by astrocytes (Saher et al., 2005). Recently the role of cholesterol 
in lipid raft formation and its interaction with myelin proteins such as PLP has 
initiated an increased interest in the role of cholesterol in myelin. Lipid rafts are 
highly  motile  regions  in  the  cell  membrane  that  are  believed  to  function  as 
platforms  for  protein  interaction and  signal  transduction  (Simons  and  Ikonen, 
1997). These rafts have also been shown to associate with PLP integration into 
the membrane (Simons et al., 2000). On the other hand, overexpression of the 
Plp1 gene results in a sequestration of cholesterol to endosomes/lysosomes and 
autophagosomes inducing storage disease-like changes (Saher et al., 2011;Simons 
et al., 2002;Karim et al., 2010). 
 
1.2.5 The oligodendrocyte precursor cell 
 
OPCs represent the undifferentiated multipotent cell pool, which develop into 
myelinating cells during post natal development (Kessaris et al., 2006).  In adult 
CNS,  OPCs  are  the  cells  that  differentiate  into  new  myelin  sheath  forming 
oligodendrocytes  after  demyelination  (2006;Zawadzka  et  al.,  2010).  OPCs  are 
dispersed over the entire CNS and constitute, in the rat, approximately 8 - 9% of 
the glial cell population in white matter and approximately 2 – 3% of the glial 
cells in grey matter (Dawson et al., 2003). OPCs derive from different regions in 
the  developing  CNS.  In  the  spinal  cord  they  originate  from  the  ventral 
neuroepithelial  tube  and  migrate  from  there  into  other  spinal  cord  areas.  A 
recent study showed that the situation in the forebrain is different. Here OPCs 
populate  the  forebrain  in  waves.  The  first  wave  originates  from  the  medial 
ganglionic  eminence  and  the  anterior  entopeduncular  area,  the  second  wave 
originates from lateral and caudal ganglionic eminence and the third wave from 
the postnatal neocortex. Only the OPCs originating from the second and third 
wave persist and supply the region with myelinating oligodendrocytes (Kessaris 
et al., 2006).  
 
The  morphology  of  OPCs  in  the  CNS  differs  during  post  natal  maturation.  In 
vitro,  at  an  early  stage  of  development,  the  cells  appear  bipolar  and  are 
identified by the expression of A2B5 and PDGFRα. In the adult in vivo, OPCs are 12 
cells  with  multiple  processes,  which  express  PDGFRα  and  the  chondroitin 
sulphate  proteoglycan  NG2.  At  this  stage  the  OPCs  are  multipotent  and  can 
develop either into oligodendrocytes, astrocytes or neurons (reviewed in Levine 
et al., 2001;Miron et al., 2011). During myelination OPCs exit the cell cycle and 
differentiate  into  oligodendrocytes  (Miller,  2002).  In  adults  after  chemically 
induced demyelination, OPCs proliferate, repopulate the demyelinated area and 
differentiate  into  myelin  forming  oligodendrocytes  (Zawadzka  et  al.,  2010). 
Remyelination  by  OPCs  after  chemical  demyelination  is  in  general  very 
successful but in diseases such as MS, failure of the repair process is commonly 
observed, and leads to chronic and permanent neuronal dysfunction. 
 
OPCs  are  not  only  responsible  for  (re)myelination.  They  influence  neuronal 
activity at the node of Ranvier (Butt et al., 1999). OPC processes have also been 
detected in close proximity to synapses, where they may contribute to synapse 
remodelling (reviewed in Frohlich et al., 2011). Recently a glutamate mediated 
interaction between yet unmyelinated axons and NG2+ cells was demonstrated 
and  is  believed  to  facilitate  rapid  axono-glial  communication  initiating 
myelination (Ziskin et al., 2007). NG2+ cells are also capable of differentiating 
into  astrocytes,  highlighting  their  stem  cell  like  multipotency  (Zhu  et  al., 
2008a).  
 
1.2.6 The astrocyte 
 
Astrocytes are characterised by their star shaped appearance and generally, by 
expression of glial fibrillary acidic protein (GFAP) (Eng et al., 1971). They can be 
divided into two main groups; fibrous astrocytes of the white matter and the 
protoplasmic  astrocytes  of  the  grey  matter  (reviewed  in  Figley  and  Stroman, 
2011). The function of astrocytes in the CNS is multifaceted. They are involved 
in electrolyte homoeostasis (reviewed in  Sofroniew and Vinters, 2010), in the 
maintenance and function of the blood brain barrier (reviewed in Abbott, 2002), 
in  regulating  local  blood  flow  (reviewed  in  Figley  and  Stroman,  2011), 
influencing  the  generation  of  synapses  and  modifying  synaptic  transmission 
(Ullian et al., 2001), influencing myelination dynamics (reviewed in Nash et al., 
2011)  and  maintaining  an  active  astrocyte-astrocyte  and  astrocyte-neuronal 13 
signalling  network  (reviewed  in  (Sofroniew  and  Vinters,  2010;Rusakov  et  al., 
2011). In the white matter astrocytes interact with the oligodendroglia via gap 
junctions (Nagy et al., 2001) and extend processes to the node of Ranvier (Butt 
et  al.,  1994).  Astrocytes  respond  to  any  kind  of  tissue  damage  including 
demyelination by proliferating and changing morphology, turning into reactive 
astrocytes (reviewed in Norton et al., 1992). 
 
1.2.7 Microglia  
 
The microglial cells are the resident macrophages of the CNS and are considered 
to constitute the innate immune system of the CNS. They originate from myeloid 
precursor  cells  and  populate  the  CNS  during  late  embryonic  development. 
Approximately 12% of CNS glial cells can be attributed to microglia (reviewed in 
Walter  and  Neumann,  2009).  In  the  normal  CNS,  microglia  monitor  their 
environment by continuously scanning to detect pathological changes, without 
disturbing the cellular network (reviewed in Hanisch and Kettenmann, 2007). As 
soon  as  there  are  abnormal  changes  in  the  CNS  tissue,  such  as  invasion  by 
microorganism,  production  of  inflammatory  cytokines,  accumulation  of 
intracellular substances or protein aggregates,  microglia change their activity 
from a surveillance mode to a reactive mode, depending on the severity and 
duration  of  the  insult.  In  general,  when  microglia  become  ‘activated’  they 
change their morphology from small cell bodies with fine processes to swollen 
cell bodies with shortened and thicker processes. Activation is mainly mediated 
through activation of Toll-like receptors, through lack of inhibition of receptors 
or  through  neurotransmitters,  making  them  respond  to  known  and  unknown 
changes.  ‘Activated’  microglia  can  interact  with  other  immune  cells  such  as 
macrophages and T-cells, can exhibit phagocytic activity, for example removing 
myelin debris after demyelination, secrete pro- or anti-inflammatory substances 
and  can  support  adult  oligodendrogliogenesis  and  neurogenesis.  In  general 
microglia  maintain  and  restore  optimal  conditions  for  normal  CNS  function 
(reviewed in Hanisch and Kettenmann, 2007). However microglial activation can 
also exacerbate and aggravate the disease process.  
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This  exacerbation  and  aggravation  of  the  disease  process  has  been  shown  in 
different models of demyelination where suppression of microglial/macrophage 
activation led to amelioration of the disease process (Ip et al., 2007;Popovic et 
al.,  2002;Kondo et  al.,  2011)  and  highlights  the  bivalent  role of  microglia  in 
white matter pathology.    15 
 
Figure 1.  White matter at a glance. 
Illustration of the architecture of major white matter tracts (A) composed of axons and their 
myelin sheath (B, C, and D), microglia (E), astroglia (F) and oligodendrocyte precursor cells (G). 
PLP (blue) and MBP (orange), the two most abundant proteins of CNS myelin, are located in 
compact myelin. CNP (red) and Sirtuin2 (green) are associated with non-compact myelin. MAG 
(purple)  traverse  the  periaxonal  space  and  binds  to  receptors  (blue)  in  the  axolemma  (MDL: 
major dense line, IPL: intraperiod line, modified from Gruenenfelder et al., 2011). 16 
1.3  Myelination of the CNS 
 
Myelination of the mouse CNS mainly occurs during post natal development with 
peak  myelination  around  P20.  The  myelination  process  is  largely  complete 
around P60 (Edgar and Griffiths, 2009). However there are some regions, such as 
the corpus callosum, where on-going myelination into late adulthood is present 
(see Chapter 3). The process of myelination is tightly controlled and involves in 
general all axons larger than 0.2µm in diameter (reviewed in Hildebrand et al., 
1993). 
 
The  process  of  myelination,  from  OPC  proliferation  to  differentiation  and 
formation of the myelin sheath is orchestrated by a precise temporal and spatial 
interaction  of  inhibitory  and  promoting  cell  intrinsic  and  extrinsic  factors 
(reviewed  in  Franklin  and  ffrench-Constant,  2008;Emery,  2010a).  Most  of  the 
known  OPC  extrinsic  factors  and  molecules  are  expressed  on  axons  and  act 
through  axonal  glial  communication.  They  are,  in  general,  inhibitors  of  OPC 
differentiation and the down-regulation or inactivation of these ligands such as 
Jagged, PSA-NCAM, NRG1-III or LINGO-1 results in decreased inhibition of OPC 
differentiation (Charles et al., 2000;Mi et al., 2005;Wang et al., 1998;Emery, 
2010a;Flores et al., 2008). Neuronal activity has additionally been identified to 
induce  OPC  differentiation  and  myelination  (Barres  and  Raff,  1993).  The 
influence  of  neuronal  activity  on  myelination  highlights  the  plasticity  of  the 
white  matter,  which is  preserved  into  adulthood and can  be  stimulated  with 
specific training (Scholz et al., 2009). 
 
Activation  of  the  canonical  Wnt  pathway  in  OPCs  is  required  for  OPC 
proliferation  but  needs  to  be  downregulated  to  induce  OPC  differentiation. 
Prolonged activation of the Wnt pathway leads to delayed myelination and also 
delayed remyelination (Fancy et al., 2009). 
 
Cell intrinsic factors involved in the regulation of OPC differentiation include 
translational,  posttranslational  and  epigenetic  mechanisms  (Emery, 
2010a;Franklin  and  ffrench-Constant,  2008).  For  OPC  development,  normal 
function of the transcriptional factor Olig2 is crucial and disruption thereof leads 17 
to absence of OPCs in the CNS (Lu et al., 2002 and reviewed in Emery, 2010b). 
During OPC differentiation other transcription factors such as Olig1, Sox10 and 
Nkx  2.2  become  more  important  and  any  disruption  thereof  impairs  the 
differentiation of OPC into myelin synthesising oligodendrocytes (Emery, 2010b). 
Recently  microRNA  has  been  shown  to  control  OPC  differentiation.  The 
transgenically mediated inhibition of the microRNA processing enzyme Dicer1 in 
cells  from  the  oligodendrocyte  lineage,  leads  to  a  dysmyelinating  phenotype 
with an elevated OPC pool. OPC differentiation and myelination was reinduced 
by  overexpression  of  miR-291  and  miR-338  which  act  through  silencing  the 
inhibitory factors Sox6 and Hes5 (Zhao et al., 2010). 
 
Finally  epigenetic  control  mechanism  involving,  for  example,  histone 
deacetylases (HDAC1 and 2) influence myelination as well as remyelination. It 
has been shown that HDACs block Wnt pathway activity believed to inhibit OPC 
differentiation (Ye et al., 2009).  
 
In contrast to the PNS, where myelination is mainly governed by axonal signals, 
the  myelination  process  in  the  CNS  is  more  complex  and  some  of  the  cell 
intrinsic  and  cell  extrinsic  influences  on  myelination  have  been  identified. 
Understanding  the  molecular  changes  involved  in  normal  myelination  during 
development could help to investigate the mechanism involved in remyelination 
and remyelination failure.    
 
1.4  The regenerative capacity of the white matter 
 
It has been shown that extensive repair can occur after a pathological insult to 
the myelin sheath where the demyelinated axons become remyelinated (Duncan 
et al., 2009). The remyelination process in the CNS can be very effective and 
extensive, leading to a full recovery of the whole demyelinated area.  Recently 
it  has  been  observed  that  demyelinated  regions  become  repopulated  by  a 
specific  multipotent  cell  type,  the  OPCs.  However  remyelination  often  fails 
especially in MS despite of OPCs being abundantly present in the demyelinated 
regions  (Chang et al.,  2002;Goldschmidt et  al.,  2009;Kuhlmann  et al.,  2008). 
These regions often stay demyelinated and secondary axonal changes develop, 18 
possibly  as  a  consequence  of  failed  remyelination.  Why  the  default 
remyelination  process  fails  with  disease  chronicity  is  not  understood  and 
research using animal models of demyelination is focusing on this phenomenon in 
order to understand the development of remyelination failure and to potentially 
find ways to enhance the regenerative process. 
 
1.4.1 Demyelination and remyelination of the CNS 
 
Demyelination  is  the  process  whereby  the  myelin  sheath  breaks  down. 
Demyelination of the CNS occurs in two ways:  
 
a) Primary demyelination, where pathology mainly affects the myelin sheath, 
causing a demyelination  
 
b) Wallerian degeneration, where the breakdown of the myelin sheath follows 
axonal degeneration. 
 
Primary demyelination of the white matter is a common pathology in humans 
and  two  major  disease  groups  affect  the  CNS  myelin  sheath:  inflammation 
induced primary demyelination, with MS being the most common aetiology, and 
much less common, demyelination mediated through a genetic defect, such as 
the leukodystrophies, for example, PMD or Krabbe’s disease.  
 
In  general,  the  regeneration  potential  of  the  CNS  is  limited.  However,  with 
regard  to  regeneration  of  the  myelin  sheath,  it  has  been  shown  that 
remyelination  is  a  highly  effective  and  dynamic  process  following  a 
demyelinating  insult  (Blakemore,  1974;Coman  et  al.,  2005;Woodruff  and 
Franklin,  1999;Kuhlmann  et  al.,  2008;Franklin  and  ffrench-Constant, 
2008;Duncan  et  al.,  2009;Miron  et  al.,  2011).  It  has  been  demonstrated  that 
OPCs are responsible for remyelination in the adult CNS (Zawadzka et al., 2010). 
This regenerative capacity of the OPC is believed to be maintained throughout 
life (reviewed in Franklin and ffrench-Constant, 2008). 
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This regenerative capacity has also been observed in patients suffering from MS, 
in that virtually complete restoration of myelin can occur after an acute event 
(Kuhlmann et al., 2008). However there appears to be a different situation in 
chronically  demyelinated  lesions,  where  the  remyelination  capacity  of  OPCs 
becomes diminished (Goldschmidt et al., 2009). 
 
Chronic remyelination failure is leading to permanent demyelination as seen in 
chronic  MS.  The  reasons  for  remyelination  failure  are  not  fully  understood. 
However the consequence of this failure is that axonal loss, which is believed to 
lead to permanent disability and which can be caused by inflammation-mediated 
demyelination,  is  also  recognised  in  association  with  remyelination  failure 
(reviewed  in  Trapp  and  Nave,  2008).  Consequently,  more  attention  has  been 
given to investigating the axonal glial interaction, and it has been suggested that 
the axonal loss evident in chronic demyelinated regions is due to the long term 
loss  of  trophic  factors  derived  from  the  myelin  sheath  (Pohl  et  al.,  2011; 
reviewed in Bjartmar et al., 2003;Nave, 2010a;Nave, 2010b). Evidence for the 
trophic supporting role of the myelin sheath has been provided from the study of 
various  genetically  modified  mouse  models  (reviewed  in  Edgar  and  Garbern, 
2004), such as the Plp1 (Griffiths et al., 1998;Garbern et al., 2002) and Cnp1 
knock out (Lappe-Siefke et al., 2003;Edgar et al., 2009) mice in which axonal 
degeneration  occurs  over  time  despite  an  abundance  of  relatively  normal 
myelin.  This  suggests  that  biochemically  abnormal  myelin  may even be  more 
detrimental to axonal health, than no myelin (Edgar et al., 2010; reviewed in 
(Nave, 2010a). 
 
1.4.2 Successful  remyelination  is  dependent  on  a  finely  tuned 
interaction between oligodendrocyte precursor cell intrinsic and 
cell extrinsic changes 
 
It  has  been  postulated  that  for  effective  remyelination  to  take  place,  cell 
intrinsic and extrinsic factors must interact in a precise spatial and temporal 
manner (reviewed in  Franklin and  ffrench-Constant,  2008). Briefly, the initial 
step  after  demyelination  involves  clearance  of  the  affected  region  of  myelin 
debris  by  local  microglia/macrophages.  Normal  microglial/macrophage 20 
phagocytic  function  is  an  important  prerequisite  for  successful  remyelination 
(Kotter et al., 2001;Pohl et al., 2011). This is followed by OPC migration into the 
demyelinated area and OPC proliferation, leading to OPC repopulation of the 
demyelinated area. OPCs must then differentiate into early oligodendrocytes in 
order  to  initiate  remyelination.  Cell  processes  of  the  newly  formed 
oligodendrocytes then contact the demyelinated axons, resulting in upregulation 
of  the  expression  of  myelin-related  genes  (reviewed  in  Franklin  and  ffrench-
Constant,  2008).  Finally,  successful  restoration  of  the  myelin  sheath  leads  to 
functional recovery (Duncan et al., 2009). 
 
Given  the  complexity  of  the  repair  process,  minimal  interference  with  the 
process could result in perturbation of the remyelination process, which in the 
worst case could end in failure of remyelination. 
To understand the role of intracellular and extracellular compartments during 
demyelination and remyelination it is necessary to address the structural and 
molecular  changes  within  the  differentiating  OPC  intrinsic  and  extrinsic 
environment including the astroglia, the microglia and the extracellular matrix. 
Successful remyelination is mediated by OPCs (Zawadzka et al., 2010). However 
the mere presence of OPCs within and around the demyelinated lesion is not 
always sufficient for successful remyelination. This situation has been observed 
in chronic MS lesions where, despite the presence of OPCs, there is no evidence 
of  remyelination,  suggesting  that  there  is  a  block  in  OPC  differentiation 
(Kuhlmann  et  al.,  2008).  The  transition  of  the  OPC  from  a  proliferating  to 
differentiating  cell  is  thought  to  be  a  critical  point  during  the  remyelination 
process (reviewed in Fancy et al., 2010;Franklin and ffrench-Constant, 2008).   
 
1.4.3 The role of OPC intrinsic factors in successful (re)myelination 
 
1.4.3.1 Intrinsic control of the cell cycle is crucial for OPC differentiation 
 
As  previously  stated,  a  crucial  factor  in  initiating  (re)myelination  is  the 
differentiation  of  OPCs  to  young  oligodendrocytes.  This  starts  with  the  OPCs 
exiting the cell cycle. Depending on the dominance of cell cycle promoters or 21 
inhibitors, the OPC will either continue to proliferate and go through another 
cell cycle, or will exit the cell cycle and start to differentiate into a non-dividing 
oligodendrocyte.  Cell  cycle  arrest  in  OPCs  depends  on  a  decrease  in  cyclin-
dependent kinase (CDK), with mainly CDK2 and p27Kip-1, which is part of the 
retinoblastoma  (Rb)  pathway,  as  the  main  regulator  (reviewed  in  Casaccia-
Bonnefil and Liu, 2003). Additionally, the p53 pathway influences the cell cycle, 
especially during the differentiation step. The NH2-terminus of p53 appears to be 
important  for  the  development  of  the  cytoskeleton  during  differentiation, 
whereas the COOH-terminus of p53 affects exit from the cell cycle (reviewed in 
Casaccia-Bonnefil and Liu, 2003). 
 
1.4.3.1.1  Wnt  pathway  activity  interacts  with  the  timing  of  OPC 
proliferation and differentiation  
 
As described in Section (1.3 Myelination of the CNS), the Wnt pathway plays a 
regulatory  role  in  the  induction  of  OPC  differentiation  during  development 
(Fancy  et  al.,  2009),  but  also  during  remyelination  (Fancy  et  al.,  2009). 
Constitutive activation of the Wnt pathway in mice led to delayed but normal 
myelination  during  development  and  delayed  remyelination  after  chemical 
demyelination  (Fancy  et  al.,  2009).  It  has  been  suggested  that  delayed 
differentiation,  during  myelin  repair,  may  lead  to  incomplete  or  failed 
remyelination by missing the narrow time window for the proliferating OPC’s to 
respond  to  parameters  favouring  remyelination  (Fancy  et  al.,  2009).  Further 
evidence for a regulatory role for the Wnt pathway came from a study showing 
that suppression of the Wnt pathway, mediated through Axin2 stabilisation, a 
negative  feedback  regulator  of  the  Wnt  pathway,  resulted  in  enhanced 
remyelination capacity of OPCs in mice (Fancy et al., 2011). 
 
1.4.3.1.2  The Notch pathway and remyelination 
 
The  role  of the  Notch  pathway in  remyelination  is  controversial.  It  has  been 
postulated  that  Notch1  signalling  is  involved  in  the  precise  timing  of  the 
myelination process during development. The effect appears to depend on the 22 
involvement  of  either  the  canonical  or  non-canonical  pathway.  Blocking  of 
Notch1 receptor stimulation may therefore contribute to remyelination failure in 
MS  (Blaschuk  and  ffrench-Constant,  1998).  However,  blocking  the  canonical 
Notch1 pathway in young and adult mice did not influence the remyelination 
rate after chemically induced demyelination in mice (Stidworthy et al., 2004). 
However, remyelination failure in chronically demyelinated MS lesions, in which 
Notch1 receptors were saturated with Contactin and therefore activated, was 
not attributed to Notch pathway activation, but rather to a failure of nuclear 
translocation of the intracellular non-canonical Notch1 domain (Nakahara et al., 
2009). On the other hand, during white matter development and myelination, 
inhibition of Notch1 through the canonical pathway resulted in impaired OPC 
differentiation, leading to an increase in prematurely differentiated immature 
oligodendrocytes (Genoud et al., 2002). 
 
Together,  these  data  show  that  the  Notch  signalling  pathway  can  act  as  an 
inhibitor or promoter depending on activation pathway, suggesting that Notch 
signalling  plays  a  regulating  role  in  remyelination  kinetics  and  is  not  just  an 
inhibitor of OPC differentiation during remyelination (Fancy et al., 2010). 
 
1.4.3.1.3  The activation of Neuregulin1/ErbB signalling in remyelination 
is important but not crucial 
 
In the PNS axonal expressed Neuregulin1-III (NRG1-III) ligands control almost the 
entire  myelination  process  by  binding  to  glial  ErbB2/ErbB3  receptors,  which 
upregulate myelin gene expression through a phosphatidylinositol-3-kinase (PI3K) 
mediated activation of Akt1/mTor (Michailov et al., 2004). In contrast, in the 
CNS the role of axonal NRG1-III ligands is not crucial for successful myelination 
(Brinkmann  et  al.,  2008;Flores  et  al.,  2008).  However,  transgenic  mice  with 
continuous activation of the Akt1 pathway develop a hypermyelination of the 
CNS  (Flores  et  al.,  2008;Brinkmann  et  al.,  2008).  Although  the  Akt1/mTor 
pathway is involved in myelin gene upregulation and formation of the myelin 
sheath, the importance of this pathway for successful remyelination is not clear. 
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1.4.3.1.4  The  spatial  and  temporal  interaction  between  transcription 
factors is crucial for successful remyelination 
 
Recently,  the  role  of  transcription  factors  in  the  remyelination  process  has 
gained  increased  attention.  As  previously  discussed,  during  developmental 
myelination, oligodendrocyte specific transcription factors such as Olig1, Olig2, 
Nkx  2.2  and  Sox10  are  responsible  for  OPC  development,  differentiation, 
myelination and survival.  It has also been shown that in adult CNS transcription 
factors  are  involved  in  OPC  proliferation  and  differentiation  mandatory  for 
successful remyelination (Kuspert et al., 2011).  
Accurate  subcellular  localisation  of  the  basic  helix-loop-helix  (bHLH) 
transcription factor Olig1 is crucial for (re)myelination. In normal mice, transient 
intranuclear  translocation  of  transcription  factor  Olig1  occurs  during 
remyelination following chemically induced demyelination.  In the Olig1 knock 
out mouse, in which developmental myelination occurs normally, remyelination 
is  severely  impaired  after  chemical  demyelination  (Arnett  et  al.,  2004).  In 
contrast, overexpression of Olig1 in transgenic mice had no enhancing effect on 
developmental myelination (Maire et al., 2010). However the influence of Olig1 
overexpression  during  remyelination  has  not  been  examined.  Another  bHLH 
transcription factor, Olig2 regulates OPC and motoneuron specification during 
embryonic development (Lu et al., 2002). Olig2 knock-out mice display a severe 
reduction of OPCs and motoneurons and do not survive post-natally making it 
impossible  to  evaluate  the  influence  of  absent  Olig2  in  myelination  and 
remyelination  (Lu  et  al.,  2002).  Furthermore,  transplantation  of  transfection 
induced  Olig2  overexpressing  human  stem  cells  into  shiverer  mouse  brain 
resulted in increased differentiation and MBP expression by transplanted OPCs 
(Maire  et  al.,  2009;Maire  et  al.,  2010).  This  suggests  that  increasing  Olig2 
expression increases OPC proliferation and differentiation and that manipulating 
Olig2 levels could potentially enhance remyelination. 
 
However, Olig2 does not function in isolation. During remyelination, increased 
Olig2 expression is always linked to Nkx 2.2 expression in differentiating OPCs. A 
delay  in  co-expression  leads  to  a  reduced  remyelination,  indicating  that  the 
combination of Olig2/Nkx 2.2 expression is critical for the remyelination process 
(Fancy  et  al.,  2004;Kitada  and  Rowitch,  2006;Othman  et  al.,  2011). 24 
Furthermore, Olig2 regulates Sox10 expression, ensuring OPC survival and acting 
as a direct promoter of myelin gene expression (Stolt et al., 2002;Finzsch et al., 
2008;Kuspert et al., 2011).  
 
In  summary,  the  temporally  and  spatially  regulated  action  of  transcription 
factors is crucial for (re)myelination and only minor disruption can have severe 
consequences for the repair process. 
 
1.4.3.2 Epigenetic influences on (re)myelination 
 
The  deacetylation  of  histones  by  HDAC,  an  important intracellular  epigenetic 
control mechanism of gene expression, modulates the remyelination capacity of 
the  white  matter.  In  the  case  of  OPCs,  the  HDACs  positively  influence 
remyelination by blocking the function of molecules such as Tcf4, Sox2, Hes5 
and Id4, which are thought to inhibit OPC differentiation  (Shen and Casaccia-
Bonnefil, 2008). The reduction of HDAC in mice, especially HDAC1 and HDAC2, 
causes the level of the intracellular inhibitory molecules for OPC differentiation 
to be elevated. The negative effect on remyelination capacity in the absence of 
HDAC1/2 is mediated through the absence of a competing interaction with Tcf4 
function, which is plays a central part of the Wnt pathway. 
 
Briefly multiple intracellular signalling pathways involved in changing cell status 
from  a  proliferating  one  to  a  differentiating  one  play  a  pivotal  role  during 
myelination  and  remyelination  and  knowledge  of  specific  cell  intrinsic 
interactions provides an opportunity to manipulate these factors in favour of the 
remyelination process. 
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1.4.4 Factors in the OPC extrinsic compartment that can disrupt the 
remyelination process leading to remyelination failure 
 
1.4.4.1 Mitogens  and  differentiation  factors  act  through  specific  cell 
receptors on OPCs 
 
Although OPC intrinsic factors are mandatory for successful (re)myelination, a 
permissive environment for OPC differentiation and myelin sheath formation is 
of equal importance. A variety of OPC extrinsic factors can have a stimulatory or 
inhibitory effect on either proliferation or differentiation. 
 
Mitogens  such  as  PDGF,  basic  FGF,  BDNF  and  NT3  are  responsible  for  OPC 
proliferation (reviewed in  Casaccia-Bonnefil and Liu,  2003)  and for increasing 
the  number  of  OPCs.  In  order  to  differentiate  into  new,  non-dividing 
oligodendrocytes, OPCs must exit the cell cycle. Extracellular factors such as 
TGF-β,  cAMP  and  thyroid  hormone  enhance  OPC  differentiation  (reviewed  in 
Casaccia-Bonnefil  and  Liu,  2003).  However,  it  is  not  only  mitogens  and 
differentiating inducing molecules that are important, mandatory receptors on 
the  OPC  membrane  such  as  the  Erb  family,  and  integrins  are  required  for 
successful (re)myelination (reviewed in Casaccia-Bonnefil and Liu, 2003;Taveggia 
et al., 2010). 
 
1.4.4.2 The  influence  of  the  extracellular  matrix  on  the  remyelination 
process 
 
The  composition  of  the  extracellular  matrix  substantially  influences  the 
generation of new oligodendrocytes (reviewed in Franklin and ffrench-Constant, 
2008).  For  example  hyaluronan,  a  glycosaminoglycan  composed  of  glucuronic 
acid and N-acetylglucosamine, impairs OPC differentiation (Back et al., 2005). 
The accumulation of high molecular weight (HMW) hyaluronan has been found to 
negatively  impact  the  activation  and  differentiation  of  OPCs  in  chemically 
induced and demyelinated lesions in vitro in a model of chronic demyelination 
and  in  chronic  MS  biopsy  samples  (Back  et  al.,  2005).  Recently  it  was 26 
demonstrated that the blocking mechanism of hyaluronan on OPC differentiation 
is mediated by binding of low molecular weight (LMW) hyaluronan to Toll-like 
receptor 2 (TLR2)  on OPCs.  Hyaluronidase,  expressed on OPCs, locally breaks 
down the HMW to LMW hyaluronan and is responsible for the accumulation of 
LMW hyaluronan (Sloane et al., 2010). 
 
Another  inhibitory  molecule  that  accumulates  in  chronic  MS  lesions  is 
Semaphorin  3A  (Williams  et  al.,  2007a).  Semaphorin  3A  is  synthesised  by 
microglia, astroglia and/or a subset of cells belonging to the oligodendroglial 
lineage  (Williams et al., 2007a).  The receptor NP-1,  to which Semaphorin 3A 
binds,  is  expressed  on  OPCs.  Recent  in  vitro  and  in  vivo  work  showed  that 
Semaphorin 3A acts as an inhibitor of OPC differentiation (Syed et al., 2011). 
 
1.4.4.3 Inhibition of the initial axonal glial contact impairs the remyelination 
process 
 
Initiation of myelination is dependent on glia-axonal interaction and it has been 
suggested that polysialation of the neural cell adhesion molecule (PSA NCAM) on 
axons may play a role in inhibiting remyelination after demyelination (Charles et 
al., 2002). PSA NCAM is present on astrocytes and axons during CNS development 
and is involved in O-2A cell migration in vitro (Wang et al., 1996) and axonal 
growth in vitro (Doherty et al., 1990). In the mature CNS, PSA NCAM is no longer 
expressed on axons (Charles et al., 2002), but it is re-expressed in chronic MS 
lesions,  possibly  impairing  remyelination  (Charles  et  al.,  2002).  The  contact-
mediated inhibitory effect of PSA NCAM results in OPC differentiation failure and 
a lack of myelin forming oligodendrocytes (Taveggia et al., 2010). 
 
Structural integrity of the axon is also likely to be crucial for remyelination. Of 
interest, there is evidence that the length of time axons remain demyelinated 
does  not  impact  on  the  remyelination  potential  of  the  demyelinated  axons 
(Setzu et al., 2004). 27 
1.4.4.4 Astroglia,  microglia/macrophages  and  inflammation  influence 
remyelination  
 
The  important  role  of  macrophages  in  remyelination  was  demonstrated  by 
experimental  depletion  of  macrophages,  using  clodronate-liposome,  after 
demyelination  in  experimental  animals.  This  led  to  reduced  levels  of  growth 
factors, insulin growth factor 1 (IGF-1) and transforming growth factor β1 (TGFβ-
1), and had a negative impact on OPC recruitment into the demyelinated region 
(Kotter et al., 2001;Kotter et al., 2005). 
 
The important role of the phagocytic activity of macrophages is demonstrated by 
the  observation  that  the  accumulation  of  myelin  debris  products  impairs 
remyelination by inhibiting OPC differentiation (Kotter et al., 2006;Syed et al., 
2008).  
 
1.4.4.4.1  Microglial activation and inflammation can stimulate or inhibit 
the remyelination process 
 
The role of inflammation during the remyelination process is controversial. In 
rodents, zymosan, a TLR2 binding glycan, induces an acute inflammation which 
causes transplanted OPC to myelinate retinal axons more efficiently (Setzu et 
al., 2006). It has also been shown that a saline mediated acute inflammation 
induced after transplantation of OPCs into the chronically demyelinated dorsal 
columns of taiep rats had a beneficial effect on transplanted OPCs to effectively 
remyelinate the chronically demyelinated regions (Foote and Blakemore, 2005a). 
 
On the other hand, minocycline induced suppression of microglial activation in 
Long Evans shaker rats leads to enhanced function and survival of transplanted 
OPCs. This observation suggests that fully activated microglia, characterised by 
expressing MHCII and iNOS and by secretion of cytokines and active phagocytosis, 
may  contribute  to  the  non-permissiveness  for  remyelination  by  making  the 
environment detrimental for transplanted OPCs (Zhang et al., 2003). 
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Furthermore,  studies  using  genetically  induced  models  of  demyelination  and 
experimental  autoimmune  encephalitis  showed  that  suppressing  microglial 
activation ameliorates progressive demyelination (Ip et al., 2007;Popovic et al., 
2002). 
 
1.4.4.4.2  Astrocytes – promoter or inhibitor? 
 
Astroglia  also  have  an  ambiguous  role  during  (re)myelination.  Remyelination, 
induced by injection of OPCs and Schwann cells into a chemically and radiation 
induced  astroglia-free  demyelinated  lesions  in  vivo,  was  more  effective  than 
remyelination  after  transplantation  into  a  demyelinated  area  containing 
astrocytes. This implies a negative influence of the endogenous astroglia on the 
remyelination  capacity  (Blakemore  et  al.,  2003).  Reactive  astrocytes  secrete 
hyaluronan, which inhibit OPC differentiation (Back et al., 2005;Sloane et al., 
2010)  (see  section  1.4.4.2  The  influence  of  the  extracellular  matrix  on  the 
remyelination  process).  On  the  other  hand,  using  an  EAE  model,  it  was 
demonstrated  that  astrocytes  in  the  demyelinated  lesions  secrete  substances 
such  as  insulin-like  growth  factor  binding  protein  2  (IGFBP-2)  which  helps  to 
target insulin-like growth factor 1 (IGF-1) to insulin-like growth factor receptor 1 
(IGFR-1) expressing oligodendrocytes, essentially having a promoting effect on 
the  newly  formed  oligodendrocytes  to  remyelinate  (Liu  et  al.,  1994). 
Furthermore  a  bivalent  role  during  the  remyelination  process  has  been 
postulated  since  astrocytes  may  amplify  the  damage  caused  by  inflammation 
mediated through TNF-α. This may lead to repulsion and apoptosis of OPCs. On 
the other hand the astrocytes facilitated debris clearance, attracted OPCs to the 
demyelinated  region  and  promoted  OPC  differentiation  by  secretion  of  IL-6 
related cytokines (reviewed in Williams et al., 2007b)    
 
1.4.4.5 Thyroid hormone 
 
Thyroid  hormone is  known  for its  positive  effect  on  cell  metabolism.  Various 
experimental studies focussing on myelin repair and on functional recovery after 
spinal cord injury have shown the positive effect of T3, the biologically active 29 
form of thyroid hormone. Acute and also chronic illness has been shown to cause 
the  phenomenon  of  a  non-thyroidal  illness  syndrome  (NTIS)  (reviewed  in 
Papanicolaou,  2000).  To  date  the  NTIS  is  believed  to  be  elicited  by  a 
combination  of  systemically  suppressive  effects  on  thyroid  hormone  synthesis 
and  locally  on  thyroid  hormone  metabolism  and  transport.  Of interest in  the 
complex aetiology of NTIS are for example tanycytes, which are located on the 
floor of the third ventricle. The tanycytes respond to acute and chronic illness 
with local upregulation of deiodinase 2 (D2) which controls the secretory activity 
of thyroid releasing hormone (TRH) producing cells in the periventricular nuclei 
(reviewed in Herwig et al., 2008). The upregulation of D2, which is responsible 
for converting T4 to T3, causes a local hyperthyroidism inhibiting TRH secretion 
and elicits a centrally mediated systemic hypothyroidism. 
 
An  effective  local  regulator  of  active  thyroid  hormone  levels  in  tissue  is  the 
deiodinase 3 (D3), which inactivates T4 and T3, locally depriving the tissue of 
active T3, despite thyroid levels being normal (reviewed in Visser et al., 2011). 
D3 is expressed on neutrophilic granulocytes and macrophages and is believed to 
be involved in the development of NTIS in inflammatory diseases (Boelen et al., 
2005).  Finally  T3  has  to  be  actively  transported  into  the  cell  by  active 
transporters such as monocarboxylase transporters (MTC). In the CNS, MTC8 is 
the major intracellular transporter for T3 and abnormal function and distribution 
has been reported to cause PMD like disease development (Vaurs-Barriere et al., 
2009).  All  of  these  components  have  been  described  to  be  involved  in  the 
development  of  NTIS.  The  positive  effect  on  remyelination  activity  observed 
after application of high T3 doses in different models of EAE may be explained 
by  overriding  a  potential  local  tissue  hypothyroidism  mediated  through 
inflammation,  by  saturating  the  D3  activity  and  by  optimising  the  impaired 
intracellular transport by artificially elevating the T3 concentration in tissue. 
 
1.4.4.6 Age as an ubiquitous negative factor for remyelination capacity 
 
Increasing age negatively influences both remyelination promoting cell intrinsic 
and  cell  extrinsic  factors.  Simultaneous  expression  of  Nkx2.2/Olig2,  which  is 
important for OPC differentiation and remyelination, diminishes with age (Fancy 30 
et al., 2004). Also the HDAC1 and 2 activity becomes reduced with age, leading 
to reduced suppression of myelin suppressing pathways, thereby slowing down 
the remyelination process (Shen et al., 2008;Ye et al., 2009).  Aging also affects 
phagocytic  activity,  delaying  myelin  clearance  and  consequently  leading  to 
inefficient  remyelination  (Kotter  et  al.,  2005;  reviewed  in  Neumann  et  al., 
2009). 
 
1.5  Diseases affecting the myelin sheath 
 
The myelin sheath in the CNS can be affected by various diseases leading to two 
main forms of pathology: 
 
1.) Dysmyelination, in which myelin formation and/or structure is perturbed 
2.)  Demyelination, in which there is destruction of the myelin sheath. 
 
The archetypal disease of white matter in humans is MS, which classically leads 
to widespread formation of demyelinated patches in the white matter. Some 
demyelinated  lesions  remyelinate  and  some  develop  into  chronically 
demyelinated lesions (reviewed by Agrawal and Yong, 2007;Noseworthy et al., 
2000).  Another  group,  where  an  initial  dysmyelination  may  be  followed  by 
demyelination,  has  a  genetically  determined  background  such  as  in  Pelizaeus 
Merzbacher  diseases  (Hudson  et  al.,  2004;Garbern,  2007),  Krabbe’s  disease 
(Duffner  et  al.,  2009),  adrenoleukodystrophy  (Moser  et  al.,  2005), 
metachromatic  leukodystrophy  (Gieselmann,  2008)  and  Alexander’s  disease 
(Johnson  and  Brenner,  2003).  Other  reasons,  such  as  metabolic  disturbances, 
toxins, radiation, vascular events or chemotherapy induced demyelination, have 
been also been described (reviewed in Schmahmann et al., 2008). 
 
In  acute  diseases  affecting  the  white  matter,  remyelination  with  complete 
restoration  of  neurophysiological  function  may  occur.  However  in  MS  or  in 
genetically induced demyelination, the repair process often fails and, with time, 
an  accumulation  of  chronically  demyelinated  regions  eventually  leads  to 
permanent neurological dysfunction  (Kuhlmann et al., 2008).  The reason why 
remyelination  fails,  and  the  regenerative  process  stops,  is  a  major  research 31 
area.  Classically,  the  experimentally  induced  autoimmune  encephalitis  (EAE) 
model has been used to study the immunological component of demyelination 
(Swanborg,  1995).  In  contrast,  the  regenerative  capacity  of  white  matter,  is 
often studied using chemically induced demyelination. Genetically determined 
models can also be used to investigate remyelination failure in the absence of an 
overt immune component. 
 
1.5.1 Models of myelin pathology 
 
In vitro and in vivo models of demyelination are routinely used to investigate 
remyelination  biology  and  pathology  (Fressinaud,  2005;Thomson  et  al., 
2006;Woodruff  and  Franklin,  1999;Zhang  et  al.,  2011).  In  vitro  and  ex-vivo 
models such as cell and tissue culture are useful in the study of remyelination 
biology with respect to the fact that they are easily manipulated, imaged and 
assessed. The main disadvantage is that they never reflect the in situ situation 
properly. For example, they are generally generated from embryonic or early 
post-natal tissue and, due to their limited lifespan, cannot be used to reproduce 
chronic demyelination. Ideally remyelination should be studied in situ, either in 
an animal model or in humans. For studying white matter biology and pathology 
in  situ,  a  prominent  white  matter  tract  without  neuronal  cell  bodies  is 
preferred.  The  long  dorsal  columns  of  spinal  cord,  the  optic  nerve  and  the 
corpus callosum fulfil these criteria. The advantage of the corpus callosum is 
that it is a large but anatomically confined myelinated white matter tract in the 
CNS that is readily accessible in vivo and in which manipulation does not usually 
result in substantial clinical deficits. 
 
There  are  three  pathologically  distinct  groups  of  animal  models  that  have 
become useful in investigating myelin pathology: 
 
1.) Inflammatory mediated models of demyelination such as the experimental 
allergic encephalitis (EAE) or the Theiler’s murine encephalomyelitis virus 
(TMEV) models (reviewed in Dal Canto et al., 1995;Swanborg, 1995). EAE, 
which can be induced in a wide spectrum of experimental animals such as 
rodents  (Swanborg,  1995),  pigs  (Feng  et  al.,  2009)  and  non-human 32 
primates  (D'Intino  et  al.,  2011),  has  provided  valuable  insight  into  the 
aetiology of immune mediated demyelination and proved to be invaluable 
for  the  development  and  evaluation  of  effective  immune  modulatory 
drugs that have been used in the treatment of MS (reviewed in  Lublin, 
2005;Agrawal and Yong, 2007;Korniychuk et al., 2007) 
 
2.) Genetically modified models of dysmyelination and demyelination such as 
the Plp1 gene related models of the leukodystrophies (reviewed in Yool et 
al., 2000), the Mbp related shiverer (Readhead and Hood, 1990) or the 
newer models of genetically inducible demyelination (Pohl et al., 2011) 
have  highlighted  the  importance  of  normal  axonal  glial  interaction 
(Anderson et al., 1998;Edgar et al., 2002;Edgar et al., 2004b;Edgar et al., 
2009;Edgar et al., 2010;Griffiths et al., 1998;Lappe-Siefke et al., 2003; 
reviewed  in  Gruenenfelder  et  al.,  2011)  and  the  influence  of  myelin 
proteins on myelin sheath integrity (reviewed in Griffiths et al., 1995b), 
demyelination (Anderson et al., 1999;Inoue et al., 1996b;Mastronardi et 
al., 1993;Readhead et al., 1994;Kagawa et al., 1994) and remyelination 
impairment (Ma et al., 2006). 
 
3.) The third group consists of chemically induced models of demyelination 
such  as  focal  injection  of  ethidium  bromide  (Blakemore,  1982)  or 
lysolecithin (Hall, 1972) or systemic application of cuprizone (Blakemore, 
1974).  Chemically  induced  models,  especially  the  focally  demyelinated 
models,  have  been  extremely  helpful  in  identifying  and  analysing  the 
endogenous  remyelination  process  in  the  CNS  (Woodruff  and  Franklin, 
1999). 
  
The  focus  of  this  study  is  the  homozygous  Plp1  gene  overexpressing  mouse 
model,  line  #72,  a  mouse  model  of  Pelizaeus-Merzbacher  disease.  Previous 
studies have demonstrated changes in the myelin development in spinal cord and 
optic  nerve  (Anderson  et  al.,  1998;Edgar  et  al.,  2010)  and  recently,  using  a 
combination  of  DTI  measures  and  histopathology  have  provided  evidence  for 
widespread hypomyelination in the adult brain (Ruest et al., 2011). However, a 
complete characterisation of the temporal progression of myelin pathology and 
associated changes has not been undertaken other than in the optic nerve. 33 
1.5.2 The Leukodystrophies  
 
The leukodystrophies represent are a relatively rare group of diseases affecting 
the white matter. So far, more than 40 leukodystrophies with various genetic 
causes  have  been  identified  and  only  a  few  will  be  mentioned.  The  most 
common  leukodystrophy  is  the  X-linked  adrenoleukodystrophy  in  which  an 
accumulation of very long chain fatty acids is associated with neuroinflammation 
and  demyelination  (Schiffmann  and  van  der  Knaap,  2004).  Other 
leukodystrophies include metachromatic leukodystrophy, in which deficiency in 
arylsulfatase  A  leads  to  a  slowly  progressive  demyelination  (reviewed  in 
Gieselmann,  2008;Kohler,  2010)  and  globoid  cell  leukodystrophy  (Krabbe’s 
disease),  which  is  caused  by  a  deficiency  in  the  enzyme  galactosylceramide 
beta-galactosidase  leading  to  a demyelination  (Kohler,  2010).  Haematopoietic 
stem cells transplantation in X-ALD (Cartier et al., 2009) and Krabbe’s disease 
has led to post natal improvement in treated children. However reports of rapid 
deterioration in older children and adolescents with Krabbe’s disease has raised 
questions about the long term efficacy of the treatment (Duffner et al., 2009). 
Finally,  Pelizaeus  Merzbacher  disease  (PMD)  and  the  allelic  disorder  Spastic 
Paraplegia type 2 (SPG2), in which the genetic defect lies in the  PLP1 gene, 
(reviewed in Yool et al., 2000) will be described in more detail.  
 
1.5.2.1 The proteolipid protein gene in the CNS: normal structure, function 
and the role in the aetiology of Pelizaeus-Merzbacher disease 
 
1.5.2.1.1  The PLP1 gene  
 
The  PLP1  gene  encodes  the  major  tetraspan  transmembranous  proteolipid 
protein and its isoform DM20. The gene is X-linked and is located on a single 
locus at Xq21.33-22 in man (Mattei et al., 1986). The PLP1 gene is expressed in 
mature oligodendrocytes,  but other CNS cells  such as specific neurons in the 
olfactory  bulb,  hippocampus  and  cerebellum  may  also  express  PLP1/Plp1 
(Bongarzone et al., 1999). Outside the CNS PLP1/Plp1 gene expression is also 
found in Schwann cells, lymphoid tissue, spleen and cardiac myocytes (Puckett 34 
et al., 1987;Campagnoni et al., 1992;Voskuhl, 1998). The size of the PLP1 gene 
is approximately 17 kb and contains eight exons and seven introns (Diehl et al., 
1986;Macklin  et  al.,  1987;Bongarzone  et  al.,  1999).  The  gene  contains  three 
polyadenylated  sites  and  two  translation  initiation  codons  (Griffiths  et  al., 
1995a). Exon 1 contains the major translation initiation codon (Yool, 2000). The 
second translation initiation codon lies on exon 1.1 (Bongarzone et al., 1999). 
Exon  7  encodes  the  carboxy  terminus  and  the  entire  3’UTR  (Macklin  et  al., 
1987;Yool,  2000).  Two  major  protein  isoforms  (PLP  [30  kDa]  and  DM20  [26.5 
kDa]) and two minor isoforms (srPLP and srDM20; in mice) are generated through 
alternate splicing of the primary transcript  (Figure  2). Recently two exons in 
intron1  were  identified  on  the  human  PLP1  gene,  possibly  leading  to  the 
expression of three more isoforms (Sarret et al., 2010). Between species there is 
a  high  level  of  sequence  conservation.  Comparing  the  protein  coding  region 
between  man  and  rodents  the  identity  reaches  100%.  The  non-coding  and 
regulatory regions are also highly conserved, with the upstream regulatory and 
the 5’ non-coding region of the mouse gene having a 92% homology with the 
human gene (Macklin et al., 1987). The high level of conversation within the 
protein coding region point to strict regulatory control is vital for normal gene 
function (Yool, 2000). 35 
 
Figure 2.  Organisation of the murine Plp1 gene and its major transcription 
products.  
Chromosomal arrangement of the Plp1 gene (a). Four major products are generated from the 
Plp1 gene, the two most abundant transcripts Plp and Dm20, followed by the two less frequently 
transcribed srPlp and srDm20 (b) (Yool, 2000). 
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1.5.2.1.2  Regulation of the Plp1 gene expression 
 
Expression  of  the  Plp1  gene  is  controlled  mainly  at  the  level  of  gene 
transcription and the protein production mirrors transcription levels (Cook et al., 
1992). Promoter and enhancer regions have been identified on intron 1 and as 
little as 225bp of the promoter region is sufficient to induce oligodendrocytic 
specific Plp1 expression (Cambi and Kamholz, 1994).  Interestingly the Plp1 gene 
transcripts are expressed parallel to the Mbp gene transcripts, which indicates 
that these two genes share a common controlling pathway (Cook et al., 1992). 
  
1.5.2.1.3  Posttranscriptional modification and regulation  
 
Both  Plp  and  Dm20  share  the  same  pre-mRNA  and  are  produced  through 
alternate splicing of the pre-mRNA. Dm20 mRNA differs from the Plp-mRNA by 
the exclusion of exon 3b (Nave et al., 1987b). The expression pattern of the two 
isoforms  is  spatially  and  temporally  distinct  (Levine  et  al.,  1990).  Dm20 
dominates premyelination, but by the time of maximal Plp1 gene expression, Plp 
supersedes Dm20 and becomes the predominant form in the oligodendrocyte. 
 
The two minor isoforms, srPlp and srDm20 show a similar splice site within exon 
3 but additionally retain exon 1.1 (Bongarzone et al., 1999). More Plp isoforms 
have been detected recently but the role of these isoforms has not yet been 
clarified (Jahn et al., 2009;Sarret et al., 2010). 
 
1.5.2.1.4  Plp1 gene expression during development 
 
In the mouse Plp expression can first be detected post-natally between P0 and 
P2. The myelination pattern of the CNS follows that of Plp upregulation, starting 
at the medulla and progressing rostrally to the cerebrum and caudally to the 
spinal cord (Verity and Campagnoni, 1988). At peak myelination, which is around 
22 days post natal in the mouse, Plp expression is at its highest level and then 
drops to approximately 60% (Sorg et al., 1987). Dm20 transcripts on the other 
hand  can  be  first  detected  at  day  9.5  of  embryonic  development  and  DM20 37 
protein is first detected at E12 in the basal plate of the diencephalon and caudal 
hypothalamus (Spassky et al., 1998). From there, these cells populate the major 
white  matter  tracts.  DM20  expressing  cells  belong  to  the  oligodendrocyte 
precursor population and later develop into myelin synthesising oligodendrocytes 
(Dickinson  et  al.,  1996).  Post-natally  Dm20  expression  is  observed  in  close 
relation to  Plp  expression  and  maximally  reaches  50%  of the  Plp  mRNA  level 
(Nave et al., 1987b). 
 
1.5.2.1.5  The PLP/DM20 protein 
 
PLP  is  a  transmembranous  hydrophobic  tetraspan  myelin  protein,  which  is 
composed of 276 amino acids. PLP is located in the lipid bilayer of the myelin 
sheath membrane. DM20, which contains 35 amino acids less than PLP, has a 
similar location in the cell membrane. The Plp and Dm20 mRNA are translated in 
the rough endoplasmatic reticulum and the proteins are transported through the 
secretory  pathway  to  the  myelin  sheath  membrane  where  they  become 
integrated into the lipid bilayer (Gow et al., 1994). There are only two post-
translational  modifications  of  the  protein;  removal  of  the  amino  terminal 
located methionine and acylation, reviewed in (Yool, 2000). 
 
The six cysteine residues of the PLP protein (four in DM20) are acetylated with 
long  chain  fatty  acids,  mainly  palmitic,  oleic,  palmitoleic  and  stearic  acids 
(Bizzozero  and  Lees,  1999).  The  acylation  of  PLP  renders  the  protein  more 
hydrophobic and influences the protein conformation. 
 
1.5.2.1.6  The function of PLP and DM20 in the CNS 
 
To date the precise function of PLP/DM20 has still not been fully elucidated. The 
abundance  and  transmembranous  configuration  of  PLP  in  the  myelin  sheath 
membrane  suggests  that  PLP  has  a  structural  function  and  provides  the 
compaction and stability to the myelin sheath (Boison et al., 1995). Plp1 gene 
mutants  often  show  a  hypomyelination  and  an  altered  myelin  periodicity, 
especially  as  condensed  intraperiod  lines  (Duncan  et  al.,  1987;Yool,  2000). 38 
Furthermore PLP/DM20 mediates the provision of trophic support for axons. Mice 
containing a Plp1 null allele myelinate relatively normally but develop a late 
onset  axonal  pathology,  suggesting  a  supportive  role  of  glial  cells  for  axonal 
integrity (Griffiths et al., 1998). The PLP protein structure also shows similarities 
to ion channel proteins and in vitro data suggests that PLP isoforms may act as 
ionophores (Diaz et al., 1990;Mobius et al., 2008). 
 
DM20 is expressed during embryonic development and also during myelination. 
The  presence  of  Dm20  transcripts  in  a  subset  of  OPCs  during  embryonic 
development  suggests  that  DM20  is  involved  in  embryonic  oligodendrocyte 
development  (Dickinson  et  al.,  1996).  However,  Plp1  knockout  mice  are  not 
deficient in oligodendrocytes. 
 
1.5.2.2 Pelizaeus-Merzbacher disease 
 
PMD  (OMIM  312080)  and  the  allelic  form  SPG2  (OMIM  312920)  are  X-linked, 
recessive leukodystrophies caused by mutations in the PLP1 gene. The severity 
of the disease is to some extent dependent on the precise mutation (Cailloux et 
al., 2000;Garbern, 2007).  So far over 100 different mutations in the PLP1 gene 
have  been  identified,  including  duplication  of  the  gene,  null  mutation  and 
various  missense  mutations  (Hudson  et  al.,  2004).  The  clinical  signs  include 
nystagmus,  psychomotor  developmental  retardance,  stridor,  spasticity, 
cerebellar  symptoms,  mental  deterioration,  seizures  and  optical  atrophy 
(Seitelberger, 1995). The marked spectrum of clinical severity of the disease has 
led to the classification of the PMD into three main categories  (Seitelberger, 
1995): 
 
1.) Type I, which is the connatal form with early onset and rapid progression 
leading to death within the first two years of life 
 
2.) Type  II,  which  is  the  classical  form  with  an  early  onset  and  slow 
progression with a survival rate up to 40 + years 
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3.) Type  III,  which  is  an  intermediate  form  between  Type  I  and  II,  with 
survival rates up to early adolescence  
 
The variety of mutations in the PLP1 gene causing PMD may explain, in part, the 
clinical spectrum of disease severity, ranging from severe lethal to mild, late 
onset forms (reviewed in Koeppen and Robitaille, 2002). 
 
The pathology of PMD consists of a generalised, symmetric hypomyelination of 
the  CNS  with  reduced  numbers  of  oligodendrocytes  and  a  dense  fibrillary 
astrocytosis.  Regions  with  myelin  patches  are  sometimes  present  and 
macroscopically visible. Neuronal architecture appears normal. Ultrastructurally 
the compaction and lamellar order of the myelin sheath may appear abnormal. 
The PNS is unaffected and myelinates normally. In the acute connatal form the 
CNS is severely hypomyelinated (Seitelberger, 1995). 
 
Due to the X-linked mode of inheritance, males are predominantly affected and 
females act, in general, as unaffected carriers. However juvenile (Hodes et al., 
1995) and adult (Hodes et al., 1997) PMD has also been observed in females. Due 
to random X-inactivation in females, female carriers are chimeric at the PLP1 
locus.  Most  females  do  not  develop  clinical  disease  despite  50%  of 
oligodendrocytes potentially being affected by the mutation.  The observation 
made in jimpy mice, where the genetically altered oligodendrocytes die during 
post  natal  development  (Kagawa  et  al.,  1994)  and  are  replaced  by  the 
oligodendrocytes  expressing  the  wild  type  Plp1  gene,  may  provide  an 
explanation.  Whether  the  situation  is  similar  in  humans  is  unknown,  but 
assuming so the survival of individual cells most likely depends on the nature of 
the  mutation  (Koeppen  and  Robitaille,  2002),  since  cells  harbouring  a  mild 
mutation are more likely to survive than those with a severe mutation (Edgar et 
al., 2002). 
 
1.5.2.2.1  Genetic basis of PLP1 gene related disorders in man 
 
The first PLP1 gene abnormalities leading to PMD to be identified were point 
mutations (Gencic et al., 1989;Hudson et al., 1989;Trofatter et al., 1989). To 40 
date more than 100 point mutations causing PMD have been identified (reviewed 
in  Woodward,  2008;Garbern  et  al.,  1999).  Recently,  PLP1  deletion  or  loss  of 
function (Raskind et al., 1991) and PLP1 gene duplication (Inoue et al., 1999) has 
been linked to PMD (Inoue et al., 1996a). PLP1 gene duplication accounts for 60 – 
70%  of  PMD  cases  (Sistermans  et  al.,  1998).  Duplication  (or  occasionally, 
triplication) of the PLP1 gene is probably caused by unequivocal sister chromatid 
exchange  during  meiosis  in  the  male  (Inoue  et  al.,  1999;Mimault  et  al., 
1999;Yool et al., 2000). 
 
From the disease severity point of view the missense mutations, which result in 
non-conservative amino acid substitution, often cause the most severe form of 
PMD, whereas PLP1 gene duplication in general causes a moderate form and in 
the case of PLP1 gene deletion or loss of function mutations, a mild form of PMD 
(reviewed  in  Woodward,  2008).  The  effect  of  PLP1  gene  overexpression  or 
deletion further suggests that altered gene regulation plays a role in the PMD 
pathogenesis. In short, gain of function or cytotoxic effects of PLP are believed 
to  be  largely  responsible  for  early,  more  severe  forms  with  dysmyelination, 
whereas loss of function is seen in relation with the later milder forms, where 
mainly CNS and PNS demyelination is observed (reviewed in Woodward, 2008). 
 
Presumptive diagnosis of PMD is made based on clinical signs and white matter 
changes detected on MRI. Final diagnosis can often be achieved with specific 
genetic tests. Since most of the cases are caused by PLP1 gene overexpression, 
interface fluorescence in situ hybridisation (FISH) technique (Woodward et al., 
1998) is the first choice to apply on suspected PMD cases. If FISH turns out to be 
normal,  PLP1  gene  sequencing  is  used  to  identify  mutations  (reviewed  in 
(Woodward,  2008).  However  in  about  20%  of  all  suspected  PMD  cases  no 
abnormalities  are  detected,  which  suggests  that  either  changes  in  regulatory 
sequences or other loci can cause PMD (reviewed in Woodward, 2008). 
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1.5.2.3 Plp1 gene related disease in animals 
 
1.5.2.3.1  Plp1 gene mutation in animals 
 
Plp1 gene mutations has been described in various species such as the mouse 
(Plp
jp (Nave et al., 1987a), Plp
jp-4 (Pearsall et al., 1997), Plp
jp-msd (Gencic and 
Hudson,  1990),  Plp
jp-rsh  (Schneider  et  al.,  1992)),  the  rat  (Plp
md  (Boison  and 
Stoffel, 1989;Duncan et al., 1987)), the dog (Plp
sh Nadon et al., 1990) and the 
rabbit (Plp
pt (Tosic et al., 1994), Table 1). 
 
The jimpy mouse harbours a point mutation in intron 4 of the Plp1 gene leading 
to aberrant RNA processing by disrupting the 3’ acceptor splice site, which leads 
to a deletion of exon 5. This produces a truncated protein with a novel cysteine 
rich carboxy terminus (Nave et al., 1987a). The other mutants harbour Plp1 gene 
point mutations, which lead to amino acid substitutions.  
 
Most  of  these  mutants  develop  a  severe  hypomyelination  of  the  CNS,  often 
accompanied by a loss of oligodendrocytes, microglial proliferation (Vela et al., 
1996) and astrocytic hypertrophy (Billings-Gagliardi et al., 1995;Harsan et al., 
2007). Clinically, the affected animals develop tremors, ataxia and seizures and 
in general die prematurely (Thomson et al., 1997). However, rumpshaker mice 
show a mild phenotype with a normal life span (Griffiths et al., 1990;Thomson et 
al., 1997;Edgar et al., 2004a). Nevertheless, the clinical course depends on the 
genetic background of the mouse (Al-Saktawi et al., 2003). 
 
Although profoundly hypomyelinated, some axons still contain a myelin sheath. 
The  ultrastructure  of  these  myelin  sheaths  in  mutants  is  often  abnormal, 
apparent as thin and loosely compacted sheaths. In the md rat for example, the 
intraperiod line becomes condensed, which leads to a measurable reduction in 
the periodicity from 11 nm in the wild type to 9 nm in the md rat (Duncan et al., 
1987). 
 
The reason for the hypomyelination in the jimpy mouse, the msd mouse or the 
md  rat  is  considered  to  be  the  result  of  an  increased  apoptosis  of  mature 42 
oligodendrocytes, although the numbers of immature oligodendrocytes is normal 
(Gow et al., 1998;Nadon and Duncan, 1995;Skoff, 1995;Cerghet et al., 2001). 
The  situation  in  the  shaking  pup  dog  appears  to  be  different,  where  the 
oligodendrocytes  remain immature  and  fail  to  myelinate  (Nadon  and  Duncan, 
1996). 
 
Different studies have focused on the intracellular effects of abnormal Plp1 gene 
function  due  to  point  mutations  (Gow  et  al.,  1998;Southwood  et  al., 
2002;McLaughlin  et  al.,  2007;  reviewed  in  Woodward,  2008).  In  the  variants 
caused  by  missense  mutations  of  the  Plp1  mouse/rat  gene  the  mutant  PLP 
appears  to  accumulate  in  rough  endoplasmatic  reticulum  and  Golgi  vesicles 
causing  endoplasmic  reticulum  stress,  which  activates  the  unfolded  protein 
response (UPR) and eventually leads to oligodendrocytic death (Cerghet et al., 
2001; reviewed in Woodward, 2008). Mutated PLP protein appears to be poorly 
tolerated  by  the  oligodendrocyte  and  apoptosis  appears  to  be  the  main 
mechanism preventing the synthesis of a potentially abnormal myelin sheath. 
 
1.5.2.3.2  Transgenic animals  
 
1.5.2.3.3   Plp1 gene deletion, null alleles and knock out models 
 
In  models  with  Plp1  gene  deletion  or  loss  of  function,  myelin  development 
initially appears normal. However, with age a progressive axonopathy develops. 
The  late onset  of axonal  degeneration is believed to be caused  by  disrupted 
axonal  glial  interaction  resulting  from  a  lack  of  PLP/DM20  (Griffiths  et  al., 
1998;Yool, 2000). 
 
These  observations  further  highlight  the  multifaceted  effects  of  Plp1  gene 
mutations and that PLP does not only play a structural role in myelin sheath, but 
is also involved in axono-glial interactions and oligodendrocyte-mediated axonal 
support. 
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1.5.2.3.4  Plp1 gene overexpressing animals 
 
PLP1 gene duplication is considered to be the major cause of PMD (Sistermans et 
al., 1998) and is characterised by a dysmyelination of the CNS  (Seitelberger, 
1995). So far, no spontaneous model with Plp1 gene overexpression has been 
described. There are three transgenic engineered mouse models overexpressing 
the  entire  Plp1  gene,  the  4e  (Kagawa  et  al.,  1994)  the  #66  and  the  #72 
(Readhead  et  al.,  1994)  mouse  model,  each  with  different  numbers  of  extra 
copies of the Plp1 gene (Table 1). The extra copies, including all the exonic 
sequences linked to 5’ and 3’ gene flanking sequences of the murine Plp1 gene, 
were  inserted by  pronuclear  microinjection  and  randomly  integrated into  the 
genome (Readhead et al., 1994;Kagawa et al., 1994). The 4e contain 2 (Kagawa 
et al., 1994), the #72 contain 3 (Readhead et al., 1994) and the #66 contain 7 
extra Plp1 gene copies (Readhead et al., 1994) per haploid genome. All three 
homozygote  models  develop  hypomyelination  with  associated  tremors  and 
seizures  (Inoue  et  al.,  1996b;Readhead  et  al.,  1994;Anderson  et  al., 
1999;Kagawa et al., 1994). However the severity of the phenotype is markedly 
different; the homozygous 4e and #66 develop early clinical signs and die around 
60 days of age whereas the homozygous #72 shows a slower disease progression 
in which clinical signs appear later and die around 120 days of age. The mRNA 
level in these animal models does not correlate with the number of Plp1 gene 
copies and some of these transgenes are probably less effectively transcribed 
than others (Kagawa et al., 1994;Inoue et al., 1996b;Readhead et al., 1994). 
 
Hemizygotes from all three lines, on the other hand, appear to develop normally 
and produce similar levels of myelin compared to the wild type. With age, a 
progressive  demyelination  of  the  CNS  becomes  apparent  in  the  hemizygotes 
(Inoue et al., 1996b;Anderson et al., 1998;Ma et al., 2006). The demyelination is 
accompanied  by  axonal  changes  such  as  axonal  swellings,  which  are  mainly 
present in tracts with small diameter fibres. 
Transgenic  animals,  which  overexpress  only  Dm20  have  also  been  generated 
(Johnson et al., 1995;Mastronardi et al., 1993). These mice also develop a late 
onset demyelination with age and the disease severity is dependent on the level 
of Dm20 overexpression. There appears to be no correlation between the level 
of Dm20 overexpression and DM20 protein levels (Johnson et al., 1995).   44 
Line  Source 
Structural  gene 
unit 
Haploid  copy 
number 
Reference 
#66  Mouse  7 exons / 6 introns  7 
(Readhead  et  al., 
1994) 
#72  Mouse  7 exons / 6 introns  3 
(Readhead  et  al., 
1994) 
4e  Mouse  7 exons / 6 introns  3 
(Kagawa  et  al., 
1994) 
PlpTg1  Human  Plp – cDNA  30 
(Nadon  et  al., 
1994) 
Dm20Tg2  Human  Dm20 – cDNA  ? 
(Nadon  et  al., 
1994) 
ND3a  Human  Dm20 – cDNA  17 
(Mastronardi et al., 
1993) 
ND4  Human  Dm20 – cDNA  70 
(Johnson  et  al., 
1995) 
 
Table 1.  Transgenic animals overexpressing Plp genomic transgenes and 
human cDNA transgenes (Yool, 2000). 45 
1.5.2.3.5  Pathogenesis in Plp1 gene overexpression  
 
The situation in Plp1 overexpressing mouse models is different to that in the 
point  mutations.  With  low  Plp1  gene  copy  numbers,  relatively  normal 
myelination takes place during post natal development and the formed myelin 
appears ultra-structurally normal. However with increasing numbers of copies of 
the  Plp1  gene,  the  CNS  pathology  becomes  more  severe,  with  marked 
dysmyelination  occurring  during  post  natal  development  (Kagawa  et  al., 
1994;Anderson et al., 1998;Anderson et al., 1999;Readhead et al., 1994). The 
homozygous #72 mouse, which is the subject of this PhD thesis, with 3 extra 
copies of Plp1 gene per haploid, has a relatively mild degree of dysmyelination 
in development that is followed by progressive demyelination, at least in the 
optic nerve (Anderson et al., 1998;Anderson et al., 1999;Edgar et al., 2010;Inoue 
et al., 1996b). The effect on disease severity of Plp1 gene overexpression is not 
only dependent on the numbers of Plp1 gene extra copies but most likely also on 
modifying  loci  (Inoue  et  al.,  1999).  A  prominent  astrogliosis  and  microglial 
response have also been described in relation to Plp1 gene overexpression (Ma et 
al.,  2006;Tatar  et  al.,  2010)  and  has  been  suggested  to  contribute  to  the 
progression and severity of the demyelination process (Ip et al., 2007;Ip et al., 
2006). 
 
1.5.2.3.6  Biochemical changes related to Plp1 gene overexpression 
 
 A study investigating the biochemical effect of Plp1 gene overexpression in cell 
lines  has  shown  substantial  disruption  in  myelin  protein  transport  and 
distribution  (Simons  et  al.,  2002).  The  overexpression  of  Plp1  leads  to 
accumulation of PLP and cholesterol in late endosomes and lysosomes (Simons et 
al.,  2002).  In  PLP  overexpressing  cells,  sphingolipids  become  missorted  from 
their normal location in the Golgi apparatus (Simons et al., 2002).  
 
Using spinal cord and brain from a Plp1 gene overexpressing mouse model (line 
#66), Karim et al. showed that PLP/DM20 accumulates in the cell body and is 
reduced  in  myelin  (Karim  et  al.,  2007).  This  study  also  reported  that  the 46 
overexpression of the Plp1 gene significantly reduced MBP steady state levels in 
myelin, emphasizing that overexpression of the Plp1 gene causes an imbalance 
in the assembly of myelin components (Karim et al., 2007). Further in vitro and 
in  vivo  investigation  of  oligodendrocytes  from  homozygous  #66  and  #72  mice 
confirmed the perturbed trafficking and assembly of PLP/DM20 into myelin and 
lipid rafts. Ultra structural investigation showed an increase of autophagosomes, 
which  are  thought  to  function  as  a  storage  vehicle  for  over  synthesised 
PLP/DM20, in oligodendrocytes. The severity of the ultra-structural changes in 
the oligodendrocyte cell body was gene dose dependent (Karim et al, 2010).  
 
The  biochemical  changes  in  myelin  in  the  Plp1  gene  overexpressing  mouse 
models  are  believed  to  result  in  disturbed  myelin  formation,  leading  to 
perturbation  of  myelin  and  oligodendrocyte  development  (Readhead  et  al., 
1994;Kagawa et al., 1994;Inoue et al., 1996; Simons et al., 2002:Karim et al., 
2007, Karim et al, 2010). The different biochemical and morphological changes 
that are evident suggest that disruption of normal protein distribution leads to 
impaired cell function and results in abnormal morphological development. 
 
1.5.3 Demyelination in Plp1 overexpressing mice 
 
Plp1 overexpression has an adverse effect on normal myelin maintenance, which 
over time leads to instability of the myelin sheath, progressive demyelination, 
an inflammatory response and axonal changes  (Inoue et al., 1996b;Kagawa et 
al., 1994;Anderson et al., 1999;Edgar et al., 2010;Readhead et al., 1994). The 
findings of some studies using transgenic models with a low number of Plp1 gene 
extra  copies  or  just  overexpression  of  Dm20  gene,  suggest  that  these  mouse 
models  may  mimic  chronic  MS  demyelinated  lesions  and  might  provide  new 
insights  into  the  development  of  remyelination  failure  (Ma  et  al., 
2006;Mastronardi et al., 1993). So far no detailed description of the temporal 
and  spatial  pathological  development  and  progressive  demyelination  in  Plp1 
gene overexpressing mouse models has been published, except in the optic nerve 
(Edgar et al., 2010), although other studies have shown that the spinal cord is 
demyelinated in older mice (Inoue et al., 1996b;Kagawa et al., 1994;Anderson et 
al.,  1998;Readhead  et  al.,  1994).  The  spontaneous  demyelination  and  the 47 
development  of  chronic  demyelinated  regions  are  of  high  interest.  Major 
intracranial white matter tract, such as the corpus callosum, have been shown 
to have reduced myelin content in the adult #72 mouse (Ruest et al., 2011) and 
hemizygote 4e model (Ma et al., 2006), but the development of the pathological 
process in these two models has not been described to date.  Considering the 
myelin phenotype in these animals, the relative clinical normality of the #72 
mice up to 90 days is remarkable. After 90 days the mice show a subtle tremor 
and generalised mild ataxia with seizures, which eventually leads to premature 
death.  The  relatively  late  development  of  clinical  deficits  suggests  that  post 
natal development is largely normal but is followed by apparently progressive 
clinical  signs,  suspicious  of  a  progressive  demyelination,  presumably  without 
repair. 
 
1.6  Use of MRI in diagnosing white matter changes 
 
One of the difficulties in monitoring the progression of white matter lesions in 
vivo (including the effect of any intervening therapy) has been visualising the 
CNS.  In  the  past  the  full  distribution  and  extent  of  the  pathology  was  only 
evident  at  the  point  of  necropsy.  With  the  advent  of  advanced  imaging 
modalities  including  magnetic  resonance  imaging  (MRI),  the  diagnosis  and 
monitoring of white matter lesions in vivo has become possible. In the case of 
multiple  sclerosis,  MRI  has  resulted  in  improved  accuracy  of  diagnosis, 
localisation and monitoring of the course of white matter pathology (Ciumas et 
al.,  2008;Fox,  2008).  Repeated  MRI  allows  mapping of  lesion  distribution  and 
provides the ability to compare temporal changes in lesion size and location. 
One major disadvantage of conventional MRI sequences in the characterisation 
of  white  matter  pathology  is  the  inability  to  distinguish  between  different 
pathological changes, in particular between areas of acute active inflammation 
with ongoing demyelination and inactive, chronically demyelinated areas (Fox, 
2008;Inglese  et  al.,  2005b;Inglese  et  al.,  2005a).  A  modality  capable  of 
distinguishing these two different stages of white matter pathology would have a 
major  impact  on  monitoring  disease  development,  treatment  regime  and 
accurate  prognosis  for  the  affected  patient  and  would  also  allow  better 
monitoring of experimental models of demyelination. 48 
Advanced MRI techniques such as magnetisation transfer imaging (MTI), magnetic 
resonance spectroscopy (MRS) and diffusion weighted MRI (DW MRI) are being 
used to detect pathological changes in relation to the myelin sheath (reviewed 
in  Zivadinov  and  Cox,  2007).  The  most  commonly  used  technique  in  clinical 
settings is MTI, which is based on the interaction between unbound free protons 
in water and protein bound molecules (reviewed in  Horsfield, 2005). MTI  has 
proven useful in evaluating lesion type in MS and EAE and correlations have been 
found with regard to lesion development (reviewed in Horsfield, 2005;Zivadinov 
and Cox, 2007). However, not only myelin, but also inflammation, is responsible 
for protein-proton interaction and the value of MTI in distinguishing inflamed 
from non-inflamed demyelinating lesions is therefore still speculative. 
 
Magnetic  resonance  spectroscopy  has  mainly  been  used  in  neurodegenerative 
disorders (reviewed in Zivadinov and Cox, 2007). MRS in MS has not yet been 
used  extensively,  but  it  has  been  demonstrated  that  inflammation  correlates 
with  increased  choline,  lactate  and  lipid  peaks,  whereas  axonal  damage 
correlates with an increased N-acteylaspartate (NAA) peak. MRS is considered to 
be helpful in detecting axonal damage and could become valuable in specifically 
detecting  progressive  axonal  degeneration  (reviewed  in  Zivadinov  and  Cox, 
2007).  
 
The  DW  MRI  technique  utilises  the  movement  of  molecular  water  within  the 
tissue. The motion of water molecules is caused by the natural phenomenon of 
random  thermal  motion  of  molecules,  also  referred  to  as  Brownian  motion 
(reviewed in Mori and Zhang, 2006;Zivadinov and Cox, 2007). In pure water, the 
water molecules can move around freely. Water molecules in tissue, however, 
are restricted in movement, with this restriction depending on the composition 
of the surrounding tissue. Cell type, cell number, cell integrity and extracellular 
composition all contribute to the water diffusivity. White matter is a complex 
network composed of axons, myelin sheaths and the associated supporting cell 
populations of oligodendrocytes, astrocytes, microglia, trafficking immune cells 
and  OPCs.  All  these cells  could  potentially  influence  the  Brownian  motion  of 
water molecules. In normal tissue axons have the most pronounced effect on 
water diffusivity (Basser and Pierpaoli, 1996;Beaulieu and Allen, 1994;Beaulieu, 
2009;Zivadinov and Cox, 2007), but myelin and, in all probability, the density of 49 
the supporting cell population also contribute substantially to the direction of 
water  diffusivity.  Since  axons  in  specific  tracts  are  arranged  in  a  parallel 
fashion, DTI becomes useful for fibre tract examination and tracking. In these 
white  matter  tracts,  the  parallel  nature  of  the  nerve  fibres  leads  to  a  net 
movement of water molecules parallel to the axonal alignment and this can be 
detected  and  measured  by  DTI  sequences  (Alexander  et  al.,  2007).  The  high 
sensitivity of the sequence for water molecule diffusion may also be used to 
identify pathological states of white matter or pathological process interfering 
with  the  normal  course  of  water  diffusion  along  axons  (Laule  et  al.,  2007). 
However, distinguishing between chronic demyelination and active inflammation 
with ongoing demyelination has not been fully elucidated. 
 
1.6.1 The  homozygote  #72  optic  nerve  as  a  model  to  evaluate  the 
ability  of  MRI  techniques  to  detect  specific  white  matter 
pathological states 
 
Ideally a mouse model in which an inflamed demyelinated and a chronic non-
inflamed  “silent”  demyelination  exists  simultaneously  along  one  major  white 
matter tract would be used to evaluate the sensitivity of novel MRI techniques to 
detect  different  white  matter  lesion  types.  The  adult  #72  homozygote  optic 
nerve,  with  spatially  distinct  regions  of  active  and  complete  demyelination 
(Edgar et al., 2010), is as an ideal model to evaluate MTI, MRS or DW MRI. 
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1.7  Aim of the thesis 
 
The study aims are 
 
1.) To describe the temporal histological changes in white matter elements in 
the corpus callosum in the #72 mouse model in order to understand the 
nature  and  progression  of  the  pathology  that  leads  to  profound 
hypomyelination in this model. 
 
2.) To evaluate changes in OPC intrinsic and extrinsic factors in relation to 
the reduced myelin content using in vivo and in vitro strategies. 
 
3.) To use the optic nerve of the #72 mouse model of PMD to test if DW MRI 
techniques can distinguish between specific white matter lesion types. 
 
The  results  of  these  three  chapters  will  be  critically  assessed  and  future 
areas,  where  the  findings  can  be  integrated  and  which  could  induce  new 
work, will be discussed in the final discussion of the thesis. 
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2  Material and Methods 
 
2.1  Miscellaneous 
 
All  experiments  were  carried  out  according  to  the  guidelines  laid  out  in  the 
Animals  Scientific Procedures  Act  under  a project  license  from the UK  Home 
Office, and were approved by the local Ethics and Welfare review panel of the 
Faculty of Veterinary Medicine, University of Glasgow. 
 
Inorganic  chemicals  were  of  molecular  biology  grade  and  were  sourced  from 
Sigma  or  VWR.  Solutions  were  sterilised  as  appropriate.  Bulk  solutions  were 
autoclaved using a stovetop steam autoclave (Prestige classic steam autoclave 
2100,  Prestige  Medical  UK).  Small  volumes  and  fluids  that  could  not  be 
autoclaved  were  either  filter  sterilised  through  a  0.2µm  filter  (Minisart  Plus 
filter,  Sigma  Aldrich  17823K)  in  a  sterile  laminar  flow  hood  (Biogen)  or  UV 
sterilised, where each sample was placed in a UV steriliser for twelve minutes. 
Gloves,  eye  protection  and  protective  clothing  were  worn  when  appropriate. 
Fixatives,  volatile  liquids  and  toxic  powders  were  prepared  in  a  specifically 
designated fume cupboard. 
 
Details of the preparation of fixatives, stains, buffers, staining and processing 
protocols can be found in the Appendix and are cross referenced by page number 
in this section. 
 
2.2  Mouse breeding 
 
2.2.1 Animal breeding facilities 
 
Mice  were  bred  in  designated  animal  breeding  facilities,  Biological  Services, 
Faculty of Veterinary Medicine, University of Glasgow. Picorna virus and murine 
hepatitis virus infections have occurred in the past within the unit and both are 
known to be associated with neurological disease in mice (Fujiwara, 1994;Lipton 52 
et al., 1994). During the period of the study, there was no evidence of clinical 
disease. The wild type mice did not show the phenotype and pathology seen in 
the transgenic mice. 
 
2.2.2 Transgenic mouse lines 
 
2.2.2.1 The Plp1 transgenic overexpressing #72 transgenic mouse line 
 
72 transgenic mice were generated by (Readhead et al., 1994). A rat Plp1 cDNA 
probe  was  used  to  isolate  the  murine  Plp1  gene  from  a  cosmid  library.  The 
isolated murine Plp1 gene was used to generate a purified 26.6 kb Cla1 fragment 
that contains the transgene construct including 3.5 kb of the PLP 5’ regulatory 
region and a transgene unique T7 promoter at the PLP 3’ region. To generate 
transgenic  mice,  pronuclear  microinjection  into  BDF2-fertilized  ova  of  the 
transgene  cassette  was  performed.  Two  transgenic  lines  were  produced 
containing  intact  Plp1  transgenes,  the  66  and  the  72  line.  These two  lines 
were assessed by southern blotting, estimating seven copies in the 66 line and 
three copies in the 72 line per haploid genome. The transgene cosegregated in 
subsequent  generations  in  an  autosomal  inheritance  pattern  suggestive  of 
tandem integration at autosomal sites (Readhead et al., 1994). In our study we 
only used the 72 line on a C57BL/6N (Charles River) background, containing 6 
extra copies of the Plp1 gene in the homozygote mouse (Figure 3). 
 
2.2.2.2 The  Plp1  transgenic  and  cyan  fluorescing  protein  (Thy-1  CFP) 
expressing mouse line 
 
Mice expressing cyan fluorescence protein (CFP) under the Thy1 reporter gene 
(B6.Cg-Tg(Thy1-CFP)23Jrs ⁄J) produced by (Feng et al., 2000) were introduced 
into the Plp1 transgenic 72 mouse line on a C57BL/6N background and bred for 
more than six generations. In the CNS, Thy1 is mainly expressed in neurons. The 
CFP gene has been inserted into the Thy1.2 gene excluding part of exon 2 and 4, 
completely  excluding  exon  3  and  the  flanking  introns  of  exon  3  (Caroni, 53 
1997;Feng  et  al.,  2000).  The  product  was  introduced  by  pronuclear 
microinjection into fertilised oocytes obtained from mating C57BL/6J with CBA 
hybrids (Feng et al., 2000). Although Thy1 is expressed in most neurons (Kollias 
et al., 1987;Vidal et al., 1990), it has been observed that in the transgenic Thy1 
CFP mice generated by Feng et al., the CFP expression is limited to a certain 
subset of neuronal cells. About 25 different founder lines have been described so 
far (Feng et al., 2000). The reason for the variable expression pattern in the 
different  lines  is  not  clear  but  is  thought  to  most  likely  be  due  to  genetic, 
epigenetic and stochastic components on transgene expression in relation to the 
insertion site of the CFP transgene copies (Feng et al., 2000). However, the CFP 
expression from a specific line does not vary in the following generations (Feng 
et al., 2000). In our Thy 1-CFP expressing mouse line, only a subset of motor and 
sensory  neurons  express  CFP.  Therefore  not  all  axons  in  the corpus  callosum 
express  CFP.  CFP  is  located  unbound  in  the  cytoplasm  and  is  distributed  in 
neuronal cell bodies, axons and dendrites (Feng et al., 2000). The fluroescing 
protein  tends  to  accumulate  in  axonal  swellings,  which  are  early  changes  in 
axonal pathology. Therefore, CFP expressed in axons can be used as a sensitive 
marker for early axonal changes. 
 
The  newly  created  mouse  line  carries  the  Plp1  transgene  and  the  Thy1-CFP 
transgene (CFP+/Plp1+). Only CFP positive male mice were used in the current 
study.  The  group  of  neurons  expressing  CFP  can  be  readily  detected  under 
epifluorescence microscopy without further processing. Due to the fluorescence 
microscope filters used in the Olympus IX-70, CFP appears green instead of blue. 
To increase the probability of producing homozygous  Plp1 overexpressing and 
CFP positive samples for transplantation studies the CFP+/Plp1+ line was mated 
with a homozygote #72 mouse (Figure 4). 
 
2.2.2.3 The green fluorescent protein (β-actin GFP) expressing mouse line 
 
The GFP expressing mouse line containing the reporter gene GFP, was generated 
by (Ikawa et al., 1995). The GFP transgene was linked to the chicken β-actin 
promoter possessing a cytomegaly virus enhancer (Ikawa et al., 1995). The GFP 
construct  was  introduced  by  microinjection  into  male  pronuclei  of  B6C3F1 54 
fertilized  oocytes.  The  resulting  offspring  expressed  GFP  under  a  β-actin 
promoter. In the cell, GFP is located unbound in the cytoplasm  (Ikawa et al., 
1995) and is detected under UV light without additional processing. In vivo GFP 
positive pups can be detected easily by exposing them to ultraviolet (UV) light, 
where the pups display green fluorescence (Figure 4).  
 
2.2.2.4 The Plp1-LacZ fusion protein transgenic mouse line 
 
Mice harbouring a Plp1-LacZ fusion gene were generated by (Wight et al., 1993). 
The Plp1-LacZ transgene contains the proximal 2.4 kb of 5’-flanking Plp DNA, 
exon1, intron 1 and the first 37bp of exon 2 ligated to a trpS-LacZ fusion gene 
and SV-40 polyadenylation signal. The transgene was introduced by pronuclear 
microinjection  into  BDF2  fertilised  mouse  oocytes  (Wight  et  al.,  1993).  The 
resulting transgene product is a protein where β-galactosidase is fused to 13 
amino  acids  from  the  NH2-terminal  of  PLP  and  is  only  expressed  when  PLP 
expression occurs. The fusion of β-galactosidase with the thirteen amino acids 
from  the  NH2-terminal  of  PLP  is  sufficient  for  the  transgene  product  to  be 
integrated into the myelin sheath (Wight et al., 1993) and is a marker of myelin 
sheaths (Figure 5). 
2.2.3 Maintenance of transgenic lines of mice 
 
The Plp1 overexpressing #72, Thy-1 CFP/Plp1, β-actin GFP and Plp1- LacZ lines 
of transgenic mice were maintained by creating colonies of transgene positive 
animals with a C57BL/6N background. 
 
2.2.3.1 Maintenance of the #72 mouse line 
 
For  the  histopathological  evaluation  of  the  #72  corpus  callosum  and  the  MRI 
study,  non-litter  mate  72  hemizygote  mice  on  a  C57BL/6N  (Charles  River) 
background  were  bred  to  generate  homozygote,  hemizygote  and  wild  type 
offspring. Only homozygote and wild type mice were used for the experiments.  
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For  the  cell  intrinsic  and  cell  extrinsic  pathway  evaluation  experiments,  cell 
culture  experiment  and  the  transplant  study,  homozygote  Plp1  gene 
overexpressing  #72  males  were  mated  with  homozygote  Plp1  gene 
overexpressing  #72  females  to  generate  homozygote  samples  and  wild  type 
males were mated with wild type females to generate wild type samples.  
 
To identify homozygote #72 mice at an early stage (P30) to establish the specific 
homozygote  #72  lineage,  genotyping  using  quantitative  real  time  PCR  to 
ascertain gene copy number and therefore identification of homozygote animals 
was outsourced to Embark Scientific. To confirm that the line contained the Plp1 
transgene, amplification by PCR was performed as described below. At regular 
intervals, breeding mice from this line were killed by a schedule 1 method and 
the  optic  nerves  were  dissected  and  examined  to  confirm  that  the  line  was 
homozygous  for  the  transgene.  The  optic  nerve  of  homozygous  mice  appears 
relatively transparent compared to the nerve of wild type or hemizygous mice 
 
2.2.3.2 Maintenance of the CFP+/Plp1+ mouse line  
 
For  histopathological  evaluation  of  the  axons  in  the  #72  mouse  during 
demyelination and after transplantation of neurospheres, the  CFP Thy-1 mice 
were crossed with transgene positive  72 mice with a CL57BL/6N background 
(Charles River) for at least six generations. The newly created mouse line was a 
carrier of the Plp1 transgene and the Thy1-CFP transgene (CFP+/Plp1+). For the 
transplant  study,  the  CFP+/Plp1+  line  was  always  mated  with  a  known 
homozygote  #72  mouse  in  order  to  increase  the  probability  of  producing 
homozygote Plp1 overexpressing and CFP fluorescing samples. Only CFP and Plp1 
transgene positive male mice were used for this specific study. 
2.2.3.3 Maintenance of the GFP expressing mouse line 
 
For generation of a GFP expressing mouse line, a male mouse expressing the 
reporter gene GFP was crossed with a wild type female from the #72 line with a 
C57BL/6N  (Charles  River)  background.  For  generation  of  GFP  expressing 56 
neurospheres and GFP expressing OPCs only GFP+ #72 wild type male pups were 
used. 
 
2.2.3.4 Maintenance of the LacZ expressing mouse line 
 
In order to generate neurospheres,  expressing β-galactosidase under the  Plp1 
promoter, P1 pups from -homozygous Plp1-LacZ mice on a C57BL/6 background 
were used. 
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Figure 3.  Schematic representation of the Plp1 #72 transgene. 
a) Genomic organization of the transgene construct. The Plp1 exons are depicted as numbered 
cylinders, dark grey regions represent the coding regions. The transgene specific T7 promoter is 
shown as a green cylinder  
b) Endogenous Plp1 allele of a wild type mouse lacking the transgene specific T7 promoter. The 
Plp  primer  (red  arrow)  binds  to  the  Plp1  gene.  However  as  the  T7  promoter  is  absent,  the 
reverse T7 primer cannot bind to the DNA, accordingly no PCR product can be amplified.  
c) The 3/ end of Plp1 transgene with the T7 promoter. The Plp1 primer (red arrow) and the T7 
primer (green arrow) will generate a PCR product of approximately 400bp readily detectable by 
ethidium bromide gel electrophoresis (modified from Yool, 2000). 
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Figure 4.  Schematic representation of CFP and GFP transgene constructs. 
a) Schematic representation of CFP Thy1 transgene. Exons are numbered and are coloured in 
dark grey and the CFP gene in turquoise. The CFP gene was inserted into the Thy1.2 gene as a 
construct comprising part of exon 2 and full length exon 4 (Caroni, 1997;Feng et al., 2000).  
b) Schematic representation of GFP β-actin transgene. Expression of the GFP β-actin transgene is 
driven by a combination of two regulatory elements comprising a cytomegaly virus (CMV-IE, light 
grey cylinder) enhancer and a chicken – β- actin promoter (dark cylinder).  A rabbit β-globin 
polyadenylation signal (dark grey) is inserted in the 3
/ end of the GFP transgene (Ikawa et al., 
1995).     
 
 
Figure 5.  Schematic representation of the LacZ transgene construct. 
The construct contains exon 1, intron 1 and the first 37bp of exon 2 followed by the LacZ gene 
linked to a SV40 polyadenylation signal (Wight et al., 1993). Coding regions are in dark grey, 
LacZ transgene in blue and the SV40 polyA signal in green (modified from Yool, 2000). 
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2.3  Isolation of nucleic acid 
 
2.3.1 Tissue biopsy procedure 
 
Ear biopsies for DNA extraction were taken using an ear punch, transferred into 
an Eppendorf tube and stored at -20ºC. In the case of CFP expressing animals, 
fresh ear biopsies were used for CFP evaluation. Tissue from tail biopsies were 
place in an Eppendorf tube, stored at -20ºC and later used for DNA extraction. 
The ear biopsies were performed in a systematic manner so that the location of 
the ear punch was also used for animal identification (Figure 5). 
 
2.3.2 Extraction of genomic DNA from tissue 
 
DNA  was  extracted  from  ear  or  tail  biopsies  using  100µl  of  50mM  sodium 
hydroxide  (Fisher,  1310-73-2).  The  tissue  was  lysed  on  PHC-3  thermal  cycler 
(Techne) for 90 minutes at 95ºC, then cooled to 4ºC and neutralised using 10µl 
Tris buffer, pH 5.0 per sample (Truett et al., 2000).  
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2.4  PCR Genotyping 
 
2.4.1 PCR core programme 
 
Amplifications for genotyping were performed on a Perkin Elmer DNA thermal 
cycler 
 
1)  Initial cycle    denaturing temperature    94ºC    3min 
annealing temperature    58ºC    1min 
extension temperature    72ºC    2min 
 
2)  Step cycle    denaturing temperature    93ºC    40sec  
(35 cycles)    annealing temperature    58ºC    1min 
extension temperature    72ºC    30sec 
 
3)  Final cycle    denaturing temperature    93ºC    40sec  
      annealing temperature    58ºC    1min 
extension temperature    72ºC    2min 
 
2.4.2 Genomic PCR 
 
All plastic ware was UV treated prior to use and the work surface was wiped 
with  70%  ethanol.  A  commercially  available  polymerase  chain  reaction  assay 
(RedTaq, Sigma, R2523) was used to amplify the transgene specific product in 
the  72  mouse.  25  µl  PCR  reactions  were  carried  out  in  0.1  ml  PCR  tubes 
containing 12.5 µl RedTaq with MgCl2, 0.5 µl Plp1 primer (concentration:300nM 
in  sterile    pure  H2O),  0.5  µl  T7  primer (concentration:300nM  in  sterile   pure 
H2O), 10.5 µl sterile pure H2O and 1 µl of lysed tissue solution. The transgene 
specific marker, the T7 promoter, is attached at the 3’ end of the transgenic 
cassette.  The T7 primer (αT7 5’ GCA-TAA-TAC-GAC-TCA-CTA-TAG-GGA-TC 3’) 
recognising the T7 promoter region and the Plp1 primer (PLP 5’ CAG-GTG-TTG-
AGT-CTG-ATC-TAC-ACA-AG 3’) recognising a specific region at the 5’ end of the 61 
murine  Plp1-gene  produce  a  PCR  product  of  approximately  400bp  from  the 
transgene (Readhead, 1994).  
 
2.4.3 DNA electrophoresis 
 
Routine  analysis  of  PCR  products  was  performed  on  a  2%  agarose  gel  in  tris 
acetate  ethylene-di-amine-tetra-acetate  (TAE)  buffer.  Gels  were  made  from 
ultra-pure,  electrophoresis  grade  agarose (Invitrogen,  15510-027)  dissolved  by 
heating in 1x TAE buffer. Ethidium bromide (from a stock of 5mg/ml) was added 
to the cooling gel to give a final concentration of 0.5µg/ml. 10µl of the PCR 
product was loaded in each well. A one kb DNA ladder (Invitrogen, 15615-016) 
was used as a control for the PCR product size. In each gel a positive, a negative 
and a H2O control sample were run. PCR products were run for 25 minutes at 70 
volt.  The PCR product of approximately 400bp was visible under UV light (Figure 
6). The test was qualitative and only detected the presence or absence of the 
Plp1-transgene. Gels were viewed with an ultraviolet trans illuminator (Fotoprep 
I, Fotodyne Inc.). Gels were recorded using a digital Camera (Kaiser RA1 CCD) 
and a video graphic thermal printer (Sony UP-890CE). For colour photographs a 
Canon  G4  Powershot  digital  camera  was  used  and  the  images  were  stored 
digitally (Figure 6). 
 
2.4.4 Identification of CFP expression in Thy-1 CFP mice 
 
CFP  positive  mice  were  identified  by  evaluation  of  fresh  ear  biopsies  under 
fluorescence microscopy (Olympus IX70). The filter available was a FITC filter, 
which excites at 450nm and makes the CFP appear green. Samples containing 
green fluorescing axons in the pinna were regarded as a positive. Questionable 
and non-fluorescing tissue was regarded as negative (Figure 7). 
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2.4.5 Identification of GFP expression in β-actin GFP mice 
 
GFP positive mice were identified by exposing the new born litter to a handheld 
UV lamp in a dark room. GFP positive pups could readily be identified by green 
fluorescence of their skin. 
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Figure 6.  Representative image of a gel after electrophoresis with twelve 
PCR products, each from an individual mouse ear sample.  
A 1 kb DNA ladder (asterisk) was used to confirm the correct size of the PCR product (400bp). 
One  positive  sample  (+),  one  negative  sample  (-)  and  a  water  sample  (H2O),  were  used  as 
controls.  Lanes 1-7 and 8-12 contain test samples. Transgene positive samples are identified by 
the presence of a fluorescent band at the level around 400bp. Transgene negative samples have 
complete absence of a band. 
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Figure 7.  Identification of CFP expression was made on fresh ear biopsies. 
Image of a pinna from a CFP expressing mouse as seen under epifluorescent microscopy (Olympus 
IX-70, x10). The axons in the pinna of a CFP expressing mouse are visible as green fine lines 
running across the pinna (arrows). 65 
2.5  Experimental procedures 
 
2.5.1 Intraperitoneal injection of 5-bromo-2-deoxyuridine (BrdU) as a 
marker for cell proliferation 
 
To  evaluate  cell  proliferation  a  single  intraperitoneal  injection  of  50µg/gram 
body weight 5-bromo-2-deoxyuridine (BrdU) (Sigma, B5002) was performed one 
hour prior to euthanasia. 
 
2.5.2 Cell culture 
 
2.5.2.1 Isolation of adult OPCs from corpus callosum for culture 
 
For each OPC co-culture experiment, OPCs were isolated from two adult wild 
type GFP expressing corpus callosa and from two adult #72 homozygote corpus 
callosa. The isolated wild type OPCs were mixed with the isolated homozygote 
#72 OPCs at the same density immediately before plating down on poly-L-lysine 
coated glass coverslips. 
 
To isolate adult OPCs, P120 homozygote #72 and wild type GFP expressing mice 
were killed using CO2. Decapitation and collection of the head into a sterile Petri 
dish  was  performed  after  spraying  the  head  with  70%  ethanol.  Using  sterile 
instruments,  the  brain  was  removed  from  the  skull  cavity  and  placed  into  a 
sterile Petri dish containing 500µl of cold Leibovitz’s L15 with L-glutamine and 
without  phenol  red  (L15,  Gibco,  21083-027).  The  meninges  were  carefully 
removed before isolating the corpus callosum from each brain. Two dissected 
corpus callosa where placed on a sterile Petri dish and cut into 1mm
3 pieces. The 
cut tissue was transferred into a small sterile bijou filled with 3ml HBSS (Sigma, 
H-4891)  solution  containing  0.125%  trypsin  (Sigma,  T-3924).  30µl  of  DNAse 
(50mg/ml,  Sigma,  DN25-100mg)  was  finally  added  to  3ml  of  HBSS/Trypsin 
solution and incubated for 90 minutes in 5% CO2 at 37°C 
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After  90  minutes  the  tissue  digestion  was  stopped  by  adding  100µl  of  heat 
inactivated foetal bovine serum (HIFBS) (Invitrogen, 10082147) per 1ml solution. 
The cell emulsion was then transferred into a 15ml tube using a curved, flame 
polished glass pipette and filled with L15 containing 10% HIFBS and centrifuged 
at 1000 rpm for 10 minutes at room temperature. The supernatant was removed 
and the remaining pellet was resuspended in 2ml of L15 containing 10% HIFBS 
and triturated at least 6 times or until no tissue chunks were visible through a 
flame polished, bent glass pipette on ice. 
 
After trituration, the cell suspension was diluted to a total volume of 6.5ml using 
L15 containing 10% HIFBS in which 65µl of DNAse (50mg/ml) was added. A 90% 
Percoll® (Sigma, 4937) solution was obtained by adding an appropriate volume 
of  10x  Dulbecco’s  phosphate  buffered  saline  (Gibco,  14200-067)  to  Percoll®.  
3ml of the 90% Percoll® solution was added to the cell suspension and gently 
mixed. The solution was then transferred into an Oakridge tube and centrifuged 
at 30000g at 4°C for 30 minutes. After the centrifugation the myelin layer sitting 
on top of the gradient and some of the Percoll® gradient were removed until 
approximately 1 – 1.5cm above the red blood cell layer. The OPCs were then 
harvested immediately above the red blood cell layer. The OPC suspension was 
then  diluted  in  a  minimum  of  5ml  of  L15  containing  10%  HIFBS  before 
centrifugation at 1000rpm for 10 minutes at room temperature. The excess fluid 
was removed and the pellet was resuspended in 100µl of L15  containing 10% 
HIFBS. 10µl of the cell suspension was mixed with 10µl trypan blue and placed 
into a haemocytometer for cell counting. Following the cell count the remaining 
suspension was diluted to a concentration of 10
5 cells/100µl. The high cell count 
was chosen because test runs demonstrated that adult OPCs appeared to have a 
high rate of cell death in vitro. Before plating the OPCs on poly-L-lysine coated 
12mm diameter glass coverslips, Plp1 transgenic and GFP wild type OPCs were 
mixed  together  in  equal  numbers  for  co-culture  and  plated  down  at  a 
concentration  of  10
5  cells/coverslip.  Three  coverslips  were  contained  in  one 
Petri dish of 3cm diameter. 
 
Purification of P5 old OPCs was performed using the same technique as for the 
purification of adult OPCs. However, since young OPCs can be expected to be 
more robust in relation to the isolation process, less cell death can be expected 67 
during  the  in  vitro  experiment,  the  number  of  cells  plated  down  in  young 
animals was reduced to 30,000 to 40,000 cells/coverslip.    
 
2.5.2.2 Maintenance of the OPC culture  
 
The  OPC  cell  culture  was  maintained  in  5%  CO2  at  37°C  for  seven  days. 
Differentiation medium (7.5 Media for cell culture) was used to feed the cells 
during the experiment. Every second day, 480µl of media was removed from the 
Petri  dish  containing  the  three  coverslips  and  replaced  by  520µl  of  fresh 
differentiation media.  
 
2.5.3 Generation of Plp1 Lac-Z expressing neurospheres and generation 
of β-actin GFP expressing neurospheres 
 
Neurospheres carrying the LacZ reporter gene under the control of  Plp1 gene 
promoter  (Wight  et  al.,  1993)  or  the  GFP  reporter  gene  under  the  β-actin 
promoter  (Okabe  et  al.,  1997)  were  generated  from  LacZ  or  GFP  expressing 
mice. These mice were wild type at the Plp1 locus.  
 
Post-natal day 0 or 1 (P0 and P1) animals were sacrificed using isofluorane. The 
brain  was  removed  from  the  calvarium  and  transferred  into  a  Petri  dish 
containing neurosphere (NS) medium (7.5 Media for cell culture). The brain was 
cut in half in the sagittal plane. The meninges, the ependymal intraventricular 
layer, brainstem, midbrain and olfactory bulb were removed. The striatum was 
then isolated, transferred into a separate Petri dish containing NS medium and 
cut into small pieces. The tissue was triturated with a bent, flame-polished glass 
pipette using an automatic pipette until a single cell suspension was achieved. 
The single cell suspension was then transferred into a T25 flask containing 5ml of 
NS  medium.  The  cells  were  triturated  twice  to  achieve  even  dispersion 
throughout the medium. One microliter of epidermal growth factor (EGF, stock 
concentration 20ng/ml, Gibco, 13247-010) per 5ml NS medium was added to the 
flask and incubated at 37°C in 5% CO2. 
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Every second day, depending on cell growth, 2 - 4ml of medium was removed 
and replaced by 5 – 10ml fresh NS medium. For every 5ml of fresh NS media, 1μl 
(stock concentration 20ng/ml) of EGF was added to the flask. Each week the 
neurospheres  were  passaged  into  a  new  flask.  The  flask  size  used  during  NS 
culture was dependent on cell proliferation, but in general the cell suspension 
was put into a T75 flask after one week in culture, containing a minimum of 
20ml of NS media. Neurospheres were removed for transplantation between the 
second and the fourth passage, depending on the neurosphere density in the 
flask.  
 
2.5.3.1 Preparation of neurosphere for transplantation into homozygote #72 
mice 
 
On the day of transplantation 10 - 20ml of neurosphere medium containing LacZ 
expressing neurospheres and 10 – 20ml of neurosphere medium containing GFP 
expressing neurospheres (the volume was dependent on the actual neurosphere 
density  in  the  flask,  based  on  a  required  density  of  approximately  50,000 
cells/ml) were mixed together and centrifuged at 1000r.p.m. for 5 minutes. The 
supernatant was then removed and the cell pellet was resuspended in 1ml 1x 
L15 and placed in an Eppendorf tube. The cell suspension was then triturated 
with  a  flame  polished  glass  pipette  until no  cell  clusters  were  visible  to the 
naked eye. 
 
At this stage 10µl of cell suspension was removed and mixed with 10µl trypan 
blue  to  evaluate  the  viability  of  the  cells  and  perform  an  approximate  cell 
count.  The  remaining  cell  suspension  was  centrifuged  at  1000r.p.m.  for  five 
minutes, the supernatant removed and finally resuspended in 20 – 30µl ice cold 
L15, forming a visible, dense neurosphere cell mass, which corresponded to at 
least 50000 cells/µl. The Eppendorf tube containing the cell suspension was then 
stored on ice until immediately before intraparenchymal injection.  
 
To evaluate the viability and potency of the neurospheres, neurospheres that 
were surplus to requirements following transplantation where diluted in plating  
medium at the end of the transplantation procedure,  plated down on poly-l-69 
lysine covered coverslips and cultured for three days in the differentiation media 
used for oligodendrocyte precursor cell culture.    
 
2.5.4 Identification of stereotactic coordinates for corpus callosum cell 
transplantation 
 
Two areas of the corpus callosum were selected for transplantation based on the 
results from the histopathological study of the homozygote #72 corpus callosum. 
The areas of interest chosen were 0.5mm parasagittal to the midline, at the 
level at which the fimbria hippocampi merged with the corpus callosum (Figure 
8).  The  selected  regions  were  stereotactically  accessible  and could  safely  be 
used for the intraparenchymal injections cells. The stereotactic coordinates for 
the  selected  regions  of  the  corpus  callosum  were  then  determined  from  a 
stereotactic  atlas  of  the  mouse  brain  (Paxinos  and  Franklin,  2001).  The 
coordinates of the first injection site were -0.58mm caudal to the Bregma point 
0, 0.5mm lateral to the midline suture and 1.5mm ventrally to the brain surface. 
The second injection site coordinates are -1.34mm caudal to Bregma point 0, 
0.5mm lateral to the midline suture and 1.5mm ventrally from the brain surface. 
To  avoid  extensive  haemorrhage  the  injection  site  was  adjusted  intra-
operatively to avoid large meningeal vessels. The accuracy of the coordinates 
was confirmed prior to the start of the study on the basis of test injections with 
toluidine blue into freshly euthanized animals.  
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Figure 8.  Identification of the corpus callosal region for histopathological 
characterisation and potential external modulation. 
Parasagittal view of a mouse brain. The corpus callosum is delineated with dotted lines. The 
area of interest is where the fimbria merges with the corpus callosum  (square) and the two 
potential injection sites are marked with a black and a white star. (R: rostral, C: caudal, Ceb: 
Cerebrum, Hip: Hippocampus, Fim: Fimbria, Mid: Midbrain, Bs: Brainstem, Cbl: Cerebellum. Nissl 
stain. Image taken from http://brainmaps.org/HBP-JPG/8/m17b.jpg).  71 
2.5.4.1 Identification of injection sites for homozygote #72 P1 neonates 
 
Four injection sites were chosen to allow even distribution over the two cerebral 
hemispheres. Two injections were made into the rostral part of the cerebrum, 
immediately right lateral and left lateral to Bregma point 0. Two injections were 
made into the caudal part of the cerebrum, immediately right and left lateral to 
where the midline suture crosses the caudal suture line. A waterproof mark was 
set 1.5mm proximal to the needle tip in order to have a constant injection depth 
in each mouse brain. 
 
2.5.5 Surgical  procedure  and  injection  of  neurospheres  into  adult 
homozygote #72 corpus callosum 
 
Anaesthesia was induced with isoflurane and maintained at 2% isoflurane, 30% O2 
and 70% NO2 during the whole procedure. The anaesthetised animal was fixed in 
a rodent stereotactic frame with a mouse face mask and non-traumatic ear bars. 
Presurgical subcutaneous injection of 0.3ml carprofen (Rimadyl® large animal 
injection  solution,  Pfizer;  diluted  in  1:100  sterile  H2O  to  a  concentration  of 
0.5mg/ml) was administered to each mouse for pain management. Longitudinal 
incision of the skin was performed from the rostral aspect of the frontal bone to 
the  caudal  aspect  of  C1.  The  skull  was  exposed  and  prepared  for  the 
craniectomy. 
 
The  margins  of  the  craniectomy  window  were  made  along  the  following 
anatomical hallmarks: The starting point was at Bregma point 0. A rostro-lateral 
drill line was continued along the rostral suture line for approximately 5mm. A 
medial  drill  line  was  continued  along  the  midline  suture  for  approximately 
7.5mm,  terminating  just  rostral  to  the  occipital  protuberance.  The  midline 
suture line was included in the drill line. A caudo-lateral drill line was continued 
till 5mm lateral to the end point of the medial drill line. The craniectomy was 
completed by connecting the rostro-lateral and the caudo-lateral points, forming 
a square shaped bone flap. During drilling, sterile NaCl was used to cool the drill 
bit and the bone. 72 
Once the bone had been thinned along the entire drill line, the skull bone was 
penetrated  along the  drill  lines  using  a  fine  dental  hook.  The bone flap  was 
removed, exposing the right lateral cerebral hemisphere and the intact dorsal 
sagittal sinus. A glass capillary was connected to a microinfusion pump (CellTram 
Oil  manual  piston  pump,  Eppendorf).  The  air  in  the  capillary  was  removed 
completely and L15 was drawn up to form a barrier between the oil from the 
microinjection  system  and  the  cell  suspension.  At  least  2µl  of  neurosphere 
suspension with a minimum density of 50,000 cells/µl was transferred into the 
glass capillary. The glass capillary containing the neurospheres was placed at 
Bregma 0, touching the brain in order to calculate the stereotactic coordinates 
for the two previously defined injection sites. At each injection site the dura 
was  pierced  with  a  sharp,  bent  25G  needle  tip  before  advancing  the  glass 
capillary into the parenchyma. Once the capillary reached the injection site, the 
glass capillary was advanced for another 0.5mm, left in place for 1 minute and 
then retracted to the calculated injection site where the injection of the cell 
suspension commenced (Figure 8). The total volume injected at each site was 
1μl with an injection rate of 0.1μl/min. After the injection was finished, the 
needle was left in place for 5 minutes, then slowly retracted and removed from 
the brain. 
 
After finishing the two injections, the surgical site was moistened and closed by 
suturing the skin using 5-0 absorbable Vicryl (Ethicon) with a cutting needle. 
 
Before  recovering  the  mouse  from  anaesthesia,  a  subcutaneous  injection  of 
0.5ml 0.85% NaCl was given. 
 
For continuous pain management, Rimadyl® was added to the drinking water to 
a concentration of 0.05mg/ml for three days.  
 
2.5.5.1 Injection of neurospheres into neonate homozygote #72 mice 
 
The entire litter was removed from the mother prior to surgery to minimise the 
risk of rejection, afterwards. Anaesthesia was induced by putting the pups into a 
box containing 5% isoflurane and O2 for approximately 30 – 45 seconds. The pups 73 
were then placed under the operating microscope. The head was manually fixed 
and a  5µl  Hamilton  syringe  (Hamilton  65RN,  7633-01)  was  used  to  inject the 
neurospheres. At each injection site,  after advancing the needle through the 
skin and soft skull into the brain parenchyma to a depth of 1.5mm, 0.5µl of the 
neurosphere cell suspension was injected slowly. A total of 2µl of neurosphere 
suspension was injected into each pup. The injections were made free handed 
under visual control. After injection, the pups were left to recover in a heated 
recovery box before returning them to their mother. 
 
2.6  Tissue sampling and processing  
 
2.6.1 Fixatives 
 
2.6.1.1 Periodate – lysine – paraformaldehyde (PLP) fixative 
 
PLP  fixative  (McLean  and  Nakane,  1974;  7.1.1  Periodate  lysine 
paraformaldehyde)  was  used  for  preservation  of  all  the  tissue  used  in  the 
descriptive  histopathological  study  of  the  corpus  callosum  and  in  the  in  situ 
evaluation of the cell intrinsic and cell extrinsic compartments in remyelination 
failure.  
 
2.6.1.2 4% paraformaldehyde in PBS     
 
4% paraformaldehyde in PBS (7.1.2 4% Paraformaldehyde in PBS) was used for 
preservation of the tissue used for the MRI experiment. All cell culture and cell 
transplantation  samples  were  also  preserved  in  4%  paraformaldehyde  before 
immunohistochemical  evaluation.  Tissue  where  PSA-NCAM  and  hyaluronan 
markers were used, were also fixed in 4% paraformaldehyde. All CFP positive 
mice were preserved in 4% paraformaldehyde.  
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2.6.1.3 Karnovsky’s  modified  fixative  (paraformaldehyde  /  glutaraldehyde 
4%/5%) 
 
Karnovsky’s  modified  fixative  (7.1.3  Karnovsky’s  modified  fixative 
(paraformaldehyde  /  glutaraldehyde  4%  /  5%))  was  used  for  preservation  of 
tissue destined for resin embedding and electron microscopy evaluation.  
 
2.6.2 Fixation technique and processing 
 
2.6.2.1 Cardiac perfusion 
 
Mice over 10 days of age were euthanized in a CO2 chamber. Mice under 10 days 
of age were euthanized using Isoflurane. All mice older than 20 days were fixed 
via cardiac perfusion. This was performed as follows: once the mice were dead 
they were pinned down to a cork board.  The thorax was opened to expose the 
heart and the right atrium was incised to allow blood,  saline and fixative to 
escape. Intracardiac injection of 20ml 0.85% saline was performed through a 25 
gauge 1.5 inch hypodermic needle into the left ventricle (Figure 9). Once all the 
blood was flushed out of the circulatory system, 2 x 10 - 20ml (depending on the 
mouse size) of fixative was injected into the left ventricle. 
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Figure 9.  Correct  needle  placement  is  of  major  importance  to  achieve 
optimal perfusion of the specimen.  
Image of a midaxial section through a fixed mouse heart showing the correct positioning of the 
needle  for  optimal  tissue  perfusion.  After  correct  placement  of  the  needle  into  the  left 
ventricle, injection of 0.8% NaCl was followed by the injection of the fixative solution, allowing 
even distribution into all organs supplied by the left ventricular system. The fixative returned to 
the heart via the right atrium, which was incised to allow drainage of excess fluid from the 
circulatory system (LV: left ventricle, LA: left atrium, RV: right ventricle, RA: right atrium, scale 
square 1 x 1mm) 
 
Figure 10.  #72  homozygote  mice  were  identified  by  progressive 
macroscopic changes in the optic nerve, which correlated with the degree of 
demyelination.  
Image  of  a  wild  type  and  a  homozygote  optic  nerve  at  P120  extending  from  the  sclera  (*) 
caudally to the chiasm (6.4x magnification). The optic nerves have been dissected and removed 
from their calvaria.  The wild type optic nerve (WT), which appeared opaque and was clearly 
distinguishable from the #72 homozygote mouse optic nerve, which became, with progressive 
demyelination, increasingly translucent (HOMO). With experience the changes could be detected 
as early as P40. In general the changes were readily identifiable from P60 onwards.   76 
2.6.2.2 Tissue dissection  
 
Tissues  were  harvested  using  a  low  power  dissection  microscope  and 
microsurgical tools. Skin and muscles were removed from the head and from the 
dorsal part of the spinal cord. The calvarium was opened and the bone removed. 
Dorsal laminectomy of the entire spinal column was performed. After removing 
the meninges, the spinal cord was transected and separated from the brain at 
the atlanto-occipital level. The brain was gently removed from the calvarium. 
The optic nerves were cut at the caudal level of the optic tracts and were gently 
removed from the brain tissue leaving the optic chiasm intact. The brain was 
then removed and the visual system, including the caudal part of the optic tracts 
and the eye balls, was removed from the calvarium as a single unit. The spinal 
cord was completely removed from the spinal canal. An approximately 1cm long 
proximal section of the sciatic nerve was also removed after blunt exposure. 
 
The  following  tissues  were  collected  and  frozen:  longitudinal  sections  of  the 
brain, transverse sections of the brain where the rostral 5mm of the brain was 
removed using a brain matrix, longitudinal sections of optic nerve including the 
optic tract, transverse sections of the retinal, chiasmal and optic tract portion 
of the optic nerve, longitudinal and transverse sections of cervical spinal cord at 
C1 – C3 level and lumbar spinal cord at L4 – L6 level. Spleen, liver and distal 
colon for positive controls for various antibodies were also removed from the 
abdominal cavity. 
 
2.6.2.3 Morphological identification of homozygote Plp1 gene overexpressing 
#72 mice  
 
Homozygote animals become clinically apparent at around P90, with affected 
animals becoming increasingly more ataxic, demonstrating a mild body tremor 
and also developing generalised tonic-clonic seizures. However the homozygote 
status  of  an  animal  was  definitively  confirmed  at  the  point  of  dissection  by 
evaluating the optic nerves. From P40 on, the optic nerves from homozygote 
Plp1  transgene  overexpressing  #72  mice  were  macroscopically  distinguishable 
from the wild type, as progressive demyelination resulted in the optic nerves 77 
turning  gradually  more  translucent  (Figure  10).  The  optic  nerves  from 
hemizygote  mice  were  indistinguishable  from  the  wild  type.  Since  the  PCR 
technique  utilised  in  this  study  could  only  confirm  the  presence  of  the  Plp1 
transgene the presence of macroscopic changes in the optic nerve was used to 
distinguish between hemizygote and homozygote specimens.  
 
2.6.2.4 Processing of fixed tissue and storage 
 
PLP or 4% paraformaldehyde fixative perfused tissue was immediately dissected 
after perfusion and post fixed in in the same fixative for 2 hours. In the case of 
CFP expressing tissue the tissue was immediately dissected after perfusion and 
post  fixed  in  4%  paraformaldehyde  for  20  minutes  only.  The  tissue  was  then 
placed  in  0.1  M  Glycine  (Sigma,  7126-1kg)  for  10  minutes  to  suppress  auto 
fluorescence originating from paraformaldehyde. 
 
After  fixation  in  PLP  fixative  or  4%  paraformaldehyde  the  tissue  was 
cryoprotected in 20% sucrose and then frozen in OCT (Sakura, 4583). The frozen 
OCT blocks were then wrapped in wax film and stored at either  -20°C -80°C 
until  further  processing.  Tissue  fixed  with  modified  Karnovsky’s  fixative  was 
dissected within 7 days and stored in fixative at 4°C until processing.  
 
2.6.3 Cryopreservation and sectioning 
 
2.6.3.1 Cryopreservation of fresh neural tissue 
 
Fresh, unfixed brain and optic nerve tissue for B-cell immunostaining (see Table 
2) was collected immediately after euthanasia. The tissue was suspended in an 
OCT  compound  filled,  self-built  aluminium  container  and  frozen  in  2-
methylbutane  (Isopentane,  Fisher,  78-78-4)  cooled to at  least  -80°C  in  liquid 
nitrogen. The frozen OCT blocks were wrapped in Nescofilm (Carl Roth, 2569.1) 
and stored at –20°C or –80°C until further processing. 
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2.6.3.2 Cryopreservation of fixed material 
 
The  following  tissues  were  collected  and  frozen  for  immunohistochemistry: 
longitudinal and transverse sections of the brain,  longitudinal sections of the 
optic nerve and the optic tract, transverse sections of the retinal, chiasmal and 
optic tract portion of the optic nerve, longitudinal and transverse sections of 
cervical spinal cord at C1 – C3 level and lumbar spinal cord at L4 – L6 level. After 
perfusion the tissue was cryoprotected by immersing the tissue into 20% sucrose 
in PBS for 24 hours and freezing in OCT as described above. The frozen OCT 
blocks were wrapped in Nescofilm and stored at –20°C or –80°C until further 
processing. 
 
2.6.3.3 Sectioning of cryopreserved tissue 
 
Cryopreserved tissue was sectioned on an OTF cryostat (Bright Instruments) at 10 
– 30µm thickness. The sections were mounted on poly-l-lysine coated slides, left 
for 2 hours at room temperature to dry and attach to the slide, then stored at –
20°C or –80°C. 
 
2.6.4 Resin processing and sectioning 
 
For resin embedding only neural tissue from mice processed with Karnovsky’s 
modified  fixative  were  used.  The  Lynx  microscopy  tissue  processor  (Leica) 
automated  the  dehydration  and  resin  infiltration  process  (7.2.1  Resin 
processing). 
  
After processing, the tissue was placed in resin filled rubber moulds and left 
overnight in an incubator at 60°C for polymerisation. Resin blocks were cut on 
an  ultratome  (Ultracut-E,  Reichert  Jung).  For  light  microscopy  1µm  thick 
sections were produced using a glass knife. The sections were then placed on 
plain slides, covered and sealed with glass coverslips using DPX (BDH, 36029417).  
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For  electron  microscopy  70nm  thick  sections  were  produced using  a diamond 
knife. The sections were mounted on 200-mesh 3.06mm diameter copper grids.     
 
2.6.5 Processing of transplanted tissue 
 
2.6.5.1 Tissue  sampling  and  processing  for    -  galactosidase  staining  and 
immunohistochemistry after cell transplantation 
 
Fourteen days after cell transplantation, the mice were euthanized using a CO2 
chamber.  Intracardiac  perfusion  of  0.85%  saline  was  followed  by  4% 
paraformaldehyde perfusion to achieve optimal tissue fixation. The brain was 
then dissected and transferred into a mouse brain matrix and cut into 1 mm 
thick  slices.  In  transplants  where  neurospheres  containing  the  LacZ  or  GPF 
reporter gene were injected simultaneously, only the sections containing green 
cells were further processed. To identify the sections containing GFP +ve cells, 
fluorescence microscopy (Olympus IX-70) was used. To visualise LacZ reporter 
gene containing neurospheres, the whole brain section was processed using the 
X-gal method (7.3.3 X-gal staining). 
 
2.6.5.2 Tissue  sampling  and  processing  for  electron  microscopy  after  cell 
transplantation 
 
Samples  used  for  electron  microscopy  (EM,  Joel  100CX)  evaluation  were 
collected after perfusion. Samples containing green fluorescing cells or samples 
with blue sections in the corpus callosum after X-gal staining were selected for 
EM evaluation. The brain slices containing GFP positive or blue cells were then 
immersed  overnight  in  4%  formaldehyde  /  5%  glutaraldehyde.  Before  EM 
processing,  the  brain  samples  were  trimmed  to  approximately  20mm
3  large 
pieces, containing corpus callosum and part of the injection tract. The prepared 
tissue samples were then embedded into resin blocks. 
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2.7  Staining techniques 
 
2.7.1 Immunofluorescence 
 
2.7.1.1 Immunohistochemical markers 
 
2.7.1.1.1  Primary antibodies used in the study 
 
The origin, titres and the host for specific antibodies are described in Table 2. 
 
2.7.1.1.2  A2B5 
 
A2B5, an early surface marker for oligodendrocyte precursor cells (Schnitzer and 
Schachner, 1982) was used to identify undifferentiated OPCs in vitro.  
 
2.7.1.1.3  Adenomatous polyposis coli (APC) 
 
Adenomatous  polyposis  coli  (APC,  CC1)  is  a  protein  involved  in  tumour 
suppression  and  cell  division.  The  antibody  against  APC  recognises  the 
adenomatous  polyposis  coli  protein  and,  in  the  CNS,  is  a  specific  marker  for 
mature oligodendrocytes (Bhat et al., 1996). Antibodies against APC were used 
to label mature oligodendrocytes. 
 
2.7.1.1.4  Axin2 
 
Axin2 is a protein involved in the Wnt pathway. It serves as a negative feedback 
regulator like Axin1. However unlike Axin1, which is constitutively present at 
low levels, Axin2 is only expressed when the Wnt pathway is upregulated (Fancy 
et al., 2009). Antibody against Axin2 was used to identify cells where the Wnt 
pathway was activated.  81 
2.7.1.1.5  5 – Bromo – 2 – deoxyuridine (BrdU) 
 
5  –  Bromo  –  2  –  deoxyuridine  (BrdU)  is  an  analogue  to  thymidine  and  is 
incorporated, when present, into the DNA during the S-phase. Antibody against 
BrdU was used to label dividing cells incorporating BrdU.    
 
2.7.1.1.6  Caspase3 
 
Antibody against Caspase 3, which is an enzyme from the cysteine aspartic acid 
proteases involved in cell apoptosis pathway (Denault and Salvesen, 2002), was 
used to evaluate the effect of Plp1 gene overexpression on cell apoptosis in situ. 
 
2.7.1.1.7  Inflammatory cell population 
 
The following antibodies were used to characterise the inflammatory population: 
Antibodies against CD169, which is a marker for activated macrophages (Perry et 
al.,  1992).  CD3,  which  labels  T-cells  (Tsoukas  et  al.,  1987).  CD45,  which  is 
expressed on all nucleated haematopoietic cells and is used as a panleukocytic 
marker (Huntington and Tarlinton, 2004). CD45R, a marker for identifying B-cells 
(Coffman, 1982). 
 
2.7.1.1.8  Type 3 deiodinase (D3) 
 
Type 3 deiodinase (D3) is an intracellular enzyme expressed in various cell types 
such as neurons,  neutrophils,  macrophages,  monocytes (reviewed in  Visser et 
al., 2011). Antibody detecting Type 3 deiodinase (D3) (a gift from Dr. T. Visser) 
was used to identify D3. 
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2.7.1.1.9  Glial fibrillary acidic protein (GFAP) 
 
Glial  fibrillary  acidic  protein  (GFAP)  is  a  structural  intracellular  protein  in 
astrocytes (Bignami et al., 1972). Antibody against glial fibrillary acidic protein 
(GFAP) was used to label the astrocytic population. 
 
2.7.1.1.10  Green fluorescing protein (GFP) 
 
Depending on the associated promoter, the GFP is linked to specific cell lines, 
allowing the cell lines to be traced due their expression of GFP (Feng et al., 
2000). A GFP antibody, which recognises GFP and CFP was used to enhance the 
fluorescence of GFP and CFP in the tissue.  
 
2.7.1.1.11  Hyaluronan binding protein (HABP) 
 
Hyaluronic acid, a glycosaminoglycan in the extracellular matrix, is believed to 
have a negative influence on OPC differentiation after demyelination (Back et 
al., 2005) The biotinylated hyaluronic acid binding protein, was used to label 
hyaluronic acid in the CNS. 
 
2.7.1.1.12  Myelin basic protein (MBP) 
 
Myelin basic protein (MBP) is one of the major myelin proteins in mature myelin. 
MBP  is  synthesised  in  free  ribosomes  in  the  oligodendrocytic  processes  and 
becomes incorporated into the myelin sheath soon after synthesis  (Colman et 
al., 1982). Antibody against MBP was applied to evaluate for the presence of 
myelin in the white matter. 
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2.7.1.1.13  Chondroitin sulphate proteoglycan NG2 
 
NG2 is a single spanning membranous chondroitin sulphate proteoglycan, which 
is expressed on residing OPCs (Nishiyama et al., 2009). Antibody against NG2 was 
used to label oligodendrocyte precursor cells  
 
2.7.1.1.14  O4 sulfatides 
 
O4  is  an  antigen  of  the  O  family,  which  are  sulfatides  located  in  the  cell 
membrane. O4 is expressed at most stages of oligodendrocyte development and 
is detectable from early OPCs up to mature oligodendrocytes in culture (Sommer 
and Schachner, 1981). Antibody against O4 was applied during living cell culture 
experiments to label the cells belonging to the oligodendrocytic lineage.  
 
2.7.1.1.15  Basic Helix-Loop-Helix transcription factors Olig1 and Olig2 
 
Olig1 and Olig2 are basic Helix-Loop-Helix (bHLH) transcription factors expressed 
in OPCs and oligodendrocytes. (Lu et al., 2002). Antibodies detecting Olig1 and 
Olig2  were  used  to  characterise  the  response  of  adult  OPCs  during  the 
development of chronic demyelination. 
 
2.7.1.1.16  Platelet derived growth factor receptor alpha (PDGFRa) 
 
Platelet  derived  growth  factor  receptor  alpha  (PDGFRa)  is  expressed  on 
developmental and adult OPCs from a relatively early time point (Pringle et al., 
1992). Antibody detecting PDGFRa (gift from Dr. C. Heldin) was used to identify 
OPCs.  
 
2.7.1.1.17  Proteolipid protein / DM20  
 
PLP/DM20 is the major myelin protein. It is a tetraspan protein located in the 
cell  membrane.  Antibody  against  the  PLP-C  terminal  recognises  the  carboxy 84 
terminus  of  the  PLP  protein  isoforms  and  was  used  to  label  PLP  and  DM20 
(Fanarraga et al., 1992) in order to identify wild type and transgenic PLP. 
2.7.1.1.18  Polysialation of the neural cell adhesion molecule (PSA NCAM) 
 
Polysialation of the neural cell adhesion molecule (PSA NCAM) on axons has been 
suggested to play a role in inhibiting remyelination after demyelination (Charles 
et  al.,  2002).  PSA  -  NCAM  antibody  was  used  to  assess  if  axonal  surface 
expression was altered. 
 
2.7.1.1.19  SMI31 and SMI32 
 
In  the  CNS  axons,  neurofilaments  are  structural  proteins  important  for  cell 
structural  integrity,  axonal  and  dendritic  growth  (reviewed  in  Lee  and 
Cleveland,  1994;Grant  and  Pant,  2000).  SMI-31  antibody  recognises  the 
phosphorylated  neurofilaments,  whereas  SMI-32  antibody  recognises  non 
phosphorylated neurofilaments. These two markers were used to label axons.  
 
2.7.1.1.20  Secondary fluorescent antibodies 
 
All  secondary  fluorescent  antibodies  were  raised  in  goat  and  their  specific 
binding affinities to primary antibodies are listed in Table 3.  
For  green  fluorescence,  secondary  antibodies  labelled  with  fluorescein 
isothiocyanate (FITC), with an excitation spectrum peak at 491nm and emission 
spectrum peak at 521nm, or labelled with Alexa Fluor (AF488, Invitrogen,  A-
11008), with an excitation spectrum peak at 495nm and emission spectrum peak 
at 519nm, were used.   
 
For  red  fluorescence,  secondary  antibodies  labelled  with  sulforhodamine  101 
acid chloride (Texas Red, TxR) with an excitation spectrum peak at 589nm and 
emission spectrum peak at 615nm were used.  
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2.7.1.1.21  Nuclear stain 
 
4’,6-diamidino-2-phenylindol (DAPI), a blue fluorescent nuclear stain, strongly 
binds to double stranded DNA, with a preference for binding at AT cluster sites, 
and has an excitation spectrum peak at 358nm and emission spectrum peak at 
461nm (Kubista et al., 1987). DAPI was used to counterstain the cell nucleus in 
cryosections.  
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Primary Antibody  Host 
Manufacturer 
Cat. Nr. 
Dilution  Method 
A2B5  Mouse IgM    1:3  live 
APC (CC1)  IgG2b 
Abcam 
ab16794 
1:100  DV 
Axin2  Rabbit IgG 
Abcam 
ab32197 
1:100 
0.5% 
Triton X 
BrdU  Mouse IgG1  Sigma B8434  1:500  HCl 
Caspase 3  Rabbit IgG 
Cell  Signaling 
#9661 
1:4000  Methanol 
CD169  Rat IgG2a 
Serotec 
MCA884 
1:100  Methanol 
CD3  Rat IgG1 
Serotec 
MCA1477T 
1:100  Methanol 
CD45  Rat IgG 
AbD  Serotec 
MCA1388 
1:600  Methanol 
CD45R  Rat IgG2a 
BD 
Pharmingen 
550286 
1:100 
Fresh 
frozen 
D3 (676)  Rabbit IgG 
Gift from Dr. T 
Visser 
1:1000 
0.5% 
Triton X 
GFAP  Mouse IgG1  Sigma G3893  1:1000  Methanol 
GFP  Rabbit IgG  Abcam ab290  1:1000  Methanol 
HABP 
Biotinylated 
Protein 
Seikagaku 
400763 
2µg/ml  Methanol 
MBP  Rat IgG 
Serotec 
MCA4095 
1:500  Methanol 
NG2  Rabbit IgG 
Millipore 
AB5320 
1:150 
Methanol 
or  0.5% 
Triton X 
O4  Mouse IgM 
Gift from Dr. I  
Sommer 
1:5  Live 
Olig-1  Mouse IgG2b  Millipore  1:1000  0.5% 87 
Primary Antibody  Host 
Manufacturer 
Cat. Nr. 
Dilution  Method 
MAB5540  Triton X 
Olig-2  Rabbit IgG 
Millipore 
AB9610 
1:500 
0.5% 
Triton X 
PDGFRa2  Rabbit IgG 
Gift  from  Dr 
C. Heldin 
1:500  Methanol 
PLP-C term  Rabbit IgG  Groome 226/7  1:600  Methanol 
PSA (E-NCAM)  Mouse IgM 
Millipore 
MAB5324 
1:500  Methanol 
SMI-31  Mouse IgG1 
Convance 
SMI31-R 
1:1500  Methanol 
SMI-32  Mouse IgG1 
Convance 
SMI32-R 
1:1500  Methanol 
 
Table 2.  List of primary antibodies used in all studies.  88 
  
Secondary Antibody  Manufacturer / Cat Nr.  Dilution 
Goat anti Rat IgG FITC  Southern Biotech / 1050-02  1:50 
Goat anti Mouse IgG FITC  Southern Biotech / 1034-02  1:30 
Goat anti Mouse IgG1 FITC  Southern Biotech / 1070-02  1:80 
Goat anti Mouse IgG2a FITC  Southern Biotech / 1080-02  1:25 
Goat anti Mouse IgG2b FITC  Southern Biotech / 1090-02  1:100 
Goat anti Mouse IgM FITC  Southern Biotech / 1021-02  1:50 
Goat anti Rabbit IgG FITC  Southern Biotech / 4050-02  1:80 
     
Goat anti Rabbit IgG AF488  Invitrogen / A11008  1:1000 
     
Goat anti Rat IgG TxR  Southern Biotech / 1050-07  1:50 
Goat anti Mouse IgG TxR  Southern Biotech / 1034-07  1:50 
Goat anti Mouse IgG1 TxR  Southern Biotech / 1070-07  1:75 
Goat anti Mouse IgG2b TxR  Southern Biotech / 1090-07  1:70 
Goat anti Mouse IgM TxR  Southern Biotech / 1021-07  1:50 
Goat anti Rabbit IgG TxR  Southern Biotech / 4050-07  1:100 
     
Extravidin FITC  Sigma / E2761  1:75 
     
DAPI  Sigma / D1306  1:1500 (1 min) 
 
Table 3.  List of secondary antibodies used in all studies.  89 
2.7.1.2 Immunohistochemistry protocol using methanol to permeabilise cell 
membranes 
 
Immunohistochemistry was performed on PLP fixative and 4% paraformaldehyde 
fixed tissue. After thawing, the slides containing the sections were immersed in 
PBS for 10 minutes to remove the OCT embedding. Cell permeabilisation was 
performed by immersing the sections in –20°C methanol (Fisher, 67-56-1) for 10 
minutes. After permeabilisation the sections were washed twice in PBS for ten 
minutes. Blocking of non-specific binding of secondary antibodies was performed 
using PBS containing 10% normal goat serum (NGS, Sigma G9023)  was applied to 
the sections for 1 hour. After removing the excess fluid from the sections, the 
primary antibody was applied overnight at 4°C in PBS containing 10% NGS. After 
washing the sections three times in PBS for 10 minutes the secondary antibody 
was applied in PBS containing 10% NGS for one hour at room temperature and 
then again washed three times in PBS for ten minutes. For nuclear staining, 4'6-
Diamidino-2-Phenylindole  (DAPI,  Sigma,  32670)  in  PBS  was  applied  for  one 
minute. The samples were washed in PBS and running water for 5 minutes and 
mounted in glycine / PBS. The coverslips were sealed using nail varnish.    
  
2.7.1.3 Immunohistochemistry  protocol  using  Triton-X  100  to  permeabilise 
cell membranes 
 
Immunohistochemistry  was  performed  on  PLP  and  4%  paraformaldehyde  fixed 
tissue.  After  thawing,  the  sections  were  immersed  in  PBS  for  10  minutes  to 
remove the OCT embedding. Cell permeabilisation was performed by applying 
Triton-X 100 (Sigma, 9002-93-1) for one hour at various concentrations (0.2 – 
0.5%  in  10%  NGS)  to  the  sections.  This  procedure  also  served  to  block  non-
specific binding  of  secondary  antibodies.  After  removing  the excess  from  the 
sections, the primary antibody was applied overnight at 4°C in PBS containing 
0.2 – 0.5% Triton-X and 10% NGS. The following day the sections were washed 
three  times  in  PBS  for  10  minutes  followed  by  application  of  the  secondary 
antibody in PBS containing 0.2 - 0.5% Triton-X and 10% NGS for one hour at room 
temperature.  90 
The  final  steps,  including  nuclear  staining  and  mounting,  were  performed  as 
previously described. 
 
2.7.1.4 Immunohistochemistry protocol using the DV method 
 
Immunohistochemistry staining for APC (CC1) (see table for origin and dilution) 
was performed on PLP and 4% paraformaldehyde fixed tissue. After thawing, the 
sections were immersed in PBS for 10 minutes to remove the OCT embedding. 
Cell permeabilisation was performed by applying DV solution for one hour to the 
sections. This procedure also served to block non-specific binding of secondary 
antibodies. After removing the excess from the sections, the primary antibody 
was applied over night at 4°C in DV solution. The following day the sections 
were washed three times in PBS for 10 minutes followed by application of the 
secondary antibody in DV solution for one hour at room temperature. The final 
steps  including  nuclear  staining  and  mounting  were  performed  as  previously 
described. 
 
2.7.1.5 Hydrochloric acid immunohistochemistry protocol for BrdU staining 
 
Double labelling of PDGFRα positive cells and BrdU positive cells on tissue fixed 
with PLP fixative was performed as follows: The staining protocol for the first 
antibody (OPC marker PDGFRα) has been previously described. After completion 
of the PDGFRα staining the slides were immersed in 50% ethanol / 50% glacial 
acetic acid (see Appendix) for ten minutes and then in 50% hydrochloric acid 
containing  1%  Triton-X  100  (see  Appendix)  for  ten  minutes.  The  slides  were 
washed  three  times  in  PBS  for  ten  minutes.  Antibody  against  BrdU  in  PBS 
containing 1% Triton-X 100 and 10% NGS was applied overnight at 4 C to the PBS 
washed slides. The unbound BrdU antibody was then removed by immersing the 
slides three times in PBS for 10 minutes. The secondary antibody recognising the 
BrdU antibody was applied for 2 hours at room temperature. The subsequent 
steps were as described for the PLP fixative fixed tissue staining protocol.        
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2.7.1.6 Immunohistochemistry protocol on unfixed, fresh frozen tissue 
 
Fresh frozen samples for staining with the B-cell marker CD45R were thawed and 
processed  unfixed.  The  primary  antibody  was  applied  for  one  hour  at  room 
temperature.  The  samples  were  then  fixed  for  10  minutes  in  4% 
paraformaldehyde before applying the secondary fluorescent antibody or before 
applying  other  primary  antibodies.  The  subsequent  steps  were  as  described 
above. 
2.7.1.7 Immunohistochemistry protocol on live culture 
 
Live staining to identify OPCs and oligodendrocytes was performed on adult OPC 
cultures using the markers O4 or A2B5. The coverslips were washed three times 
in  DMEM  at  37°C  for  ten  minutes.  The  antibody  against  A2B5  or  O4  were 
suspended in DMEM, applied to the coverslips, and incubated for 1 hour at 37°C 
in a 5% CO2 atmosphere. The coverslips where then washed three times in DMEM 
at 37°C for ten minutes and once in PBS at 37°C before fixing the cells in 4% 
paraformaldehyde  at  room  temperature  for  ten  minutes.  After  fixation  the 
methanol protocol was used for application of the subsequent second primary 
antibodies.    
 
2.7.1.8 Immunohistochemistry protocol of fixed cultured cells  
 
After fixation, the coverslips were washed three times in PBS then the secondary 
fluorescent antibody in DMEM was applied for one hour at room temperature. 
The  coverslips  were  then  washed  three  times  in  PBS  and  the  cells  were 
permeabilised in methanol for 10 minutes at -20°C. After 3 washes in PBS 10% 
normal  goat  serum  in  PBS  for  applied  for  one  hour.  In  coverslips  where  O4 
antibody was applied to label the OPCs, the second primary antibody used was 
against GFP. In coverslips where antibody against O4 was not used, either an 
antibody  against  MBP  (Table  2)  or  an  antibody  against  PLP  (Table  2)  was 
combined  with  the  GFP  antibody.  After  incubation  of  the  second  primary 
antibody,  the  coverslips  were  washed  in  PBS  and  the  second  fluorescent 
antibody was applied (Table 3). Finally, after washing in PBS, the cell nuclei 92 
were stained using DAPI (Table 3). Coverslips were then briefly washed in PBS 
and water before mounting and sealing the coverslips on a microscope slide.     
 
2.7.1.9 Immunofluorescence of transplanted tissue 
 
The following antibodies were used to label the transplanted cells. An antibody 
against  GFP  was  used  to  identify  the  cell  population  originating  from  GFP 
expressing neurospheres. An antibody against MBP was used to identify myelin 
sheaths.  To identify the astrocytic population,  an antibody against GFAP  was 
used.  To  identify  the  microglial  population  CD45  and  CD169  antibodies  were 
used.  For  nuclear  staining,  4'6-Diamidino-2-Phenylindole  (DAPI)  was  applied. 
Secondary antibodies used in this study were FITC labelled antibodies for GFP 
detection and TxR labelled antibodies to label the antibodies against MBP, GFAP, 
CD45 and CD169. Dilution and origin of the primary and secondary antibodies and 
DAPI are listed in Tables 2 and 3. 
 
2.7.2 Light microscopy 
 
2.7.2.1 X-gal staining of Plp1 LacZ expressing samples   
 
X-gal staining was performed on 4% paraformaldehyde fixed tissue either as a 
whole  mount  tissue  or  on  10µm  thick  frozen  sections.  After  fixation,  the 
transplanted brain was cut into 2mm thick axial sections using a 1mm step brain 
matrix (Harvard Apparatus, 62-0050). The sections were then briefly washed in 
PBS followed by 1M MgCl2 for 10 minutes on ice. The tissue was then immersed 
into  detergent  solution  for  another  10  minutes  on  ice,  followed  by  the 
application of X-Gal staining solution (7.3.3 X-gal staining) over night at room 
temperature. The reaction product after X-Gal treatment of tissue containing β-
galactosidase  is  5-bromo-4-chloro-3-indolyl  β-D-galactoside,  which  is  a  blue 
product  visible  to  the  naked  eye.  The  sections  were  then  washed  in  and 
immersed in 20% sucrose for 24 hours, immersed in OCT and frozen and stored as 
described above.    93 
Alternate 10 and 20µm thick mounted cryosections from NS transplanted brains 
were taken for β-galactosidase staining.  
 
2.7.2.1.1  Tissue sampling and processing for  - galactosidase staining 
and immunohistochemistry of P1 injected homozygote #72 mice 
 
Following  the  cell  transplantation  two  mice  were  euthanized  on  each  of  the 
following days post cell transplantation: day 7, 14, 35, 80 and 120. The mice 
were euthanized using a CO2 chamber. The procedure for fixation and processing 
of the tissue was identical to that previously described.  
 
2.7.2.1.2  Methylene blue / azur II 
 
For  light  microscopy,  resin  sections  were stained  with  methylene blue (VWR, 
340484B)/ azur II (VWR, 340064Y) (7.4.1 Methylene blue / azur II). Sections were 
placed on a hot plate (60 C) and flooded with stain. Once the rim of the stain 
solution  appeared  golden  the  sections  were  washed  in  running  water.  The 
sections were mounted in DPX (BDH, 360 294 17) after drying overnight on a hot 
plate (60 C). 
 
2.7.3 Electron microscopy 
 
2.7.3.1 Tissue sampling and processing for electron microscopy of P1 injected 
homozygote #72 mice 
 
Samples  for  electron  microscopic  (EM)  evaluation  were  collected  at  P7,  P14, 
P21, P40, P80 and  P120 after intracardiac perfusion with 4% PF. Post fixation 
was performed by immersion in 4% formaldehyde / 4% glutaraldehyde for one 
week.  
 
Before EM processing, the brain samples were cut to approximately 10mm
3 large 
pieces,  containing  the  corpus  callosum  and  part  of  the  injection  tract.  The 94 
prepared  tissue  samples  were  then  embedded  into  resin  blocks  (7.2.1  Resin 
processing).  
 
For EM evaluation resin blocks were trimmed and the brain samples were cut 
into 1µm thick sections for myelin sheath evaluation of the transplantation site 
using  toluidine  blue.  After  methylene  blue/azur  II  evaluation,  60m  thick 
sections of the areas containing myelin (presumed to be from the transplanted 
cells) were cut for EM evaluation. 
 
Uranyl acetate (AGAR Scientific, R1260) and lead nitrate (VWR, 290384R) was 
used  to  stain  the copper  grid  mounted thin  resin  sections  (7.3.4  Staining  for 
electron microscopy). 
 
2.8  Morphological studies 
 
2.8.1 Cell quantification of immunolabelled samples 
 
Quantification of cells was performed on 10µm thick axial cryosections from the 
corpus  callosum,  retinal  and  chiasmal  portion  of  optic  nerve.  Sections  were 
placed on slides at 100µm intervals to avoid counting the same cell twice.   
 
Immediately after staining, images from the area of interest were taken using an 
Olympus  IX70  microscope,  QIcam  Fast  digital  camera  (Qimaging  Surrey,  Bcm 
Canada) and Image ProPlus 6.0 software (Media Cybernetic, Silver Spring, MD, 
USA). 
 
The cells positive for the immunohistochemical marker of interest were counted 
manually in a defined area of interest using Image ProPlus 6.0 software. For the 
immunohistochemical marker, the area of interest in the corpus callosum was 
20515.176µm
2. In the optic nerve the area of interest was 28060.455µm
2. DAPI 
was used to identify the nucleus for calculating the total cell density using the 
automatic cell count function in Image ProPlus 6.0. The area of interest in the 
corpus callosum and optic nerve for DAPI positive cells nuclei was 6986.3584µm
2. 95 
The cells were included in the cell count if they were lying within the area of 
interest. Cells crossing the top (north) and the right (east) side border were also 
included.  Cells  crossing  the  bottom  (south)  and  left  (west)  side  border  were 
excluded from the cell count. 
 
2.8.2 Quantification  of  GFAP  positive  area  in  optic  nerve  after 
immunolabelling 
 
In  the  optic  nerve  the  GFAP  area  was  measured  using  a  semi-automated 
programme  in  ImagePro  6.0.  A  minimum  of  six  images  per  optic  nerve  were 
used. Briefly, the images were opened in ImagePro 6.0. A copy of the original 
was made and converted into a black and white image, where fluorescent areas 
appear  white.  The  original  image  was  used  as  a  template  for  manual 
segmentation of the black and white image until the white area was judged to 
match the fluorescent area of the original image. An area of interest (AOI) of 
16397.771µm
2 was applied to the image and the area occupied by white pixels 
within the AOI was then automatically calculated, giving the area occupied by 
GFAP in µm
2 per µm
2 of the total AOI. For each optic nerve the measurement 
was then used to calculate the area occupied by GFAP per mm
2. 
 
2.8.3 Quantification of percentage myelinated axons 
 
Images  obtained  from  electron  microscopy  were  used  to  calculate  the 
percentage  of  myelinated  axons  within  the  region  of  interest  in  the  corpus 
callosum. Eight images were randomly taken from the mid corpus callosum at 
8000x magnification using a film camera system (JOEL 100CX). After developing 
the film negatives were scanned (EPSON Perfection 3200 PHOTO) and evaluated 
in  ImagePro  6.0.  Axonal  numbers  were  manually  counted  using  an  area  of 
interest of 45.166µm
2. Myelinated axons and non myelinated axons were counted 
after placing a grid square over the digital image, from which to select fibres for 
counting.  All fibres lying under an intersection were only counted once. The 
percentage of myelinated axons was calculated in relation to myelinated and 
non myelinated axons, after placing a counting grid over the digital image. All 96 
axons lying beneath the grid lines were counted and designated as myelinated or 
non myelinated 
 
2.8.4 Measurement of cell process length of cultured OPCs 
 
To evaluate and quantify the morphological changes of OPC differentiation in 
vitro,  6  semi  randomly  chosen  fields  per  coverslip  were  photographed  using 
phase  microscopy  and  fluorescence  microscopy  (Olympus  IX-70,  x200 
magnification). The reason why the photographing process was not performed in 
a completely random fashion was the low yield of cells on the coverslips. Wild 
type  differentiating  OPCs  were  distinguished  from  homozygote  OPCs  by  the 
presence of GFP. Semiautomatic tracing of OPC processes were performed in 
ImageJ® using the NeuronJ® plug-in on phase microscopy images. 
  
2.9  Statistical analysis and graphical presentation of the data 
 
In the histopathological study an unpaired t-test was used to analyse the cell 
count, axonal count and percentage myelinated area data. In the MRI study an 
unpaired and paired t-test was used to analyse the histological and diffusion 
data.  In  the  cell  culture  study  an  unpaired  t-test  was  used  to  compare  the 
process length. Statistical significance was set at p< 0.05 throughout the study.  
 
Cell density and axonal density were always presented as the count per mm
2. 
The percentage of myelinated axons was displayed as a proportion relative to 
the total axonal count. Area occupied by GFAP was presented as the area of 
GFAP in µm
2 per 1000000µm
2.  
 
Statistical analysis and the graphical presentation of data were performed using 
GraphPad Prism 4
®.  
 
Specific Materials and Methods are described in 3.3 Material and Methods, 4.3 
Material and Methods and 5.3 Material and Methods. 97 
3  The  development  of  the  phenotype  and  pathology  of 
the homozygote #72 corpus callosum  
 
3.1  Introduction 
 
The Plp1 gene overexpressing mouse (homozygous; line #72) model of PMD due 
to gene duplication appears phenotypically normal during development and in 
early adulthood. At around 3 months of age however, mice develop a mild ataxia 
and  exhibit  seizure  activity,  particularly  if  disturbed.  The  generalised  ataxia 
becomes  progressively  more  pronounced,  a  very  mild  whole  body  intention 
tremor develops and the seizure activity increases. Mice  rarely live beyond 4 
months of age and death probably occurs as a consequence of prolonged seizure 
activity, which most likely causes a cardio-respiratory arrest. 
 
Diffusion  magnetic  resonance  imaging  of  the  brain  of  4  month  old  #72  mice 
demonstrated  widespread  changes  in  diffusion  parameters  in  all  major  white 
matter  tracts  (Ruest  et  al.,  2011).  Quantification  of  myelination  in  three  of 
these tracts, the anterior commissure, hippocampal fimbria and the mid corpus 
callosum,  demonstrated  that  there  was  an  almost  complete  lack  of  myelin 
sheaths. In the absence of an early clinical phenotype, the paucity of myelin 
sheaths at this age probably reflects a loss of previously formed myelin rather 
than a complete failure of developmental myelination. Indeed, both the optic 
nerve  (Edgar  et  al.,  2010)  and  the  spinal  cord  (Anderson  T.J.  PhD  thesis; 
Anderson et al., 1998) are well myelinated in the young #72 homozygote mouse.  
 
As described in Chapter 1, the myelin sheath, which surrounds axons in the CNS 
white matter can be successfully restored by endogenous OPCs, following injury 
(Zawadzka et al., 2010). The repair mechanisms that restore the myelin sheath 
are highly effective and full restoration often follows a demyelinating event. 
However, for reasons that are not fully understood, this repair process is not 
universal. Various models of dysmyelination and demyelination have been used 
to investigate (re)myelination biology and pathology and some of these models 
have  been  presented  in  Chapter  1.  So  far  the  most  common  model  used  in 98 
demyelination research is the immune mediated inflammatory disease model of 
experimental  autoimmune  encephalitis  (EAE).  Although  this  model  has 
facilitated  the  identification  of  immune  mediated  pathways  in  demyelination 
and has also helped to develop drugs to treat MS, it is not a particularly useful 
model with which to examine the (re)myelination biology, since the background 
on which repair must take place is hostile. The Plp1 gene overexpressing mouse 
model, where the phenotype develops spontaneously, and in which the immune 
response is mild may represent a better model to investigate (re)myelination 
biology. Therefore it is of interest to know if the paucity of myelin sheaths in 
the  P120  #72  homozygote  mouse  represents  a  failure  of  developmental 
myelination and/or a failure of repair following demyelination. 
 
The  corpus  callosum  is  commonly  used  in  the  investigation  of  white  matter 
development, myelination, remyelination biology and the pathology thereof. It is 
a large intracranial white matter structure, divided into five major regions; the 
rostrum, the genu, the midbody, the isthmus and the splenium (Highley et al., 
1999). As a pure white matter structure, it comprises axons, oligodendrocytes, 
OPCs, astrocytes, microglia and trafficking immunological cells and few, if any, 
neuronal cell bodies. The neurophysiological function of the corpus callosum is 
to conduct electrical signals between the cortical neurons of two hemispheres 
for interhemispheral communication (Zarei et al., 2006). In mice, approximately 
60 –70% of the axons are myelinated (Xie et al., 2010). A study by (Olivares et 
al.,  2001)  showed  that  the  percentage  of  myelinated  axons  is  similar  across 
species such as rats, rabbits, cats, dogs, cows, horses and macaque. However 
other studies show a variation between species that, in reality, is probably due 
to the investigation of different corpus callosal regions and different time points 
at which myelination was evaluated (Sturrock, 1980;Looney and Elberger, 1986). 
Therefore,  given  the  region  and  time  dependent  differences  in  myelin 
composition within the corpus callosum it is essential to characterise and specify 
the specific region to be examined.  
 
There  are  some  major  advantages  that  make  the  corpus  callosum  an  ideal 
structure to investigate (re)myelination biology and pathology. Individual regions 
are easily identifiable in histological samples and with newer in vivo techniques 
such as magnetic resonance imaging. This has the advantage that myelination 99 
changes and white matter responses to pathological impacts along the corpus 
callosum can be investigated over time in vivo (Harsan et al., 2006;Harsan et al., 
2010). Secondly, the development of the corpus callosum has been extensively 
described  in  mouse  (Ozaki  and  Wahlsten,  1998)  and  the  time  point  of 
myelination in various species is known (Olivares et al., 2001). Thirdly, the size 
of the corpus callosum facilitates the implantation of cells for transplantation 
studies  and  the  structure  can  be  reached  with  minimally  invasive  surgical 
techniques using stereotactic equipment for in vivo transplantation experiments. 
  
A disadvantage of the corpus callosum, however, is the high number of small 
diameter axons. Fibers with a diameter below 0.2µm do not become myelinated 
(reviewed in Hildebrand et al., 1993). However, external manipulation (specific 
training) or compensation of lost neuronal function by another area of the brain 
could  induce  small  fibre  growth.  If  the  fibre  diameter  grows  above  0.2µm, 
myelination will commence. If this is the case, the change in myelination would 
not be due to remyelination but to myelination. In this specific situation, it is 
nearly  impossible  to  distinguish  between  these  two  entities,  new  myelin 
formation or remyelination. 
   100 
3.2  Aims 
 
The overall aim of this Chapter was to characterise the white matter changes 
leading  to  the  paucity  of  myelin  and  apparent  lack  of  repair  in  the  corpus 
callosum in the #72 homozygote mouse 
 
The specific aims were to: 
 
1.) Examine and quantify myelination in the corpus callosum at various ages 
up to P120 
2.) Describe  and  quantify  accompanying  changes  in  neighbouring  white 
matter cells, including oligodendrocyte precursor cells 
3.) Examine  and  characterise  OPC  intrinsic  and  OPC  extrinsic  factors  that 
could contribute to myelin pathology 
 
3.3  Material and Methods 
 
3.3.1 Animals 
 
Mice used in this study were the Plp1 overexpressing transgenic mouse (#72), 
generated  by  (Readhead  et  al.,  1994)  and  the  Thy1-cyan  fluorescent  protein 
(CFP) (B6.Cg-Tg(Thy1-CFP)23Jrs⁄J) expressing mouse model produced by (Feng 
et al., 2000). Animals were killed and tissue was collected at P40, P60, P90 and 
P120. Further details are provided in 2 Material and Methods. 
 
3.3.2 Intraperitoneal BrdU injection for OPC proliferation studies 
 
To  label  cells  in  the  s-phase  of  the  cell  cycle,  one  single  intraperitoneal 
injection of BrdU (50µg/g) was administered one hour prior to euthanasia, at 
12.00 midday ± 2 hours. BrdU in sterile saline, which was stored in aliquots at -
20
oC,  was  warmed  to  room  temperature  before  injecting.  Sometimes  BrdU 101 
precipitated  in  the  solution  and  was therefore  vortexed  to  dissolve  the  BrdU 
before injecting. 
 
3.3.3 Tissue sampling and processing for histopathological examination 
 
After euthanasia, intracardiac injection of 0.85% saline followed by fixative was 
performed. The choice of the fixative was based on which histological technique 
followed. Detailed description of the fixatives and the techniques are listed in 
Chapter 2 and the Appendix. Samples used for B-cell evaluation were directly 
frozen after 0.85% saline injection without fixation. 
 
3.3.4 Tissue sectioning 
 
For immunohistochemical evaluation, 10µm thick tissue sections were prepared 
with a cryotome at -22
oC, from frozen samples embedded in OCT. From each 
animal, a minimum of 80 sections were cut and mounted, consecutively, onto 10 
slides, such that each slide contained a series of sections, each separated by 
100µm from the next. For light and electron microscopic evaluation, the tissue 
was  moulded  into  resin  blocks  and  cut  into  1µm  and  60  nm  thick  sections, 
respectively. Immunohistochemistry was performed on fixed or unfixed frozen 
sections, depending on the primary antibody used. Details of staining protocols, 
primary and secondary antibodies and concentrations used are listed in (Chapter 
2 Table 2 & Table 3).  
 
3.3.5 Quantification of percentage myelinated axons 
 
Electron  microscopy  (EM)  images  were  taken  at  8000x  magnification.  The  EM 
images  were  scanned  and  imported  into  Image  ProPlus  6.0  software.  Axonal 
density was calculated from six randomly taken images per animal, of the mid 
corpus callosal region using a rectangular area of interest (AOI: 47.269µm
2). All 
axons in the AOI were counted except those touching its southern and western 
borders of the AOI. 102 
 
To calculate the percentage of myelinated axons, a grid comprising 4 bisecting 
lines was applied to the rectangle AOI. The myelination status of all axons lying 
under any of the digital lines was assessed and the percentage of myelinated 
axons was calculated. Details of the quantification procedure are found in (2.8 
Morphological studies). 
 
3.3.6 Markers used for evaluation of the corpus callosum 
 
3.3.6.1 Characterisation  of  myelin  integrity  and  identification  of  cells 
originating from the oligodendroglial lineage 
 
To  identify  the  myelin  integrity,  antibodies  against  MBP  and  PLP/DM20  were 
used. For ultrastructural evaluation of the myelin sheath, resin sections were 
evaluated using light microscopy on methylenblue/azur II stained sections and 
using  electron  microscopy.  Mature  oligodendrocytes  were  identified  using  an 
antibody  against  APC  (CC1).  For  identification  of  OPCs,  antibodies  against 
PDGFRα  and  NG2  were  used.  To  characterise  OPC  proliferation,  an  antibody 
against  BrdU  was  used  in  combination  with  an  antibody  against  PDGFRα.  For 
evaluation  of  OPC  differentiation,  an  antibody  against  Olig1  was  used  in 
combination with an antibody to NG2 (Table 2 and Table 3).  
 
3.3.6.2 Identification extraglial changes 
 
The  astrocytic  population  was  identified  using  an  antibody  to  GFAP.  Immune 
cells, including B-cells, T–cells and microglia/macrophages were identified using 
antibodies against CD3, CD45R and CD45 and CD169, respectively. 
 
To identify axonal changes antibody SMI32, that recognises non-phosphorylated 
neurofilament,  was  used.  In  Thy1-CFP  /  Plp1  transgenic  mouse,  where  CFP 
accumulates in axonal swellings, an antibody against GFP was used to enhance 
the CFP fluorescence. 103 
To  examine  the  Wnt  pathway  in  cells  from  the  oligodendrocytic  lineage,  an 
antibody against Axin2 in combination with an antibody against Olig1 was used. 
To  characterise  deiodinase  3  (D3)  expression  in  microglia/macrophages  an 
antibody against D3 was used in combination with an antibodies against CD45. 
 
To  investigate  PSA  NCAM  expression  in  demyelinating  corpus  callosum  an 
antibody against PSA NCAM was used.  
 
The biotinylated hyaluronic acid binding protein (HABP) was used to identify the 
presence of hyaluronan in the extracellular matrix of the corpus callosum (Table 
2 and Table 3). 
 
3.3.6.3 Cell quantification 
 
Immediately after staining, two images of the corpus callosum, parasagittal to 
the  midline  and  dorsal  to  the  lateral  ventricle,  were  taken  from  each  brain 
section at x400 magnification, using an Olympus IX70 microscope with a QIcam 
Fast digital camera. A maximum of 20 images and minimum of 6 images from 
each mouse were available for cell quantification. The micrographs were opened 
in Image ProPlus 6.0 software and an area of interest (AOI: 20515.176µm2) was 
applied manually on each image covering the corpus callosum only. All cells, 
which were fully or partially located in the AOI, were counted except the cells 
touching the southern and the western borders of the AOI. The cell density per 
mm
2 was then calculated based on the cell count from a minimum of 6 AOIs. 
 
3.3.7 Statistical analysis 
 
The unpaired student t-test was used to compare the cell count and percentage 
of myelinated axons between the wild type and the #72 homozygote. Statistical 
analysis was performed using GraphPad Prism 5®. 
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3.4  Results 
 
3.4.1 Extensive  myelin  degradation  was  observed  in  the  #72 
homozygote corpus callosum 
 
To globally assess myelin integrity over time, cryostat sections containing the 
mid corpus callosum were labelled with antibodies against MBP (Figure 11) and 
PLP/DM20  (Figure  12)  and  examined  by  fluorescence  microscopy.  At  P40, 
staining appeared similar in the #72 homozygote compared to the wild type. 
With time, a progressive reduction in MBP and PLP/DM20 staining was observed 
in the #72 mouse, reaching a minimum at P120, the oldest age examined. This 
staining pattern suggests that there is a progressive degeneration of myelin in 
the corpus callosum. The intense, patchy staining in some regions of the #72 
mouse corpus callosum (Figure 11 and Figure 12) probably represents increased 
penetration of antibodies into the degenerating myelin sheaths. PLP/DM20 was 
found in cell bodies as well as in myelin sheath-like structures and a substantial 
number of PLP/DM20 positive cells were present at the time point of complete 
demyelination (Insert Figure 12). 
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Figure 11.  Progressive  reduction  in  myelin  staining  in  the  #72  corpus 
callosum.  
Micrographs of MBP stained sections through the corpus callosum of wild type (A – D) and #72 
mice (E – H; x100, scale bar 400µm) between P40 and P120. At P40 MBP staining in the #72 
corpus callosum appeared similar to the wild type. MPB staining diminished with increasing age. 
The patchy appearance of the staining probably reflects the binding of the antibody to myelin 
breakdown products. Auto fluorescent lipofuscin (arrows) was present and contributed to the 
staining pattern.   106 
 
Figure 12.  Progressive  loss  of  PLP/DM20  staining  in  the  #72  corpus 
callosum.  
Micrographs of PLP/DM20 stained sections through the corpus callosum of wild type (A – D) and 
#72 mice (E – H; x100, scale bar 400µm) between P40 and P120. The progressive reduction in 
PLP/DM20 staining followed a comparable pattern when MBP was used as a marker. The myelin 
status at P40, in the #72 mouse was comparable to the wild type. Later, a progressive loss of 
PLP/DM20 staining was observed. The paucity of staining appeared less severe with the antibody 
recognising PLP/DM20 compared to staining with antibody to MBP. This was due to the presence 
of PLP/DM20 in cell bodies (I, x400, scale bar 25µm). 107 
3.4.2 The corpus callosum is almost completely demyelinated at P120 
in the #72 mouse 
 
For qualitative and quantitative assessment of myelination, resin sections were 
examined  using  light  and  electron  microscopy.  Light  microscopy  revealed 
comparable amounts of myelin in the corpus callosum of P40 72 and the wild 
type mice. Subsequently, there was a progressive reduction in myelin volume, 
until  demyelination  was  virtually  complete  at  P120  (Figure  13).  Electron 
microscopy  demonstrated  normal  appearing  myelin  sheaths  in  the  #72  mouse 
corpus callosum (Figure 14). The percentage of myelinated axons was calculated 
from  electron  micrographs.  A  significant  reduction  in  the  percentage  of 
myelinated axons was observed in the #72 mouse compared to the wild type at 
P60, P90 and P120, with a virtually complete absence of myelinated axons at 
P120 (Figure 15). 
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Figure 13.  Progressive demyelination follows initial myelination of the #72 
homozygote corpus callosum. 
Methylene blue / azur II stain of the mid corpus callosum between P40 and P120 in wild type (A - 
D) and 72 mice (E – H, x1000, scale bar 40 m). At P40, myelin volumes appeared similar in the 
#72  mouse  compared  to  the  wild  type  mouse.  With  increasing  age,  the  amount  of  myelin 
appeared to increase in the wild type showing that myelination of the corpus callosum continued 
into  adulthood.  In  contrast,  in  the  #72  mouse,  the  corpus  callosum  became  progressively 
demyelinated between P60 (B, F), P90 (C, G) and P120 (D, H). There was an almost complete 
absence  of  myelinated  axons  at  P120.  At  this  age  cell  nuclei  (black  arrows)  appeared  more 
numerous in the #72 mouse compared to the wild type and numerous large astrocytic processes 
(asterisk) were also observed.   109 
 
Figure 14.  Initial  myelination  of  the  #72  mouse  corpus  callosum  was 
followed by progressive demyelination. 
Electron micrographs of the corpus callosum between P40 and P120 in wild type (A – D) and 72 
mice (E – H, x8000, scale bar 2 m). At P40, myelin volume in the #72 mouse corpus callosum 
appeared similar to that in the age-matched wild type mouse. The myelin that was present in 
the  #72  mouse  had  a  morphologically  normal  appearance.  At  subsequent  time-points,  the 
proportion of myelinated axons appeared to decrease progressively from P60 till P120, by which 
time the corpus callosum was almost completely demyelinated. 110 
 
Figure 15.  Demyelination  progresses  with  increasing  age  in  the  corpus 
callosum.  
N=3 (for each given time point and genetic background), adding up to a total number of 24 
quantified specimens. Bars display s.e.m. There is a progressive loss of myelin sheaths with time 
in  the  #72  mouse  corpus  callosum,  leading  to  a  significant  reduction  in  the  percentage  of 
myelinated axons in the #72 mouse corpus callosum compared to wild type, at  P60, P90 and 
P120. At P40 the percentage of myelinated axons was similar in the #72 mouse compared to the 
wild type mouse, suggesting that developmental myelination is relatively normal in #72 mouse 
corpus callosum (**: p<0.01, ****: p<0.0001). 111 
3.4.3 Mature oligodendrocytes were present in the demyelinating #72 
homozygote corpus callosum 
 
To  determine  if  demyelination  in  the  #72  homozygote  corpus  callosum  was 
accompanied by a loss of mature oligodendrocytes, an antibody to APC, a marker 
for  mature  oligodendrocytes,  was  used.  At  all  time  points  investigated,  APC 
positive  oligodendrocytes  were  present  (Figure  16).  The  distribution  of 
oligodendrocytes in the #72 mouse corpus callosum was comparable to the wild 
type. Even at P120, when the corpus callosum was completely demyelinated, 
APC positive cells were present. This suggests that myelin degeneration in the 
#72 mouse is not entirely due to oligodendroglial cell death. 
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Figure 16.  Mature oligodendrocytes were present at all time points during 
demyelination. 
Micrographs of wild type (A – D, I) and #72 mouse (E – H, x100, scale bar 400µm; K, x400, scale 
bar 25µm) corpus callosum labeled with an antibody to APC (CC1), between P40 and P120. The 
distribution of mature oligodendrocytes appeared similar in the #72 mouse compared to the wild 
type. Despite progressive demyelination, mature oligodendrocytes were present in the corpus 
callosum, suggesting that the demyelination is not caused by primary oligodendrocyte cell death. 113 
In  summary,  these  studies  demonstrate  that  there  is  a  slowly  progressing 
demyelination in the #72 mouse corpus callosum with no evidence of effective 
remyelination. Since, in rodents, remyelination is usually a default response to 
demyelination, I went on to examine various factors that could contribute to 
remyelination  failure,  such  as  the  presence  and  response  of  OPCs  and  the 
astroglial and the microglial response in the #72 mouse. 
 
3.4.4 Oligodendrocyte precursor cells were abundantly present in the 
#72 corpus callosum 
 
OPCs  are  responsible  for  regenerating  myelin  sheaths  in  the  CNS  after  a 
demyelinating event (Zawadzka et al., 2010). In the context of the progressive 
demyelination of the #72 homozygote corpus callosum and in the absence  of 
effective remyelination, I examined the oligodendroglial lineage.  
 
To determine if OPCs were present in the demyelinating corpus callosum, OPC 
markers NG2 (Figure 17) and PDGFRα were used to label and to quantify the OPC 
population (Figure 18 & Figure 19). In the #72 mouse corpus callosum, NG2 and 
PDGFRα +ve cells were present at all time points examined, at a similar density 
to the wild type. The NG2 +ve cell density was significantly elevated at P120 in 
the #72 mouse, compared to the wild type. 
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Figure 17.  NG2+  cells  were  present  in  the  #72  mouse  corpus  callosum 
during all stages of demyelination. 
Micrographs of sections stained for NG2, between P40 and P120, in wild type (A – D) and #72 
mouse (E – H, x100, scale bar 400µm) corpus callosum. At all time points during the progressive 
demyelination, NG2 +ve cells were present in the #72 homozygote corpus callosum. The density 
appeared similar to the wild type. The NG2 cell processes appeared thicker and more branched 
in the #72 mouse (K) compared to the wild type (I, x400, scale bar 50µm). 115 
 
Figure 18.  NG2+ cells in the #72 mouse corpus callosum between P40 and 
P120. 
Graph illustrating the NG2 +ve cell density between P40 and P120 in wild type and #72 mice. N=3 
(for each given time point and genetic background), adding up to a total number of 24 quantified 
specimens. Bars display s.e.m. Mean NG2 cell density was similar in the #72 mice compared to 
the  wild  type  up  to  P90.  At  P120,  when  demyelination  is  complete,  there  was  a  significant 
increase in NG2 +ve cell density in the #72 mice compared to wild type  (*: p<0.05). 
 
Figure 19.  PDGFRα  positive  cells  in  the  demyelinating  #72  mouse  corpus 
callosum.  
Graph  illustrating  PDGFRα  +ve  cell  density  in  the  wild  type  and  #72  mouse  corpus  callosum 
between P40 and P120. N=3 (for each given time point and genetic background), adding up to a 
total number of 24 quantified specimens. Bars display s.e.m. Bars displaying s.e.m There was no 
significant  difference  in  the  density  of  PDGFRα  +ve  cells  in  the  #72  mouse  corpus  callosum 
compared to the wild type. The PDGFRα +ve cell density was, in both wild type and #72 mouse 
corpus callosum, lower compared to the NG2 +ve cell population. 116 
In short although progressive extensive demyelination occurs during adulthood in 
the #72, OPCs are abundantly present at all time points. Despite the abundant 
OPC population there was no evidence of an effective attempt at remyelination 
and the question therefore arises of how the OPCs respond to the demyelination. 
 
3.4.5 Characterisation of OPC response during progressive myelin loss 
 
3.4.5.1 Waves  of  OPC  proliferation  occurred  during  progressive 
demyelination  
 
To study the proliferation activity of OPCs in the #72 corpus callosum, one single 
intraperitoneal injection of the thymidine analogue Bromodeoxyuridine (BrdU) 
was  performed  one  hour  prior  to  euthanasia.  BrdU  is  incorporated  into 
replicating DNA during the s-phase of the cell cycle and can be used to identify 
proliferating  cells.  For  quantification  of  OPC  proliferation  the  sections  were 
double labelled with antibodies against PDGFRα and BrdU (Figure 20).  
 
Initially the PDGFRα/BrdU +ve cell density was similar in #72 and wild type mice. 
There was a continuous decline in PDGFRα/BrdU +ve cell density in the wild type 
after  P40  up  to  P120.  In the  #72  corpus  callosum  the PDGFRα/BrdU  +ve cell 
density initially followed a similar decline between P40 and P60. However there 
was a significant increase in PDGFRα/BrdU +ve cell density at P90 in the #72 
compared to the wild type. This was followed by a decline in BrdU/PDGFRα +ve 
cell density at P120, when the cell density again appeared similar to wild type 
(Figure 21). 
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Figure 20.  Cell proliferation occurred in response to demyelination. 
Micrographs of BrdU +ve cells in the corpus callosum between P40 and P120 in wild type (A - D) 
and #72 homozygote mice (E - H, x100, scale bar 400µm). Initially at P40 and P60 BrdU +ve cells 
were present in a comparable fashion between the wild type and #72 homozygote mice. However 
there was a marked increase in BrdU +ve cells in the #72 homozygote compared to the wild type 
at P90. At P120 the quantity of BrdU +ve cells appeared similar in the #72 and wild type mice. 
Some of these BrdU +ve cells were PDGFRα +ve, suggesting that OPC proliferation occurs during 
demyelination (I, K, x400, scale bar 25µm). 118 
 
Figure 21.  OPC  proliferation  occurred  in  association  with  progressive 
demyelination.  
Graph  illustrating  the  OPC  proliferation  in  wild  type  and  #72  homozygote  mouse  during 
progressive demyelination. N=3 (for each given time point and genetic background), adding up to 
a  total  number  of  24  quantified  specimens.  Bars  display  s.e.m.  In  order  to  focus  on  OPC 
proliferation  only  BrdU/PDGFRα  +ve  cells  were  counted.  Initially  the  OPC  proliferation  was 
similar in both the wild type and the #72 mouse. Proliferation was higher at this age compared to 
older ages, probably reflecting ongoing myelination. There was a reduction in PDGFRα/BrdU +ve 
cell density at P60 in both the wild type and #72 mouse, followed by a significant increase in 
PDGFRα/BrdU +ve cells, suggesting an increased OPC proliferation at P90 in the #72 mouse. By 
P120, the proliferative pool was similar to the wild type.  119 
3.4.5.2 OPC differentiation is virtually absent in the demyelinated #72 corpus 
callosum 
 
Since  proliferation  of  the  OPCs  take  place  in  response  to  progressive 
demyelination  in  the  #72  corpus  callosum,  the  next  step  was  to  identify  the 
differentiation status of the OPCs during progressive demyelination. It has been 
shown  that  the  basic  Helix-Loop-Helix  (bHLH)  transcription  factor  Olig1  is 
required  during  remyelination  and  that  the  absence  of  Olig1  leads  to 
remyelination failure (Arnett et al., 2004). For remyelination to be successful 
OPCs  must  differentiate  into  oligodendrocytes.  The  change  in  subcellular 
distribution of Olig1, which has been shown to be a translocation of Olig1 from 
cytoplasm  into  the  nucleus  during  OPC  differentiation,  can  be  used  to 
characterise the status of OPCs during demyelination and remyelination (Arnett 
et al., 2004;Kitada and Rowitch, 2006). To investigate if Olig1 translocates to 
the cell nucleus in OPCs in the #72 homozygote corpus callosum, the subcellular 
localisation of Olig1 in NG2 cells was analysed and quantified. NG2 +ve cells with 
(i) intranuclear, (ii) intranuclear and cytoplasmic, (iii) partial intranuclear and 
cytoplasmic  or  (iv)  cytoplasmic  Olig1  localisation  were  identified  (Figure  22). 
NG2 +ve cells that were negative for Olig1 as well as Olig1 +ve cells that were 
negative for NG2 were also observed. P3 #72 mice had the expected intranuclear 
Olig1  expression  during  early  neonatal  development  (Figure  23).  In  adult 
animals, only extremely rare NG2 +ve /intranuclear Olig1+ve cells were found in 
either wild type or the #72 mice (Table 4). In fact almost half of all NG2 +ve 
/Olig1 +ve cells in wild type and #72 mice had a pure cytoplasmic localisation of 
Olig1 (Figure 24).  
     120 
 
Figure 22.  All variants of subcellular Olig1 localisation in NG2+ cells were 
found in the #72 mouse during demyelination. 
Micrographs from #72 corpus callosum showing NG2 +ve cells with cytoplasmic localisation of 
Olig1  (A  –  D),  with  cytoplasmic  and  partially  nuclear  localisation  of  Olig1  (E  –  H),  with 
cytoplasmic and nuclear localisation of Olig1 (I – L) and with nuclear localisation of Olig1 (M – P, 
x400, scale bar 25µm). This indicates that all stages of OPC proliferation and differentiation 
were present in the #72 homozygote mouse. Note that combined cytoplasmic and nuclear Olig1 
is also present in NG2 negative cells (arrow).  
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Figure 23.  Different  subcellular  Olig1  localisation  was  observed  in  NG2 
negative cells. 
Micrographs from #72 corpus callosum. NG2 negative cells with nuclear localisation of Olig1 were 
also detected (A – D). There were also a few NG2 +ve cells, which were Olig1 negative. In the 
same  image  there  is  a  cytoplasmic  Olig1  only  positive  cell,  which  is  most  likely  a  mature 
oligodendrocyte (E – H x400, scale bar 25µm). This shows that not only in OPCs but also in other 
cells the subcellular localisation of Olig1 can vary. In order to verify the sensitivity of the Olig1 
antibody  to  penetrate  intranuclear,  tissue  from  P3  #72  homozygote  mice  was  used  where 
intranuclear localisation of Olig1 in Olig2 positive cells is expected to be present. Intranuclear 
localisation of Olig1 in Olig2 positive cells was detected in developing #72 homozygote corpus 
callosum (I – L, x400, scale bar 25µm). This is in agreement with observations described in the 
literature. 
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NG2  &  Olig1 
intranuclear 
NG2  &  Olig1 
cytoplasmic 
NG2  &  Olig1 
intranuclear  & 
partial 
cytoplasmic 
NG2  &  Olig1 
intranuclear  & 
cytoplasmic 
Mean 
(%) 
S.E.M 
Mean 
(%) 
S.E.M 
Mean 
(%) 
S.E.M 
Mean 
(%) 
S.E.M 
WT 
P40 
0.32  ±0.32  63.347  ±2.025  24.393  ±5.272  11.94  ±6.793 
#72 
P40 
0  0  38.69  ±2.38  50.29  ±3.965  11.02  ±3.154 
WT 
P60 
0.347  ±0.347  51.293  ±6.947  41.347  ±4.394  7.013  ±2.825 
#72 
P60 
1.367  ±0.803  34.137  ±6.332  44.803  ±6.345  19.693  ±2.788 
WT 
P90 
1.170  ±1.170  57.933  ±7.153  30.563  ±4.632  10.333  ±4.535 
#72 
P90 
0  0  47.277  ±3.078  48.79  ±3.987  3.933  ±1.695 
WT 
P120 
0  0  49.373  ±2.187  49.787  ±2.11  0.477  ±0.477 
#72 
P120 
0  0  45.673  ±4.014  50.905  ±4.328  3.423  ±0.965 
 
Table 4.  Intranuclear  Olig1  was  rarely  observed  in  wild  type  and  #72 
homozygote NG2 +ve cells. 
N=3 (for each given time point and genetic background), adding up to a total number of 24 
quantified  specimens.  Olig1  was  mainly  found  in  the  cytoplasm  or  in  mixed  cytoplasmic  and 
nuclear locations. The population with mixed subcellular localisation of Olig1 were most likely 
proliferating OPCs. 123 
 
Figure 24.  The subcellular distribution of Olig1 in #72 mouse NG2 +ve cells. 
Graph representing the percentage of subcellular localisation of Olig1 in NG2 +ve cells. N=3 (for 
each given time point and genetic background), adding up to a total number of 24 quantified 
specimens. Bars display s.e.m. In NG2 +ve cells in the #72 mouse, Olig1 was mainly localised in 
both  cytoplasm  and  nucleus.  Only  a  very  few  NG2  +ve  cells  had  a  uniquely  intranuclear 
localisation of Olig1.  124 
3.4.6 Astrocytic response during demyelination of the #72 homozygote 
corpus callosum 
 
In  general,  astrocytes  react  to  demyelination  by  proliferation  and  activation 
(reviewed in (Moore et al., 2011a;Ayers et al., 2004). The role of astrocytes in 
demyelinating  pathology  is  controversial.  Both  beneficial  (Franklin  et  al., 
1991;Liu  et  al.,  1994;Moore  et  al.,  2011b)  and  inhibitory  (Back  et  al., 
2005;Blakemore et al.,  2003;Su  et al.,  2011)  roles  in remyelination has  been 
reported reviewed in (Nash et al., 2011). To characterise the astrocytic response 
during demyelination in the #72 mouse, an antibody to GFAP was used (Figure 
25). GFAP +ve cell density was increased in the #72 homozygote compared to the 
wild type at all ages examined. Significant increase was observed (p<0.05) from 
P60 onwards and increased with the severity of demyelination (Figure 26).   
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Figure 25.  A progressive astrocytic response accompanied demyelination in 
the #72 mouse corpus callosum. 
Micrographs of sections stained for GFAP, between P40 and P120, in wild type (A – D) and #72 
mouse (E – H, x100, scale bar 400µm) corpus callosum. At P40 the density of astrocytes was 
similar in #72 and wild type mice. From P60 onwards, the astrocyte density was significantly 
increased in the #72 mouse corpus callosum compared to the wild type. Astrocyte morphology 
changed with progressive demyelination. In the #72 mouse, astrocyte processes appeared thicker 
and more branched (K, magnification x400, scale bar 25µm) than in wild type mice (I, x400, scale 
bar 25µm). 126 
 
Figure 26.  Astrocyte  cell  density  is  increased  in  the  #72  mouse  corpus 
callosum. 
Graph illustrating the astrocytic cell density during progressive demyelination in the #72 mouse 
corpus callosum. N=3 (for each given time point and genetic background), adding up to a total 
number of 24 quantified specimens. Bars display s.e.m. The astrocyte density in the #72 mouse is 
comparable to the wild type at P40. A progressive increase in astrocyte cell density was present 
after  P40,  with  a  particularly  steep  increase  between  P90  and  P120.  Cell  density  was 
significantly  increased  in  the  #72  mouse,  compared  to  wild  type,  at  P60,  P90  and  P120.  (*: 
p<0.05, **: p<0.01, ***: p<0.001). 127 
3.4.7 Immune cell response in the #72 homozygote corpus callosum 
 
3.4.7.1 Progressive demyelination is accompanied by an increase in CD45 and 
CD169 positive cell population 
 
The  microglial/macrophage  population  has  been  shown  to  undergo  marked 
upregulation  (Tatar  et  al.,  2010)  and  to  contribute  to  the  progression  in 
demyelination (Ip et al., 2006;Ip et al., 2007) in Plp1 gene overexpressing mice 
(line #66). In context with remyelination, inflammation has been shown to have 
a promoting effect on remyelination efficacy (Foote and Blakemore, 2005a;Setzu 
et al., 2006). Also the phagocytic activity of microglia/macrophages is beneficial 
for remyelination (Kotter et al., 2006;Merson et al., 2010). On the other hand 
microglia  mediated  inflammation  can  also  be  cytotoxic,  which  can  cause 
unspecific severe tissue damage also on remyelination capable OPCs (Merson et 
al., 2010). 
 
The  pan  leukocytic  marker  CD45  was  used  to  characterise  the 
microglia/macrophage population during demyelination in the #72 mouse corpus 
callosum. In the normal CNS there are only a few trafficking T and B cells so the 
majority of CD45+ cells are microglia. Most of the CD45 +ve cells were dendritic 
in appearance, resembling microglial cells (Figure 27). Only a few cells lacked 
processes, suggesting they were lymphocytes (arrows in  Figure 27). Therefore 
the vast majority of CD45+ve cells most likely were microglial/macrophages. The 
density of CD45+ve cells was significantly increased from P60 onwards in the #72 
homozygote  corpus  callosum  compared  to  the  wild  type,  and  increased  in 
proportion to the severity of demyelination (Figure 28). 
 
Not only the increase in density of microglia but also their state of activation, 
which can be identified by the expression of the macrophage restricted adhesion 
molecule  sialoadhesin  (CD169),  has  been  shown  to  be  involved  in  the 
demyelination process and the development of axonal pathology. Knock out of 
sialoadhesin (CD169)  expression on microglia/macrophages in a different  Plp1 
overexpressing mouse model, (line #66) ameliorated demyelination and axonal 128 
damage  (Ip  et  al.,  2007).  Activated  microglia  also  secret  TNFα  (reviewed  in 
Merson et al., 2010), and may induce OPC apoptosis, which leads to a reduction 
in OPCs and therefore may have a negative influence on remyelination capacity 
(Mi et al., 2011). CD169 is normally not expressed on microglia and it is thought 
that CD169 expressing cells in the CNS are recruited from the periphery to the 
damaged  CNS  (Perry  et  al.,  1992).  However,  activation  of  residential 
microglia/macrophages occurs in relation to pathological processes in the CNS 
and (Ip et al., 2007) suggested that at least some of the CD169+ cells in Plp1 
overexpressing mice CNS are resident microglia (Ip et al., 2007).  
 
In the #72 homozygote corpus callosum, CD169 expression was observed after 
P60 and markedly increased up to P120 (Figure 29 and Figure 30). CD169+ cells 
were also present in the choroid plexus and blood vessels as would be expected 
(Figure 29 arrows and arrowheads) and were only occasionally present in the 
wild type corpus callosum at any of the time points examined. 
 
Edgar et al (2010) showed that B cells are rare and that there are only a few T 
cells in the #72 mouse optic nerve (Edgar et al., 2010). In this study, B-cells 
were  absent  in  the  P120  #72  mouse  corpus  callosum  (data  not  shown). 
Infiltrating T cells have been reported to contribute to the demyelination and 
axonal  pathology  in  Plp1  gene  overexpressing  mice  (Ip  et  al.,  2006).  To 
investigate if T-cells were present during demyelination in the #72 homozygote 
corpus callosum, CD3, a marker for T-cells, was examined. A small number of 
CD3+ve cells were present during the later stages of demyelination (Figure 31).  
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Figure 27.  A  marked  increase  in  microglial/macrophages  accompanies 
progressive demyelination. 
Micrographs of CD45 +ve cells in the corpus callosum at P40, P60, P90 and P120 in wild type (A – 
D) and 72 (E – F; x100, scale bar 400um) mice. An obvious increase in the density of CD45 
positive cells is evident in the #72 mouse compared to the wild type. Morphologically the CD45+ 
cells in the #72 mouse appeared altered, having thicker and shorter processes (K, x400, scale bar 
25µm) than wild type cells (I, magnification x400, scale bar 25µm). At P120 a few cells with a 
rounded morphology, resembling B or T lymphocytes, were present in the #72 mouse (arrow). 130 
 
Figure 28.  Microglial/macrophage cell density increases progressively in the 
#72 homozygote corpus callosum. 
Graph  illustrating  the  microglial/macrophage  cell  density  changes  during  progressive 
demyelination. N=3 (for each given time point and genetic background), adding up to a total 
number of 24 quantified specimens. Bars display s.e.m. The microglial/macrophage cell density 
was increased in the #72 homozygote corpus callosum compared to wild type, from  P60 and 
progressively increased up to P120, when demyelination of the corpus callosum was virtually 
complete. (**: p<0.01, ***: p<0.001). 
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Figure 29.  Sialoadhesin  expressing  cells  were  found  in  the  demyelinating 
corpus callosum. 
Micrographs of CD169 +ve cells in the corpus callosum between P40 and P120, in wild type (A – D) 
and 72 mice (E – F; x100, scale bar 400um). At all time points in the wild type mice and up to 
P60 in the #72 mouse corpus callosum there were only occasional CD169 +ve cells detected. At 
P90 and P120, several CD169 +ve cells were observed in the #72 mouse corpus callosum. CD169 
+ve cells were present in wild type and #72 mouse choroid plexus (arrows) and blood vessels 
(arrowheads). CD169 expression was detected on both the cell body and on cell processes (I, 
x400, scale bar 25µm). 132 
 
Figure 30.  The density of activated microglial/macrophages is progressively 
increased in the #72 mouse corpus callosum. 
Graph  illustrating  CD169  +ve  cell  density  changes  during  progressive  demyelination.  N=3  (for 
each given time point and genetic background), adding up to a total number of 24 quantified 
specimens. Bars display s.e.m. CD169+ve cells were observed in the corpus callosum after P60 
and the CD169 cell density increased between P90 and P120, corresponding with the severity of 
demyelination (***: p<0.001, ****: p<0.0001) 
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Figure 31.  T  cell  infiltration  accompanied  progressive  demyelination  and 
activation of the microglial/macrophage cell population. 
Micrographs of CD3+ve cells in the corpus callosum, between P40 and P120, in #72 (A, B, C, E) 
and wild type mice (D, x100, scale bar 400µm). CD3+ve cells were only observed at P90 and P120 
(F, x400, scale bar 50µm), suggesting that the T cell infiltration succeeded the earliest stages of 
demyelination. 134 
3.4.8 Progressive  demyelination  and  inflammation  is  associated  with 
axonal swelling in the #72 homozygote corpus callosum  
 
Axonal damage and neuronal degeneration is considered to be the main cause of 
permanent  disability  in  multiple  sclerosis  (reviewed  in  Bjartmar  and  Trapp, 
2001).  Dystrophic  axons  are  also  believed  to  become  non  permissive  for 
remyelination  (reviewed  in  Franklin  and  ffrench-Constant,  2008)  and  may 
contribute to remyelination failure. A previous study from (Edgar et al., 2010) 
showed  the  presence  of  axonal  swellings  in  the  inflamed,  demyelinating 
chiasmal region of #72 homozygote mouse optic nerve. 
 
To test if axonal swellings occur in the #72 homozygote corpus callosum I used 
an  antibody  to  SMI32  that  labels  non-phosphorylated  neurofilaments.  Prior  to 
myelination, axonal neurofilaments are largely non-phosphorylated (Brady et al., 
1999;Petzold, 2005). Myelination is accompanied by increased phosphorylation of 
neurofilaments  and  increase  in  axonal  diameter.  Following  demyelination, 
neurofilaments become dephosphorylated (Trapp et al., 1998). Antibodies that 
recognise  non-phosphorylated  neurofilaments  are  routinely  used  to  identify 
axonal changes in relation to demyelination. At P40, SMI32 staining appeared 
similar in the #72 mouse compared to the wild type. However, at P120 SMI32 
staining appeared markedly increased in the #72 mouse, compared to the wild 
type (Figure 32).   
 
To visualise morphological changes in axons, a Thy-1 / CFP expressing mouse was 
crossed  with  the  #72  homozygote  mouse  to  create  homozygous  Plp1 
overexpressing mice that were hemizygous for the transgenic Thy-1 / CFP gene, 
as described in Chapter 2. Using CFP as a sensitive marker of axonal changes, 
axonal swellings appeared to be increasingly prevalent in the homozygote 72 
mice corpus callosum from P90 onwards (Figure 33).  
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Figure 32.  Axonal  changes  increased  with  progressive  demyelination  and 
inflammation. 
Micrographs of sections stained using antibody to SMI32 in the corpus callosum of P40  and P120 
wild type (A, B) and #72 (C, D, magnification x100, scale bar 400µm) mice. SMI32 labels non-
phosphorylated neurofilaments and is a useful marker of pathology in the adult. Axons positive 
for SMI32 were more prevalent in the #72 mouse than in the wild type, at P120. An SMI32 +ve 
axonal swelling was observed occasionally (arrow).  
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Figure 33.  Axonal  swellings  as  a  sign  of  axonal  injury  were  increasingly 
present with progressive demyelination and inflammation. 
Micrographs of CFP +ve axons in the corpus callosum of P40 to P120 #72 (A, B, C, E) and P120 
wild type mice (D, x100, scale bar 400µm). CFP is expressed in a subset of sensory and motor 
neurons and is located in the cytoplasm (black asterisk). Visualisation of GFP analogues is a more 
sensitive  marker  of  axonal  swellings  (arrows)  than  antibody  staining  (Bridge  et  al.,  2009).  A 
number of axonal swellings (K, confocal image, x670) were present after P90 in the #72 mouse.  137 
3.4.9 Axonal density in the #72 homozygote was unaltered compared 
to the wild type corpus callosum  
 
Demyelination  and  associated  processes,  such  as  inflammation,  can  lead  to 
axonal changes resulting in permanent axonal loss. To determine if axonal loss 
could contribute to the failure of remyelination in the #72 homozygote corpus 
callosum,  electron  micrographs  were  used  to  calculate  axonal  density.  The 
axonal density decreased slightly with increasing age in wild type and in the #72 
homozygote corpus callosum. However, there was no significant difference in 
axonal density in the #72 homozygote corpus callosum compared to wild type, at 
any of the ages examined (Figure 34).  138 
 
Figure 34.  Axonal  density  was  not  reduced  in  the  demyelinated  corpus 
callosum of the #72 mouse. 
Graph of axonal density in the wild type and #72 mouse corpus callosum. N=3 (for each given 
time point and genetic background), adding up to a total number of 24 quantified specimens. 
Bars display s.e.m. There was no significant difference in axonal density in the #72 mouse corpus 
callosum compared to the wild type, at any of the time points examined.  139 
Demyelination and remyelination failure was not caused by Caspase3 
mediated cell apoptosis 
 
In dysmyelinating mutants such as the jimpy mouse (Gow et al., 1998;Cerghet et 
al., 2001), the rumpshaker mouse (McLaughlin et al., 2007) or the msd mouse 
(Gow et al., 1998), the mutated PLP/DM20 accumulates in the cell body and 
causes an unfolded protein reaction (UPR) causing a Caspase12 mediated cleaved 
Caspase3 induction, leading to cell apoptosis. However it has also been shown 
that in another Plp1 gene overexpressing mouse model (line #66) the degree of 
cell apoptosis is less severe than for example in the jimpy mouse (Cerghet et al., 
2001). A recent study has shown that inflammation induces Caspase3 mediated 
OPC apoptosis by DR6 activation, which is highly expressed on immature OPCs 
leading to impaired remyelination capacity (Mi et al., 2011). Antibody against 
cleaved  Caspase3  was  used  to  characterise  cell  apoptosis  mediated  through 
Caspase3 signalling (Figure 35). Caspase3 +ve cells were scarce at all time points 
examined  in  the  #72  homozygote  corpus  callosum,  indicating  that  if  cell 
apoptosis was present it is not Caspase3 mediated.  
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Figure 35.  Caspase3 mediated cell apoptosis was not detected in the #72 
homozygote corpus callosum. 
Micrographs  of  Caspase3  +ve  cells  in  the  corpus  callosum  between  P40  and  P120  in  #72 
homozygote mice (A - E), at P120 in wild type mice (F) and in spleen (G, x100, scale bar 400µm, 
H, x400, scale bar 50µm). Caspase3 positive cells were only rarely observed in the #72 mouse 
(E). Lipofuscin (arrows) contributes to the fluorescent signal in the #72 mouse.  141 
3.4.10  OPC cell differentiation inhibition: an in situ screening of 
OPC  intrinsic  and  extrinsic  factors  known  to  be  involved  in 
remyelination failure  
 
Multiple  OPC  intrinsic  and  extrinsic  factors  have  been  identified  to  interact 
during  the  complex  remyelination  process  after  demyelination.  It  has  been 
stated that only a slight interruption in any of these finely tuned interactions 
during the remyelination processes can eventually lead to remyelination failure 
(reviewed in Franklin and ffrench-Constant, 2008). In my study I focused on a 
few potential factors, such as prolonged Wnt pathway activation, accumulation 
of hyaluronan, polysialation of neural cell adhesion molecule and local thyroid 
hormone regulation which have been described to alter remyelination capacity. 
 
3.4.10.1  There is no evidence that OPC cell differentiation is inhibited by 
abnormal Wnt pathway activation  
 
The activation of the Wnt pathway has been shown to play a pivotal role in 
coordinating remyelination after demyelination. During the OPC recruitment and 
proliferation phase, the Wnt pathway is activated. For OPC differentiation on 
the other hand, the Wnt pathway needs to be deactivated. It has been shown 
that  in  the  case  of  prolonged  Wnt  pathway  activation,  remyelination  after 
chemically induced demyelination is delayed (Fancy et al., 2009). It has been 
hypothesized that if the delay is prolonged, the narrow temporal window during 
which  the  demyelinated area  is  favourable  for  remyelination  may  be  missed, 
potentially leading to remyelination failure (Fancy et al., 2009).  
 
To  investigate  the  possibility  that  abnormal  activation  of  the  canonical  Wnt 
pathway  contributes  to  OPC  differentiation  block  in  the  #72  mouse  corpus 
callosum, antibody labelling of Axin 2 was undertaken. Axin2 provides negative 
feedback  of  the  Wnt  pathway  and  is  only  expressed  when  the  pathway  is 
activated. At P40 and P90, when BrdU +ve OPC density was elevated, Axin2 +ve 
cells were present. At P60 and P120, where BrdU +ve OPC density was low, Axin2 
was not detected (Figure 36). This is compatible with the Wnt pathway being 142 
active  during  OPC  proliferation  phase.  Double  labelling  with  Olig1  confirmed 
that most of the Axin2 positive cells were of oligodendroglial lineage (Figure 37 
A - D). Incidentally, Axin2 staining also co-localised with axonal swellings (Figure 
37 E - H). 
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Figure 36.  Activation  of  the  canonical  Wnt  pathway  was  present  at  time 
points where OPC proliferation was upregulated. 
Micrographs  of  #72  (A  -  D)  and  wild  type  (I)  corpus  callosum  and  colon  (K,  x100,  scale  bar 
400µm), stained using antibody to Axin2. In the #72 corpus callosum, a higher proportion of Axin2 
positive cells were present at P40 and P90 compared to P60 and P120 as well as to the wild type. 
Axin2 localisation was intranuclear (E) or cytoplasmic (G). Axin2 positive structures that were 
not related to cell nucleus resembled axonal swellings. (F, H, x400, scale bar 25µm). 
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Figure 37.  Axin2  is  located  in  cells  originating  from  the  oligodendroglial 
lineage.  
Micrographs of #72 corpus callosum at P90. Double labeling with Olig1 (A – D) showed that Axin2 
positive  cells  expressed  Olig1,  indicating  that  the  Wnt  pathway  is  active  in  cells  of  the 
oligodendroglial lineage, during demyelination. Since the Axin2 structures, which could not be 
correlated with a nucleus, resembled axonal swellings, Axin2 expression in the Thy-1-CFP was 
investigated. (E –F, x400, scale bar 25µm) Axin2 staining overlapping with CFP in axonal swellings 
(arrows). Neuronal cell bodies (arrowhead), which were filled with CFP, were Axin2 negative, 
showing that Axin 2 labeling was not due to unspecific binding of Axin2 to CFP. There were also 
Axin2 positive cells that were negative for CFP (asterisk) that had a similar morphology to the 
Olig1/Axin2 positive cells in the #72 homozygote corpus callosum. 145 
3.4.10.2  Accumulation  of  hyaluronan  was  present  at  the  end  stage  of 
demyelination in the #72 homozygote corpus callosum 
 
Hyaluronan,  which  is  secreted  by  astrocytes  in  chronic  demyelination,  is  a 
potent inhibitor of OPC maturation and contributes to remyelination failure in 
chronic  demyelinated  lesions  (Back  et  al.,  2005).  The  inhibitory  effect  being 
mediated  through  TLR2  receptors  on  OPCs  (Sloane  et  al.,  2010).  To  test  if 
hyaluronan  was  expressed  in  the  extracellular  matrix  I  used  a  biotinylated 
hyaluronan  binding  protein  (bHABP).  At  P60,  when  demyelination  is 
commencing,  there  was  no  evidence  of  hyaluronan  expression  in  the  #72 
homozygote corpus callosum, similar to wild type. At P120 an accumulation of 
hyaluronan was identified in the #72 homozygote corpus callosum. To rule out 
non-specific binding with myelin debris a double stain with MBP  showed that 
HABP did not bind to myelin debris (Figure 38). 
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Figure 38.  Hyaluronan  accumulation  was  identified  in  the  demyelinated 
corpus callosum at P120. 
Micrographs showing the hyaluronan labelling of wild type (A, B) and #72 mouse corpus callosum 
(C,  D).  At  P60,  when  demyelination  commenced,  the  distribution  of  hyaluronan  in  the  #72 
homozygote  appeared  similar  to  the  wild  type.  An  increase  in  hyaluronan  expression  was 
observed at P120 in the #72 mouse and could potentially contribute to the OPC differentiation 
block. Tarsus was used as a positive control (E) The specificity of hyaluronan binding protein 
(HABP) was tested using tissue incubated with bovine hyaluronidase (F, x100, scale bar 400µm). 
To confirm that HABP was not binding to myelin debris, double  labelling using HABP and an 
antibody to MBP was performed (G – I, x400, scale bar 25µm). The HABP positive structures did 
not co-label with myelin debris, stressing the specificity of the HABP to bind to hyaluronan. 147 
3.4.10.3  Poly-sialated  neural  cell  adhesion  molecule  (PSA-NCAM) 
expression  was  identified  on  astrocytes  but  not  on  axons  in  the 
chronically demyelinated #72 homozygote corpus callosum 
 
The  polysialation  of  NCAM  on  axonal  surfaces  has  been  shown  to  inhibit  the 
initiation of contact between OPC and unmyelinated axons. During development, 
PSA-NCAM plays a key role in regulating the precise timing of myelination and 
the  expression  of  PSA-NCAM  on  axons  is  not  detected  after  myelination 
commences  (Coman  et  al.,  2005).  In  pathology,  such  as  in  chronic  MS,  re-
expression  of  PSA-NCAM  on  demyelinated  axons  has  been  detected  and  it  is 
thought to prevent remyelination by inhibiting the initial axonal glial contact 
which is needed to initiate remyelination after demyelination  (Charles et al., 
2002). Antibodies against PSA-NCAM were used to examine the polysialation of 
NCAM on axons in the chronic demyelinated #72 homozygote corpus callosum. At 
P120, axons did not express PSA-NCAM, suggesting that is unlikely to be involved 
in the inhibition of myelination. However PSA-NCAM expression was detected on 
spindle shaped cells, which were also positive for GFAP (Figure 39).  
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Figure 39.  PSA-NCAM  expression  was  detected  on  astrocytes  and  not  on 
axons in the #72 mouse corpus callosum.  
Micrographs form wild type (A) and #72 mouse corpus callosum (B, x100, scale bar 400µm) at 
P120. A few PSA-NCAM +ve cells were present in the P120 wild type corpus callosum (C). In 
contrast, the #72 mouse corpus callosum contained a marked number of PSA-NCAM positive cells 
(D,  magnification  x400,  scale  bar  25µm).  Double  labelling  with  PSA-NCAM  and  Olig2  to  label 
oligodendroglia (E – H, x400, scale bar 50µm) or with PSA-NCAM and GFAP (I – L, x400, digitally 
magnified, scale bar 50µm) to label astrocytes, showed that most of the PSA-NCAM positive cells 
were GFAP +ve, suggesting that these cells are reactive astrocytes. 149 
3.4.10.4  Deiodinase  3  expression  was  not  detected  on  activated 
microglial cells in chronic demyelinated corpus callosum at P120  
 
The enzyme deiodinase 3, which converts T4 to reverse T3 (rT3) or T3 to T2 and 
therefore inactivates thyroid hormone activity, is believed to be responsible for 
tightly regulating the local concentration of active T3 in tissue  (Bates et al., 
1999). It is believed that, especially in the case of inflammation, increased D3 
expression can cause local tissue specific hypothyroidism, which has negative 
effects on cell metabolism and repair. Since there is chronic inflammation with 
activation  of  microglia  in  the  #72  homozygote  mouse  model,  a  potential 
expression of D3 on activated microglia/macrophages could contribute to the 
remyelination failure. To characterize D3 expression in the #72 corpus callosum, 
in  this  case  mainly  microglia/macrophages  during  chronic  demyelination,  an 
antibody to D3 in combination  with antibody to CD45 were used. D3 was not 
detected  by  immunohistochemistry  in  the  adult  #72  mouse  corpus  callosum 
(Figure 40). 
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Figure 40.  The microglia/macrophage population did not express D3 in the 
adult, chronically demyelinated #72 homozygote corpus callosum. 
Micrographs of wild type (A  – C) and #72 homozygote (D – F, x100, scale bar 400µm) corpus 
callosum. Spleen was used as a positive control tissue (G – K, x400, scale bar 50µm). The CD45 
positive cell population in the #72 homozygote corpus callosum did not express D3. 151 
3.5  Discussion 
 
3.5.1 Progressive  demyelination  was  accompanied  by  remyelination 
failure in the #72 homozygote corpus callosum 
 
The data presented in this chapter demonstrates that myelination in the corpus 
callosum of the homozygous Plp1 overexpressing mouse (#72 mouse) proceeds 
relatively  normally  initially,  but  is  followed  by  a  progressive,  non-remitting, 
demyelination,  starting  after  P40  and  terminating  in  virtually  complete 
demyelination  by  P120.  Demyelination  is  accompanied  by  activation  of 
microglia/macrophages and astrocytes and by the infiltration of a small number 
of  T  cells.  Axonal  densities  are  unaltered,  but  in  older  mice,  there  is  some 
evidence  of  axonal  injury.  These  pathological  changes,  which  are  probably 
present throughout the brain as suggested by DTI findings (Ruest et al., 2011), 
account for the clinical signs observed in these mice. 
 
While it has previously been shown that demyelination is a characteristic of the 
optic  nerve  and  spinal  cord  of  various  lines  of  Plp1  overexpressing  mice 
(Anderson  et  al.,  1998;Edgar  et  al.,  2010;Ma  et  al.,  2006),  the  evolution  of 
demyelination has not been reported, except in the case of the #72 mouse optic 
nerve  (Edgar  et  al.,  2010).  Therefore  the  nature  and  evolution  of  the 
degenerative and reparative processes are not known.  
 
Furthermore,  despite  the  suggestion  that  in  the  hemizygous  Plp1  transgenic 
mouse “remyelination intermingles with myelin destruction/degeneration” and 
that  in  older  mice  “most  axons  are  demyelinated  …  with  no  signs  of 
remyelination…” (line 4e of Ma et al., 2006) there is actually no evidence in the 
literature (including publications cited by Ma) to show that this is actually the 
case.  Indeed  the  only  evidence  presented  to  support  the  assertion  that 
remyelination fails in line 4e is a single high power image showing a marked 
reduction in PLP staining in the optic nerve of that model.  
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In the present study, a progressive demyelination in the absence of effective 
remyelination  was  demonstrated  unequivocally,  using  a  combination  of 
immunofluorescence,  light  microscopy  and  EM.  The  initially  formed  myelin 
appeared  morphologically  normal,  showing  that  during  early  post  natal 
development,  #72  OPCs  are  capable  of  appropriately  myelinating  axons.  The 
inability to effectively (re)myelinate axons developed later on during the disease 
process. 
 
3.5.1.1 Demyelination in the #72 mouse corpus callosum 
 
Demyelination  was  not  accompanied  by  an  apparent  decrease  of  mature 
oligodendrocytes,  suggesting  that  the  degenerative  process  in  the  #72  mouse 
represents  a  dying-back  of  the  genetically  defective  oligodendrocyte,  as 
suggested previously by (Anderson et al., 1998), which may be related to (i) an 
intrinsic instability of the biochemically abnormal sheath (Karim et al., 2007) as 
well as (ii) secondary immune reactions (Ip et al., 2006;Ip et al., 2007). In my 
study a marked increase and activation of microglia together with a subtle but 
definite  elevation  of  intraparenchymal  T  cells  accompanied  the  progressive 
demyelination, suggesting that secondary immune reactions also contribute to 
the demyelination in the #72 mouse, although leukodystrophies are classically 
considered to be non-inflammatory demyelinating diseases. 
 
Severe  gliosis  with  astrocytic  activation  has  also  been  reported  to  damage 
myelin  and  oligodendrocytes  by  secretion  of  TNFα  (Selmaj  and  Raine,  1988; 
reviewed in Nash et al., 2011). Since there is a considerable astrocytic response 
accompanying demyelination in the #72 corpus callosum, the progression of the 
demyelination could also be mediated through the marked astrocytic response.   
 
3.5.1.2 The response of OPCs to demyelination 
 
It  is  notable  that  developmental  myelination  proceeds  almost  normally, 
demonstrating that juvenile #72 OPCs are myelination competent in contrast to 153 
the  situation  in  the  adult,  where  there  is  no  evidence  of  a  remyelination 
attempt during progressive demyelination.  
 
OPCs, as identified using antibodies to NG2 and PDGFRa, were present in the 
corpus callosum during the entire period of demyelination. Using BrdU labelling 
of  proliferating  cells,  I  showed  that  OPCs  responded  to  demyelination  by 
proliferating. Surprisingly however, this did not lead to a marked increase in OPC 
densities, suggesting that either immature OPCs undergo apoptosis or that OPC 
proliferation is not extensive enough. OPC numbers were similar to those in the 
wild type mouse, except that at P120, where the density of NG2 +ve cells was 
increased  in  the  #72  mouse.  However,  no  such  change  was  observed  in  the 
PDGFRα population and the NG2 data must be regarded with caution since NG2 
antibodies show unspecific binding to pericytes and a subset of macrophage like 
cells (MacFadyen et al., 2007;Matsumoto et al., 2008). NG2 +ve cells have also 
been shown not only to develop into oligodendroglia but also into astroglia, and 
neurons, which suggests that not all NG2 +ve cells are per se OPCs (Zhu et al., 
2008b;Zhu et al., 2008a;Nishiyama et al., 2009). Nonetheless, this data suggests 
that repair in the #72 mouse is not due to the complete absence of OPCs, and 
the increase in OPC proliferation at P90 suggests that the cells respond to the 
demyelinating stimulus. 
 
In  MS  lesions,  remyelination  sometimes  fails  despite  OPCs  being  present 
(Wolswijk, 1998;Chang et al., 2002;Back et al., 2005;Kuhlmann et al., 2008). To 
determine if a differentiation block contributes to remyelination failure in the 
#72  mouse,  I  analysed  OPC  characteristics  during  demyelination  by 
characterising  the  subcellular  localisation  of  Olig1  in  NG2+  cells.  It  has 
previously been demonstrated that the localisation of Olig1 during myelination 
and remyelination is a useful indicator of the developmental stage of the OPCs 
(Arnett et  al.,  2004;Kitada  and  Rowitch, 2006).  Notably,  the translocation of 
Olig1 from the cytoplasm to the cell nucleus is a prerequisite for (re)myelination 
(Arnett  et  al.,  2004).  In  the  demyelinating  #72  mouse,  there  was  an  almost 
complete absence of pure intranuclear Olig1 in NG2+ cells, suggesting that the 
differentiation of OPCs into myelinating oligodendrocytes is either not initiated 
by the OPC or is inhibited.  154 
In both the #72 and wild type mouse, a relatively large proportion of NG2 +ve 
cells  had  a  cytoplasmic  Olig1  localisation.  This  type  of  cell  was  only  rarely 
observed in a recent detailed study focusing on the subcellular localisation of 
Olig1  (Kitada  and  Rowitch,  2006).  However  the  study  by  Kitada  and  Rowitch 
focused  on  OPCs  in  the  spinal  cord  but  not  on  intracranial  white  matter 
structures  raising  the  possibility  that  corpus  callosal  OPCs  may  behave 
differently from spinal cord cells. Notably, both dys- and demyelination have 
been observed preferentially in the corpus callosum in some mice (Kassmann et 
al., 2007;Taveggia et al., 2008). 
 
In short it appeared that the final step in myelin repair, the OPC differentiation, 
was blocked in the #72 mouse, contributing to remyelination failure.  
 
3.5.2 Potential inhibitors of OPC differentiation 
 
The  final  step,  where  OPC  differentiate  into  oligodendrocytes,  has  been 
suggested  to  be  the  most  vulnerable  step  during  the  entire  remyelination 
process and often minimal disturbances at this time point leads to remyelination 
failure (reviewed in Franklin and ffrench-Constant, 2008). Based on the previous 
findings  in  this  study,  OPC  differentiation  block  also  seems  to  lead  to 
remyelination failure in the #72 mouse and the question now arises why OPC 
differentiation is impaired in the adult #72 mice. Recently, different intrinsic 
and extrinsic factors, such as canonical Wnt pathway signalling (Fancy et al., 
2009), inhibited axonal glial contacts (Charles et al., 2002;Coman et al., 2005) 
or changes in the extracellular matrix (Back et al., 2005), have been identified 
to  specifically  block  OPC  differentiation  during  remyelination  after 
demyelination and were further subject to this study.  
 
3.5.2.1 OPC intrinsic factor 
 
The study by (Fancy et al., 2009) showed that the canonical Wnt pathway is 
active during OPC proliferation but needed to be downregulated for successful 
OPC  differentiation.  The  study  also  showed  that  prolonged  activation  of  the 155 
canonical Wnt pathway lead to delayed myelination and impaired remyelination 
capacity after chemically induced demyelination (Fancy et al., 2009). 
 
In  the  #72  mouse,  the  Wnt  pathway  activation  pattern  corresponded  to  the 
proliferation study using BrdU. Initially at P40, the Wnt pathway activity was 
similar in the #72 homozygote compared to the wild type, most likely reflecting 
developmental myelination activity. The peak, which was observed in P90 old 
#72  mice  and  not  in the  wild type,  was  believed  to  be an  OPC  proliferation 
response to the ongoing demyelination. Double labelling with Olig1 confirmed 
that most of the Axin2 positive cells were from the oligodendroglial lineage. At 
P120, when demyelination was virtually complete and remyelination would be 
expected, Axin2 expression was rare, suggesting that the Wnt pathway was not 
active at the point of virtually complete demyelination. The results suggested 
that an abnormal Wnt pathway activity was not involved in the development of 
an absent remyelination response. However the weakness in this study was that 
the conclusion was based only on Axin2 staining and the described canonical Wnt 
pathway  expression  pattern  needs  to  be  confirmed  by  identifying  other  Wnt 
pathway induced proteins such as Tcf4 and by proving the increase in Axin2 using 
western blot techniques. Also the effect of pharmacological manipulation of the 
canonical  Wnt  pathway  as  described  in  (Fancy  et  al.,  2011)  had  not  been 
performed and may provide further information about the influence of the Wnt 
pathway in the #72 mouse on remyelination failure. 
 
Interestingly in this study I identified the presence of Axin2 in axonal swellings. 
The reason for Axin2 expression in the swellings is not understood and has not 
been  previously  reported  to  my  knowledge.  The  presence  of  Axin2  in  axonal 
swellings may be due to either accumulation of Axin2 in the swellings as a result 
of disturbed axonal transport or it may be explained by an upregulation of the 
Wnt pathway in axons as a response to axonal damage or demyelination.  
 
With  regard  to  abnormal  Wnt  pathway  activation,  age  has  been  shown  to 
influence the canonical Wnt pathway by reduced HDAC1 and HDAC2 function, 
leading to impaired OPC recruitment and differentiation, which had a reductive 
effect on remyelination efficacy (Sim et al., 2002). However the #72 homozygote 
model does not live much longer than 4 months. Despite this, when looking at 156 
the successful initial myelination during post natal development, which is then 
followed  by  remyelination  failure  during  adulthood,  a  discrepancy  between 
neonate and adult OPCs seems to be present. Although repeated focal chemical 
injury  to  normal  CNS  is  known  not  to  negatively  influence  the  remyelination 
capacity (Penderis et al., 2003), this does not reflect a pathology affecting the 
entire  CNS.  OPCs  can  migrate  from  unaffected  areas  to  affected  areas.  The 
majority  of  the  OPCs  will  therefore  not  be  subject  to  repeated  injury.  A 
continuous injury, at least in vitro, to the total OPC population has shown to 
have a marked negative impact on the remyelination capacity (Fressinaud, 2005) 
and  reflects  probably  better  the  situation  in  the  #72  mouse.  Chronic 
environmental changes accompanying the progressive demyelination in the #72 
corpus callosum could cause sustained injury to the total intracranial OPC pool, 
suggesting that repeated chronic injury may impair the remyelination capacity of 
#72 OPCs with time.  
 
3.5.2.2 OPC extrinsic factors  
 
When looking at the histopathological changes in the cell population of the #72 
corpus callosum during demyelination, some of the observed changes may be 
responsible for interfere with OPC differentiation. 
 
Mature oligodendrocytes, which are still abundantly present despite complete 
demyelination  of  the  #72  corpus  callosum,  are  known  to  be  unable  to 
remyelinate the demyelinated axons. The presence of mature oligodendrocytes 
in  demyelinated  areas  potentially  may  inhibit  OPC  migration  into  the 
demyelinated  lesions  (Keirstead  and  Blakemore,  1997).  The  mature 
oligodendrocytes  present  in  the  #72  may  therefore  contribute  to  low  OPC 
migration into demyelinated regions, which may lead to insufficient numbers of 
OPCs to maintain effective remyelination.   
 
Marked increase in, and activation of, the microglia/macrophage population has 
been  shown  to  accompany  the  progressive  demyelination  in  the  #72  corpus 
callosum. Microglial activation has been proven to aggravate the demyelination 
and  to  be  involved  in  the  development  of  axonal  pathology  (Popovic  et  al., 157 
2002;Ip  et  al.,  2006;Howell  et  al.,  2010).  However,  in  correlation  to 
remyelination  the  microglia/macrophage  cell  population  has  been  shown  to 
positively influence the remyelination process (Arnett et al., 2003;Neumann et 
al.,  2009).  In  general,  acute  inflammation  and  activation  of  the 
microglia/macrophage  population,  even  when  superimposed  on  chronic 
demyelinated tissue (Foote and Blakemore, 2005a), has been shown to have a 
beneficial effect on remyelination (Setzu et al., 2006;Kondo et al., 2011). Even 
in  MS,  the  presence  of  activated  microglia/macrophages  enhanced  the 
remyelination capacity (Patani et al., 2007). This remyelination enhancing effect 
is believed to be mediated through phagocytic activity (Kotter et al., 2001) and 
secretion of promoting substances such as TNFα (Arnett et al., 2001), which is 
secreted  by  activated  microglia  (reviewed  in  Merson  et  al.,  2010).  However, 
TNFα  seems  to  play  a  controversial  role  in  the  remyelination  process.  An 
inhibitory effect mediated through LPS activated microglia secreting TNFα has 
also been observed to have a negative impact on remyelination capacity in vitro 
(Miller et al., 2007). The negative effect of microglial activation, which leads to 
increased OPC apoptosis, appears mainly to depend on the differentiation status 
of OPCs. More mature OPCs, which are differentiating towards oligodendrocytes 
show  less  apoptosis  compared  to  the  immature  OPCs,  where  apoptosis  was 
increased after microglial activation (Miller et al., 2007). These findings were in 
agreement  with  a  recent  study  of  (Mi  et  al.,  2011),  which  has  shown  that 
immature OPC express death receptor 6 (DR6), a receptor from the TNF family, 
and activation of this receptor mediates Caspase3 induced cell apoptosis (Mi et 
al., 2011). Since TNFα induced apoptosis of OPCs is mediated through Caspase3, 
it is questionable if a negative effect mediated through TNFα is present in the 
#72 corpus callosum, where Caspase3 mediated apoptosis could not be detected 
at any time point in this study. However, in the Plp1 gene overexpressing mouse 
models,  sialoadhesin expressing microglia/macrophages definitively aggravates 
demyelination (Ip et al., 2007) and may still negatively impact remyelination 
through another unknown mechanism.  
Another role of the present inflammation in the #72 corpus callosum may the 
influence  of  inflammatory  cells  on  local  tissue  thyroid  homeostasis  mediated 
through D3. Treatment with relatively high doses of the active thyroid hormone 
T3  have  been  shown  to  have  an  enhancing  effect  on  remyelination  after 
demyelination  (Harsan  et  al.,  2008;D'Intino  et  al.,  2011).  As  previously 158 
mentioned, deiodinases control tissue specific thyroid hormone levels, where D3 
is responsible for inactivation of the thyroid hormone (Huang, 2005). Increased 
expression  of  D3  has  been  reported  in  experimentally  induced  focal  chronic 
inflammation (Boelen et al., 2005) and in an EAE model on macrophages and 
granulocytes (Boelen et al., 2009). The upregulation of D3 can lead to a local, or 
in severe cases, to a general non-thyroid induced hypothyroidism leading to a 
reduced cell metabolism and consequently to an impaired tissue repair. So far 
D3 expression on activated microglia has never been described and in this study 
D3 expression on the activated microglia was examined.  
 
In the #72 homozygote mouse the expression of D3, which could potentially lead 
to  a  restricted  availability  of  T3  for  the  OPCs  to  differentiate  during 
demyelination,  was  not  present  in  the  corpus  callosum.  Local  T3  depletion 
causing a local hypothyroid state in white matter therefore seemed unlikely to 
play a role in the development of remyelination failure in the #72 homozygote 
mouse.  However,  if  D3  expression  was  below  the  detectable  level  for  the 
antibody, final proof that D3 is not involved in the development of remyelination 
failure in the #72 brain would be gained by the measurement of #72 CNS D3 
activity.  
 
The  progressive  astrocytic  response  which  is  observed  in  context  with  the 
progressive demyelination in the #72 corpus callosum may also influence OPC 
differentiation.  The  astrocytic  population  is  also  considered  to  play  an 
ambivalent role by influencing remyelination both negatively (Blakemore et al., 
2003;Su et al., 2011) and positively (Liu et al., 1994;Moore et al., 2011a;Franklin 
et al., 1991). The interaction of the astrocytes with OPCs is regulated by the 
direct effect of promoting molecules such as IGF-1 (Liu et al., 1994) or inhibitory 
molecules  such  as  hyaluronan  (Back  et  al.,  2005;Sloane  et  al.,  2010)  or  the 
ambivalent TNFα (Su et al., 2011). Astrocytes can also indirectly interact with 
other cells such as microglia or neurons, which then secrete substances, such as 
FGF-2  (reviewed  in  Moore  et  al.,  2011a),  influencing  OPC  development. 
Hyaluronan is certainly present during the late stage of demyelination at P120 in 
the #72 corpus callosum.  
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Hyaluronan is known to inhibit remyelination in vitro and in vivo (Back et al., 
2005) and is mediated through activation of toll like receptor 2 expressed on 
OPCs. For hyaluronan mediated activation of the TLR2 receptor, the presence of 
the adaptor molecule MyD88 is required (Sloane et al., 2010). Unlike previously 
described,  it  is  not  the  high  molecular  weight  hyaluronan  which  causes  the 
inhibitory effect, but through low molecular weight hyaluronan oligomers, which 
are generated by hyaluronidase expressed on OPCs (Back et al., 2005;Sloane et 
al., 2010). There is an obvious accumulation of hyaluronan present in the #72 
homozygote  corpus  callosum  compared  to  the  wild  type  and  which  could 
potentially contribute to the remyelination failure. When looking at the cellular 
changes in the #72 tissue, the astrocytes are probably the source of hyaluronan. 
However, the HABP used in this study did not distinguish between high or low 
molecular weight hyaluronan. Also the amount of hyaluronan was not quantified 
by western blotting and the expression of TLR2 receptors as well as the presence 
of MyD88 was not investigated.  
 
Another  alteration  in  the  #72  corpus  callosum  extracellular  matrix  was  the 
persistence of myelin breakdown products up to P120.  Accumulation of myelin 
debris in demyelinated regions has been shown to inhibit OPC differentiation 
(Kotter et al., 2006). The OPC inhibition can be overcome by pharmacological 
induction of Fyn Rho and PKC signalling (Baer et al., 2009). In the #72 mouse, a 
substantial  amount  of  myelin  debris  was  present  at  the  time  of  complete 
demyelination and could therefore potentially contribute to OPC differentiation 
block.  
 
Finally the observed axonal changes and their influence on the remyelination 
process also need to be addressed in the #72 mouse, which potentially can have 
a negative effect on remyelination. In the adult Plp1 overexpressing #66 and #72 
mice,  inflammation  and  activation  of  microglia  have  also  been  suggested  to 
cause axonal  damage  (Ip  et  al.,  2006;Ip  et  al.,  2007;Edgar  et al.,  2010)  and 
dystrophic  or  destroyed  axons  are  believed  not  to  become  remyelinated.  In 
general  after  pure  demyelination  without  axonal  loss  an  increase  in  axonal 
density would be expected. However the glial response could fill the gap caused 
by demyelination. Since extensive axonal loss would cause a decrease in axonal 160 
density the comparable axonal density between wild type and #72 homozygote 
suggests that extensive axonal loss is not present.  
 
Because of the difficulties to establish axonal numbers in the corpus callosum 
due to its size and its spatial variability of axonal number, I decided to calculate 
axonal density of the selected corpus callosum region. The use of axonal density 
in screening and evaluating axonal loss, however, is problematic because axonal 
loss may not be reflected properly by changes in axonal density. The insensitivity 
of axonal density to evaluate axonal loss is caused by the influence of  extra 
axonal  structures  on  axonal  density.  Demyelination  will  cause  an  increase  in 
axonal density by the loss of the space expanding property of the myelin sheath. 
On the other hand the astrocytic response may fill the space for the lost myelin 
sheath.  Stereological  estimation,  which  is  used  to  estimate  entities  of  large 
dimensional samples based on the information from lower dimensional samples, 
could  solve  the  problem  of  evaluating  axonal  numbers  within  the  corpus 
callosum. 
 
However, axonal injury, mainly axonal swellings, were observed during the late 
stages of demyelination in the #72 homozygote corpus callosum Axonal changes 
are  believed  to  render  damaged  axons  non-permissive  for  remyelination 
(reviewed  in  Franklin  and  ffrench-Constant,  2008)  and  therefore  extensive 
axonal damage may contribute to remyelination failure. Axonal swellings may 
also inhibit the initial axon-glial contact required to initiate remyelination. In 
order  for  OPCs  to  myelinate  axons  they  must  engage  with  the  naked  axon. 
Integrin signalling between the oligodendrocyte and the axon  (Camara et al., 
2009;Laursen et al., 2009) and axonal electrical activity (Zalc and Fields, 2000) 
are important modulators of the early events of myelination in the CNS. Extreme 
distention  of  the  axonal  membrane  at  the  site  of  axonal  swelling  could 
potentially have a bearing on both of these factors. 
The importance of the initial engagement of demyelinated axons with OPCs can 
also be seen in context with re-expression of PSA NCAM on axons. In chronic MS 
tissue, PSA NCAM expression on demyelinated axons was suggested to contribute 
to the remyelination failure by blocking this crucial initial contact between OPCs 
and axons and therefore causing a block of OPC differentiation and contributing 
to the failure of remyelination (Charles et al., 2002). 161 
In  the  #72  homozygote  corpus  callosum,  PSA  NCAM  was  not  detected  on 
demyelinated axons. However at P120, astrocytes expressed PSA NCAM, which 
has been reported to occur on activated astrocytes (Massaro, 2002;Massaro et 
al., 2002). In this study the PSA NCAM positive astrocytes were considered to be 
reactive astrocytes and were only found at P120. 
 
3.6  Conclusion 
 
The pathological development of the demyelination and remyelination failure 
has now been described in detail in the #72 mouse. The characterisation of the 
corpus callosum is a prerequisite for the transplantation studies that follow in 
Chapter 4. Future experiments will involve the investigation of the role of the 
cell  intrinsic  and  cell  extrinsic  compartment  in  the  development  of  the 
remyelination  failure.  The  cell  intrinsic  and  cell  extrinsic  compartment 
preferably should be tested individually. The possibility to isolate and culture 
OPCs in vitro gives an opportunity to investigate the cell intrinsic compartment 
without influence of the cell extrinsic compartment. In vivo experiments using 
cell transplantation or pharmacological intervention will give the opportunity to 
evaluate the influence of cell extrinsic and to a certain extent the cell intrinsic 
compartment in the development of remyelination failure.     162 
4  An evaluation of cell intrinsic and cell extrinsic factors 
that contribute to remyelination failure 
 
4.1  Introduction 
 
In Chapter 3 I showed that after initial myelination of the corpus callosum, a 
spontaneous  progressive  demyelination  followed.  Despite  the  fact  that  OPCs 
were  present  in  the  demyelinating  environment,  there  was  no  evidence  of 
successful remyelination. This was somewhat unexpected, since, with relatively 
normal myelin formation during development, a certain remyelination capacity 
during the advanced disease process might have been expected. The histological 
studies  described  in  Chapter  3  indicated  that  both  OPC  intrinsic  and  OPC 
extrinsic factors could potentially be implicated in remyelination failure. In this 
chapter I use cell culture and cell transplantation to address these issues more 
directly.  
 
For remyelination to occur successfully, cell intrinsic and extrinsic factors must 
interact  together  in  a  precise  spatial  and  temporal  manner  (reviewed  in 
(Franklin, 2002;Franklin and ffrench-Constant, 2008;Peru et al., 2008). Briefly, 
microglia/macrophages first clear the affected region of myelin debris (Kotter et 
al.,  2001).  OPCs  then  migrate  into  the  demyelinated  area,  where  they 
proliferate  leading  to  repopulation  of  the  demyelinated  area  (Foote  and 
Blakemore, 2005b).  Following repopulation, the OPCs differentiate into early 
oligodendrocytes  (Shen  et  al.,  2008).  The  newly  formed  oligodendrocyte 
processes  contact  the  demyelinated  axons  after  which  the  upregulation  of 
myelin related genes in the contacting OPC are induced (Coman et al., 2005). 
Finally,  the  restoration  of  the  myelin  sheath  leads  to  functional  recovery 
(Duncan et al., 2009; reviewed in Franklin and ffrench-Constant, 2008). Given 
the  complexity  of  the  repair  process,  dysregulation  of  intracellular  or 
extracellular signalling can perturb the finely balanced remyelination process, 
which in the worst case could end in the failure of remyelination. 
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Remyelination  failure  as  a  consequent  of  Plp1  gene  overexpression  has  been 
investigated in another model, the 4e mouse line (Ma et al., 2006). In that study 
it  was  suggested  that  a  combination  of  OPC  intrinsic  and  OPC  extrinsic 
abnormalities  led  to  remyelination  failure.  However,  demyelination  and 
remyelination were only assumed in this mouse model and only a very limited 
histological  assessment  of  the  OPC extrinsic  compartment  were  performed  in 
situ. Adult OPC differentiation was only evaluated in vitro and was considered to 
be normal. 
 
The complex interaction between the cell intrinsic and cell extrinsic pathways 
during  remyelination  makes  it  difficult  to  evaluate  the  two  compartments 
individually  in  vivo.  To  investigate  the  role  of  cell  intrinsic  factors  in  OPC 
differentiation,  in  vitro  systems  possess  the  advantage  that  the  extrinsic 
influence (i.e. potentially inhibitory factors in the in vivo environment) on OPC 
differentiation and maturation can be eliminated. To date the differentiation 
potential  of  young  and  adult  #72  mouse  brain  derived  OPCs  has  not  been 
evaluated in vitro. 
 
The  OPC  extrinsic  compartment  consists  of  multiple  different  cellular 
components, which have been shown to interact with the remyelination process 
such as axons (Charles et al., 2002;Coman et al., 2005;Piaton et al., 2010;Zalc 
and Fields, 2000), astroglia (Blakemore et al., 2003;Liu et al., 1994), microglia 
and  trafficking  immune  cells  (Foote  and  Blakemore,  2005a;Kotter  et  al., 
2001;Kotter et al., 2005;Arnett et al., 2003) as well as the extracellular matrix 
(Arnett  et  al.,  2001;Back  et  al.,  2005).  To  assess  the  role  of  the  extrinsic 
compartment  in  remyelination  failure  in  the  #72  mouse,  these  components 
should  be  left  as  unaltered  as  possible.  One  way  to  study  the  extrinsic 
compartment  is  to  perform  in  vivo  transplantation  experiments  in  the 
demyelinated  region.  Transplantation  of  myelination  competent  cells  such  as 
neurospheres  into  demyelinated  areas  can  be  used  to  evaluate  the 
permissiveness  of  the  environment  for  remyelination  (Foote  and  Blakemore, 
2005a;Blakemore  et  al.,  2003;Setzu  et  al.,  2006;Zhang  et  al.,  2003).  The 
(re)myelination capacity of transplanted neuronal stem cells or glial progenitor 
cells have been shown in various dys- and demyelinating animal models (Edgar et 
al.,  2004a;Fukuhara  et  al.,  2006;Mothe  and  Tator,  2008;Pluchino  et  al., 164 
2003;Windrem  et  al.,  2008;Zhang  et  al.,  2003)  with  successful,  long  lasting, 
stable  chimerisation  of  the  CNS  leading,  in  some  cases,  to  phenotypic 
normalisation of affected animals (Windrem et al., 2008).  
 
So far, cell transplant experiments aiming to evaluate the influence of the cell 
extrinsic  compartment  in  chronically  demyelinated  white  matter  on 
remyelination  failure  has  not  been  conducted  in  the  #72  homozygote  mouse 
model.  
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4.2  Aims of the study 
 
The overall aim of the work presented in this Chapter was to determine if OPC 
intrinsic and/or environmental factors contribute to remyelination failure in the 
#72 homozygote mouse.  We  used the corpus callosum, a major white matter 
tract where the pathology has been described in detail in Chapter 3, to address 
the role of the cell intrinsic compartment and the cell extrinsic compartment in 
remyelination failure in this model. 
 
Specifically the aims were:   
 
1. To determine if adult #72 homozygote OPCs are capable of differentiating 
normally if removed from demyelinated environment  
 
2.  To  determine  if  the  #72  homozygote  corpus  callosum  is  permissive  for 
(re)myelination 
 
To  elaborate  these  two  problems,  the  following  experimental  methods  were 
used:  
 
1.) A  co-culture  system  of  isolated,  adult  #72  homozygote  and  wild  type 
OPCs, where the differentiation of the cells can occur in the absence of 
confounding environmental factors. 
2.) Transplantation of wild type neurospheres into a predefined region of the 
adult #72 homozygote corpus callosum to evaluate if the cell extrinsic 
compartment is permissive for remyelination by myelination competent 
cells.  
3.) Injection of wild type neurospheres into P1 #72 homozygote mice to test 
the  proof-of-principle  that  normal  neurospheres  can  survive,  integrate 
into  the  #72  homozygote  CNS,  replace  the  genetically  altered 
oligodendroglial cells and generate stable myelin, essentially rescuing the 
#72 homozygote mouse phenotype. 
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4.3  Material and Methods 
 
4.3.1 Mouse colony 
 
Homozygote male #72 mice expressing GFP under the β-actin promoter and mice 
harbouring  a  Plp1-LacZ  fusion  gene  were  used  in  the  cell  culture  and  cell 
transplant experiments. Technical details, generation and maintenance of the 
different mouse lines are described in Chapter 2.2 Mouse breeding. 
 
4.3.2 Identification  of  GFP  expression  in  the  β-actin-GFP  expressing 
line 
 
In the  β-actin-GFP expressing mouse model GFP  is, amongst other cells,  also 
present  in  epithelial  cells.  GFP  positive  pups  can  therefore  be  identified  by 
simply exposing them to a handheld UV light in darkness. In these circumstances, 
green  fluorescence  is  visible  to  the  human  eye.  Further  details  are  found  in 
Chapter 2.2 Mouse breeding. 
 
4.3.3 Isolation and culture of adult and neonate OPCs from the corpus 
callosum for culture 
 
Preliminary  studies  of  isolating  OPCs  using  a  Percoll®  gradient  showed  that, 
especially when using adult #72 homozygote corpus callosum, contamination by 
microglia was unavoidable. To expose the wild type and #72 homozygote OPCs to 
the  same  in  vitro  environment  I  cultured  wild  type  and  #72  OPCs  and 
contaminating microglia together.   
 
For each OPC co-culture experiment, OPCs were isolated from two adult GFP 
expressing and two adult #72 homozygote corpus callosa. The same number of 
isolated wild type cells (mainly OPCs) and isolated #72 homozygote cells (mainly 
OPCs  and  microglia/macrophages)  were  mixed  together  immediately  before 
plating down on poly-L-lysine coated glass coverslips. The same procedure was 167 
also  followed  when  performing  this  experiment  using  neonate  OPCs.  The 
isolation procedure and maintenance of the culture is described in Chapter 2.2 
Mouse breeding. 
 
4.3.4 Generation  of  Plp1  Lac-Z  and  β-actin  GFP  expressing 
neurospheres 
 
As described in Chapter 2, neurospheres carrying the LacZ or GFP reporter genes 
under the control of Plp1 (Wight et al., 1993) and β-actin promoter (Okabe et 
al., 1997), respectively, were generated from transgenic mice. These mice were 
wild type at the Plp1 locus. Detailed information about neurosphere generation 
can be found in Chapter 2.5.3 Generation of Plp1 Lac-Z expressing neurospheres 
and generation of β-actin GFP expressing neurospheres. 
 
4.3.5 Preparation of neurosphere for transplantation  
 
On  the  day  of  transplantation  the  neurospheres  were  prepared  for 
transplantation as described in Chapter 2.5.3.1 Preparation of neurosphere for 
transplantation into homozygote #72 mice.  
 
4.3.6 Adult mice used in the transplant study 
 
Male #72 homozygote mice at P100 were used in the transplantation experiment. 
As  previously  described in  Chapter  3  The development  of  the phenotype  and 
pathology of the homozygote #72 corpus callosum, the corpus callosum is almost 
completely demyelinated at this stage. After transplantation, mice were kept 
for 14 days then the brains were processed for immunofluorescence, histological 
and  ultrastructural  analysis  as  described  in  Chapter  2.6  Tissue  sampling  and 
processing; 2.7 Staining techniques. As a control, an adult male shiverer mouse 
was transplanted at the same time. The CNS of adult shiverer mice is permissive 
to  myelination  by  transplanted  neurospheres  (J.M.  Edgar  personal 
communication).  None  of  the  mice  were  immunosuppressed.  Details  of  the 
surgical procedure, including the Bregma coordinates, are described in Chapter 168 
2.5.5 Surgical procedure and injection of neurospheres into adult homozygote 
#72 corpus callosum. 
4.3.7 Neonate mice used in the transplant study  
 
One day old (P1) neonatal #72 homozygote male pups were used for injection of 
wild type neurospheres into the forebrain parenchyma at four locations. Details 
of  the  surgical  procedure  are  described  in  Chapter  2.5.5.1Injection  of 
neurospheres into neonate homozygote #72 mice. 
 
4.3.8 Processing of cell cultures and transplanted tissue 
 
Processing  of  cell  cultures  and  the  transplanted  tissue  for  light  microscopy, 
epifluorescence microscopy and electron microscopy are described in Chapter 2 
(2.7 Staining techniques). Antibodies against O4, GFP, MBP, PLP, NG2, PDGFRa, 
GFAP, CD45, CD169 were used in this study. Protocols and antibody dilutions are 
described in Chapter 2 (Table 2 & Table 3) and in Chapter 7 Appendix.    
 
4.3.9 Measurement  of  oligodendrocytic  processes  from  co-cultured 
OPCs 
 
In this study the measurement of oligodendrocyte process length was used as a 
parameter for OPC differentiation in vitro using NeuronJ (Meijering et al., 2004), 
a plugin program in ImageJ. The culture experiment was repeated 3 times using 
adult cells and twice using neonatal cells. A total of 234 wild type and 49 #72 
homozygote cells were measured in the experiment using adult OPCs. A total of 
145 wild type and 166 #72 homozygote cells were measured in the experiment 
using neonatal OPCs. The mean of the mean total process length per cell from 
all  wild  type  OPCs  was  compared  with  the  mean  of  the  mean  total  process 
length per cell from all the #72 homozygote OPCs. Details of the procedure can 
be found in Chapter 2 (2.5.2 Cell culture).    
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4.3.10  Statistical analysis 
 
An unpaired Student’s t-test was used to analyse the data obtained from the cell 
culture experiment. Statistical analysis was made in GraphPad Prism 5®.   
 
4.4  Results 
 
4.4.1 Evaluation  of  the  differentiation  potential  of  OPCs  using  an  in 
vitro co-culture system  
 
To determine if remyelination failure in the #72 mouse is due to an intrinsic 
defect in the adult OPCs,  I  removed these cells from a potentially inhibitory 
environment and analysed their potential to differentiate in vitro, in comparison 
to wild type OPCs. 
 
4.4.1.1 Contamination  of  activated  microglial  cells  was  unavoidable  when 
using a Percoll® gradient to isolate OPCs from #72 homozygote brain 
tissue 
 
Preliminary  experiments  evaluating  the  OPC  purification  technique  using  a 
Percoll®  gradient  showed  that  cells  expressing  PDGFRa  and  O4  were  present 
after one day in vitro. This demonstrated that OPCs were successfully isolated 
using this technique (Figure 41). However, a second population was present in 
even greater numbers. Immunostaining with an antibody to sialoadhesin (CD169), 
a macrophage restricted sialic acid binding protein that is expressed in the CNS 
following damage to the blood–brain barrier (Perry et al., 1992), demonstrated 
that  these  cells  were  activated  microglia/macrophage  (Figure  42).  The 
microglia/macrophages survived well in the culture system and were present, 
together with differentiated OPCs, after seven days in vitro. 
 
Since I was unable to separate the adult #72 OPCs from the microglia it became 
imperative  that the wild  type  OPCs,  against  which the  #72  OPCs  were to  be 170 
compared, were cultured in the same environment. To achieve this, I isolated 
normal adult OPCs from β-actin-GFP expressing mice and combined them with 
the OPC/microglial mix derived from the adult #72 mice. Thus, I was able to 
distinguish the normal from the mutant cells on the basis of GFP expression. 
 
4.4.1.2 Adult #72 OPCs showed an impaired development compared to the 
wild type OPCs in vitro 
 
Adult OPCs from the ~P120 corpus callosum survived and differentiated in vitro. 
After  seven  days  in  culture  #72  cell  processes  appeared  shorter  and  showed 
reduced branching compared to the wild type cells. I measured the length of all 
processes branching from the cell body on phase contrast images taken from 
cells that stained for 04. The mean total process length per cell after seven days 
in vitro was significantly (p<0.05) reduced in the #72 homozygote cells compared 
to the wild type cells (Figure 43).  
 
To test if this impairment in differentiation of adult #72 OPCs was related solely 
to  their  genotype,  I  next  determined  whether  neonatal  #72  OPCs  behaved 
similarly.   
 
4.4.1.3 Neonatal  #72  and  wild  type  OPCs  were  morphologically 
indistinguishable after 7 days in vitro  
 
Co-cultures containing neonatal GFP positive wild type and non-GFP positive #72 
homozygote OPCs were established. The isolated neonatal normal and #72 OPCs 
developed similarly during seven days in vitro (Figure 44). The average of the 
total process length per cell obtained from two separate experiments showed no 
significant difference (p = 0.44) between the two genotypes.  
   171 
 
Figure 41.  OPCs were successfully isolated from adult corpus callosum using 
a Percoll
® gradient technique.  
Micrographs of cultured cells isolated from adult corpus callosum at 1 day in vitro using antibody 
against PDGFRα and O4 to identify OPCs. During the early stages of differentiation, OPCs co-
express PDGFRα (A) and the surface marker O4 (B). DAPI was used to identify the cell nucleus 
(C).  After  one  day  in  vitro,  multiple,  PDGFRα  and  O4  positive  cells  were  present  (D).  This 
suggests that the purified cells are OPCs (x400, scale bar 50µm).       
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Figure 42.  Microglial/macrophage  contamination  could  not  be  prevented 
when using the Percoll
® gradient protocol to purify adult #72 homozygote 
OPCs. 
Micrograph of a cell culture using only cells isolated from adult #72 homozygote corpus callosum. 
Antibody  against  CD169  was  used  to  identify  activated  microglia/macrophages  and  antibody 
against O4 was used to identify cells from the oligodendroglial lineage. It was not possible to 
exclude activated microglial/macrophage cells (A) when using the Percoll® gradient protocol. 
Both microglia/macrophages and OPCs were present after seven days in vitro (B). DAPI was used 
to identify the cell nuclei (C). The two cell types were growing in close proximity to each other 
(D, x200, scale bar 100µm).  
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Figure 43.  The  cell  process  length  of  adult  #72  homozygote  OPCs  was 
significantly reduced when compared to the co-cultured wild type OPCs. 
Micrographs of co-cultured adult #72 and wild type to the Plp1 gene, GFP expressing cells after 
seven days in vitro. O4 was used to identify cells of oligodendroglial origin (A). The presence of 
GFP (B) was used to differentiate between the wild type and #72 homozygote cells (D, asterisk), 
of which the latter lack GFP (A – D, x200, scale bar 100µm). Phase contrast images were used to 
quantify the process length per cell as previously described (E, F, x200, digitally magnified, scale 
bar 50µm). The adult #72 homozygote cells appeared morphologically different (F) compared to 
the wild type (E) and had a significantly reduced mean total cellular process length per cell after 
seven days in vitro when compared to the wild type cells (G, *: p<0.05). The graph shows the 
mean total length of all processes per OPC (+ s.e.m.); each experiment was repeated 3 times.   174 
 
Figure 44.  The  mean  total  process  length  of  neonatal  #72  and  wild  type 
OPCs was not significantly different after 7 days in vitro. 
Micrographs of co-cultured neonatal wild type to the Plp1 gene (green) and #72 OPCs at 7 DIV. 
The surface marker O4 (A) was used to confirm that the cells were from the oligodendroglial 
lineage. The presence of cytoplasmic green fluorescent protein (B) indicated that the cells were 
of  wild  type  origin.  DAPI  was  used  to  label  the  nuclei  (C).  The  merged  image  was  used  to 
distinguish between wild type and #72 homozygote (asterisk) OPCs, in which GFP was absent (D, 
x200, scale bar 100µm). Very rarely, astrocytes (arrowhead) were present in the cultures. After 
identifying  the  genotype  of  the  differentiating  OPCs,  phase  contrast  images  were  used  to 
measure, in a semi-automated manner, the total process length per cell (E, F, x200, digitally 
magnified, scale bar 50µm). There was no significant (p=0.44) difference in total process length 
between the neonate #72 homozygote OPCs and wild type cells (G) after 7 days in vitro. The 
graph shows the mean total length of all processes per OPC (+ s.e.m.); each experiment was 
repeated 3 times.   175 
4.4.2 Evaluating  the  cell  extrinsic  compartment:  Cell  transplantation 
into demyelinated corpus callosum 
 
The  results  from  the  in  vitro  experiment  suggest  that  adult  #72  OPCs  are 
impaired in their differentiation compared to wild type cells. To determine if 
their  environment  is  permissive  for  myelination,  I  transplanted  myelination 
competent cells into the adult #72 mouse corpus callosum. 
 
4.4.2.1 Advanced demyelination and a marked microglial/astroglial response 
was present in the #72 homozygote corpus callosum at P100 before 
transplantation 
 
In Chapter 3, I quantified cellular changes in the #72 corpus callosum at P40, 60, 
90 and 120. Before transplanting cells into the P100 corpus callosum, I confirmed 
by immunostaining, that the environment was similar to that at P120. The PLP 
and MBP staining showed a loss of myelin integrity. There was an increase in 
microglia,  which  was  accompanied  by  microglial  activation  and  an  astroglial 
response. NG2 positive cells were abundantly present (Figure 45). 
 
4.4.2.2 The transplanted neurospheres were viable and showed multipotency 
in vitro   
 
To  evaluate  the  viability  and  the  differentiation  potential  of  transplanted 
neurospheres,  surplus  cells  remaining  at  the  end  of  the  transplantation 
procedure  were  plated  onto  poly-L-lysine  coated  coverslips.  Neurosphere-
derived cells used in the transplant study developed within three days in vitro 
into  O4,  MBP  and  PLP/DM20  positive  cells  proving  the  viability  and  the 
differentiation  potential  of  the  neurospheres.  Cultured  neurospheres  also 
developed into GFAP+ astrocytes and occasionally also into neurons, identified 
by the neuronal nuclear marker NeuN (Figure 46), confirming the multipotency 
of the neurospheres in vitro, as described by others (Zhang et al., 1998;Mokry et 
al., 2005). 176 
 
Figure 45.  Pronounced changes in myelin integrity and astroglial, microglial 
and  OPC  populations  were  present  in  the  #72  mouse  corpus  callosum  at 
P100. 
Micrographs of #72 corpus callosum at P100 using antibody against MBP, PLP/DM20, CD45, CD169, 
GFAP  and  NG2  to  characterise  the  environmental  changes.  Myelin  integrity  was  severely 
compromised, as shown using immunohistochemistry against myelin proteins PLP/DM20 (A) and 
MBP (B). There was also an apparent microglial (C) and astroglial (D) cell response. A proportion 
of microglia/macrophage cells expressed CD169 (E) a macrophage restricted sialic acid binding 
protein. At the same time there were abundant NG2 positive (F) cells in the corpus callosum 
(x100, scale bar 400µm). 
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Figure 46.  LacZ  transgene  expressing  neurospheres  are  multipotent  and 
develop into oligodendrocytes, astrocytes and neurons in vitro. 
Micrographs of coverslips with cultured surplus neurospheres after transplantation for three days 
in  vitro.  Antibody  to  O4,  MBP,  GFAP  and  NeuN  were  used  to  identify  the  multipotency  of 
transplanted  cells  in  vitro.  X-Gal  staining  was  used  to  visualise  PLP/DM20  expression  (β-
galactosidase  generates  enzymatically  the  blue  appearing  5-bromo-4-chloro-3-indolyl  β-D-
galactoside product after X-gal treatment). After 3 days in vitro a relatively high density of O4 
positive cells was present (A, x200, scale bar 200µm, insert, x400), some of which expressed MBP 
(B,  x400)  and  PLP/DM20  (C,  x200,  scale  bar  100µm).  This  showed  the  capacity  of  the 
transplanted neurospheres to differentiate into oligodendroglia. However, the neurospheres also 
differentiated  into  GFAP  expressing  astrocytes  (D,  x400)  and  even  into  a  few  neurons 
(arrowheads) expressing NeuN (E, x400, scale bar 50µm) when plated in differentiating media.  178 
4.4.2.3 Transplanted  neurospheres  survived  for  14  days  in  the  adult  #72 
homozygote corpus callosum 
 
To  assess  the  influence  of  the  OPC  extrinsic  compartment  on  remyelination 
failure in the #72 homozygote mouse, wild type neurospheres expressing GFP or 
carrying  a  Plp1  LacZ  fusion  gene  were  introduced,  together,  into  the 
demyelinated corpus callosum of #72 homozygote mice at P100. 
 
Fourteen  days  after  transplantation,  GFP  and  β-galactosidase  positive 
transplanted  cells  were  present  within  the  #72  homozygote  mouse  corpus 
callosum.  Transplanted  cells  were  observed  in  close  proximity  to  the  needle 
track and also up to approximately 1.2mm distal from the injection site (Figure 
47).  
 
4.4.2.4 Axons in the demyelinated #72 homozygote mouse corpus callosum 
are myelination competent 
 
On high  power images of the transplant region,  β-galactosidase positive cells 
showed  a  morphology  which  resembled  myelin  sheath  producing 
oligodendrocytes.  Most  of  the  GFP  positive  cells  appeared  similar  to  the  β-
galactosidase positive oligodendroglia. Co-labelling with GFP and MBP (the latter 
a  relatively  late  marker  of  oligodendroglial  differentiation  and  myelin 
compaction)  indicated  that  transplanted  GFP  positive  neurospheres  had 
differentiated into ensheathing/myelinating oligodendrocytes (Figure 47). 
 
To test if the transplanted cells formed a compact myelin sheath around axons, I 
examined  resin  section  of  areas  containing  transplanted  cells  in  the  corpus 
callosum. On the resin sections thin, ring like structures were seen around axons 
in  the  area  where  cells  had  been  transplanted  (Figure  48).  The  relative 
abundance of ring like structures (arrows in A) became obvious when compared 
to  a  non-transplanted  region  of  the  corpus  callosum  from  the  same  animal, 
where only a few similar structures were present (arrows in B).  
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Electron  microscopy  was  used  to  evaluate  the  ultrastructure  of  the  myelin 
sheath in the transplanted corpus callosum. The corpus callosum treated with 
transplanted cells was compared to an untreated corpus callosum and showed an 
increased presence of myelinated axons. Ultrastructural evaluation of the myelin 
sheath  showed  a  normal  myelin  sheath  with  an  inner  tongue,  and  normal 
appearing major dense and intraperiod lines (Figure 49).  
 
   180 
 
Figure 47.  Transplanted neurospheres survived and (re)myelinated axons in 
the adult chronically demyelinated #72 homozygote corpus callosum. 
Micrographs  of  the  corpus  callosum  of  an  adult  #72  homozygote  mouse  14  days  after 
transplantation,  using  antibodies  to  MBP  and  GFP.  X-gal  treatment  was  used  to  visualise 
PLP/DM20  expression.  Transplanted  neurospheres  differentiated  into  (re)myelinating 
oligodendrocytes  in  the  adult  #72  homozygote  mouse.  The  transplanted  neurospheres 
differentiated into Plp1 expressing oligodendrocytes indicated by cells turning blue after X-gal 
treatment (A, x40, scale bar 400µm, insert in A, x400, scale bar 20µm). The X-gal positive cells 
formed myelin sheath-like structures (insert in A, x400, scale bar 20µm). Co-expression of MBP 
on  the  GFP  positive  myelin-like  structures  confirmed  that  the  transplanted  cells  formed 
myelinating oligodendrocytes (B, C, D, x100, scale bar 200µm, insert in D, x400, scale bar 20µm). 
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Figure 48.  Neurospheres formed myelin sheaths after transplantation into 
the adult #72 corpus callosum. 
Micrograph  of  methylene  blue/azur  II  sections  from  a  #72  homozygote  mouse  14  days  after 
injection of neurospheres. On the methylene blue/azur II stained, 1µm thick resin sections, ring 
like structures resembling myelin sheaths were identified. When comparing a transplanted #72 
homozygote  mouse  corpus  callosum  (A)  with  an  untreated  corpus  callosum  (B),  more  myelin 
sheaths (arrows in A) were present in the transplanted corpus callosum than in the untreated 
corpus callosum (arrows in B) (x1000, scale bar 20µm). 
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Figure 49.  Formation  of  normal  compact  myelin  sheaths  14  days  after 
neurosphere transplantation into #72 homozygote corpus callosum. 
EM  micrographs  from  areas  of  neurosphere  transplantation  in  the  #72  homozygote  corpus 
callosum  14  days  after  transplantation.  To  illustrate  the  changes  after  neurosphere 
transplantation an untreated #72 corpus callosum, which was almost completely demyelinated at 
P120 (A, x8000) was compared to the transplanted region of the corpus callosum (B, x8000, scale 
bar  2µm).  After  transplanting  neurospheres  into  the  demyelinated  region,  axons  became 
(re)myelinated by an ultrastructural normal myelin sheath (B, x8000, C, D, x50000, scale bar 
250nm) with normal appearing inner tongue (arrow in C) and periaxonal space (arrowheads C) 
and its characteristic major dense (asterisks in D) and intraperiod (dots in D) lines. 183 
4.4.2.5 Transplanted neurospheres differentiated into astroglial cells 
 
These  results  suggest  that  the  axons  in  the  adult  #72  corpus  callosum  are 
permissive  for  myelination.  However  neonatal  neurospheres  differentiate  into 
cell  types  other  than  oligodendrocytes  and  it  was  important  to  determine  if 
other  neurosphere  derived  cells  populations  were  produced,  that  could 
potentially alter the environment.  
 
In the transplanted region, some of the neurospheres differentiated into stellar 
shaped cells, resembling astrocytes. The identity of the cells was confirmed by 
double immunohistochemical staining with antibodies to GFP and the astrocytic 
marker, GFAP (Figure 50). 
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Figure 50.  Transplanted neurospheres also differentiated into astroglia. 
Micrographs  of  a  #72  homozygote  corpus  callosum  after  X-Gal  treatment  to  visualise  the  β-
galactosidase  positive  transplanted  cells.  The  transplanted  neurospheres  also  developed  into 
astrocytes reflecting their multipotent capacity in vivo. After transplantation of neurospheres 
into the demyelinated #72 homozygote corpus callosum there were not only Plp1 expressing cells 
(A, x100) but also a subset of the GFP+ (B) transplanted cells, which had differentiated into 
astrocytes (C, D, x100, scale bar 200µm; insert, x400, scale bar 20µm). 
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4.4.3 Long  term  survival  and  integration  of  transplanted  wild  type 
neurospheres  after  neonatal  cell  transplantation  into  CNS 
parenchyma 
 
Besides addressing the basic questions posed at the start of this Chapter, the 
results of these experiments suggest that transplanted cells could potentially be 
used therapeutically to restore myelin in the adult CNS. However, the literature 
has shown that widespread myelination of the adult CNS is virtually impossible to 
achieve  through  focal  transplantation  of  cells,  principally  because  the 
transplanted  cells  are  relatively  slow  in  populating  the  adult  CNS,  failing  to 
reach the pro (re)myelinating environment of acute lesions in time and therefore 
fail  to  initiate  remyelination  in  the  demyelinated  region  (Blakemore  et  al., 
2002). Additionally, migration through normal tissue has been shown to be less 
effective  than  through  lesioned  tissue  (Franklin  et  al.,  1996)  and  finally  the 
presence of dysfunctional OPCs within the demyelinated region may inhibit the 
population  by  transplanted  cells  (Chari  et  al.,  2003).  The  advantage  of 
transplanting  multipotent  cells  in  the  new-born  has  been  shown  to  be  more 
effective for wide spread distribution and integration of the transplanted cells in 
the CNS (Learish et al., 1999;Windrem et al., 2008). With this in mind, I asked if 
transplantation  of  neurospheres  into  the  brain  of  new-born  #72  mice  would 
provide proof-of-principle of the potential for cell transplantation to treat PMD. 
Previous transplant studies, mainly from the Duncan laboratory, have focussed 
on  models  of  PMD  due  to  point  or  missense  mutations  ((Duncan  et  al., 
1988;Zhang  and  Duncan,  2000;Zhang  et  al.,  2003)  and  a  recent  study  by 
(Windrem et al., 2008) achieved a complete replacement of CNS oligodendroglia 
after  neonatal  injection  of  human  glial  progenitor  cells  in  shiverer  mice. 
However  the  potential  of  cell  transplantation  to  treat  PMD  due  to  gene 
duplication has not previously been tested. The main difference in PMD models 
caused by mild overexpression of Plp1 gene is that early post natal OPCs are 
relatively  healthy  and  the  initial  myelination  of  the  CNS  is  virtually  normal, 
unlike in the missense mutations where virtually no myelin is formed in the first 
place.  Therefore  the  competition  between  transplanted  cells  and  relatively 
healthy  endogenous  OPCs  may  lead  to  a  less  effective  establishment  of 
transplanted cells. 186 
At  7,  14,  35,  80  and  120  days  post  transplantation,  two  male  mice  were 
sacrificed and the brain was evaluated for donor cell survival, integration and 
ensheathment/myelin  formation.  Macroscopically,  extensive  regions  of  β-
galactosidase positive cells in white and grey matter were found from P35 to 
P120.  At  P35  cells  of  transplant  origin  were  mainly  present  in  major  white 
matter  tracts.  At  P120  patches  of  X-gal  staining  were  found  in  the  corpus 
callosum,  anterior  commissure,  thalamus,  hypothalamus,  optic  chiasm  and 
hippocampus.  At  P14,  the  first  β-galactosidase  positive  cells  with  myelin-like 
structures  could  be  seen  using  light  microscopy.  With  time  the  areas  of 
transplanted  cells  forming  myelin-like  structures  in  white  matter  tracts 
increased, showing that the transplanted cells had survived, migrated after focal 
injection  to  various  white  matter  tracts  in  the  cerebrum,  and  successfully 
integrated  and  ensheathed/myelinated  axons  in  the  host  brain  parenchyma 
(Figure 51). 
 
To see if the transplanted cells formed a normal myelin sheath EM was used to 
evaluate the myelin morphology. A substantial amount of myelinated axons were 
found in the transplant integrated white matter at P120 when comparing areas 
of successful integration of transplanted cells to areas without integration of 
transplanted  cells  in  the  same  mouse.  The  myelin  sheath  appeared 
morphologically  normal  although  some  myelin  sheaths  appeared  thicker  than 
others and occasionally redundant myelin was observed (Figure 52). 
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Figure 51.  Successful integration, ensheathment/myelination and long term 
survival  of  neurospheres  after  intracerebral  transplantation  into  neonatal 
#72 homozygote mice. 
Photographs  of  2mm  thick  brain  tissue  slices  taken  from  mice  at  14,  35  and  120  days  after 
transplantation  of  neurospheres  harbouring  the  Plp1/LacZ  transgene  into  neonatal  brain 
parenchyma. At 35 (A) and 120 (B, scale bar 5mm) days post injection (DPI) the areas containing 
myelin of donor cell origin was made visible after X-Gal treatment, which stained cells and the 
myelin sheath expressing Plp1 gene promoted β-galactosidase blue. In general, LacZ expressing 
transplant  derived  cells  occurred  in  clusters.  Myelin-like  sheaths  of  transplant  origin  were 
detected from 14 DPI (C, x100, scale bar 200µm). The transplanted neurospheres had not only 
integrated into various regions such as the corpus callosum (black arrow), anterior commissure 
(white arrow), thalamus (black arrowhead) and hippocampal regions (white arrowhead) but had 
also  differentiated  into  Plp1  expressing  oligodendrocytes,  which  formed  myelin  sheath-like 
structures, presumably around axons. Transplanted donor cells were present at 14 (C), 35 (D, x40 
scale bar 400µm), 80 (data not shown) and 120 (E, x40, scale bar 400µm) DPI, suggesting that the 
transplanted cells survived and differentiated into myelin synthesising oligodendrocytes, which 
were stably integrated up until 120 DPI, without immunosuppression.     188 
 
 
Figure 52.  A large amount of transplant-derived myelin is present in regions 
of  the  adult  #72  mouse  corpus  callosum  after  transplantation  of 
neurospheres into the neonatal brain. 
EM  micrographs  of  a  transplanted  #72  corpus  callosum  120  days  post  injection,  in  which 
transplant-derived myelin is absent (A, x5000) compared to an area in which transplant-derived 
myelin is present (B, x5000, scale bar 2µm). At this age, the areas of corpus callosum where cell 
transplants did not integrate are virtually devoid of myelin sheaths, confirming that the myelin 
that is present is likely to be derived from the transplanted cells. The myelin appears relatively 
normal  (C,  D  x40000,  scale  bar  250nm),  although  some  redundant  myelin  is  present  (arrows 
head) and some sheaths appear thicker (filled arrow) or thinner (empty arrow) than normal.   189 
4.4.3.1 Early post  natally injected donor  cells locally ameliorate the white 
matter microglial response 
To investigate if the changes in the local environment are mainly a response to 
demyelination I also investigated the effect of the neonatal cell transplantation 
on the local environment at 120 DPI. In regions where the transplanted cells had 
formed extensive myelin the cell density was visibly reduced (Figure 53). This 
was primarily due to the fact that the leukocyte population, labelled with an 
antibody recognising CD45, appeared reduced in areas containing large amounts 
of transplant-derived myelin (Figure 54).   
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Figure 53.  The cell density appeared normal in white matter regions where 
donor cells populated and myelinated the white matter. 
Micrographs from two prominent white matter tract regions, the corpus callosum (A – D) and the 
rostral part of the anterior commissure (E – H, x400, scale bar 50µm), from #72 homozygote mice 
120 days after neonatal implantation of transgenic neurospheres containing a LacZ Plp1 fusion 
gene. The myelin, which was produced by transplanted cells, stained blue (5-bromo-4-chloro-3-
indolyl  β-D-galactoside)  after  X-Gal  treatment,  due  to  the  incorporation  of  the  PLP/β-
galactosidase fusion protein into the myelin sheath. Using DAPI as a nuclear stain, there were 
obvious differences between regions where there was extensive myelin formation of transplant 
origin compared to a similar region with only a few or no myelin sheaths from transplanted cells.  
When comparing  the areas without (B) or with only few (F) transplanted cells there was a visible 
reduction of cell nuclear density in the anterior commissure (D) and in the corpus callosum (H) 
when myelinating oligodendrocytes of transplant origin were present.   191 
 
Figure 54.  The inflammatory response was reduced in white matter regions 
if  the  #72  CNS  was  populated  by  transplanted,  Plp1  expressing 
oligodendroglia.  
Micrographs from two prominent white matter tract regions, the corpus callosum (A – D) and the 
rostral part of the anterior commissure (E – H, x400, scale bar 50µm), from #72 homozygote mice 
120 days after neonatal implantation of transgenic neurospheres containing a LacZ Plp1 fusion 
gene. A marked microglial response was present in regions containing none or only a few donor 
cells  (A,  B,  E,  F).  This  was  in  contrast  to  regions  where  many  myelinating  donor  cells  were 
present (C, D, G, H, x400, scale bar 50µm). In the myelinated regions, the microglia appeared 
normal. This suggested that the previously observed reduction of cell nuclei in regions where 
extensive amounts of myelin of donor cell origin were synthesised was mainly due to a reduction 
of CD45 positive leukocytes. Note that the 5-bromo-4-chloro-3-indolyl β-D-galactoside appeared 
dark when using the red spectra in immunofluorescence microscopy.  192 
4.5  Discussion 
 
In  this  study  I  assessed  the  role  of  the  OPC  intrinsic  and  the  OPC  extrinsic 
compartments in remyelination failure in the #72 mouse corpus callosum, using 
cell culture and cell transplantation techniques. The in vitro and in vivo results 
suggest  that  there  is  mainly  an  intrinsically  mediated  impairment  in  OPC 
function  contributing  to  the  remyelination  failure.  The  reduced  cell 
development of OPCs appears to be age related, as neonatally derived #72 OPCs 
developed comparable to wild type cells in vitro. The in vivo evaluation of the 
OPC extrinsic compartment by using neurosphere cell transplants showed that 
the axons are permissive for remyelination in the adult #72 corpus callosum.  
 
This suggests that the OPC differentiation block and the remyelination failure, 
which  has  been  observed  in  adult  #72  mouse  in  situ  is  most  likely  cell 
intrinsically mediated. 
 
The development of an age dependent OPC differentiation block mediated by 
cell  intrinsic  abnormalities  results  in  a  limited  or  even  absent  endogenous 
remyelination response. Whether endogenous remyelination can be stimulated in 
this model is questionable and the benefit is doubtful since differentiating OPCs 
would still harbour the gene defect, which is known to lead to unstable myelin 
sheaths. This raises the question of whether it would not be more beneficial to 
patients  suffering  from  PMD  caused  by  gene  duplication  to  consider  early 
replacement of endogenous OPCs with genetically normal glial progenitor cells, 
rather than to initiate treatment during the stage of progressive demyelination. 
By transplanting neurospheres, which are wild type to the Plp1 gene, I provided 
proof-of-principle for the potential of cell transplantation into the neonate as a 
therapy for PMD caused by gene duplication.  
 
4.5.1 Impaired OPC differentiation is age dependent in #72 mouse  
 
Here  I  attempted  to  assess  the  differentiation  potential  of  adult  #72  OPCs, 
compared  to  normal  age-matched  OPCs,  in  the  absence  of  confounding 
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to  isolate  OPCs,  I  was  unable  to  obtain  pure  OPCs  without  contaminating 
microglia/macrophages.  To  eliminate  the  contaminating  cells,  I  attempted  to 
enrich for OPCs using a magnetic bead separation method. However, the cell 
yield was prohibitively low and the cells became severely damaged during the 
purification procedure and did not survive in vitro. Furthermore the total cell 
yield  obtained  per  experiment  using  the  Percoll  gradient  separation  was 
maximally 600000 cells and was considered too low for FACS sorting of OPCs and 
microglia/macrophages.   
 
Since  the  contaminating  microglia/macrophages  from  the  demyelinated  #72 
corpus callosum could potentially influence the differentiation potential of the 
OPCs, it was imperative that the normal OPCs and the #72 OPCs were cultured 
under the same conditions. In order to be able to distinguish the two genotypes, 
the normal OPCs were generated from mice expressing GFP under the β-actin 
promoter, rendering the cells green.     
 
Under  these  conditions,  adult  #72  homozygote  OPCs  had  a  reduced  process 
outgrowth compared to adult wild type OPCs. In contrast, #72 OPCs derived from 
neonates  differentiated  similarly  to  wild  type  OPCs,  suggesting  that  the 
genotype of the cells alone is not responsible for the impaired differentiation. 
Rather, factors specific to the adult #72 OPCs, seem to play a role in impairing 
the  process  growth.  Assuming  this  is  also  true  in  vivo,  the  impaired 
morphological development would be predicted to lead to a delayed or reduced 
development  of  a  myelin  sheath.  Axonal  glial  interactions,  for  example  as 
mediated  through  NRG1-III  (Brinkmann  et  al.,  2008),  are  important  for  the 
induction of remyelination in the CNS but appear not to be the sole required 
component. Instead the remyelination process is also influenced by a complex 
interaction of different secreted myelin inducing signals such as insulin growth 
factor 1 (Carson et al., 1993), apotransferrin (Marta et al., 2003) and astrocyte 
leukaemia  inhibitory  factor  (Ishibashi  et  al.,  2006;Nave,  2010a).  The  time 
window,  where  the  remyelination  process  is  positively  influenced  after  the 
demyelination, is thought to be limited and something as simple as a delay in 
OPC differentiation has been shown to be sufficient to impair the remyelination 
process (Fancy et al., 2009). With slow OPC differentiation and growth, as might 
be the case in the #72 adult OPCs,  which leads to a prolonged delay of the 194 
remyelination  process  by  delayed  axonal-glial  interactions,  the  extracellular 
remyelination permissive environment might change to a more restrictive one, 
which would additionally contribute to an OPC differentiation block (reviewed in 
Fancy et al., 2010).      
 
To find an explanation for the abnormal in vitro growth of differentiating OPCs, 
it may be relevant that the DM20 transcript and protein is expressed in pre-
myelinating oligodendrocytes in vitro (Yamada et al., 1999) and in a subset of 
murine spinal cord OPCs (Dickinson et al., 1996) before active myelination takes 
place.  In  the  Plp1  gene  overexpressing  mice,  both  PLP  and  DM20  will  be 
overexpressed. Although the published results are from normal embryonic cells 
and observed in vivo during embryonic development up till P20, the results may 
be extrapolated to explain the differentiation block in adult #72 homozygote 
OPCs. If chronic abnormal overexpression of Dm20 into adulthood is present in 
#72 OPCs, a low grade accumulation of DM20 may occur with time. This low 
grade accumulation could potentially stress cells, leading to an inhibitory effect 
on adult OPC differentiation during the demyelinating process. Further evidence 
that overexpression of DM20 alone can cause late onset myelin impairment is 
derived from a mouse model where overexpression of Dm20 only has been shown 
to induce a slowly progressing demyelinating phenotype, which developed over 8 
months  (Mastronardi et al., 1993) suggesting that accumulation of DM20 as a 
minimum impairs myelin integrity and, over time, potentially the capacity for 
remyelination. However, DM20 expression in non myelinating cells has only been 
demonstrated in the spinal cord and around the ventricular zone between E12 
and E14 (Yu et al., 1994) and it is questionable if DM20 is expressed in OPCs at 
all and if DM20 plays a role in the #72 mouse model.  
 
An age dependent derangement of intracellular pathways may be responsible for 
the  differentiation  block  of  OPCs.  Histone  deacetylase  (HDACs)  induced 
deacetylation  of  remyelination  promoter  regions  is  an  important  step  in  the 
regulation of remyelination. With age the regeneration in white matter generally 
becomes  altered,  amongst  other  mechanisms  by  a  reduction  in  the  HDAC 
activity,  leading  to  impaired  remyelination  (Shen  et  al.,  2008).  Alteration  of 
HDAC1 and/or HDAC2 has been shown to lead to β-catenin stabilisation, a pivotal 
part  of  the  canonical  Wnt  pathway,  which  resulted  in  blocked  OPC 195 
differentiation  (Ye  et  al.,  2009).  The  canonical  Wnt  pathway  has  been 
investigated  in  Chapter  3  and  abnormal  prolonged  activation  had  not  been 
observed. However, the apparent normal development of neonate OPCs in my in 
vitro experiment still underlines an age dependent component leading to an OPC 
differentiation block.  
 
This is in contrast to the similar study by (Ma et al., 2006) where they stated 
that  “The  ability  of  oligodendrocytes  from  older  Plp1  gene  overexpressing 
transgenic  animals  to  produce  a  myelin  membrane-like  structure  was  not 
impaired when cultured in vitro, which indicates that the lack of remyelination 
is  not  simply  caused  by  changes  in  the  intrinsic  properties  of  the 
oligodendrocytes.” Nevertheless, this study is inconclusive and while Ma et al. 
reported the characteristics of adult OPCs in the brain or in isolated form of the 
4e-PLP model, there is no evidence in the literature (including publications cited 
by Ma) to show that the brain is demyelinated and that a remyelination failure 
occurs in the 4e-PLP model.  
 
Another study by (Karim et al., 2010) however, showed that the development of 
oligodendrocytes derived from P5 #72 mouse spinal cord developed significantly 
less  membranous  sheaths  compared  to  the  wild  type  cells  in  cultures.  The 
observed  differences  where  reversible  by  applying  siRNA  to  suppress  PLP 
overexpression  in  vitro  (Karim  et  al.,  2010).  In  my  study  I  did  not  see  any 
difference in development of #72 and wild type neonatal brain derived OPCs. 
However it is difficult to compare the study from (Karim et al., 2010) with my 
experiment because firstly they used a different cell isolation protocol, where a 
mixed population of OPCs and young oligodendrocytes were cultured. This is in 
comparison to my study were only OPCs,  which will develop differently from 
young oligodendrocytes, were cultured. Secondly they cultured only spinal cord 
derived cells, which is in contrast to my study, where I only cultured cerebral 
derived OPCs, which are known to have a different developmental background 
(Kessaris et al., 2006). Thirdly in my study the significant effect occurred only in 
adult OPCs and (Karim et al., 2010) did not investigate adult cells. 
 
PLP expression is present in isolated OPCs after 7DIV (data not shown) and, due 
to  the  primary  genetic  defect  leading  to  the  overexpression  of  PLP,  may 196 
interfere  with  the  differentiation  phase  eventually  being  responsible  for  the 
impaired  development  in  #72  OPCs.  On  the  other  hand  PLP  expression  starts 
after the OPC has differentiated into an oligodendrocyte and it shows that the 
OPCs can differentiate  in vitro under ideal conditions which may lead to the 
reduced cell growth. However PLP expression is also present in the neonatally 
derived OPCs after 7DIV and these cells developed similarly compared to the 
wild  type.  Again  an  age  dependent  component  is  probably  involved  in  the 
development of impaired differentiation. 
 
Finally  the  ability  of  adult  #72  to  differentiate  into  PLP  expressing 
oligodendrocytes in vivo also suggest that with age changes in the cell extrinsic 
component may also contribute to the OPC differentiation block. 
 
4.5.2 The  adult  #72  homozygote  corpus  callosum  is  permissive  for 
(re)myelination when neurospheres are transplanted. 
 
Transplanted multipotent cells from the neuroglial lineage have been shown to 
be  capable  of  restoring  demyelinated  areas  in  young  and  adult  genetically 
altered mouse models of dysmyelination, including the myelin deficient (md) rat 
(Learish et al., 1999;Brustle et al., 1999) and the shiverer mouse (Warrington et 
al., 1993;Nistor et al., 2005;Windrem et al., 2008). The myelination capacity 
and the effect after intravenous and intracranial injection of adult neurospheres 
in  chronic  EAE  mouse  models  have  also  been  evaluated  (Pluchino  et  al., 
2003;Einstein et al., 2006). However, the permissiveness for remyelination in the 
#72 homozygote mouse model has never been investigated and I used the known 
(re)myelinating potential of neurospheres in this study to evaluate the role of 
the cell extrinsic compartment on remyelination failure in the #72 homozygote 
mouse. I also decided to use neurospheres for this study, because like rat OPCs, 
but in contrast to mouse OPCs, they can be generated in large numbers (Kondo 
and Duncan, 2009) 
 
In my study I showed that neurospheres derived from neonatal wild type mice 
transplanted into demyelinated corpus callosum survive, integrate and locally 
(re)myelinate the #72 homozygote CNS. Electron microscopy was used to confirm 197 
that the newly generated oligodendrocytes formed compact myelin sheaths. I 
was unable to confirm that the sheaths that were imaged by EM were derived 
from the LacZ expressing cells, because the X-gal staining could not be discerned 
by EM. However, since demyelination was virtually complete at this age, the 
relative abundance of sheaths in the transplanted regions suggested that they 
were derived from the transplanted cells. 
 
Considering  the  short  time  given  for  the  transplanted  neurospheres  to 
differentiate  and  remyelinate,  the  local  remyelination  process  appears  to  be 
relatively  effective  in  the  #72  homozygote  corpus  callosum  after 
transplantation. This finding suggests that the OPC extrinsic compartment is, to 
a certain degree, permissive for remyelination. The results show that the axons 
are capable of being (re)myelinated. The transplants survived and remyelinated 
in an area with a marked activated microglial/macrophage population, many of 
which expressed sialoadhesin. Sialoadhesin positive microglia/macrophages have 
been shown to contribute to demyelination in another Plp1 gene overexpressing 
transgenic mouse model (#66) (Ip et al., 2007), possibly through the recruitment 
of  pathogenically  relevant  CD8+ve  T  cells.  In  my  study  the 
microglia/macrophages  population  seemed  not  to  interfere  with  the 
transplanted cells, at least within an intermediate timeframe (14 days). 
 
With  regard  to  remyelination  failure,  the  influence  of  activated  microglia  on 
OPCs  is  controversial.  A  study  using  cell  culture  and  tissue  slice  culture 
suggested that the activation of microglia supports OPC proliferation (Filipovic 
and Zecevic, 2005). However this was an in vitro study and the proliferation of 
OPCs is not indicative that differentiation and remyelination will eventually take 
place.  On  the  other  hand  it  has  been  observed  that  after  suppressing  the 
microglial  response  in  a  dysmyelinating  rat  model  using  minocycline  in  vivo, 
more  effective  remyelination  after  neuronal  stem  cell  transplantation  took 
place, suggesting that activation of microglia inhibits the remyelination process 
after transplantation (Zhang et al., 2003). But then again a more recent study by 
the  same  group  showed  that  genetic  depletion  of  microglia/macrophages 
worsens disease severity in a mouse model of globoid cell leukodystrophy (Kondo 
et  al.,  2011).  In  general,  microglial/macrophage  responses  (Kotter  et  al., 
2001;Kotter  et  al.,  2005)  and  acute  inflammation  (Foote  and  Blakemore, 198 
2005a;Setzu et al., 2006).have been shown to promote OPC differentiation and 
remyelination  
 
It  is  important  to  keep  in  mind  that  after  cell  transplantation,  an  acute 
inflammation will result, additional to the existing chronic inflammation. This 
will  cause  considerable  change  in  the  OPC  extrinsic  environment  and  could 
potentially  shift  the  inhibitory  environment  into  a  permissive,  supportive 
environment. It has been shown that an acute lesion induced on top of a chronic 
inflammatory demyelinated lesion has a promoting effect for implanted neuronal 
stem cells to develop into myelinating oligodendrocytes (Foote and Blakemore, 
2005a).  It  may  well  be  that  in  my  study  the  cells  were  only  capable  of 
remyelinating  the  demyelinated  area  because  of  the  change  in  environment 
caused by external manipulation. A certain capacity of immunomodulation has 
also  been  attributed  to  neonatal  neurospheres  themselves  after  implantation 
into acute and chronic EAE mice (Einstein et al., 2006;Einstein et al., 2003). 
 
By using GFP expressing neurospheres, I was able to show that the transplanted 
cells differentiated into astrocytes, as well as into oligodendrocytes. Astrocytes 
are known to influence myelination either positively by secreting for example 
IGF-1 (Liu et al., 1994) or CNTF (Albrecht et al., 2003) or negatively by secreting 
semaphorin 3 (Syed et al., 2011;Williams et al., 2007a) or hyaluronan (Back et 
al., 2005; reviewed by Williams et al., 2007b). The bivalent role of the astrocyte 
is  also  influenced  by  their  functional  status,  where  activated  astrocytes  are 
considered  to  promote  remyelination  and  reactive  astrocytes  to  inhibit  the 
remyelination  process  (reviewed  in  Nash  et  al.,  2011).  Therefore  the 
neurosphere derived astrocytes could also influence the remyelination potential 
of the environment and since the astrocytes of neurosphere origin are in close 
physical  relationship  to  the  transplanted  OPCs,  a  locally  confined  supportive 
environment could be the reason for the observed focal remyelination. 
 
It  is  possible  that  some  of  the  newly  formed  myelin  sheath  originated  from 
endogenous  OPCs  that  acquired  remyelination  competence  in  the  altered 
environment.  Nevertheless,  if  there  was  a  response  by  the  endogenous  OPC 
population then it did not seem to be extensive, since most of the MBP positive 
sheath-like structures were also GFP positive, confirming that they were derived 199 
from  cells  of  transplant  origin.  Taking  the  findings  from  the  cell  intrinsic 
evaluation  of  the  in  vitro  experiment  into  consideration,  the  adult  #72 
homozygote OPCs seemed in general to be impaired in their differentiation into 
oligodendrocytes.     
 
A more parsimonious view, but one that cannot be completely discounted, is 
that failed remyelination could also be due to the short life span of the #72 
homozygote  mice.  It  may  be  that  remyelination  is  just  about  to  begin 
effectively.  However  since  none  of  the  mice  during  this  study  period  had 
survived longer than 135 days it is difficult to say if this is the case. An answer to 
this unsolved question may be found when looking at the #72 homozygote optic 
nerve, where two pathologically distinct regions can be identified at P120 (Edgar 
et al., 2010). The retinal region, which seems to be demyelinated earlier than 
the rest of the optic nerve turns into a non-inflammatory, chronic demyelinated 
region where OPCs are still present (shown in Chapter 5 Evaluation of advanced 
diffusion  weighted  magnetic  resonance  imaging  as  a  molecular  probe  to 
distinguish between acute and chronic demyelination in the optic nerve of the 
#72 mouse). The chiasmal region shows a high degree of demyelination but is 
also filled with activated microglia (as seen in the Chapter 5 and in Edgar et al., 
2010) which is believed to be a less advanced stage of the disease process. Given 
the presence of an acute inflamed demyelinating region and a chronic “silent” 
demyelinated  region,  the  pathology  in  the  #72  homozygote  seems  to  evolve 
towards a chronic demyelinating disease.    
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4.5.3 Early  post  natal  transplanted  gene  wild  type  neurospheres 
integrate and form a stable myelinating cell population in the #72 
CNS – a potential treatment for PMD 
 
Duplication of the X-linked PLP1 gene is the most common cause of PMD. In the 
absence  of  a  treatment  for  PMD,  the  replacement  of  genetically  defective 
oligodendrocytes  with  intact  ones  through  cell  transplantation  represents  a 
potential therapeutic approach. PMD spans a broad clinical spectrum, ranging 
from connatal forms associated with an almost complete lack of CNS myelin to 
milder forms with nearly normal numbers of, but structurally defective, myelin 
sheaths.  For  cell  transplantation  to  bring  about  functional  recovery  in  PMD, 
transplanted cells would have to produce and maintain widespread myelination 
of the CNS. While previous studies have shown that transplanted cells can form 
large amounts of myelin in murine (Hammang et al., 1997;Learish et al., 1999) 
and canine (Archer et al., 1997;Milward et al., 1997) models of the most severe 
forms of the disease, studies to test the feasibility of this approach in animal 
models of milder (but still profoundly disabling forms) are lacking. Here I showed 
that the transplantation of neural stem cells at multiple sites, into the brain of 
new-born Plp1 gene overexpressing mice led to the production and maintenance 
of CNS myelin in competition with the myelination competent, but defective, 
endogenous cells. 
 
I  showed,  using  X-gal  staining  and  electron  microscopy  that  the  transplanted 
neurospheres differentiated into myelin forming oligodendrocytes that populated 
diverse  white  matter  tracts  in  the  forebrain.  Transplant  cell  derived  sheaths 
were not evident in P7 brains by X-gal staining, but could be detected by P14. 
Given  that  increasing  volumes  of  myelin  were  present  with  time  after 
transplantation, it seems most likely that at least some of the myelin that was 
present at P120 had been generated much earlier. Thus, I tentatively concluded 
that,  unlike  the  endogenous  myelin,  the  transplant  derived  myelin  does  not 
undergo degradation.   
 
The  X-Gal  staining,  however,  turns  the  cell  in  vicinity  of  intracellular  β-
galactosidase blue. This process causes unexpected difficulties, when using the 201 
tissue for immunofluorescence microscopy. The blue product (if present in high 
concentration) obliterates the epifluorescent signal, as seen in my study. This 
effect on epifluorescent microscopy renders the image difficult to interpret. A 
simple  and  effective  way  to  solve  this  problem  is  to  avoid  using  the  X-Gal 
technique and to visualise intracellular β-galactosidase by using normal antibody 
labelling technique.  
 
Since  myelin  degradation  in  the  Plp1  overexpressers  has  been  shown  to  be 
related to the presence of sialoadhesin positive microglia/macrophages  (Ip et 
al.,  2007),  I  examined  the  relationship  between  microglial/macrophage  cell 
density  and  transplant  myelin.  Given  the  previously  described  pathological 
changes  involving  the  activation  of  microglia  in  the  #72  homozygote  mouse 
corpus callosum, it is of interest that the neonatally transplanted cells appear to 
interact locally with the environment. In areas, where myelin originated mainly 
from  transplanted  cells,  the  cell  density  was  visible  lower  than  in  areas 
containing no or only a few myelin forming transplanted cells Regions where a 
substantial amount of transplanted cells turned into a stable, myelin forming 
population at P120 seemed to have a less severe microglial response, suggesting 
that the intact transplants don’t elicit the microglial response, or when looking 
at this finding the other way round, the progressive breakdown of the abnormal 
#72 homozygote mouse myelin most likely fuels the microglial response, starting 
a  negative  spiral  of  increased  demyelination  and  probably  impaired 
remyelination. 
 
The  distribution  cells  derived  from  the  neonatal  transplanted  neurospheres 
demonstrates that the transplanted cells migrate into white and grey matter. 
Why the transplants grow in a patchy pattern cannot be explained at this stage. 
However  when  looking  at  other  studies,  similar  patterns  have  been  observed 
(Archer et al., 1997;Learish et al., 1999;Windrem et al., 2004;Yandava et al., 
1999)  and  a  competition  between  the  endogenous  and  transplanted  cells 
probably  occurs  during  development,  where  the  successful  population  finally 
establishes locally, possibly as a result of clonal expansion (Edgar et al., 2002). 
 
Most  experiments  involving  neuronal  stem  cell  transplantation  into  murine 
neonates were either of shorter duration  (Learish et al., 1999;Webber et al., 202 
2009;Yandava  et  al.,  1999),  in  normal  animals  (Learish  et  al.,  1999),  in 
immunocompromised animals (Windrem et al., 2008) or in shiverer mice, where 
severe  dysmyelination  is  already  present  during  development  (Nistor  et  al., 
2005;Windrem et al., 2004;Windrem et al., 2008;Yandava et al., 1999). 
 
The  long  term  survival  of  cells  without  immunosuppression  is  of  interest.  As 
others  have  shown  in  different  models  of  dysmyelination  (Windrem  et  al., 
2004;Archer  et  al.,  1997)  the  absence  of  graft  rejection  is  probably  due  to 
perinatal  toleration  of  the  injected cells  (Windrem et al.,  2004;Ridge  et  al., 
1996). This shows that at least in mice and dogs, neuronal stem cells can be 
introduced  into  the  neonate  CNS  parenchyma  without  the  necessity  of 
immunosuppression.  This finding could be of importance for humans suffering 
from  severe  PMD,  where  neonatal  injection  of  neuronal  stem  cells  is  FDA 
approved (http://www.stemcellsinc.com/Therapeutic-Programs/PMD.htm). 
 
4.6  Conclusion  
 
I have shown that an OPC intrinsic impairment is most likely the cause of the 
remyelination failure in the #72 homozygote mouse. Based on in vitro an in vivo 
data the adult OPCs seem to be impaired in differentiation, which causes the 
OPCs  to  be  blocked  in  a  premyelinating  state,  failing  to  initiate  the 
remyelination  process.  The  in  vivo  experiments  have  shown  that  the  cell 
extrinsic  compartment  seems  to  be  permissive  for  a  certain  degree  of 
remyelination, or at least that the axons are not inhibiting myelination after 
implantation  with  normal  neurospheres  derived  from  young  mice.  However,  I 
cannot  exclude  the  possibility  that  the  environment  becomes  permissive  to 
myelination due to the effect of the transplantation itself.  
 
I have also shown that the neurospheres derived from young animals integrate, 
myelinate and persist without immunosuppression in the #72 homozygote mouse 
brain, either after neonatal or adult injection. In particular, the data obtained 
from  neonatal  transplantation  of  stem  cells  is  of  practical  interest. 
Overexpression of the PLP1 gene is the most frequent genetic aberration leading 
to PMD in humans (Sistermans et al., 1998) and the #72 mouse is a valid model of 203 
this disease. Post natal injection of stem cells has been approved in patients 
with PMD and is a potential treatment option. The results show the potential of 
early stem cell injection to compete and integrate into #72 homozygote CNS 
tissue,  with stable long term myelin formation.  With this observed finding in 
mind, transplantation of neuronal stem cells may ameliorate or even result in 
the rescue of the PMD phenotype in some human patients.   
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5  Evaluation  of  advanced  diffusion  weighted  magnetic 
resonance imaging as a molecular probe to distinguish 
between acute and chronic demyelination in the optic 
nerve of the #72 mouse 
 
5.1  Introduction 
 
In  Chapter  3  and  4  I  showed  that  the  #72  mouse  develops  a  progressive 
demyelination with failed remyelination. A previous study (Edgar et al., 2010) of 
the optic nerve of this model demonstrated a progressive demyelination that 
resulted  in  the  development  of  two  spatially  separate  regions,  a  chronic 
demyelinated region without inflammation and an acute inflamed demyelinated 
region. MRI has facilitated the detection and distribution of CNS pathologies in 
vivo  (Ciumas  et  al.,  2008;Fox,  2008;Guttmann  et  al.,  1995;Inglese  et  al., 
2005b;Inglese  et  al.,  2005a).  However,  the  specificity  is  still  low  and 
identification  of  lesion  type  often  remains  speculative.  New  MRI  techniques, 
such as diffusion weighted MRI, which aims to serve as a molecular probe, have 
been  developed  but  remain  poorly  understood.  The  #72  mouse  brain  has 
previously been analysed using diffusion weighted MRI (DW MRI) (Ruest et al., 
2011), showing that DW MRI is a valuable tool for detecting widespread white 
matter changes in relation to myelin integrity. I speculated that the #72 mouse 
optic  nerve,  with  its  clear  anatomical  features  and  its  spatially  defined 
histopathology (Edgar et al., 2010), would make an ideal model to evaluate the 
capability  of  modified  DW  MRI  sequences  to  distinguish  white  matter  lesion 
types.  
 
5.1.1 The  impact  of  conventional  magnetic  resonance  imaging  in 
diagnosing central nervous system white matter changes 
 
Historically, the diagnosis and monitoring of progression of demyelinating lesions 
in vivo has been difficult.  In order to investigate lesion development, surgical 
procedures  to  obtain  serial  biopsy  samples  from  CNS  tissue  were  necessary. 205 
However, the invasive nature of this procedure meant that disease progression 
was altered (complicating evaluation of disease development). Additionally, the 
surgical  procedures  were  associated  with  detrimental  effects  on  the 
animal/patient.  The  full  distribution  and  extent  of  the  pathology  could 
previously only be assessed at the point of necropsy.  
  
With  progress  in  the  development  of  advanced  imaging  modalities,  including 
magnetic resonance imaging (MRI), in vivo evaluation and monitoring of white 
matter lesions dispersed over the whole CNS, has become possible.  In the case 
of multiple sclerosis, MRI has improved the accuracy of diagnosing, localising and 
monitoring the course and extent of white matter pathology (reviewed in Ciumas 
et  al.,  2008;Inglese  et  al.,  2005b).  Repeated  MRI  allows  mapping  of  lesion 
distribution and reveals temporal changes in lesion size and location (Guttmann 
et  al.,  1995;  reviewed  in  Ciumas  et  al.,  2008).  One  major  weakness  of 
conventional MRI sequences in the characterisation of white matter pathology is 
the low sensitivity to distinguish lesion types,  in particular between areas of 
acute  active  inflammation  with  ongoing  demyelination  and  inactive,  chronic 
demyelination (Bitsch et al., 2001; reviewed in Inglese et al., 2005b). 
 
5.1.2 The use of diffusion weighted imaging of central nervous system 
white and grey matter in the research and clinical settings 
 
The provision of a modality capable of distinguishing active inflammation with 
ongoing demyelination from inactive, chronic demyelination would have a major 
impact on monitoring disease development, response to treatment and accurate 
determination of the long-term prognosis for the affected patient. It may also 
provide  greater  insight  into  myelination  dynamics  that  lead  to  the  failure  of 
remyelination observed in experimental demyelinating models and in MS.  
 
One  modality  that  might  permit  differentiation  of  lesion  types  is  diffusion 
weighted  imaging  (DWI).    DWI  sequences  measure  the  movement  of  water 
molecules within tissues (Basser et al., 1994; reviewed in Basser and Oezarslan 
E, 2009).  The diffusion of water molecules refers to the natural phenomenon of 
random thermal motion that all molecules at temperatures above zero degrees 206 
Kelvin  undergo;  also  referred  to  as  Brownian  motion  (reviewed  in  Mori  and 
Zhang,  2006).    In  liquids,  individual  molecules  can  move  freely,  with  the 
diffusion coefficient depending on molecular size, viscosity and temperature of 
the media (reviewed in Beaulieu, 2002;Mori and Zhang, 2006).  In tissue such as 
the white matter, the degree and direction of diffusion of water molecules is 
restricted  by  the  tissue  microstructure  (Moseley  et  al.,  1990a;Turner  et  al., 
1990).  Intracellular structures, cell membranes and tissue properties (including 
cell  type,  density,  size  and  integrity,  as  well  as  extracellular  matrix)  all 
influence water diffusivity (reviewed in Beaulieu, 2009).   
 
The sensitivity of DWI in detecting changes in water diffusion due to pathological 
processes  in  the  CNS  means  that  DWI  is  being  increasingly  used  in  clinical 
applications (Warach et al., 1995;Larsson et al., 1992; reviewed in Goldberg-
Zimring  et  al.,  2005).  One  example  is  in  the  early  detection  of  cerebral 
ischemia:  while  standard  sequences  still  appear  normal  during  the  pre-acute 
stage, pathological changes are usually already apparent in DWI (Mintorovitch et 
al., 1991;Moseley et al., 1990b;Warach et al., 1995).  Following white matter 
ischemia, DWI differentiates cytotoxic oedema, which is present soon after the 
ischaemic event, and vasogenic oedema, which is present at a later stage (Ebisu 
et al., 1993). DWI is also more sensitive in detecting white matter lesions than 
standard  T2  weighted  magnetic  resonance  sequences,  as  demonstrated  in  a 
monkey model of experimental autoimmune encephalitis (Heide et al., 1993). 
 
5.1.3 Diffusion  tensor  imaging  and  its  application  in  investigating 
central nervous system white matter physiology and pathology 
 
In order to measure diffusion, diffusion sensitising gradients are applied to a 
pulsed  gradient  spin  echo  (PGSE)  sequence  (reviewed  in  Beaulieu,  2002).    In 
“standard” diffusion weighted imaging (DWI) the diffusion sensitising gradients 
are applied along a single direction, sensitising the signal to diffusion only along 
that direction.  Two gradient pulses separated by a defined time and a gradient 
strength of a defined duration are applied to the scan area.  These adjustable 
parameters  are  part  of  the  b-value,  which  is  a  diffusion  sensitising  factor 
(reviewed  in  Basser  and  Oezarslan  E,  2009).  The  attenuation  of  the  signal 207 
measured after applying the sequence is caused by diffusion of the ‘labelled’ 
water molecules (Norris, 2001). 
 
The b-value is defined as follows:  
 
Equation 1:         (   )  (    
 
 ) 
 
  is  the  magnetogyric  ratio  (depends  on  the  nucleus  used  e.g. 
1H),  G  is  the 
gradient strength,  is the duration of the applied gradient and  is the time 
between the two gradient pulses (called the observation time).   
 
Diffusion can be measured in any direction using a linear combination of the X, Y 
and Z gradients (Basser et al., 1994; reviewed in Jones, 2009). This directional 
application  of  the  gradient  is  also  used  in  diffusion  tensor  imaging  (DTI),  a 
modification of DWI (Basser et al., 1994; reviewed in Jones, 2009).  Using the 
assumption that there is a Gaussian diffusion process and that the signal decay 
occurs mono-exponentially as a direct result of water molecule diffusion, DTI 
requires  diffusions  to  be  measured  along  a  minimum  of  6  directions.  In  DTI, 
diffusion in each direction is measured using a PGSE pulse sequence with two 
different b-values, usually 0 and ~ 1000 s/mm
2.  This allows the calculation of 
diffusion and diffusivity in any direction of interest (reviewed in Jones, 2009). 
Quantification of diffusion directionality, which is the basis of DTI, is possible 
because  diffusion  can  be  anisotropic  or  isotropic,  depending  on  the 
microstructure of tissue (Doran et al., 1990;Moseley et al., 1990a).  Anisotropy 
arises  when  the  water  molecule  movement  is  more  restricted  in  certain 
directions than others (Doran et al., 1990;LeBihan D. et al., 1993;Moseley et al., 
1990a;  reviewed  in  Beaulieu,  2002;Mori  and  Zhang,  2006).  Faster  diffusion in 
certain directions compared to others results in a specific directionality of bulk 
water  molecule  movement  in  tissue,  which  can  be  expressed  in  terms  of  an 
ellipsoid.  In contrast, isotropic diffusion is present when water diffusion is equal 
in  all  directions,  and  can  be  expressed  in  terms  of  a  sphere  (reviewed  in 
Beaulieu, 2002;Mori and Zhang, 2006).  As mentioned before, water diffusivity 
can be measured in different directions, allowing determination of the direction 
of the largest versus the mid-range versus the lowest principal diffusivity.  The 208 
higher  the  anisotropy  of  tissue,  the  simpler  it  is  to  determine  the  main 
directionality of diffusion by means of DTI (reviewed in Mori and Zhang, 2006).  
High anisotropy is particularly evident in tissue such as the CNS white matter 
(reviewed in  Beaulieu,  2002),  which comprises  parallel  arrays  of  nerve  fibres 
(Figure 55). 
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Figure 55.  Examples of anisotropic and isotropic diffusion.  
Dorsal view of a 3D fast spoiled gradient echo image of a cat brain (A). White matter tracts such 
as the internal capsule (rectangle with dotted lines) are composed of dense axonal bundles. The 
strict anatomical organisation of nerve fibers guides the bulk diffusion along a main direction, 
which  is  the  basis  of  anisotropic  diffusion  in  white  matter  (B,  C).  Anisotropic  diffusion  is 
expressed  in  form  of  a  diffusion  ellipsoid  (D).  The  diffusion  ellipsoid  reflects  the  difference 
between the parallel (ADCII or λ1) and perpendicular (ADC┴ or λ2 and λ3) diffusion in relation to 
the neural fibers, showing that diffusion is faster in the parallel than perpendicular direction to 
the nerve fibers (ADCII > ADC┴). An example of isotropic diffusion in the CNS is found in the 
ventricular system (rectangles with solid lines in A; E; three dimensional reconstruction of the 
ventricular system in a dog), which contains cerebrospinal fluid (CSF), a virtually acellular fluid 
with low protein content. In the CSF filled ventricular system, diffusion similar in all directions, 
and can be expressed in terms of a sphere. (F, ADCII = ADC┴). Adapted from (Beaulieu, 2009). 210 
Studies aimed at understanding the tissue correlates of the DTI parameters have 
shown that axons, with the axonal membrane as the main barrier, are the main 
contributors  to  anisotropy  (reviewed  in  Beaulieu,  2002;Beaulieu,  2009).  The 
influence of intra-axonal structures on diffusion is considered to be insignificant 
(Beaulieu and Allen, 1994;Ono et al., 1995;Gulani et al., 2001;Mori and Zhang, 
2006).  Furthermore,  correlative  studies  in  dysmyelinating  and  demyelinating 
mouse models such as shiverer (Nair et al., 2005;Song et al., 2002), jimpy (Ono 
et al., 1995;Harsan et al., 2007), the transgenic olig-TTK mouse (Harsan et al., 
2006) or lysolecithin induced demyelination models (Xie et al., 2010) have shown 
that  myelin  sheaths  have  a  modulatory  effect  on  diffusion  anisotropy. 
Consequently  DTI  sequences  can  be  used  to  identify  pathological  changes  in 
myelin, which interfere with the normal diffusion of water along white matter 
tracts (reviewed in Barkovich, 2000;Laule et al., 2007). For example, it has been 
shown that demyelination is associated with increased radial (perpendicular to 
the axons) diffusivity (Song et al., 2002;Song et al., 2005) and axonopathy with 
reduced  axial  (parallel  to  the  axons)  diffusivity  (Budde  et  al.,  2008).  
Interestingly remyelination reverses the changes in radial diffusivity (Harsan et 
al., 2006).  
 
The potential influence on diffusion measures of other white matter components 
such as of astrocytes, microglia, trafficking immune cells and OPCs has often 
been neglected. However, recent studies investigating the role of extra-axonal 
factors  on  diffusion  parameters  have  shown  that  these  cells  also  influence 
diffusion (Harsan et al., 2007;Xie et al., 2010;Ruest et al., 2011), albeit to a 
considerably lesser extent than the nerve fibres themselves.  
 
5.1.4 Multiexponential  signal  decay  –  an  opportunity  to  differentiate 
between  inflammation  with  acute  demyelination  and  chronic 
silent demyelination? 
 
In  DWI,  the  diffusion  of  water  molecules  (i.e.  H  nuclei)  results  in  signal 
attenuation,  which  can  be  directly  related  to  diffusion  rate.  The  higher  the 
diffusion  rate  the  more  pronounced  is  the  signal  decay  (Westbrook  et  al., 
2005;Jones,  2009).  Generally,  diffusion  is  considered  to  produce 211 
monoexponential signal decay. However, a number of studies have shown that 
there is non-monoexponential signal decay if the DWI sequence is extended by 
applying multiple increasing b-values, extending up to 40000 s/mm
2 (Stanisz et 
al.,  1997;Clark  and  LeBihan  D.,  2000;Ronen  et  al.,  2006).  The  origin  of 
biexponential, or even triexponential (Assaf and Cohen, 1998) signal decay is not 
fully understood and various models have been investigated and proposed.   
 
Some  groups  have  suggested  that  biexponential  decay  is  the  result  of 
microstructures restricting or hindering diffusion in characteristic ways (Stanisz 
et  al.,  1997;Pfeuffer  et  al.,  1999).  If  this  is  assumed  to  be  the  case  then 
multiexponential diffusion decay can be analysed by dividing the data into two 
or more independent monoexponential diffusion components, each representing 
a distinct micro anatomical entity within the tissue. In white matter these micro 
anatomical entities have been classified as the intracellular space versus the 
extracellular space, or more specifically, the intraaxonal space versus the extra 
axonal space including the myelin sheath (reviewed in C. Beaulieu, 2002). 
 
Others state that the compartmentalisation into slow and fast diffusion does not 
sufficiently explain the presence of biexponential signal decay (Niendorf et al., 
1996;Schwarcz et al., 2004). It has been suggested that different binding states 
of water molecules to protein fragments or conformational changes in proteins 
after  injury  may  also  contribute  to  the  presence  of  the  biexponential  signal 
decay phenomenon (Schwarcz et al., 2004).  
 
Demyelinating lesions in MS patients possess the capacity to remyelinate, even 
after long term disease  (Patani et al., 2007;Patrikios et al., 2006). However, 
some chronically demyelinated regions fail to remyelinate (Chang et al., 2002). 
Axonal  loss,  which  is  considered  to  be  the  major  contributor  to  permanent 
disability (Kornek et al., 2000;Bjartmar and Trapp, 2003;Bjartmar et al., 2003), 
is  associated  with  chronic  demyelination,  highlighting  the  importance  of 
preventing the development of chronic lesions. If a method such as DWI with 
multiple increasing b-values is capable of identifying lesion type non-invasively, 
this  would  substantially  improve  the  diagnostic  accuracy,  inform  the  most 
suitable treatment and allow accurate determination of the long term prognosis.  
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I  hypothesised  that  using  multiple  increasing  b-values  might  increase  the 
sensitivity of DWI to differentiate between different pathological states such as 
inflammation  and  demyelination  versus  chronic  demyelination  without 
inflammation. If true, then this technique may become particularly useful as a 
molecular probe for diagnosing different stages of inflammatory demyelinating 
white matter disease.  In particular, in MS where it could help to distinguish 
chronic, silent demyelination and active inflamed demyelination. 
 
5.1.5 The #72 mouse optic nerve as a model system in which to assess 
the potential of DWI to distinguish complete demyelination from 
inflammatory demyelination 
 
Anatomically the optic nerve comprises a region of parallel axons with a defined 
supporting  cell  population.  In  terms  of  the  application  of  DWI,  the 
unidirectionality of optic nerve axons allows the reduction of the full diffusion 
tensor (as used in DTI) to two directions; parallel and perpendicular to the fibres 
(Tu et al., 2010). The adult #72 mouse optic nerve displays a highly reproducible 
persistent demyelination in the rostral segment and active demyelination with 
inflammation in the caudal segment (Edgar et al., 2010).  The predictable lesion 
progression in the optic nerve of the #72 mouse creates an ideal model with 
which to test the hypothesis that applying multiple increasing  b-values to the 
DWI  sequence  can  increase  the  sensitivity  of  DWI  to  distinguish  lesion  types 
within nerve fibre tracts.  
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5.2  The aims of the chapter 
 
1.) To establish a protocol for the preparation of isolated optic nerves for 
high resolution DWI of CNS white matter  
2.) To  apply  DWI  with  multiple  increasing  b-values  to  normal,  completely 
demyelinated and actively demyelinating optic nerve regions 
3.) To undertake a detailed histological examination of the regions of interest 
of the scanned nerves for comparison with the DWI data 
4.) To  assess  whether  DWI  with  increasing  b-values  is  more  sensitive  than 
conventional DWI using two b-values, to distinguish active demyelination 
from complete demyelination  
 
5.3  Material and Methods 
 
5.3.1 Breeding and identification of homozygote 72 mice  
 
Plp1  overexpressing  72  transgenic  mice  were  generated  and  genotyped  as 
described in Chapter 2.2 Mouse breeding. Optic nerves from homozygote #72 and 
wild type mice were used. 
 
5.3.2 Coil and sample holder design for mouse optic nerve DWI 
 
5.3.2.1 Coil design 
 
Commercially  available  coils  did  not  meet  the  requirements  for  scanning  the 
small diameter of the mouse optic nerves (diameter of approximately 300µm 
each).  A  purpose  built  coil,  designed  and  built  by  William  Holmes  and  Jim 
McMullen was used.  The coil was of a transmit/receive solenoid design, directly 
connected to the standard scanner electronics. In order to avoid metal related 
artefacts the metal part was the coil itself, for which magnetic susceptibility 
matched wire was used. Acrylic glass was used for the front part of the coil 214 
(Figure 56). To prevent the sample from moving during the scan, an adjustable 
acrylic screw was placed beneath the coil. The acrylic screw was also used to 
adjust the position of the samples vertically within the coil (one revolution = 1 
mm movement). 
 
5.3.2.2 Sample holder design 
 
The  sample  holder  was  designed  to  allow  three  pairs  of  optic  nerves  to  be 
imaged simultaneously. The orientation of the nerves within the sample tube 
was critical because diffusion was to be measured in two directions only. The 
sample  itself  had  to  be  confined  in  order  to  avoid  motion  during  the  scan. 
Additionally, the samples had to be surrounded by fluid,  in order to prevent 
them  from  drying  out,  as  this  would  lead  to  irreversible  tissue  damage  and 
interfere with diffusion of H2O molecules. Therefore the sample holder had to 
fulfil certain criteria: it had to be small in diameter to avoid movement of the 
optic nerve, linear, waterproof and ideally made of plastic to avoid interference 
with the magnetic field. A commercially available plastic tube commonly used 
for  microinfusion  in  rats  fulfilled  all  the  requirements.  The  tube  was  readily 
available,  made  of  plastic  and  had  an  intraluminal  diameter  of  500µm.  Two 
centimetre long sections of tubing were cut  to act as sample holders.  These 
were mounted on a steel needle (0.5 x 20mm) and were left overnight on a hot 
plate (60°C) to straighten. A bundle of seven tubes were glued together using 
nail varnish to form a cylinder, which fitted tightly into a larger plastic tube. 
The larger tube was used as a template to define the coil diameter when the coil 
was built and therefore fitted securely inside the coil (Figure 57). 
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Figure 56.  Image of the purpose built transmit/receive coil. 
The scanning part of the coil, with a diameter of 4mm is marked with an asterisk. Acrylic glass 
was used in close proximity to the coil to avoid artefact generation. An acrylic screw (arrow) just 
below the coil region was used to adjust the location of the samples, and to immobilise the 
samples, which were placed vertically inside the coil.   
 
 
Figure 57.  Image of the optic nerve sample holder used for the diffusion 
weighted imaging experiment. 
Seven plastic microtubes with an inner diameter of 500µm, each assigned to hold one optic nerve 
and one to contain PBS/Multihance, were glued together using clear nail varnish. The cylinder of 
seven tubes was then fitted tightly into a larger sample tube with a 4mm outer diameter. The 
large tube was used as a template for determining the diameter of the transmit/receive coil and 
therefore fitted securely inside the coil (horizontal line 4mm, vertical line 0.5mm). 216 
5.3.3 Preparation of optic nerves for DW MRI scan 
 
Twelve 72 mice and six wild type mice were euthanized in a CO2 chamber.  
Intracardiac perfusion of 0.85% saline (20ml) followed by 4% paraformaldehyde 
(PF,  20ml)  was  performed,  as  described  in  Chapter  2.6  Tissue  sampling  and 
processing, for optimal tissue fixation. Immediately after perfusion, both optic 
nerves were dissected, leaving the eyes, the optic nerves, the chiasm and a part 
of the optic tract as one intact unit. The optic nerves were freed of surrounding 
tissue  as  thoroughly  as  possible.  The  optic  nerves  were  separated  from  each 
other longitudinally at the chiasm leaving two intact single optic nerves with 
chiasm and optic tract. After removing the lens and retina the optic nerve was 
pinned  down  at  the  sclera  and  at  the  optic  tract  on  a  wax  board,  without 
applying  tension,  to  straighten  the  nerve.  The  pinned  nerves  were  then 
transferred  into  4%  paraformaldehyde  for  another  six  hours.  Since 
paraformaldehyde  may  interfere  with diffusion  (Kim  et  al.,  2009;Shepherd et 
al., 2009;Sun et al., 2003), extensive washing of the tissue was performed to 
remove all free paraformaldehyde from the tissue. After the fixation period the 
nerves were transferred into PBS for 24 hours at 4°C. To enhance the MR signal 
the PBS solution was subsequently incubated in a 2.5mM solution of gadobenate 
dimeglumine (MultiHance, Bracco, 0.5M containing 334mg/ml gadobenic acid) 
in PBS (250l MultiHance/50ml PBS) for 6 days at 4°C. 
 
On the day of the scan the nerves were removed from the wax board, submerged 
in  a  Multihance®/PBS  bath  and  microsurgical  threads  (SurgiPro®  II  7-0, 
polypropylene, monofilament, Surgalloy) were sutured to the sclera.  Each nerve 
was  then  pulled  through  a  designated  plastic  microtube  filled  with 
Multihance®/PBS  solution.  The  optic  nerves  were  aligned  with  each  other 
longitudinally, under magnification, using the scleral-optic nerve junction as a 
landmark. Six microtubes were filled with three optic nerve pairs. The seventh 
tube  containing  Multihance®/PBS  only,  served  as  a  control.  While  still 
submerged in solution, the barrel containing the samples was transferred into 
the large sample holder (Figure 58). Once the barrel was in place the sample 
holder was sealed using Blu-Tack® (Figure 59). The alignment of the nerves was 217 
verified under high magnification and a mark was placed on the holder at 1 mm 
and 4mm caudal to the scleral-nerve junction, using graph paper as a ruler. 
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Figure 58.  Image of the sample holder filled with seven microtubes, each 
containing one optic nerve or just PBS/Multihance. 
Seven plastic microtubes were merged together to form a cylinder containing a total of 3 pairs of 
optic nerves and one empty tube filled with Multihance®/PBS. Microsurgical sutures (blue) were 
attached  to  the  sclera  (arrow)  to  facilitate  placement  of  each  optic  nerve  in  its  designated 
microtube. 
 
 
 
Figure 59.  Image of a sealed sample holder containing optic nerves ready to 
be placed into the coil for scanning.  
The large sample tube was filled with Multihance®/PBS to prevent the tissue from drying out 
during the scan procedure.  The tube was sealed with Blu-Tack® at both ends.  The scan region, 
which was positioned in the middle of the coil was 1mm (asterisk) and 4mm (o) distal to the 
scleral-optic  nerve  attachment.  The  regions  were  identified  under  magnification  using  graph 
paper and the external tube was marked with a permanent marker.  
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5.3.4 Instrumentation 
 
The MR images were acquired on a 7 Tesla Bruker Biospin Biospec 70/30 MRI 
system with a micro imaging gradient insert (model BG-6) and 100-A gradient 
amplifiers. The gradient system provides linear magnetic field gradient pulses up 
1000mT/m. 
 
5.3.5 Scan protocol 
 
A  three  dimensional  pilot  image  was  acquired.  As  the  region  of  interest  was 
physically positioned in the middle of the RF coil, the centre of the scan field 
was in the middle region of the pilot image. The imaging slice was manually 
positioned to be perpendicular to the axis of the optic nerve using the pilot 
image. In the pulse program the diffusion sensitising gradients were defined to 
be parallel and perpendicular to the imaging slice, thus avoiding the need for 
manual adjustments to the coil placement. 
 
The DW MRI of the optic nerves was acquired by performing a spin echo DTI with 
a  spin  echo  imaging  sequence  (TR/TE  of  500ms/24.35ms,  4  NEX).    Since  the 
directionality of the nerve fibres is known a full tensor was not required (Tu et 
al., 2010). Diffusion gradient pulses were instead applied along three diffusion 
directions,  one  parallel  and  two  perpendicular  directions  in  relation  to  the 
axonal fibre orientation.  Sixteen increasing b-values were applied along each 
gradient directions (94.6, 270.7, 492.3, 708.9, 922.9, 1135.3, 1661.5, 2183.6, 
2703.1, 3220.8, 3737, 4252.1, 4766.3, 5279.7, 5792.4, 6304.6 s/mm
2). Gradient 
pulse timing was fixed at  = 4ms and  = 16ms. The slice thickness was 1mm. 
The matrix of the scan region was 62 x 62, with a 65µm x 65µm resolution per 
voxel.  In each sample, a water phantom was scanned simultaneously with the 
optic nerve samples. All scans were performed at room temperature (20ºC). The 
diffusivity of water at room temperature is known and the water sample served 
as a control. 
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5.3.6 Processing and analysis of DWI data 
 
The DWI raw data was extracted using ImageJ®. The data was further processed 
in MatLab®, where curve fitting, diffusion coefficient and fractional anisotropy 
were calculated.  
 
5.3.7 Conventional analysis of the data using two b-values only 
 
The diffusion coefficient D of water molecule can be calculated based on the 
signal in spin echo sequences which is derived from proton density (PD), T1 and 
T2 relaxation time using this simplified formula (Stejskal and Tanner, 1965;Mori 
and Zhang, 2006) 
 
Equation 2           (           )            
Equation 3                
 
In diffusion experiment using two b-values: 
 
Equation 4                  
Equation 5                  
Equation 6    
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Equation 7         
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(      )      (Mori and Zhang, 2006) 
 
Based on  Equation  7 the apparent  diffusion  coefficient  for  ADCII  and  ADC┴  is 
calculated.  When  working  with  only  two  b-values  in  an  assumingly 
monoexponential  diffusion  decay  experiment,  the  optimal  b-values  are  in 
general considered to be for b1 close to 0 and for b2 between 900 and 1200 
s/mm
2 (Jones, 2009). In this case we used for b1 94.6 s/mm
2 and for b2 1135.3 
s/mm
2 to calculate ADCII and b1 68.4 s/mm2 and b2 1018.4 s/mm
2 to calculate 
ADC┴. 
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The fractional anisotropy (FA) is a numeric value that provides an indication of 
the  “directionality”  of  diffusion  in  tissue.  Values  lie  between  0  (isotropic 
diffusion) and 1 (completely anisotropic diffusion, in one direction).  
FA  is  calculated  from  the  parallel  and  perpendicular  apparent  diffusion 
coefficient ADC or, when applying the full tensor, from the three eigenvalues λ1, 
λ2, λ3. In our case, where the fibre orientation is known, ADCII is λ1 and ADC ┴ is 
λ2 and λ3. 
 
Equation 8          
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where 
 
Equation 9            
          
   
 
this  is  also  the  mean  diffusivity  <D>,  a  measurement  of  diffusion  without 
considering directionality (Beaulieu, 2009). 
 
Equation 10           
               
   
 
5.3.8 Analysis of the data using multiple increasing b-values 
 
The  data  was  further  analysed  by  fitting  the  signal  attenuation  with 
biexponential fitting routine using the following formula: 
 
Equation 11 
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Equation 12     ( )                   
 
S(g)/S0 or E(b) is the signal intensity change,  is the contribution of the fast 
portion from the total signal decay,  is the contribution of the slow portion 
from the total signal decay,  is the magnetogyric ratio of 
1H, g is the gradient 
strength,  is the length of duration of the applied gradient and  is the time 222 
between  the  two  gradient  pulses.  D1  is  the  diffusion  coefficient  of  the  fast 
diffusion and D2 is the coefficient of the slow diffusion component. The b-value 
is  defined  as  described  in  Equation  1.  The  fast  diffusion  (D1)  and  the  slow 
diffusion (D2) as well as the contribution of fast diffusion (α) and slow diffusion 
(β) on total diffusion can be calculated using Equation 12 (Figure 60).  223 
 
Figure 60.  Illustration of the two components identified after applying the 
curve  fitting  routine  on  the  signal  decay  curve  obtained  from  multiple 
increasing b-values.  
Using Equations 11 and 12 for curve fitting allowed the differentiation between two different 
components, a fast diffusion component (D1) and a slow diffusion component (D2), where the 
slope of the components, expressed as red and blue lines, displays the different diffusivities. 
Additional data were generated by calculating the contribution of each diffusion component, in 
percentage, relative to the total diffusion process.  224 
5.3.9 Tissue sampling for histological examination 
 
Immediately  following  the  scan,  the  optic  nerves  were  sectioned  into  three 
parts.  The  first  part included the  sclera  and  the  retinal  portion  of  the  optic 
nerve, extending 1.5mm caudally from the optic disc.  The second and third 
parts consisted of 1.5mm long segments, starting 1.5 and 3mm, respectively, 
from the optic disc. The first and the third parts (equivalent to the two scan 
regions) were frozen as described in Chapter 2. Ten µm thick transverse sections 
were  cut  on  a  cryostat  and  mounted  on  APES  coated  slides.  Serial  sections, 
spanning  1mm  through  the  nerve,  were  collected  on  10  slides  (consecutive 
sections were mounted on consecutively numbered slides). Each slide contained 
up to 10 sections, each one sectioned at a distance of 100µm from the previous 
one. These sections were used for immunofluorescence. The middle part each 
nerve  was  cut  in  half  and  processed  for  electron  microscopic  evaluation  as 
described  in  Chapter  2  Material  and  Methods.  Sample  processing, 
immunohistochemistry  and  EM  procedures  are  described  in  Chapter  2.7.3 
Electron microscopy. 
 
5.3.10  Primary antibodies for characterisation of cell types in the 
optic nerve 
 
The  following  antibodies  were  used  to  identify  specific  cell  populations: 
adenomatous  polyposis  coli  (APC)  to  identify  mature  oligodendrocytes, 
chondroitin sulphate proteoglycan (NG2) to identify oligodendrocyte precursor 
cells,  glial  fibrillary  acidic  protein  (GFAP)  to  identify  astrocytes  and  CD45  to 
identify  the  microglial/macrophage/leukocytic  population.  For  dilutions  and 
suppliers, see Table 2. 
 
5.3.11  Secondary antibodies  
 
Secondary  FITC  labelled  antibodies  were  used  to  visualise  primary  antibody 
binding.  Anti-mouse IgG1 for APC, anti-rabbit IgG for NG2, anti-mouse IgG1 for 
GFAP and anti-rat IgG for CD45. For dilutions and suppliers, see Table 3. 225 
5.3.12  Quantification of cell densities 
 
A minimum of 6 sections, each 90µm apart from the previous, were analysed for 
cell quantification. Micrographs were opened in Image ProPlus 6.0 software and 
an area of interest (AOI: 28060.45µm
2) was applied manually onto each image. 
To calculate total cell density, semi-automated quantification of DAPI stained 
nuclei, applying a signal threshold value between 5 and 200, was obtained from 
an AOI of 9983.98µm
2. All cells, which were fully or partially located in the AOI, 
except cells touching the southern and the western borders of the AOI, were 
counted. Cell density per mm
2 was calculated based on counts from a minimum 
of 6 AOIs. A similar procedure was used to quantify densities of specific cell 
types,  but  in  this  case,  the  immuno-labelled  cells  with  a  DAPI  nucleus  were 
identified and quantified manually. 
 
5.3.13  Statistics 
 
For both DW MRI and histological analyses, a two tailed, paired t-test was used 
to  compare  retinal  and  chiasmal  regions  of  wild  type  or  #72  optic  nerves. 
Comparisons between genotypes were made using an unpaired two tailed t-test. 
No corrections for multiple comparisons were made. All statistical analyses were 
done using GraphPad Prism® 5. 
 
5.4  Results 
 
An  initial  scan  of  6  wild  type  nerves  was  undertaken  in  order  to  test  the 
reproducibility of the protocol and the stability of the device. Once optimised, 
18 optic nerves of sex and age matched control (wild type) and #72 nerves were 
scanned. DW MRI data was obtained from 16 increasing b-values ranging from 
94.6 to 6304.4 s/mm
2.  
 
Initially  the  DW  MRI  data  generated  from  the  analysis  of  2  b-values  was 
extracted from the complete dataset  b-values (b1 = 94.6 s/mm
2; b2 = 1135.3 
s/mm
2), was analysed. These results are summarised in Table 5 and Table 6. The 226 
complete dataset (i.e. using all b-values) was then used to unveil fast and slow 
diffusion components. The results are summarised in Table  Table 7, Table 8, 
Table 9, Table 10, Table 11, Table 12.  
 
5.4.1 Good signal quality was obtained from the scanned optic nerves 
 
The signal obtained from the optic nerves during the scan in the sample holder 
was stable and a good signal to noise ratio of 25 : 1 was achieved (Figure 61).  
The  data  were  used  to  measure  diffusion  parallel  and  perpendicular  to  the 
orientation of the optic nerve fibres. 
 
5.4.2 Analysis of the data using two b-values 
 
5.4.2.1 Fractional anisotropy was reduced in the #72 optic nerves  
 
The  fractional  anisotropy  (FA),  a  measure  of  diffusion  directionality,  was 
calculated using Equation 8 from the data generated using two b-values. There 
was a significant reduction in FA in both the retinal and chiasmal regions of the 
#72 optic nerves compared to the same regions in the wild type nerves (Figure 
62, Table 5).  There was also a significant reduction in FA in the chiasmal region 
compared to the retinal region in #72 nerves (Figure 62, Table 6). 
 
5.4.2.2 Mean diffusivity increased with demyelination 
 
Mean diffusion, calculated using Equation 10, was significantly increased in both 
retinal and chiasmal regions of the #72 nerves, compared to the same regions in 
the wild type nerves (Figure 63). Furthermore, although diffusion was similar in 
both regions of wild type nerves, it was significantly greater in the retinal region 
than in the chiasmal region of the #72 nerves (Figure 63).   
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Figure 61.  Good signal to noise ratio was achieved with the purpose built 
coil.  
Representative examples of two diffusion weighted (DW) images obtained at a b-value of 94.6 
(A) and 1135.3 (B) s/mm
2 along the parallel direction in relation to the orientation of the optic 
nerve fibers. Depending on the quantity of the b–value the optic nerves can be identified as grey 
(arrowheads in A) or white (arrowheads in B), circular objects. H2O served as a control (asterisk 
in A & B). The slower the diffusion, the more 1H protons remain in the scan region, generating 
the bright signal in the object at high b-values. A quadrate region of interest was chosen in the 
middle of the optic nerve with an area composed of 2 x 2 voxels resulting in a measured area of 
130µm x 130µm x 1000µm.  
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Figure 62.  Fractional  anisotropy  was  reduced  in  both  #72  optic  nerve 
regions, compared to wild type.  
Graph representing the mean fractional anisotropy (FA) values (+ s.e.m.) in the two scanned 
regions of wild type and #72 optic nerves using two b-values b1=94.6 s/mm
2; b2=1135.3 s/mm
2. 
There was a significant decrease in FA in both regions of the #72 optic nerve compared to the 
same regions in the wild type. There was also a significant decrease in FA in the chiasmal region 
compared to the retinal region of the #72 optic nerves. Wild type: N=12, #72: N=24; WT RR: wild 
type retinal region. WT CR: wild type chiasmal region. Homo RR: #72 retinal region. Homo CR: 
#72 chiasmal region. Stars indicate p values: **p < 0.01. ***p < 0.001; ****p < 0.0001. 
 
Figure 63.   Mean diffusion was increased in the #72 mouse optic nerve. 
Graph representing the mean apparent diffusion coefficient (+ s.e.m.) in wild type and #72 optic 
nerves obtained using two b-values b1=94.6 s/mm
2; b2=1135.3 s/mm
2. The mean diffusion was 
significantly higher in the retinal and chiasmal regions of the #72 nerves compared to the same 
regions in the wild type nerve. Within the #72 nerve, the mean diffusion was significantly higher 
in the retinal region than in the chiasmal region. WT RR: wild type retinal region. Wild type: 
N=12, #72: N=24; WT CR: wild type chiasmal region. Homo RR: #72 retinal region. Homo CR: #72 
chiasmal region. Stars indicate p values: **p < 0.01; ***p < 0.001; ****p < 0.0001. 229 
5.4.2.3 Changes  in  the  parallel  apparent  diffusion  coefficient  (ADCII)  and 
perpendicular apparent diffusion coefficient (ADC┴) in the #72 nerve  
 
To  calculate  ADCII  and  ADC┴,  Equation  7  was  used  (Jones,  2009).  ADC┴  was 
significantly increased in both the retinal and chiasmal regions of the #72 nerves 
compared to the corresponding regions in the wild type nerves (Figure 64, Table 
5, Table 6).  In contrast, ADC// was significantly increased in only the retinal 
region of the #72 nerve compared to (i) the same region in the wild type nerve 
and (ii) to the chiasmal region of the #72 nerve. Conversely, in the wild type 
nerve, ADC// was slightly, but significantly, higher in the chiasmal region than in 
the retinal region. (Figure 65, Table 5, Table 6). 
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Figure 64.  Perpendicular  apparent  diffusion  coefficient  was  increased  in 
the #72 optic nerve.  
Graph presenting the mean values (+ s.e.m.) of the perpendicular apparent diffusion coefficient 
(ADC┴) taken from the two scanned regions in the wild type and the #72 optic nerves using two 
b-values b1=68.4 s/mm
2; b2=1018.4 s/mm
2. There was a highly significant increase in ADC┴ in 
both regions of the demyelinated #72 optic nerve compared to the same regions in the wild type. 
Wild type: N=12, #72: N=24; WT RR: wild type retinal region. WT CR: wild type chiasmal region. 
Homo  RR:  #72  retinal  region.  Homo  CR:  #72  chiasmal  region.  Stars  indicate  p  value:  ****p  < 
0.0001. 
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Figure 65.  Parallel  apparent  diffusion  coefficient  was  increased  in  the 
retinal, but not the chiasmal region of the #72 nerve, compared to wild type.  
Graph  presenting  the  mean  values  (+  s.e.m.)  of  the  parallel  apparent  diffusion  coefficients 
(ADCII) in the retinal and chiasmal regions of the wild type and #72 optic nerves using two b-
values b1=94.6 s/mm
2; b2=1135.3 s/mm
2.
 There was a significant increase in parallel diffusion in 
the #72 retinal region compared to the same region in the wild type nerve. There was also a 
significant increase in ADC// in the #72 retinal region compared to the #72 chiasmal region. In 
contrast, in the wild type nerve, ADC// was very slightly, but significantly, higher in the chiasmal 
region compared to the retinal region. Wild type: N=12, #72: N=24; WT RR: wild type retinal 
region. WT CR: wild type chiasmal region. Homo RR: #72 retinal region. Homo CR: #72 chiasmal 
region. Stars indicate p values: *p < 0.05; ****p < 0.0001.   232 
In summary, ADC┴ was significantly increased in the #72 optic nerves compared 
to  the  wild  type.  This  contributed  to  the  decreased  FA  values  and  to  the 
increased mean diffusion. A significant increase in ADCII in the #72 retinal region 
was also present when compared to the wild type and the #72 chiasmal region. 
Results are summarised in Table 5 and Table 6. 
 
5.4.3 Analysis of the data using multiple increasing b-values 
 
5.4.3.1 A  biexponential  signal  decay  became  apparent  in  the  optic  nerve 
when applying multiple increasing b-values  
 
I  hypothesised  that  the  application  of  multiple  increasing  b-values  would 
increase  the  sensitivity  of  DWI  to  detect  differences  between  white  matter 
lesions. Therefore, in the following sections, the entire data set generated using 
16 b-values was analysed. Signal decay curves were created, by plotting signal 
intensity as a function of b-value, for both parallel and perpendicular diffusion 
gradient  directions.  Signal  decay  deviated  from  mono-exponential  behaviour 
(Figure 66) in both wild type and #72 nerves. 233 
 
Figure 66.  Biexponential  signal  decay  became  apparent  with  increasing 
b-values.  
Signal decay curves obtained from a scanned optic nerve and from H2O, in the parallel (II, red 
line) and perpendicular (┴, green and blue lines) directions (in relation to optic nerve fibers). 
The  signal  changes  were  plotted  on  a  natural  logarithmic  scale  in  relation  to  the  b-value. 
Biexponential signal decay was present in optic nerves suggesting the presence of two different 
diffusion components; a fast and a slow. In the parallel diffusion direction (red line), the slow 
diffusion component only became visible at higher b-values, suggesting that this information was 
lost when using b-values only up to 1500 s/mm
2. Water, in which diffusion was unrestricted, 
showed  a  monoexponential  characteristic  and  served  as  a  negative  control.  The  noise  level 
(arrow)  did  not  interfere  with  the  parallel  and  perpendicular  DWI  measurement  in  the  optic 
nerve.  234 
5.4.3.2 Fast and slow diffusion were altered in #72 nerves compared to wild 
type  
 
Curve  fitting  using  Equation  11  was  applied  in  order  to  obtain  information 
regarding fast and slow diffusion components of CNS water.  
 
The perpendicular and parallel diffusion within the fast and slow components 
were calculated using Equation 12 and the results are summarised in Table 7, 
Table 8, Table 9, Table 10, Table 11 and Table 12. Although perpendicular fast 
diffusion (D1┴) was similar in wild type and #72 nerves, there was a significant 
increase in the slow diffusion (D2┴) in both retinal and chiasmal regions of the 
#72 optic nerves compared to the corresponding regions in the wild type (Figure 
67).  
 
Small, but significant differences between samples were found in fast parallel 
diffusion  (D1//).  D1//  was  slightly,  but  significantly  increased  in  retinal  and 
reduced in chiasmal regions of the #72 nerves compared to the wild type nerves. 
D1// was significantly higher in the retinal region of the #72 nerve than in the 
chiasmal region. More marked differences were found in slow parallel diffusion 
(D2//). D2II was significantly increased in both retinal and chiasmal regions of the 
#72  nerves  compared  to  that  in  the  corresponding  regions  of  the  wild  type 
nerves and was also markedly higher in the retinal region of the #72 nerve than 
in the chiasmal region (Figure 68). 235 
 
 
 
 
Figure 67.  Perpendicular  slow  diffusion  was  increased  in  #72  nerves 
compared to wild type.  
Graph displaying the means (+s.e.m) of the fast (D1┴) and slow (D2┴) perpendicular diffusion in 
wild type and #72 optic nerves. D2┴ was significantly increased in both regions of the #72 nerves 
compared to the corresponding regions in wild type nerves. WT RR: wild type retinal region. 
Wild type: N=12, #72: N=24; WT CR: wild type chiasmal region. Homo RR: #72 retinal region. 
Homo CR: #72 chiasmal region. Stars indicate p values: **p < 0.01; ****p < 0.0001. 236 
 
 
 
Figure 68.  Parallel slow diffusion was increased in the #72 nerve compared 
to wild type.  
Graph displaying the means (+s.e.m) of the fast (D1II) and slow (D2II) perpendicular diffusion in 
wild type and #72 optic  nerves. Small,  but significant,  changes in D1II were detected in #72 
nerves  compared  to  wild  type.  More  pronounced  changes  were  observed  in  D2II,  which  was 
markedly and significantly increased in #72 nerves compared to wild type, particularly in the 
retinal region of the nerve, where it was almost 3 times the corresponding wild type value. WT 
RR: wild type retinal region. Wild type: N=12, #72: N=24; WT CR: wild type chiasmal region. 
Homo RR: #72 retinal region. Homo CR: #72 chiasmal region. Stars indicate p values: *p < 0.05; 
**p < 0.01. ***p < 0.001; ****p < 0.0001. 237 
5.4.3.3 The contribution of the fast diffusion component to the total diffusion 
was increased in #72 optic nerves 
 
With  alteration  in  white  matter,  changes  in  diffusivity  might  not  just  be 
restricted to changes within the two components of fast and slow diffusion, but 
the  relative  contribution  of  the  fast  (α)  and  slow  (β)  components  could  also 
change. Particularly where the measured diffusivity itself remained unchanged, 
pathological changes could potentially still be detected by determining changes 
in the contribution of the slow and fast diffusion components, independent from 
the diffusion rate.  
 
The  contribution  of  the  fast  diffusion  to  total  diffusion  was  significantly 
increased  in  retinal  and  chiasmal  portions  of  the  #72  mouse  optic  nerve 
compared  to  the  wild  type  mouse  optic  nerve  in  both  the  parallel  and 
perpendicular orientation (Figure 69). Conversely, the opposite, was true for the 
slow diffusion contribution. Results are summarised in Table 7 and Table 8.  
 
Within the #72 nerve, the contribution of the parallel fast diffusion to the total 
diffusion  was  significantly  greater  in  the  retinal  region  than  in  the  chiasmal 
region.  Since (α + β = 100%), the contribution of slow diffusion,  reflects the 
opposite changes.  
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Figure 69.  The contribution of fast diffusion (α) was increased in the #72 
optic nerve.  
Graphs representing mean (+ s.e.m) percentage contribution of fast or slow diffusion to total 
diffusion.  A  significant  increase  in  the  contribution  of  the  perpendicular  and  parallel  fast 
diffusion component (α) was present in the #72 nerve compared to the wild type nerve. Within 
the  #72  nerve,  α  was  significantly  elevated  in  the  retinal  region  compared  to  the  chiasmal 
region,  in  the  parallel  direction.  The  contribution  of  the  slow  diffusion  component  (β) 
consequently demonstrated the same, but inverted changes. Wild type: N=12, #72: N=24; WT RR: 
wild type retinal region. WT CR: wild type chiasmal region. Homo RR: #72 retinal region. Homo 
CR: #72 chiasmal region. Stars indicate p values: **p < 0.01. ***p < 0.001; ****p < 0.0001. 239 
5.4.4 Histological examination of optic nerves confirmed the spatially 
distinct regions of silent demyelination and active inflammatory 
demyelination in the scanned regions of 72 mouse optic nerves 
 
5.4.4.1 Virtually complete demyelination was present in the #72 optic nerve 
 
Electron microscopic evaluation showed a virtually complete demyelination in 
the tissue immediately adjacent to the two scan regions, the retinal and the 
chiasmal portion of the #72 optic nerve. The demyelination appeared similar in 
both regions, which was in agreement with previously published results (Edgar et 
al., 2010). The wild type optic nerve appeared highly myelinated as expected at 
P120 (Figure 70). 
 
5.4.4.2 Marked increase in cell density in the chiasmal part of the #72 mouse 
optic nerve 
 
Quantification of DAPI stained nuclei showed a significant increase in total cell 
density in the chiasmal portion of the #72 optic nerve, compared to both the 
corresponding region of the wild type nerve and to the retinal region of the #72 
nerve (Figure 71). 
 
5.4.4.3 Inflammatory  cells  contributed  to  the  increased  cell  density  in  the 
#72 mouse optic nerve chiasmal region 
 
Immunohistochemical  staining  with  an  antibody  to  CD45,  a  pan-leukocyte 
marker,  revealed  a  marked  increase  in  numbers  of  CD45  +ve  cells  in  the 
chiasmal  region  of  the  #72  nerve.  Quantification  of  CD45  +ve  cell  density 
confirmed that the chiasmal region of the #72 nerve contained significantly more 
cells than the same region of the wild type nerve. In contrast, CD45 +ve cell 
density  in  the  retinal  region  of  the  #72  nerve  was  slightly,  but  significantly, 
reduced compared to wild type (Figure 72). 
 240 
5.4.4.4 An astrocytic response was pronounced in the #72 mouse optic nerve  
 
To examine the status of astrocytes, optic nerve sections were stained with an 
antibody to GFAP. In both regions of the #72 mouse optic nerve there was a 
significant  increase  in  the  area  occupied  by  GFAP  +ve  astrocytic  processes 
compared  to  the  same  regions  of  the  wild  type  nerve.    The  extent  of  GFAP 
immunoreactivity was similar in retinal and chiasmal regions of the #72 nerve. 
(Figure 73). 
 
5.4.4.5 Oligodendrocyte  densities  were  mildly  reduced  in  the  #72  mouse 
optic nerve 
 
An antibody to APC (clone CC1) was used to identify mature oligodendrocytes. 
Oligodendroglial  density  was  significantly  reduced  in  the  #72  optic  nerve, 
compared  to  the  wild  type  nerve.  The  #72  retinal  section  demonstrated  the 
lowest oligodendrocyte cell density (Figure 74). However, despite that fact that 
the #72 nerve was virtually completely demyelinated a remarkable number of 
mature oligodendrocytes were still present.  
 
5.4.4.6 Oligodendrocyte precursor cells were present in the #72 mouse optic 
nerve 
 
To  examine  OPCs,  an  antibody  to  NG2  was  used.  Although  completely 
demyelinated the #72 optic nerve contained NG2 positive cells, the density of 
which was significantly increased in the chiasmal region of the #72 optic nerve, 
compared to the same region in the wild type nerve (Figure 75). Since NG2 is not 
completely  OPC  specific  and  may  bind  to  a  subset  of  microglial  cells,  the 
increase in NG2 cell density may not only represent an increase in OPCs. 
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Figure 70.  The #72 mouse optic nerve was almost completely demyelinated 
at P120.  
Electron micrographs of wild type (A, B) and #72 (C, D) retinal and chiasmal optic nerve regions. 
The wild type optic nerve was highly myelinated in both sections (A, B). This was in contrast to 
the #72 optic nerve, where there was a complete absence of myelin  in both regions (C, D, 
x6700, scale bar 2µm). Artefacts, such as mitochondrial swellings (asterisk), were probably due 
to suboptimal fixation for EM processing. Graph of mean axonal density (+s.e.m) showed that 
axonal density was significantly decreased in the retinal region of the #72 optic nerves compared 
to same region in the wild type (E). No such difference was found between #72 and wild type 
nerves in the chiasmal region. Wild type: N=3, #72: N=5; WT RR: wild type retinal region. WT CR: 
wild type chiasmal region. Homo RR: #72 retinal region. Homo CR: #72 chiasmal region. Stars 
indicate p values: **p < 0.01.   242 
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Figure 71.  Cell density was markedly increased in the #72 chiasmal section 
of optic nerve.  
Micrographs of DAPI-stained 10µm-thick transverse sections of retinal and chiasmal regions of 
P120 #72 and wild type mouse optic nerves (A – D, x400, scale bar 50µm).  A marked increase in 
cellular  density was seen in the #72 chiasmal region of optic nerve  (D). Graph of mean cell 
density (+ s.e.m.) in retinal and chiasmal regions of wild type and #72 optic nerve (E). The cell 
density was significantly increased in the #72 chiasmal region compared to the corresponding 
region in the wild type and also compared to the retinal region of the #72 nerve. Conversely, cell 
density  was  very  slightly,  but  significantly,  reduced  in  the  retinal  region  of  the  #72  nerve 
compared to the same region in the wild type nerve. Wild type: N=6, #72: N=12; WT RR: wild 
type retinal region. WT CR: wild type chiasmal region. Homo RR: #72 retinal region. Homo CR: 
#72 chiasmal region. Stars indicate p values: *p < 0.05; ****p < 0.0001.   243 
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Figure 72.  The density of CD45 +ve microglia/macrophages was increased in 
the chiasmal portion of the #72 mouse optic nerve.  
Micrographs of CD45-stained 10µm-thick transverse sections of retinal and chiasmal regions of 
P120 #72 and wild type mouse optic nerves (A - D, x400, scale bar 50µm).  Lipofuscin granules 
were prominent in the #72 mouse nerve and were seen as fluorescent granules in C (arrows). The 
processes of the CD45+ cells in the #72 chiasmal region (H) appeared thickened compared to 
those  in  the  wild  type  (E,  F)  and  the  #72  retinal  region  (G),  suggesting  that  the  cells  were 
‘activated’.  Graph showing the mean (+s.e.m.) CD45 +ve cell density in retinal and chiasmal 
regions of wild type and #72 nerves (I). The density of CD45 +ve cells was significantly increased 
in the #72 nerve compared to the wild type, most markedly so in the chiasmal region, in which 
there was an approximately 10 fold increase in cell density compared to the control. WT RR: wild 
type retinal region. Wild type: N=6, #72: N=12; WT CR: wild type chiasmal region. Homo RR: #72 
retinal region. Homo CR: #72 chiasmal region. Stars indicate p values: ****p < 0.0001.   244 
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Figure 73.  The  #72  mouse  optic  nerve  was  characterised  by  a  marked 
astrocytosis. 
Micrographs of GFAP-stained 10µm-thick transverse sections of retinal and chiasmal regions of 
P120 wild type and #72 mouse optic nerves (A – D, x400, scale bar: 50µm). Astrocytes appeared 
more numerous and processes appeared enlarged in the #72 (G, H) compared to the wild type 
optic nerve (E, F). Graph showing the mean area (+s.e.m.) occupied by GFAP immunoreactivity 
in retinal and chiasmal regions of wild type and #72 optic nerves (I).  The area occupied by GFAP 
immunoreactivity was significantly increased in both regions of the #72 optic nerve compared to 
the same regions in the wild type nerve. There was no significant difference between the two 
regions  of  the  #72  mouse  optic  nerve.  Wild  type:  N=6,  #72:  N=12;  WT  RR:  wild  type  retinal 
region. WT CR: wild type chiasmal region. Homo RR: #72 retinal region. Homo CR: #72 chiasmal 
region. Stars indicate p values: ****p < 0.0001.   245 
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Figure 74.  Mature oligodendrocyte cell density was reduced in #72 mouse 
optic nerve.  
Micrographs  of  APC-stained  10µm-thick  transverse  sections  of  retinal  and  chiasmal  regions  of 
P120 wild type and #72 mouse optic nerves (A - H, x400, scale bar 50µm). (I) Graph showing the 
mean density (+s.e.m.) of APC +ve cells in retinal and chiasmal regions of wild type and #72 
optic  nerves.    Oligodendrocyte  cell  density  was  significantly  reduced  in  the  #72  optic  nerve 
compared to the wild type optic nerve, most markedly in the retinal region. Wild type: N=6, #72: 
N=12; WT RR: wild type retinal region. WT CR: wild type chiasmal region. Homo RR: #72 retinal 
region. Homo CR: #72 chiasmal region. Stars indicate p values: *p < 0.05; **p < 0.01; ****p < 
0.0001. 
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Figure 75.  Oligodendrocyte  precursor  cell  density  was  elevated  in  the 
inflamed demyelinated chiasmal region of #72 optic nerve. 
Micrographs of retinal and chiasmal regions of P120 wild type and #72 mouse optic nerves (A – D, 
x400,  scale  bar  50µm)  using  NG2  as  a  marker  for  OPCs.  The  morphology  of  the  NG2+  cells 
appeared similar in both wild type regions (E, F) and in the #72 retinal region (G), whereas cell 
processes appeared more prominent in the inflamed and demyelinated #72 chiasmal region (H). 
Graph showing the mean density (+s.e.m.) of NG2 +ve cells in retinal and chiasmal regions of 
wild type and #72 optic nerves (I). The NG2+ cell density was significantly increased in the #72 
chiasmal region of the optic nerve compared to the corresponding region of the wild type nerve 
and to the retinal regions of the #72 nerve. Wild type: N=6, #72: N=12; WT RR: wild type retinal 
region. WT CR: wild type chiasmal region. Homo RR: #72 retinal region. Homo CR: #72 chiasmal 
region. Stars indicate p values: ***p < 0.001. 247 
In quantifying axonal and cellular densities, I confirmed and extended previous 
work (Edgar et al., 2010) which showed that at P120, the optic nerve of the #72 
mouse comprises a rostral, completely demyelinated, non-inflamed region and a 
caudal, demyelinating, inflamed region. Tables summarising the DWI data in 
relation to the histological findings are presented in Table 1, Table 2, Table 3, 
Table 4 and Table 5.  
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  Myelin 
Inflam-
mation 
ADCII 
x10
-6mm
2/s 
ΔADCII 
(%) 
ADC┴ 
x10
-6mm
2/s 
ΔADC┴ 
(%) 
MD 
x10
-6mm
2/s 
FA 
ΔFA 
(%) 
WT 
RR 
Yes  No 
611.56 
(±28.43) 
+60.9 
110.08 
(±10.31) 
+120.6 
278.4 
(±41.22) 
0.79 
(±0.02) 
-10 
#72 
RR 
No  No 
984.12 
(±20.14) 
244.42 
(±16.53) 
496.3 
(±42.98) 
0.71 
(±0.02) 
WT 
CR 
Yes  No 
662.01 
(±32.22) 
+12.3 
106.23 
(±12.06) 
+115 
290.1 
(±45.94) 
0.82 
(±0.02) 
-24 
#72 
CR 
No  Yes 
743.58 
(±29.19) 
228.35 
(±9.46) 
401.8 
(±30.56) 
0.62 
(±0.02) 
 
Table 5.  Summary of diffusion parameters, calculated from two b-values 
only.  
(94.6 and 1135.3 s/mm
2 in the parallel direction and 68.4 and 1118.4 s/mm
2 in the perpendicular 
direction). ADCII and ADC┴ are mean values of all optic nerves measured in this study. Standard 
error of mean (s.e.m.) is in brackets below the values. Wild type: N=12, #72: N=24. 
 
 
  Myelin 
Inflam-
mation 
ADCII 
x10
-6mm
2/s 
ΔADCII 
(%) 
ADC┴ 
x10
-6mm
2/s 
ΔADC┴ 
(%) 
MD 
x10
-6mm
2/s 
FA 
ΔFA 
(%) 
#72 
RR 
No  No 
984.12 
(±20.14) 
-24.4 
244.42 
(±16.53) 
-6.6 
496.3 
(±42.98) 
0.71 
(±0.02) 
-12.7 
#72 
CR 
No  Yes 
743.58 
(±29.19) 
228.35 
(±9.46) 
401.8 
(±30.56) 
0.62 
(±0.02) 
 
Table 6.  Summary  of  #72  diffusion  parameters  calculated  from  two  b-
values only.  
Standard error of mean (s.e.m.) is in brackets below the mean value. Wild type: N=12, #72: 
N=24. 
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  Myelin 
Inflam-
mation 
D1┴ 
x10
-6mm
2/s 
ΔD1┴  
(%) 
D2┴ 
x10
-6mm
2/s 
ΔD2┴  
(%) 
WT 
ret 
Yes  No 
609.4 
(±55.49) 
+1.5 
32.29 
(±4.16) 
+197.12 
#72 
ret 
No  No 
618.7 
(±59.71) 
95.94 
(±8.85) 
WT 
ch 
Yes  No 
690.8 
(±110.4) 
-13.94 
37.53 
(±4.66) 
+121.53 
#72 
ch 
No  Yes 
594.5 
(±64.71) 
83.14 
(±8.35) 
 
Table 7.  Summary of the mean perpendicular fast (D1 ┴) and slow (D2┴) 
diffusion  values  including  the  percentage  of  diffusion  changes  (ΔD1┴  and 
ΔD2┴) between the wild type and the #72 optic nerves.  
Standard error of mean (s.e.m.) is in brackets below the mean value. Wild type: N=12, #72: 
N=24. 
 
 
  Myelin 
Inflam-
mation 
D1┴ 
x10
-6mm
2/s 
ΔD1┴  
(%) 
D2┴ 
x10
-6mm
2/s 
ΔD2┴  
(%) 
#72 
ret 
No  No 
618.7 
(±59.71) 
-3.9 
95.94 
(±8.85) 
-13.3 
#72 
ch 
No  Yes 
594.5 
(±64.71) 
83.14 
(±8.35) 
 
Table 8.  Summary of the mean perpendicular fast (D1┴) and slow (D2┴) 
diffusion values in #72 optic nerves.  
Standard error of mean (s.e.m.) is in brackets below the mean value. Wild type: N=12, #72: 
N=24. 
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  Myelin 
Inflam-
mation 
D1II 
x10
-6mm
2/s 
ΔD1II 
(%) 
D2II 
x10
-6mm
2/s 
ΔD2II 
(%) 
WT 
ret 
Yes  No 
1082 
(±53.72) 
+12.8 
87.08 
(±10.86) 
+143.8 
#72 
ret 
No  No 
1220 
(±26.63) 
212.3 
(±14.23) 
WT 
ch 
Yes  No 
1169 
(±42.89) 
-9.1 
92.42 
(±8.831) 
+50 
#72 
ch 
No  Yes 
1062 
(±27.93) 
138.6 
(±7.84) 
 
Table 9.  Summary of the mean parallel fast (D1II)  and slow (D2II) diffusion 
values including the percentage of diffusion changes (ΔD1II and ΔD2II) between 
the wild type and the #72 optic nerves. 
Standard error of mean (s.e.m.) is in brackets below the mean value. Wild type: N=12, #72: 
N=24. 
 
 
  Myelin 
Inflam-
mation 
D1II 
x10
-6mm
2/s 
ΔD1II 
(%) 
D2II 
x10
-6mm
2/s 
ΔD2II 
(%) 
#72 
ret 
No  No 
1220 
(±26.63) 
-13 
212.3 
(±14.23) 
-34.7 
#72 
ch 
No  Yes 
1062 
(±27.93) 
138.6 
(±7.84) 
 
Table 10.  Summary  of  the  mean  perpendicular  fast  (D1II)  and  slow  (D2II) 
diffusion values in #72 optic nerves.  
Standard error of mean (s.e.m.) is in brackets below the mean value. Wild type: N=12, #72: 
N=24. 
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  Myelin 
Inflam-
mation 
α┴ 
(%) 
β┴ 
(%) 
Δ┴ 
(%) 
αII 
(%) 
βII 
(%) 
ΔII 
(%) 
WT 
RR 
Yes  No 
25 
(±3) 
75 
(±3) 
±16 
68 
(±2) 
32 
(±2) 
±19 
#72 
RR 
No  No 
41 
(±3) 
59 
(±3) 
87 
(±1) 
13 
(±1) 
WT 
CR 
Yes  No 
19 
(±2) 
81 
(±2) 
±24 
69 
(±2) 
31 
(±2) 
±9 
#72 
CR 
No  Yes 
43 
(±3) 
57 
(±3) 
78 
(±2) 
22 
(±2) 
 
Table 11.  Summary of the contribution of fast and slow diffusion (in %) in 
the perpendicular and parallel direction.  
Standard error of mean (s.e.m.) is in brackets below the value. In the perpendicular direction 
the slow diffusion (β┴) is the main type of diffusion. This is in contrast to the parallel direction, 
where the fast diffusion (αII) is the prominent type of diffusion. Wild type: N=12, #72: N=24. 
 
 
  Myelin 
Inflam-
mation 
α┴ 
(%) 
β┴ 
(%) 
Δ┴ 
(%) 
αII 
(%) 
βII 
(%) 
ΔII 
(%) 
#72 
RR 
No  No 
41 
(±3) 
59 
(±3) 
±3.9 
87 
(±1) 
13 
(±1) 
±30.8 
#72 
CR 
No  Yes 
43 
(±3) 
57 
(±3) 
78 
(±2) 
22 
(±2) 
 
Table 12.  Summary of the contribution of fast and slow diffusion (in %) in 
the #72 optic nerves.  
Standard error of mean (s.e.m.) is in brackets below the value. Wild type: N=12, #72: N=24. 
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5.5  Discussion 
 
In this study I took advantage of the simple anatomy and stereotypic pattern of 
demyelination  and  inflammation  in  the  #72  mouse  optic  nerve  to  assess  the 
sensitivity of high resolution DW MRI and DW MRI with increasing b-values, to 
distinguish complete demyelination from inflammatory demyelination. 
 
The purpose built coil and sampling container proved useful for the application 
of DW MRI to fixed and excised mouse optic nerves. Preliminary studies were 
undertaken to show that nerves could be accurately positioned within the coil 
and that results of multiple scans of wild type nerves showed that the technique 
provided  highly  reproducible  data.  Despite  the  fact  that  such high  resolution 
scanning  is  currently  not  feasible  in  vivo,  the  data  demonstrate  proof-of-
principle of the potential of high resolution DW MRI with multiple increasing b-
values to distinguish between different types of white matter lesions.  
  
I showed that both conventional DW MRI and DW MRI with increasing b-values 
detected differences in diffusion parameters in the #72 nerves compared to wild 
type  as  well  as  between  rostral  and  caudal  regions  of  the  #72  nerves. 
Histological  analyses  confirmed  that  the  #72  nerve  comprised  a  rostral, 
completely  demyelinated  region  and  a  caudal,  inflammatory  demyelinating 
region. The demyelinated nerve was also characterised by a marked astrocytosis 
and contained both mature oligodendrocytes and NG2 +ve cells. Assessment of 
axonal integrity proved difficult due to tissue fixation being suboptimal for EM 
evaluation. The use of multiple increasing b-values proved to be more sensitive 
than  conventional  two  b-value  DW  MRI  in  detecting  the  diffusion  changes 
between  inflammatory  and  non-inflammatory  demyelination.  In  the  standard 
approach  the  diffusion  changes  between  the  non-inflammatory  and  the 
inflammatory  demyelinated  region  in  percentages  were  -24.4  %  in  the  ADCII 
direction  and  -6.6  %  in  the  ADC┴  compared  to  the  slow  diffusion  changes 
measured with multiple  b-values where the changes were  -34.7 % in the D2II 
direction and -13.3 % in the D2┴ direction (Table 6 versus Table 8 and Table 10). 
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5.5.1 Distinct  changes  in  parallel  and  perpendicular  fast  and  slow 
diffusion become apparent 
 
Using DW MRI with increasing b-values, similar changes as in standard DW MRI of 
the #72 nerve compared to wild type nerve and also between the two regions of 
the  #72  nerve  were  found.  These  changes  were  most  marked  in  the  slow 
diffusion component (D2II and D2┴). Only very minor changes were evident in the 
fast parallel diffusion component (D1II) and no changes were observed in fast 
perpendicular  diffusion  component  (D1┴).  Thus  the  slow  diffusion  component 
appeared more sensitive to the histological changes in optic nerves. Changes in 
the slow diffusion component were more pronounced compared with changes 
observed using only two b-values but did not reveal more specific information in 
regard of diffusivity changes related to histological background.  
 
5.5.2 The  basis  of  anisotropic  diffusion  and  the  relation  of  diffusion 
changes to white matter disease 
 
The  strictly  organised  arrangement  of  axons  is  believed  to  be  the  main 
contributor  to  the  anisotropic  diffusion  of  water  molecules  in  white  matter 
(reviewed in Beaulieu, 2002;Beaulieu, 2009) The organised fibre tract structure 
forms the basis for the ability of diffusion tensor imaging to detect and trace 
nerve fibre bundles (Moseley et al., 1990a).  However, studies correlating DTI 
parameters with histological measures have further demonstrated its value as a 
tool  for  assessing  white  matter  integrity    (Budde  et  al.,  2008;Harsan  et  al., 
2006;Harsan et al., 2008;Song et al., 2002;Song et al., 2005).  Indeed, a number 
of studies, particularly from the Song laboratory at Washington University St. 
Louis, Missouri USA, have provided evidence that pathological changes in specific 
white  matter  elements  can  be  deduced  from  calculation  of  the  diffusion 
coefficient perpendicular and parallel to the nerve fibre bundles.   
 
For  example,  it  has  been  shown  that  dys-  or  demyelination  increases  the 
perpendicular  diffusion  coefficient and  reduces  fractional  anisotropy  (Song  et 
al., 2002;Song et al., 2005).  Remyelination reverses the changes, emphasising 
the influence of the myelin sheath on perpendicular diffusivity (Harsan et al., 254 
2006). Axonal pathology on the other hand has been shown in several studies, to 
correlate with reduced parallel diffusion and also leads to decreased FA and MD 
values (Budde et al., 2008;Budde et al., 2009;DeBoy et al., 2007;Feng et al., 
2009;Kim et al., 2006).  
 
However most of the correlative DTI studies have only examined the status of 
myelin and axons and failed to take account of other white matter elements. 
Therefore the possibility that changes in the density and morphology of other 
cell types could influence the DTI measures has largely been neglected. Recent 
studies have shown an increased parallel diffusion in the presence of mild axonal 
pathology after demyelination (Harsan et al., 2007;Ruest et al., 2011) and yet 
others have shown a temporal reduction of parallel and perpendicular diffusion 
in the presence of mild axonal pathology, with a return to initial values despite 
more severe axonal damage after demyelination (Xie et al., 2010).  
 
While the increase in perpendicular (radial) diffusion is generally accepted to be 
related to demyelination and may be altered by cell density (Xie et al., 2010), 
the increase in parallel (axial) diffusion in the presence of mild axonal injury 
(Harsan et al., 2007;Ruest et al., 2011) is more difficult to explain. One study 
(Harsan  et  al.,  2007)  suggested  that  the  increase  in  astrocytes,  which  was 
present in the jimpy mouse model of PMD, correlated with increased parallel 
diffusion,  whereas  a  different  study  (Ruest  et  al.,  2011)  suggested  that  a 
combination of increased axonal density and astrocytosis could contribute.  
 
Nevertheless,  all  of  the  three  more  comprehensive  studies  (Harsan  et  al., 
2007;Ruest  et  al.,  2011;Xie  et  al.,  2010)  show  that,  especially  for  parallel 
diffusivity,  there  is  at  the  moment  no  clear  explanation  for  the  observed 
diffusion  changes.  Tissue  and  cellular  changes  besides  demyelination  and 
axonopathy are most likely responsible for the variation in results reported in 
the literature. 
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5.5.3 Changes in “conventional” DW MRI parameters distinguish lesion 
types in the optic nerve  
 
5.5.3.1 Fractional anisotropy and mean diffusion changes in #72 optic nerve 
 
I found that fractional anisotropy, which is a measure of diffusion directionality, 
was reduced in the #72 optic nerve compared to the wild type. This has also 
been  shown  in  other  studies  (Harsan  et  al.,  2006;Ono  et  al.,  1995)  where  a 
significant  reduction  of  FA  values  has  been  found  following  demyelination 
(Harsan et al., 2006;Ono et al., 1995; reviewed in Beaulieu, 2009). 
 
FA provides a measure of the relationship between parallel and perpendicular 
diffusion, such that it is highest (closest to one) when diffusion in one particular 
direction is markedly greater than in another and lowest (closest to zero) when 
diffusion  in  all  directions  is  of  similar  magnitude  (Equation  8).  Generally,  a 
reduction in FA in white matter is associated with either a reduction in diffusion 
in the parallel direction or an increase in diffusion in the perpendicular direction 
(reviewed in Beaulieu, 2002;Beaulieu, 2009).  
 
In contrast, in the current study, a reduction FA was associated with increases in 
both parallel and perpendicular diffusion. This can be explained by the fact that 
the  increase  in  the  perpendicular  diffusion  in  the  #72  mouse  nerves  was 
relatively greater than the increase in the parallel direction (Table 5). 
 
With  respect  to  whether  DWI  could  distinguish  complete  demyelination  from 
inflammatory demyelination, FA was also significantly reduced in the inflamed 
region of the #72 nerve compared to the non-inflamed region (see Table 6).  
Examination of perpendicular and parallel diffusions (of which FA is a function) 
showed that this was due to a disproportionately high parallel diffusion in the 
non-inflamed nerve (Table 5). This was somewhat surprising because increased 
parallel  diffusion  is  not  commonly  observed  in  relation  to  demyelination, 
although it has been recently described (Harsan et al., 2007;Ruest et al., 2011). 
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A significant increase in mean diffusivity (MD) in the #72 optic nerve was most 
pronounced in the retinal region.  This reflects the observed increase in both 
parallel and perpendicular diffusion in the #72 optic nerve. Again, loss of myelin 
causes an increase in MD (reviewed in Beaulieu, 2009)  
 
5.5.3.2 Perpendicular  diffusion  changes  were  associated  with  the  loss  of 
myelin integrity 
 
Although  significantly  different  to  the  wild  type,  there  were  no  significant 
changes  in  the  perpendicular  diffusion  between  the  retinal  and  the  chiasmal 
region of the #72 optic nerve. This implies that the differences (compared to 
wild type) are probably mainly caused by demyelination, the extent of which 
was similar in both regions. This is in agreement with other studies (Harsan et 
al., 2006;Harsan et al., 2008;Klawiter et al., 2011;Nair et al., 2005;Ruest et al., 
2011;Song  et  al.,  2002;Song  et  al.,  2005;Xie  et  al.,  2010).  Surprisingly,  the 
inflammation in the chiasmal section of #72 optic nerves did not seem to alter 
perpendicular  diffusion.  This  was  somewhat  unexpected,  since  increased  cell 
density  has  been  suggested  to  decrease  perpendicular  diffusion  (Xie  et  al., 
2010).  
 
Diffusion  in  tissue,  which  is  a  combination  of  intracellular  as  well  as 
extracellular  diffusion,  is  considered  to  be  mainly  restricted  by  the  cell 
membrane  (Beaulieu,  2009).  Since axons, which  are  believed to  be  the  main 
structure influencing diffusion, are densely packed (in the current study at least 
500,000  axons  mm
-2),  the  perpendicular  diffusing  water  molecule  will  be 
confronted with a minimum of one cell membrane within the average distance of 
an axonal diameter, which in the optic nerve is around 1µm (Edgar et al., 2010). 
A decrease in axonal density, which may be caused by enlargement of the extra-
axonal space, could also lead to facilitated extra-axonal perpendicular diffusion. 
There was a reduced axonal density in the #72 optic nerve when compared to 
the wild type retinal region which may explain the prominent increase.  
 
So  why  should  an  increase  in  cell  density  not  affect  perpendicular  diffusion? 
Given the size of microglia, which in the non-activated state is approximately 10 257 
- 20µm and considerably larger after activation, the cell is 10 – 20 times larger 
than the average axonal cross-section. If the assumption is correct that the cell 
membrane is the main barrier to diffusion (Beaulieu, 2009) the distance between 
two cell membranes of a microglial cell would be 10 – 20µm. This is in contrast 
to the axons, where on average every 1µm at least one cell membrane occurs. 
Additional cell membranes from inflammatory cells would only add one more 
obstacle  every  tenth  to  twentieth  axon  and  only  minimally  influence 
perpendicular  diffusion.  Therefore,  the  perpendicular  diffusion  is  most  likely 
governed by the density of axonal membrane and, since most of the axons are 
myelinated in the optic nerve (Edgar et al., 2010), modified by myelin sheath. 
 
In contrast to the finding of the current study, (Xie et al., 2010) suggested that 
inflammation  reduces  perpendicular  diffusion.  However,  in  their  model  (in 
contrast to the model used in my study) the corpus callosum was not completely 
demyelinated  at  the  time  point  where  elevated  microglial  cell  density  was 
observed  by  (Xie  et  al,  2010).  The  remaining  intact  myelin  sheaths  could 
potentially  still  influence  the  diffusion.  Therefore  it  is  questionable  if  the 
reduced  perpendicular  diffusion  observed  by  (Xie  et  al.,  2010)  is  due  to 
increased  cell  density  or  if  the  remaining  intact  myelin  sheaths  are  still 
numerous enough to prevent perpendicular diffusion to increase. 
 
5.5.3.3 Diffusion parallel to optic nerve fibres is altered in association with 
loss of myelin integrity and changes in cell density 
 
The  marked  increase  in  parallel  diffusivity,  especially  in  the  non-inflamed 
demyelinated  retinal region  was  unexpected.  Only  a  small  number  of  studies 
have recently demonstrated increased parallel diffusion in models of dys- and 
demyelinated tissue, with relatively mild axonal changes and increased axonal 
density (Ruest et al., 2011;Harsan et al., 2007). 
 
In the parallel diffusion direction, water molecules diffuse in and along axons, 
where  virtually  no  membranes  other  than  myelin  restrict  diffusion.  With 
demyelination, a component of the extra-axonal diffusion barrier will disappear 
and could facilitate the extra-axonal diffusion alongside axons, resulting in an 258 
increase in bulk parallel diffusion as was observed when comparing the #72 with 
the wild type nerve. However, in the presence of inflammation, multiple cell 
membranes  could  potentially  restrict  the  previously  relatively  unrestricted 
extra-axonal parallel diffusion and reduce the bulk parallel diffusivity, leading to 
the  differences  in  parallel  diffusion  observed  in  the  #72  chiasmal  region 
compared to the #72 retinal region.  
 
From an intraaxonal point of view, changes in extra-axonal structures will most 
likely have little if any impact on intraaxonal diffusion. However, studies have 
shown that with axonal swellings or transection of axons, parallel diffusion is 
reduced  (Budde  et  al.,  2008;Budde  et  al.,  2009).  The  presence  of  axonal 
swellings in the chiasmal region of the #72 optic nerve has been described in the 
previous  study  by  (Edgar  et  al.,  2010).  Despite  the  relatively  low  number  of 
axonal swellings, the difference between the retinal and the chiasmal #72 optic 
nerve may reflect this. 
  
Since  the  ultrastructural  evaluation  of  the  #72  optic  nerve  showed  a  similar 
degree  of  demyelination  in  both  regions  accompanied  by  only  mild  axonal 
changes  (Edgar  et  al.,  2010)  and  unaltered  axonal  numbers,  other 
histopathological  changes  besides  demyelination  and  axonal  pathology  may 
influence additionally parallel diffusion (diffusion #72 retinal region > chiasmal 
region, Table 5). Along the entire optic nerve there is a marked astrogliosis. 
Astrocytes  have  been  proposed  to  alter  diffusion  values  in  both  parallel  and 
perpendicular direction (Harsan et al., 2007). Two proposal have been made: 
that  hypertrophic  astrocytic  processes  align  along  axons  and  facilitate 
intracellular  diffusion  parallel  to  the  axons  (Skoff,  1976)  and  an  increase  in 
aquaporin  4,  a  transmembranous  water  channel  expressed  on  astrocytes, 
facilitate  fast  transmembranous  water  transport  (reviewed  in  Nicchia  et  al., 
2004;Harsan et al., 2007). Whereas the astrocytosis in the #72 mouse nerve may 
explain an increase in parallel and also in the perpendicular diffusivity compared 
to the wild type, the parallel diffusion differences within the #72 optic nerve 
appears not to be influenced by the astroglial population, since the astrogliosis 
is similar in the retinal region compared to the chiasmal region. 
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Finally  the  study  by  (Ruest  et  al.,  2011)  also  demonstrated  an  increase  in 
perpendicular  and  parallel  diffusivity  in  #72  corpus  callosum  at  P120.  These 
results are in agreement to the findings of the current study. Additionally when 
comparing the histological data from (Ruest et al., 2011) to Chapter 3 and the 
chiasmal  region  of  #72  optic  nerve,  all  three  regions  appears  histologically 
similar.  
 
5.5.4 Multiexponential  signal  decay  becomes  apparent  after  applying 
multiple increasing high b-values to the DWI 
 
The DTI sequences normally uses two b-values, b ~ 0 and b ~ 1000 s/mm
2. By 
applying multiple increasing b-values to the sequence, the signal decay versus b-
value  becomes  multiexponential.  It  is  believed  that  different  types  of  water 
diffusion  within  the  tissue  are  responsible  for  the  generation  of  the 
multiexponential signal decay (reviewed in Beaulieu, 2002). The distinct types of 
diffusion  detected  using  multiple  increasing  high  b-values  are  believed  to  be 
influenced by various micro anatomical structures such as microtubules,  cells 
nuclei,  cell  membranes  and  myelin  sheaths  (reviewed  in  Beaulieu,  2002). 
Therefore,  potentially  novel  information  about  tissue  architecture,  which  is 
excluded in scans only using b - value up to 1500 s/mm
2, may come to light.  
 
In  the current  study,  where  I  extended  the  diffusion experiment  by  applying 
multiple  increasing  b-values,  particular  diffusion  aberrations  were  detected 
when compared to standard monoexponential analysis.  By applying multiple b-
values ranging from 68.4 to 6304.6 s/mm
2 to the parallel and perpendicular DWI 
sequence  in  relation  to  the  optic  nerve  fibres,  a  non-monoexponential  signal 
decay became apparent.  This finding was consistent with findings in other DWI 
studies of white matter, using a similar range of b-values, in which the signal 
decay curve appears to change around the b-value of 2000 s/mm
2 (Mulkern et 
al., 2000;Ronen et al., 2006). 
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5.5.4.1 Biexponential  analysis  of  the  signal  decay  curve  allowed  the 
distinction of a fast and slow diffusion component 
 
Analysis of the signal decay curve in this study showed that curve fitting was 
accurate  when  using  a  biexponential  fitting  routine.  The  biexponential 
characteristic  of  the  curve  allowed  separation  of  the  data  into  two  distinct 
diffusion components, a fast and a slow diffusion component.  The fast diffusion 
component is assumed to be mainly under axonal influence whereas the slow 
diffusion component is assumed to be influenced by extra-axonal structures such 
as myelin sheaths and glial cells (reviewed in Beaulieu and Allen, 1994;Beaulieu, 
2002). 
 
5.5.4.2 The  slow  diffusion  components  were  sensitive  to  detect 
histopathological changes in demyelinated optic nerve  
 
When  comparing  the  percental  changes  of  ADC┴  and  ADCII  between  the  two 
regions in the #72 optic nerve (Table 2) with the percental changes in the slow 
diffusion compartment in both ┴ and II direction (Table 8 and Table 10), a clear 
augmentation  of  the  diffusion  changes  were  detected.  This  shows  the  clear 
advantage of the high resolution DW MRI with multiple b–values to enhance the 
sensitivity  to  detect  specific  histopathological  changes  such  as  inflammation 
besides demyelination.  
 
5.5.4.3 The fast and slow diffusion components provided information beyond 
diffusion rate 
 
The  distinction  of  two  different  components  also  allowed  the  analysis  of 
diffusion  changes  not  only  by  differences  in  diffusion  but  also  by  changes  in 
diffusion  characteristics.  The  contribution  of  fast  (α)  and  slow  (β)  diffusion 
components to overall diffusion showed that in the perpendicular direction the 
slow diffusion (β┴) and in the parallel direction the fast diffusion (αII) were most 
prominent α┴ and αII were significantly increased in the homozygote optic nerve 
compared to the wild type, suggesting that the contribution of the fast diffusion 261 
is  increased  after  demyelination.  The  increase  in  α  was  more  significantly 
elevated in the non-inflamed retinal region compared to the inflamed chiasmal 
region,  demonstrating  that  inflammatory  cells  could  influence  diffusion 
characteristics. The calculation of α and β provided further information about 
tissue related changes in diffusion characteristics, because D1┴ was similar in 
wild type and #72 optic nerves but still there were significant changes in the 
diffusion  characteristics.  By  calculating  α  and  β  additional  information  about 
diffusion  changes  were  gained,  which  was  especially  of  importance  when 
diffusivity within each component remained unchanged.   
 
The general increase in α in both directions in the #72 mouse nerves may also 
provide an explanation why “standard” DW MRI also detects the changes caused 
by demyelination and inflammation. Standard DW MRI values are a mixture of 
slow and fast diffusion. If changes in contribution of the fast or slow diffusion 
component occur within the range of a b-value of 1500 s/mm
2, the changes will 
also be detected in standard DW MRI as it appeared to be in my study. 
 
I used the Student’s t-test in this experiment, since the plan was not to compare 
all measurements with each other. Therefore, in order not to run inappropriate 
comparisons, I separately compared the results from the two different sections 
within the same optic nerve and the results from the same section between wild 
type  and  #72  optic  nerve  (see  5.3.13  Statistics).  Multiple  comparison  tests, 
however, which are more conservative tests with less probability of making a 
type I error, would have been more appropriate for this experiment. The use of 
one way ANOVA with post-hoc tests (e.g. Bonferroni’s multiple comparison test) 
may  have  been  a  better  choice  to  analyse  this  experiment.  In  my  opinion, 
however, using the one way ANOVA with multiple comparisons would not have 
made any changes in the results and interpretation of this experiment. 
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5.6  Conclusion 
 
I  have  shown  in  this  study  specific  diffusion  parameter  changes  in  both 
“classical”  and  modified  DW  MRI  experiment,  linked  to  demyelination  and 
inflammation in the optic nerve. The potential of DW MRI to distinguish between 
two crucial lesion types in demyelinating disease, namely acute inflammatory 
demyelination and chronic silent demyelination was demonstrated. 
However, the DW MRI parameter differences were relatively small and unless 
specific numerical values can be assigned to specific white matter lesion type, it 
will  remain  difficult  to  distinguish  lesion  types  in  vivo  in  the  absence  of  a 
comparator. 
 
The  biexponential  signal  decay  allowed  me  to  analyse  two  distinct  diffusion 
components,  the  slow  and  the  fast  diffusion  component.  In  this  study  I 
demonstrated that demyelination was associated with an increase in the slow 
diffusion coefficient parallel and perpendicular to the optic nerve fibre tracts.  
Demyelination without inflammation appeared to further increase the parallel 
slow diffusion coefficient suggesting that inflammation had a modulatory effect 
on slow diffusion along the parallel direction. Furthermore the changes in the 
contribution  of  fast  and  slow  diffusion  probably  signify  a  general  effect  on 
diffusion characteristics after demyelination and inflammation. 
 
These  new  findings  are  important  in  context  with  in  vivo  diagnosis  and 
monitoring  of  demyelinating  diseases.  I  have  shown,  that  standard  diffusion 
weighted imaging distinguishes normal and demyelinated white matter lesions 
(confirming the results published by other investigators). I also showed that it is 
possible to distinguish between demyelination accompanied by inflammation and 
chronic  demyelination  when  high  resolution  DWI  is  used.  Using  multiple 
increasing b-values, I showed that diffusion changes could mainly be attributed 
to  the  slow  diffusion  component.  Using  this  method,  the  presumptive  extra-
axonal influence especially on slow parallel diffusion became more apparent, 
demonstrating DWI with multiple b-values is a sensitive molecular probe capable 
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technical issues restricting the DWI MRI with multiple increasing b-values to be 
used in clinical settings. 
 
Considering  the  results  from  the  current  study,  “standard”  DW  MRI  also 
differentiates distinct lesion types, and may be used in clinical settings as an in 
vivo tool to identify white matter lesion type.  
 
The possibility to distinguish these two specific white matter lesion types may be 
of importance for the MS research community and patients suffering from MS in 
giving  the  opportunity  to  diagnose  demyelination  non-invasively  in  vivo,  to 
monitor lesion development more accurately, to asses therapeutic success and 
allow accurate determination of the long term prognosis.   
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6  Final discussion and future experiments 
 
Data  presented  in  this  study  provided  insight  into  the  development  of 
intracranial  demyelination  and  remyelination  failure  in  the  homozygous  Plp1 
gene overexpressing mouse, line #72. The study demonstrated that, following 
initial  myelination,  there  follows  spontaneously,  a  progressive,  non-remitting 
demyelination that eventually leads to a virtually complete absence of myelin 
sheaths.  
 
In vitro and in vivo studies (i.e. what was done in Chapter 3 The development of 
the  phenotype  and  pathology  of  the  homozygote  #72  corpus  callosum  and 
Chapter 4 An evaluation of cell intrinsic and cell extrinsic factors that contribute 
to remyelination failure) were undertaken to evaluate the role of OPC intrinsic 
and OPC extrinsic factors in the pathogenesis.  The data provided evidence that 
remyelination failure may be due to an age related impairment of differentiation 
of OPCs. This, in line with evidence that increasing age plays a major role in 
diminishing the efficacy of the repair process (Shen et al., 2008) suggests that 
final OPC differentiation during the complex remyelination process is probably 
the  most  vulnerable step.  Despite  the  fact  that  exogenous,  neonatal  derived 
neurospheres were able to myelinate axons in the adult #72 mouse brain, factors 
were  present  in  demyelinated  CNS  that  have  previously  been  shown  to  be 
inhibitory  to  remyelination.  Therefore  a  combination  of  OPC  intrinsic  and 
extrinsic factors is most likely leading to remyelination failure in the adult #72.  
 
The  transplantation  of  multipotent  neurospheres  into  neonates  provided 
evidence that early introduction of these cells has the potential to replace the 
endogenous,  genetically  defective  oligodendroglia  during  post  natal 
development,  to  form  normal  myelin  sheath  around  axons  and  to  stably 
integrate into the CNS, possibly indefinitely. These findings would support the 
development of an approved therapeutic strategy to rescue or ameliorate severe 
forms of PMD by neonatal neuronal stem cell application into the CNS.  
 
The  results  presented  also  showed  that  the  #72  mouse  with  its  highly 
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inflamed  demyelinated  region  and  a  non-inflamed  demyelinated  region  is 
valuable as a model to evaluate the potential of novel DW MRI techniques to 
function as a molecular probe, able to distinguish white matter changes. The 
aim of this section is to bring together results from the phenotypic study, the 
evaluation of the OPC intrinsic and extrinsic compartments, the cell transplant 
and the DW MRI study in order to suggest future work and discuss some of the 
points raised in the thesis.  
 
6.1  The #72 mouse as a model for chronic demyelination 
 
Although complete demyelination was present in the #72 mouse at the end stage 
of the disease and coincided with clinical signs, OPCs were still present. The 
lesion development in #72 mice is comparable, in some respects, to the situation 
described in chronic demyelinated MS lesions, where, despite the presence of 
OPCs, remyelination fails (Chang et al., 2002). Nevertheless, although Plp1 is not 
expressed in OPCs they still harbour the genetic defect, which may also have an 
effect on normal OPC function. The failed remyelination is thought to lead to a 
progressive axonal loss, which is considered to be the primary reason underlying 
permanent disability in MS patients (Bjartmar and Trapp, 2003).  
 
There  is  a  growing  interest  in  investigating  OPC  response  in  relation  to  the 
remyelination process, mainly with the aim to find possible ways to enhance the 
myelin repair mechanism and to prevent the development of irreversible axonal 
damage. However, animal models with chronic demyelination are relatively rare. 
Chronic  EAE  models  have  been  described  but  require  manipulation  of  the 
immune  system  to  induce  disease  (Swanborg,  1995).  Also  it  is  difficult  to 
evaluate the direct effect of therapeutic interventions on OPCs in EAE models, 
because  putative  effects  could  be  mediated  through  a  treatment  related 
immuno-modulatory effect and not by direct enhancement of OPC proliferation 
and differentiation.  
 
This point of view was taken into consideration in a recent study by (Huang et 
al.,  2011)  investigating  the  remyelination  enhancing  effect  of  systemically 
applied  retinoic  acid,  a  metabolite  of  vitamin  A.  The  investigators  argued 266 
against the use of the EAE model because of potential modulatory effects of the 
therapeutic substance on the immune mediated process.  
 
Furthermore  any  remyelination  enhancing  therapies  investigated  in  a 
systemically  induced  chronic  demyelination  using  a  toxin  as  for  example 
cuprizone (Torkildsen et al., 2008) must also be interpreted with caution, since 
chronic intoxication may also have not only adverse effects on oligodendrocytes 
but also on all other cells in the CNS.  
 
Bearing  in  mind  the  caveat  that  OPCs  in  the  #72  mouse  harbour  a  genetic 
abnormality,  data presented in this thesis suggest the chronically demyelinated 
(as defined earlier) #72 mouse may represent a useful tool for testing myelin 
enhancing therapies. With respect to this aspiration, this model has a number of 
strengths.  First,  demyelination  occurs  spontaneously,  obviating  surgical  or 
immunological intervention. Secondly, the background in which the reparative 
process should take place is less complex than in the EAE model, making the 
interpretation  more  straightforward.  Thirdly,  the  stereotypic  temporal  and 
spatial progression of demyelination in this model facilitates the assessment of 
effect.  
 
6.2  In vitro systems to investigate cell intrinsic pathways 
 
The integrity of the OPC is an important prerequisite for successful repair and 
any disturbance to OPC intrinsic properties could result in remyelination failure. 
Although it has been shown that Plp1 gene overexpression in oligodendrocytes 
leads to a sequestration of PLP to endosomes, lysosomes and autophagosomes, 
which results in an impaired intracellular transport of myelin proteins to the 
myelin sheath, the effect on OPCs is not understood (Karim et al., 2007;Karim et 
al., 2010). PLP/DM20 has not been identified in adult OPCs to date, but there is 
evidence  that  OPCs  transiently  express  Dm20  mRNA  and  DM20  protein  during 
embryonic  development and  it  has  been  suggested that  DM20 plays  a  role  in 
normal glial development (Dickinson et al., 1996). Interestingly, overexpression 
of  DM20  leads  to  late  onset  CNS  demyelination  with  astrocytosis  and  a 
lymphocytic infiltration (Mastronardi et al., 1993) similar to the pathology seen 267 
in adult hemizygote #72 mice (Anderson et al., 1998). In the #72 mouse Dm20 
will most likely also be overexpressed. It is not known if adult #72 OPCs express 
DM20, which could potentially impair adult cell function.  Clarification of the 
role of DM20 may render novel information in the development of  Plp1 gene 
overexpression mediated adult demyelination pathology. 
 
In  vitro  studies  provide  an  elegant  way  to  address  questions  regarding  cell 
intrinsic  properties,  in  the  absence  of  confounding  extrinsic  (environmental) 
factors. One confounding factor in the cell culture experiment that I performed 
was  contamination  by  microglia.  Although  a  co-culture  system  was  utilised, 
where wild type and #72 adult OPCs were exposed to the same environment, 
microglia might secrete substances such as free radicals to which the #72 OPCs 
could  potentially  be  more  susceptible  than  the  wild  type.  The  magnetic  cell 
sorter  technique,  as  described  in  (Windrem  et  al.,  2008),  could  provide  a 
relatively simple solution to avoid unwanted cell contamination. However, adult 
OPCs are relatively sparse and my initial attempts to use a magnetic cell sorting 
system  failed.  For  the  same  reason,  FACS  sorting  of  adult,  corpus  callosum 
derived OPCs is impractical.   
 
Most of the published work on cultured OPCs used neonatal animals as a source 
(Dietrich et al., 2006;Huang et al., 2011;Pang et al., 2005;Syed et al., 2008). 
The OPC yield from neonatal mouse is considerably higher than from the adult. If 
a higher yield of adult OPCs could be obtained, experiments involving immuno-
precipitation, western blot quantification and protein turnover could potentially 
provide more detailed information about protein-protein interaction and protein 
integrity  during  OPC  differentiation.  Also,  after  successful  purification  of 
sufficient number of OPCs in vitro, microarrays (DNA, RNA, protein and cytokine 
arrays) could be applied to screen for candidate molecules that could explain 
the OPC differentiation block observed in the #72 mouse.   
 
The results of this study should help inform hypotheses regarding putative OPC 
intrinsic  factors  that could influence  remyelination  failure in the  #72  mouse. 
Candidates identified using microarray could then be verified using a cell culture 
model of myelination such as a myelinating culture (Thomson et al., 2006) or a 
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manipulated  (i)  pharmacologically  (ii)  using  RNA  interference  and  (iii)  by 
transfection, to examine the consequence for myelination and/or remyelination 
of the up- or down-regulation of specific gene products, providing a relatively 
inexpensive, high-throughput screen.  
 
Recently the regulatory role of specific microRNA during (re)myelination, miR-
219  and  miR-338,  by  suppressing  OPC  differentiation  inhibitors,  has  shown  a 
further cell intrinsic (re)myelination control mechanism (Zhao et al., 2010). The 
role of microRNA in Plp1 gene overexpression has not been elucidated so far and 
would definitively be warranted to be further explored in the #72 mouse.  
 
More insight into the OPC function may be gained from culture of brain slices 
(Zhang et al., 2011). The advantage of tissue culture compared to cell culture is 
the  inclusion  of  the  OPC  extrinsic  compartment  including  oligodendrocytes, 
axons,  astroglia  and  microglia.  Tissue  culture  also  allows  the  possibility  to 
evaluate myelination and monitor remyelination after demyelination and may 
provide the opportunity to test remyelination enhancing substances. I obtained 
preliminary results from #72 brain slice cultures containing the corpus callosum 
and the brain stem (data not shown). The development of corpus callosum slices 
was  satisfactory  but  some  unexpected  axonal  damage  appeared  after 
lysolecithin induced demyelination, making the interpretation of (re)myelination 
difficult.  However,  complement  induced  demyelination  appeared  to  be  more 
successful  (in  collaboration  with  Dr.  Ariel  Arthur  from  the  Linington  lab, 
University  of  Glasgow)  and  may  offer  an  opportunity  to  evaluate  the 
remyelination dynamics and capacity on #72 brain slices. A further advantage of 
tissue culture is the high throughput of relatively large quantities of tissue which 
can  be  used  for  morphometric  analysis  or  for  microarray  screening  before, 
during and after demyelination.  
 
A major drawback with the culture technique is that so far adult brain slices do 
not  survive  in culture  for prolonged periods  and  the  method appears only  to 
work when using neonatal tissue. In my case neonatal tissue does not mimic the 
chronically  demyelinated  CNS  and  results  obtained  in  context  with  the 
remyelination  process  in  slice  culture  may  not  be  extrapolated  to  the  adult 
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6.3  Evaluation  of  OPC  extrinsic  changes  in  relation  to 
remyelination failure 
 
6.3.1 The  role  of  the  microglial/macrophage  response  in  the 
pathogenesis of remyelination failure in the #72 mouse 
 
The role of the profound microglial/macrophage response in the #72 mouse is 
also  of  interest  in  the  development  of  the  demyelination  and  remyelination 
failure pathology. 
 
The role of the inflammatory response in myelination and remyelination is in 
general controversial. There is evidence that acute inflammation is beneficial 
for the remyelination process (Foote and Blakemore, 2005a). On the other hand, 
excessive inflammation most likely generates a hostile environment for cells to 
survive. In the adult and neonate #72 the inflammation appeared not to injure 
transplanted  neuronal  stem  cells,  despite  the  fact  that  the  inflammatory 
response  probably  contributes  to  the  progression  of  demyelination,  as 
demonstrated  in  another  Plp1  overexpressing  line  (Ip  et  al.,  2006;Ip  et  al., 
2007).  
 
The intravenous application of neuronal stem cells may represent an alternative, 
less invasive way to promote repair (Pluchino et al., 2003). On the other hand 
even this approach renders difficulties in interpretation since another study has 
shown an indirect disease modulating effect in EAE without tissue integration of 
the  systemically  applied  stem  cells  (Einstein  et  al.,  2006).  Just  recently  the 
beneficial  effect  of  macrophages  in  globoid  cell  leukodystrophy  was 
demonstrated (Kondo et al., 2011) and further experiments aimed directly at 
reducing  the  inflammatory  response,  using  for  example  corticosteroid  or 
minocycline, may also help to determine if the inflammation in the #72 corpus 
callosum promotes or inhibits (re)myelination. 
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6.3.2 The extracellular matrix – impact on myelin repair and beyond 
 
It is possible that accumulation of hyaluronan contributes to the remyelination 
failure in the #72 mouse. Further evaluation of the role of hyaluronan in the #72 
corpus  callosum  needs  to  be  addressed  by  for  example  quantitative 
measurement of hyaluronan using western blot techniques and a metabolic and 
secretory  assessment  of  the  astrocytic  population,  the  cell  population 
predominantly  responsible  for hyaluronan synthesis  in  the CNS.  The effect  of 
hyaluronan  on  remyelination  inhibition  could  also  be  evaluated  in  vivo  by 
injecting  hyaluronidase  into  the  adult  #72  corpus  callosum  with  subsequent 
evaluation  of  the  (re)myelination  response.  The  entire  group  of 
glycosaminoglycans  are  of  interest,  especially  chondroitin  sulphate 
proteoglycan, which has been shown to interfere with axonal regeneration after 
trauma  (Massey  et  al.,  2006;Garcia-Alias  et  al.,  2009).  ABC  chondroitinase, 
which  breaks  down  glycosaminoglycans,  enhanced  axonal  growth  leading  to 
improved  recovery  if  applied  in  combination  with  task  specific  rehabilitation 
exercises (Wang et al., 2011). Since trauma not only causes axonal damage, but 
also damages the myelin sheath, it may be of interest to evaluate the extent, 
and  the  clinical  impact,  of  myelin  repair  following  trauma.  Based  on  the 
negative  influence  of  hyaluronan  on  myelin  sheath  repair,  it  may  also  be  of 
interest  to  investigate  if  hyaluronan  has  a  negative  impact  on  axonal 
regeneration after trauma.  
 
6.4  Axonal  pathology  as  a  consequence  of  Plp1  gene 
overexpression 
 
Data from this study and a previous study by (Edgar et al., 2010) demonstrated a 
progressive development of axonal swellings in the #72 mouse. In the optic nerve 
it  has  been  shown that  the presence  of  axonal  swellings  correlated  with  the 
microglial/macrophage response. This also seems to be the case in the corpus 
callosum,  where  an  increasing  microglial/macrophage  response  was 
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demonstrated  that  some  of  these  swellings  occur  on  otherwise  intact  axons 
(Edgar et al., 2011). 
 
In  the  study  by  (Edgar  et  al.,  2010)  there  was  virtually  no  axonal  pathology 
present in the chronic demyelinated retinal region of the optic nerve. This is in 
contrast to MS lesions where a progressive axonal degeneration due to long term 
demyelination is believed to be the main cause of permanent disability after 
demyelination.  Interestingly  activation  of  microglia  has  been  suggested  to 
mediate  axonal  pathology  in  EAE,  with  the  main  evidence  for  this  being  a 
reduction  in  axonal  injury  in  mice  treated  with  minocycline  (Howell  et  al., 
2010). Treating the #72 mice with minocycline could render further insight into 
the  development  of  axonal  pathology  in  relation  to  microglial  activation 
associated  with  spontaneous  demyelination.  However,  reducing  the 
inflammatory  cell  response  would  most  likely  also  lead  to  reduced 
demyelination, which could lead to a decrease in axonal damage. This makes it 
difficult to dissect the single components possibly involved in axonal pathology. 
 
6.5  The use of stem cells in long term myelin repair 
 
This  study  demonstrated  the  proof-of-concept  that  early  intracranial 
transplantation of multipotent neuronal stem cells potentially can replace the 
defective  endogenous  oligodendrocyte  population.  While  I  showed  that 
neurospheres  survive,  integrate,  myelinate  and  form  an  apparently  stable 
population  of  oligodendrocytes  after  transplantation  into  neonate  #72  mouse 
brains,  the  procedure  did  not  rescue  the  phenotype  despite  the  quite 
remarkable sizes of these patches of remyelination. Also the fate of transplanted 
cells other than myelin forming oligodendrocytes, which is unknown at present, 
could provide more insight into the distribution of the transplanted cells and to 
monitor  if  the  transplanted  cells  also  replace  the  genetically  defective  OPC 
population  in  the  subventricular  zone.  One  possible  method  to  address  this 
would be to transplant neuronal stem cells permanently expressing a fluorescent 
marker (such as GFP) into neonate mice. The fate of the transplanted cells could 
be characterised after constructing a #72 chimera, in particular to investigate if 
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6.6  Diffusion weighted imaging in myelin disorders 
 
DW MRI is increasingly being used to evaluate white matter changes in vivo, non-
invasively (Budde et al., 2009;Harsan et al., 2006;Harsan et al., 2008;Song et 
al.,  2002;Song  et  al.,  2005).  The  modification  of  DW  MRI  by  adding  multiple 
increasing b-values, as in this study, showed that it enhances the sensitivity to 
detect demyelination and inflammation. Using multiple increasing b-values may 
therefore  improve  the  diagnostic  accuracy  of  DW  MRI  for  the  detection  of 
specific white matter lesions. An experiment using multiple higher b-values has 
recently been performed in shaking pups in vivo (Wu et al., 2011). Although the 
study did not investigate the pathological changes as detailed and not the same 
diffusion parameters were calculated as I did, Wu et al. showed that from a 
technical point of view, DW MRI with multiple increasing b-values is possible in 
vivo. A further step would involve  the performance of similar experiments  in 
vivo in order to verify the changes seen in my experiment using fixed tissue and 
in order to rule out any fixation related influence.  
 
At the moment I have not evaluated the role of axonal changes in DW MRI with 
multiple increasing high b-values in detail. To further analyse the influence of 
changes  in  axonal  integrity  on  diffusion,  the  experiments  undertaken  in  this 
study could be repeated in wild type and #72 mice, subsequent to optic nerve 
crush.  
 
6.7  The use of demyelinating models in investigating psychiatric 
disorders 
 
Changes in myelin integrity recently demonstrated in psychiatric disorders such 
as  schizophrenia,  point  to  a  potential  central  role  of  myelin  integrity  and 
distribution  in  the  development  of  these  diseases  (reviewed  in  Davis  et  al., 
2003).  Schizophrenia  is  a  severe  psychiatric  disorder  where  an  impaired 
connectivity  between  brain  regions  is  regarded  as  the  main  abnormality 
(reviewed  in  Davis  et  al.,  2003).  Interestingly,  in  certain  demyelinating 
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extent  multiple  sclerosis  (MS),  patients  may  also  develop  schizophrenic-like 
symptoms (reviewed in Davis et al., 2003), emphasising the role of myelin in 
cognitive (dys)function.  
Two month old heterozygote 4e mice (another Plp1 overexpressing line), where 
mild demyelination of major white matter tracts in the spinal cord, brainstem 
and corpus callosum was present, were reported to develop schizophrenic-like 
behavioural  changes  (Tanaka  et  al.,  2009).  The  increased  awareness  of  the 
myelin related changes in the pathogenesis of schizophrenia, and the need for 
models involving spontaneous demyelination in order to study these disorders, 
means  that  the  #72  model  may  also  be  useful  for  studying  the  influence  of 
spontaneous demyelination on schizophrenic-like symptoms. 
 
6.8  Summary  
 
In short, the Plp1 gene overexpressing #72 mouse, a model of PMD, is useful for 
future  investigation  into  the  development  and  treatment  of  chronic 
demyelination  and  remyelination  failure.  Novel  stem  cell  transplantation 
strategies  for  white  matter  diseases  that  progress  into  debilitating  chronic 
demyelination can furthermore be evaluated using the #72 model. Additionally 
the #72 model has raised relevant questions about the influence of Plp1 gene 
overexpression  on  adult  OPC  function  and  integrity.  Due  to  the  endogenous 
mediated microglial changes, the model also allows us to investigate the role of 
microglial activation in demyelination and remyelination pathology and on the 
effect on axonal integrity. This study has also shown that standard and modified 
DW  MRI  with  multiple  b-values  may  serve  as  a  molecular  probe  to  evaluate 
myelin pathology and may become an important technique in diagnostic imaging 
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7  Appendix 
 
7.1  Fixatives 
 
7.1.1 Periodate lysine paraformaldehyde  
Preparation of ingredients for 1000ml of PLP fixative 
Buffered lysine solution: 
    13.7g lysine monohydrate in 375ml distilled water 
    1.8g sodium hydrogen phosphate in 100ml distilled water 
    Mix the two solutions to give 475ml buffer, pH7.4 
   
10% paraformaldehyde: 
    20g paraformaldehyde in 250ml distilled water 
    Heat to 65 C 
      Add a few drops of 1M NaOH until solution clears 
      Allow to cool under running water 
      Filter solution   
The two solutions can be stored at 4 C separately overnight if necessary.  
Immediately before use of PLP fixative, the two solutions were mixed and made 
up  to  a  final  volume  of  1  litre  using  0.1M  phosphate  buffer.  2.14g  sodium 
periodate was added and allowed to dissolve. Ready PLP fix cannot be stored 
overnight. 
 
7.1.2 4% Paraformaldehyde in PBS 
For 500ml of fixative 
25 g paraformaldehyde made up to 500 ml with PBS 
Heat to 65 C 
Add a few drops of 5m NaOH until solution clears 
Cool solution under running water 
Filter solution  
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7.1.3 Karnovsky’s  modified  fixative  (paraformaldehyde  / 
glutaraldehyde 4% / 5%) 
 
Preparation of ingredients for 500ml of fixative 
  8% paraformaldehyde 
    20g paraformaldehyde in 250ml distilled water 
    Heat to 65 C 
    Add a few drops of 1M NaOH until solution clears 
    Cool solution under running water 
    Filter solution 
    0.08M cacodylate buffer 
    17.1224g sodium cacodylate in 1 litre of distilled water 
    Adjust pH to 7.2 
  25% glutaraldehyde 
   
For 500ml Karnovsky’s modified fixative mix 
250ml 8% paraformaldehyde 
  100ml 25% glutaraldehyde 
  150ml 0.08M cacodylate buffer 
  250mg Calcium chloride 
Filter the solution, adjust to pH 7.2 and store at 4 C 
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7.2  Tissue Processing 
 
7.2.1 Resin processing 
 
Perfusion  fixed  tissue  was  passed  through  the  following  protocol  before 
embedding in resin: 
Via
l 
Solution  Time  Temp  Comments 
1  Na-cacodylate buffer
1  50 min  4°C 
 
2 
1%  Osmium  tetroxide  (OsO 4) 
in 
cacodylate buffer 
2 hrs. 
Room 
Temperatur
e 
(RT) 
toxic,  add 
vial  just 
shortly 
before 
needed, 
remove after 
use  &  pour 
into corn oil 
3  Na-cacodylate buffer  30 min  RT 
 
4  50% Ethanol  5 min  RT 
 
5  50% Ethanol  10 min  RT 
 
6  70% Ethanol  5 min  RT 
 
7  70% Ethanol  10 min  RT 
 
8  80% Ethanol  5 min  RT 
 
9  80% Ethanol  10 min  RT 
 
10  90% Ethanol  5 min  RT 
 
11  90% Ethanol  10 min  RT 
 
12  100% Ethanol  5 min  RT 
add vial just 
shortly 
before 
needed,  fill 
to  20ml 
(evaporation
) 277 
Via
l 
Solution  Time  Temp  Comments 
13  100% Ethanol  10 min  RT 
add  vial  just 
shortly 
before 
needed,  fill 
to  20ml 
(evaporation
) 
14  Propylene oxide  15 min  RT 
add  vial  just 
shortly 
before 
needed,  fill 
to  20ml 
(evaporation
) 
15  Propylene oxide  15 min  RT 
add  vial  just 
shortly 
before 
needed,  fill 
to  20ml 
(evaporation
) 
16 
1:2  araldite
2:propylene oxide 
change to fresh vial same slot 
1:1 araldite:propylene oxide 
13  hrs.  &     
6 hrs. 
RT 
 
17  2:1 araldite:propylene oxide  18 hrs.  RT 
 
18  araldite 
4  hrs.  15 
min 
RT 
 
After the procedure, processed tissue samples were placed in resin filled silicon 
moulds and left to polymerise for 24 hours at 60 C. 
 
1Isotonic cacodylate buffer 
16.05g   sodium cacodylate 
3.8g     sodium chloride 278 
0.055g   calcium chloride 
0.102g   magnesium chloride 
Dissolve in 1 litre distilled water and adjust pH to 7.2 
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2Araldite Resin 
30g   araldite (CY212)          resin 
25.2g  dodecanyl succinic anhydride      hardener 
1.2ml  2,4,6-tri-diethylaminomethyl-phenol    accelerator 
1.0ml  di-butyl phthalate          plasticiser 
 
7.3  Staining protocols 
 
7.3.1 Immunohistochemistry  using  methanol  for  cell  membrane 
penetration 
1  PBS  10 min  RT 
2  Methanol -20  C  10 min  freezer 
3  PBS  10 min  RT 
4  block  with  PBS 
containing  10% 
normal goat serum  1 hr.  RT 
5  remove  excess  and 
apply  primary 
antibody  in 
PBS/10% NGS  12 hrs.  fridge 
6  PBS x3  3x10 min  RT 
7  apply  secondary 
antibody  in 
PBS/10% NGS  1 hr.  RT 
8  PBS x3  3x10 min  RT 
9  DAPI  in  PBS 
(1:1500)   1 min  RT 
10  PBS  5 min  RT 
11  running water  5 min  RT 
12  coverslip  with 
glycine in PBS     RT 
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7.3.2 Immunohistochemistry  using  Triton-X  100  for  cell  membrane 
penetration 
1  PBS  10 min  RT 
2 
block  with  PBS 
containing  10% 
normal  goat  serum 
and  0.5%  Triton-X 
100 
1 hr.  RT 
3 
remove  excess  and 
apply  primary 
antibody  in 
PBS/10%  NGS  0.5% 
Triton-X 
12 hrs.  Fridge 
4  PBS x3  3x10 min  RT 
5 
apply  secondary 
antibody  in 
PBS/10%  NGS  and 
0.5% Triton-X 
1 hr.  RT 
6  PBS x3  3x10 min  RT 
7 
DAPI  in  PBS 
(1:1500) 
1 min  RT 
8  PBS  5 min  RT 
9  running water  5 min  RT 
10 
cover with coverslip 
containing  glycine 
in PBS 
 
RT 
 
7.3.3 X-gal staining  
 
Either freshly perfused and cryoprotected 1mm thick brain samples or 10 and 
20µm thick mounted cryosections were post fixed for 10 minutes on ice in 4% 
paraformaldehyde. The samples were then washed twice for 10 minutes on ice 
using fresh 2mM MgCl2/PBS solution followed by a 10 minute treatment with a 281 
detergent solution containing 1mM MgCl2 (Sigma), 0.01% sodium desoxycholate 
(Sigma)  0.02%  NP40.  The  samples  were  then  immersed  or  covered  for  three 
hours  at  room  temperature  with  the  X-gal  staining  solution  containing  20mM 
K3Fe(CN)6,  20mM  K4Fe(CN)6  3H2O,  2mM  MgCl2,  0.01%  sodium  desoxycholate, 
0.02% NP40 and X-gal at a final concentration of 1 mg/ml in PBS pH 7.4. Finally 
the samples were washed three times for 10 minutes in PBS and once in water 
for five minutes 
 
7.3.4 Staining for electron microscopy 
 
1 
saturated  uranyl 
acetate  in  50% 
ethanol 
15 min  RT 
2  50% ethanol  Rinse  RT 
3  50% ethanol  Rinse  RT 
4  distilled water  Rinse  RT 
5  distilled water  Rinse  RT 
6  air dry 
   
7 
Reynolds’s  lead 
citrate
1  (Sodium 
hydroxide 
moistened 
chamber) 
10 min  RT 
8 
1M  sodium 
hydroxide 
Rinse  RT 
9 
1M  sodium 
hydroxide 
Rinse  RT 
10 
1M  sodium 
hydroxide 
Rinse  RT 
11  distilled water 
several 
rinses 
RT 
 
1Reynold’s lead citrate (1.2mM lead citrate, 1.8mM sodium citrate, pH12) 1.33g 
lead citrate dissolved in 15ml distilled water for 1 min. Shake vigorously 1.76g 282 
sodium  citrate  dissolved  in  15ml  distilled  water  for  1  min.  Shake  vigorously. 
Combine the solutions and equilibrate over 30 minutes with occasional shaking. 
Clear with 1M NaOH. Make up a final volume of 50ml adding distilled water. 
 
7.4  Staining solutions 
 
7.4.1 Methylene blue / azur II 
 
1%  methylene blue 
1%  azur II 
1%  borax 
In distilled water. Filter before use. 
 
7.5  Media for cell culture 
 
7.5.1 Differentiation media with insulin (50 ml) 
 
48.85  ml  DMEM  (Gibco  31885-023)  containing  2.5  ml  Penicillin/  Streptomycin 
(Gibco, 15070-022) per 500ml DMEM 
0.583 ml 30% glucose (Sigma, G-7021) 
0.25ml of 10µM hydrocortisone (Sigma, H-0396) 
0.25 ml N1 mix  
1 ml insulin (human, recombinant, Sigma I-2767) 
50µl biotin (Sigma, B-4501) 
 
7.5.2 N1 mix (25ml) 
 
In PBS with a final concentration of  
1 mg/ml transferrin (Sigma, T-2252) 
16.11 mg/ml putrescine (Sigma, P-7505) 
4µM progesterone (Sigma P-0130) 
6µM selenium (Sigma, S-9133) 283 
7.5.3 Neurosphere media (50 ml) 
 
250 ml NS medium contains  
38 ml sterile distilled water  
5 ml 10x DMEM/F12 (GIBCO, 21700-026) 
5 ml N1 mix   
1 ml 30% Glucose 
0.75ml 7.5% NaHCO3 (Sigma, S-5761)  
0.25ml 1M HEPES (Sigma, H-9136) 
0.5ml L-Glutamine (Gibco, 25030-081) 
0.5ml Penicilline/Streptomycine  
0.125ml 4% bovine serum albumin (Sigma, A-3059).   
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8  Abbreviations 
APC:      Adenomatous polyposis coli 
ATP:       Adenosine Triphosphate 
BDNF:     Brain derived neurotrophic factor 
bHLH:     Basic helix-loop-helix 
BrdU:     5-bromo-2-deoxyuridine 
cAMP:     Cyclic adenosine monophosphate 
CASPR:    Contactin associated protein 
CDK:       Cyclin-dependent kinase 
CFP:      Cyan fluorescence protein  
CNP:      2’-3’-cyclic nucleotide-3’-phosphodiesterase 
CNS:       Central Nervous System 
CO2:      Carbon dioxide 
D2:       Deiodinase 2 
DAPI:      4’6-diamidino-2-phenylindol 
DMEM:      Dulbecco’s modified Eagle’s medium 
DNA:      Deoxyribonucleic acid 
DNase:    Deoxyribonuclease   
DTI:       Diffusion Tensor Imaging 
DW MRI:     Diffusion weighted MRI 
EAE:       Experimental autoimmune encephalitis  
EGF:       Epidermal growth factor  
EM:       Electron Microscopy   
FGF:      Fibroblast growth factor 
FISH:        Fluorescence in situ hybridisation  
FITC:      Fluorescein isothiocyanate 
GalC:      Galactocerebrosides 
GFAP:     Glial fibrillary acidic protein 
GFP:       Green fluorescence protein 
Golli-MBP:     Gene of oligodendrocyte lineage myelin basic protein 
HABP:       Hyaluronan binding protein 
HDAC:     Histone deacetylase 
HIFBS:     Heat inactivated foetal bovine serum  
HMW:      High molecular weight 285 
IGF-1:     Insulin growth factor 1  
IGFBP-2:     Insulin-like growth factor binding protein 2  
IGFR-1:     Insulin-like growth factor receptor 1 
IL6:       Interleukin 6 
iNOS:      Inducible nitric oxide synthase   
IPL:       Intraperiod line 
LINGO1:    Leucine rich repeat and Ig domain containing 1 
LMW:      Low molecular weight 
MAG:      Myelin associated protein 
MBP:      Myelin basic protein 
md rat:     Myelin deficient rat 
MDL:      Major dense line 
MHCII:     Major histocompatibility complex II 
microRNA:     Micro ribonucleic acid  
MOBP:     Myelin associated oligodendrocytic basic protein 
MOG:      Myelin/oligodendrocyte protein 
MRI:       Magnetic Resonance Imaging 
mRNA:    Messenger ribonucleic acid 
MRS:       Magnetic resonance spectroscopy 
MS:       Multiple Sclerosis 
MTC:      Monocarboxylase transporters 
MTI:       Magnetisation transfer imaging 
NAA:       N-acteylaspartate  
NF155:     Neurofascin 155 
NG2:      Neuronal/glial 2 
NGS:       Normal goat serum 
NO2:      Nitrogen dioxide 
NRG1:     Neuregulin 1 
NRG1-III:    Neuregulin 1 – III 
NS:       Neurosphere  
NTIS :       Non-thyroidal illness syndrome 
O2:      Oxygen 
OCT:        Optimal cutting temperature compound 
Olig1:     Oligodendrocyte transcription factor 1 
Olig2:     Oligodendrocyte transcription factor 2 286 
OMpg:     Oligodendrocyte myelin glycoprotein 
OPC:      Oligodendrocyte Precursor Cell 
OSP:       Oligodendrocyte specific protein 
P120:      120 days post-partum 
PBS:      Phosphate buffered saline 
PDGF:     Platelet derived growth factor 
PDGFRα:     Platelet derived growth factor receptor α 
PLP fixative:     Periodate – lysine – paraformaldehyde 
PLP/DM20:     Proteolipidprotein 
Plp1 gene:     Proteolipidprotein 1 gene (mouse) 
PLP1:      Proteolipidprotein gene 1 (human) 
PMD:      Pelizaeus – Merzbacher – Disease 
PNS:       Peripheral Nervous System 
PSA NCAM:     Polisialylated acid form of neuronal cell adhesion molecule 
r.p.m:     Rounds per minute 
Rb:       Retinoblastoma 
SPG2:     X-linked hereditary spastic paraplegia 
T3:      Thriiodothyronine     
T4:      Thyroxin   
Tcf4:      Transcription factor 4 
TGF-β:    Transforming growth factor β 
TGFβ-1:     Transforming growth factor β1 
Thy1:     Thymocyte differentiation antigen 1 
TLR-2:     Toll-like receptor 2 
TMEV:      Theiler’s murine encephalomyelitis virus  
TNFα:     Tumour necrosis factor α 
TRH:       Thyroid releasing hormone 
UPR:       Unfolded protein response 
UV:       Ultra violet   
X-ALD:     X-linked adrenoleukodystrophy 
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